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Summary of Thesis 
 
Clinicians are ‘medical knowledge experts’ who can use their training, their experience, and 
evidence based medicine to diagnose and determine healthcare options available to 
patients, but patients are ‘personal preference experts’.  Shared decision-making (SDM) 
depends on the combination of the different clinician and patient expertise, but to date 
efforts to increase SDM have largely not addressed how to enable patients to contribute 
their expertise to the process.  The work in this thesis describes the development and pilot-
testing of a theory-based intervention, which aims to prepare patients to participate in 
SDM.  
Development and pilot-testing was guided by the MRC’s framework for developing 
complex interventions.  A systematic review revealed patient-reported barriers and 
facilitators to participating in SDM (key barriers included knowledge and perceived power 
imbalance) and a literature review found that existing interventions do not sufficiently 
address patient-reported barriers; thus there was scope to develop on more comprehensive 
theory-based intervention.  
The Behaviour Change Wheel guide was used to develop a theory-based intervention: an 8-
page booklet entitled ‘Your Health, Your Choice’. Pre-testing with lay users, clinicians and 
organisational representatives revealed positive responses to the booklet’s key messages 
and design. Preliminary pilot-testing in a breast care setting showed evidence of high reach, 
dose and usage, and potential for the intervention to change patients attitudes towards the 
patient role in consultations (i.e. should patients be involved in SDM). However, the booklet 
had less impact on patients’ perceptions of whether clinicians want patients to become 
more involved (i.e. would patients be able to become involved.)  
Overall, preliminary findings suggest that the intervention could be a useful tool for 
preparing patients for SDM and for changing patients’ attitudes towards patient 
involvement. However, preparation for SDM must be followed by enablement by willing 
and skilled clinicians, and delivered within a supportive organisation.  
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Chapter 1 
‘Nobody knows me better than me’:               
Thesis introduction and overview 
‘It is much more important to know what sort of a patient has a disease than 
what sort of a disease a patient has.’ 
Sir William Osler 
Clinicians are ‘medical knowledge experts’ who can use their training, their experience, and 
evidence based medicine to diagnose and determine healthcare options available to the 
patient, but patients are ‘personal preference experts’.  Shared decision-making (SDM) 
depends on the combination of the different clinician and patient expertise, but to date 
efforts to increase SDM have largely not addressed how to enable patients to contribute 
their expertise to the process.  Further, SDM does not appear to be happening routinely in 
NHS settings in the UK, or anywhere else in the world.  
Even as early as the 19th Century, Sir William Osler understood and educated medical 
students in the importance of understanding the ‘whole patient’. His revolutionary bedside 
teaching techniques focused on interacting with and ‘knowing the patient’, achieved in part 
by taking a good history, effective observations of the patient, and asking the patient the 
right questions. Although he would not have been aware of this at the time, his quote 
above also underpins the philosophy of SDM. At the simplest level, SDM is defined a 
process whereby clinicians support patients to make healthcare decisions by providing 
them with evidence-based information about their options, eliciting and understanding the 
patient’s personal circumstances and preferences, and making sure that this knowledge is 
considered when supporting patients to choose from various different healthcare 
options.(1) If we do not understand what sort of patient we are working with, we will not 
know that the treatment they receive for their condition is right for them. Unfortunately, 
many healthcare professionals still focus predominantly on the disease and skills of 
diagnosis, not on the ‘whole patient’, skills of communication and interaction, or skills of 
diagnosing preferences.(2)  
If understanding the patient and their preferences is key to the success of the SDM 
process, the same understanding is also essential when we are trying to design the best ways 
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to implement and support this process. Patients are key partners in SDM - unfortunately, 
little attention has been paid to what patients think would help or inhibit them from 
participating in the SDM process during intervention design and implementation. To date, 
research has focused on understanding and overcoming clinician perceived barriers to 
SDM implementation, understanding and addressing organisational restraints, and 
developing information provision tools for patients.  This thesis will attempt to address this 
gap by developing a patient-targeted complex intervention to prepare patients for SDM 
with clinicians, based primarily on patient-reported barriers and facilitators to engaging 
with the SDM process.  
1.1  From ‘Doctor knows best’ to ‘nobody knows me better 
than me’ 
It is evident from Sir William Osler’s quote above that some physicians have long 
recognised the importance of interacting with patients and understanding the patient as a 
whole. Despite this, the predominant model for doctor-patient interaction during much of 
the 20th Century was paternalistic.(3) The paternalistic approach has been classified as 
‘activity-passivity’, whereby a clinician does something to the patient who is a passive 
recipient, and as ‘guidance-co-operation’, whereby a clinician tells the patient what to do, 
and the patient co-operates, or obeys.(4). The paternalistic model is hierarchical in nature, 
with the clinician placed in a position of power relative to the patient, and the patient does 
not challenge this authority. In this scenario, the clinician acts as guardian over the agent, 
they set the goals and agenda of the consultation, they dominate decision-making, and they 
assume patients’ preferences; (5, 6) however, it is trusted that the clinician acts on behalf of 
the patient in their best medical interests.  
Medical beneficence remained largely unchallenged for most of the 20th Century, and it is 
only relatively recently that the principle of patient autonomy has emerged as the dominant 
ethos in healthcare. We have witnessed a move away from the predominant biomedical 
model in healthcare, where the focus is on understanding the medical condition or disease, 
to a patient-centred model, which treats the patient as an individual by considering his or 
her own ‘biography’.(7) In his book ‘The Lost Art of Healing’, Lown states, ‘medicine is 
the art of engagement with the human condition rather than with the disease.’(8) He 
believes the most important art in healing is developing the fundamental relationship 
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between doctor and patient, and the skill of listening to the patient should not be 
understated in medical education.  
Since the 1960s and 1970s, within the social context of various anti-paternalistic rights 
movements demanding greater autonomy, patients’ rights to autonomy and consent have 
been recognised.(9) In the late 1980s, informed medical consent was increasingly being 
recognised as a legitimate right for all patients, where all patients were legally entitled to 
receive information about treatment or screening procedures before consenting. Originally, 
informed consent requirements were primarily concerned with avoiding harm, but more 
recently they have been concerned with the protection of autonomous patient choice.(10) 
The Patient’s Charter was published in 1991,(11) which highlighted several patients’ rights 
in the UK Government’s National Health Service (NHS). One of these includes the ‘right 
to be given a clear explanation of any treatment proposed, including risks and any 
alternatives before you decide whether you will agree to the treatment’. Each nation in the 
UK also published their own version of the Patient Charter. The Welsh Charter took the 
promotion of patient autonomy one step further by stating that patients may expect ‘to 
help choose care and treatment’ that was appropriate to them. Further, it encourages 
patients to ‘try to be well informed about your health condition’ and to ‘ask questions so 
you can make decisions based on better knowledge and understanding’.  
The consumerism approach emerged around this time and was strongly advocated 
throughout health policy. In this approach, the typical power relationship between patients 
and clinicians is reversed, and the medical encounter is viewed as a marketplace 
transaction.(5) In relation to healthcare decision-making, the promotion of consumerism 
translated to the informative model,(6) also referred to as the informed decision-making 
model. (12) In short, this interaction involves the clinician providing the patient with all 
relevant information about their health state and the different options available, the patient 
making the decision (presumably by also considering their personal values), and the 
clinician executing the desired course of action. Patient autonomy in this model is 
conceptualised as the patient having complete control over the decision-making process.(6) 
Although the consumerist approach recognises the importance of patients’ preferences and 
autonomy in decision-making, some believed that this approach swung too far in the other 
direction from paternalism; the informed choice model leaves the clinician outside the 
decision-making process and limits their role to information transfer.  
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In response to this, healthcare writers increasingly advocated a model of ‘mutual 
participation’ in the clinical encounter, where both the clinician and the patient share 
decision-making responsibility and share power.(6) This ‘deliberative model’,(6) or ‘shared 
decision-making’(SDM) model as it is now widely referred to,(12) is based on the principles 
of patient-clinician partnership. Various conceptual models of SDM have emerged over the 
years:(1, 6, 12-14) the earliest attempt defines SDM as a process involving at least a 
clinician and patient, who share information and who jointly engage in the decision-making 
process to agree on a decision that is consistent with patient’s personal values and 
preferences.(12) Elwyn and colleagues have published a model for clinical practice, which 
outlines three key steps in the SDM process: 1) introducing choice 2) describing options, 
often by integrating the use of patient decision support, and 3) helping patients explore 
preferences and make decisions.(1) More recent conceptualisations describe SDM broadly, 
as a component of patient-centred care; this most accurately reflects my interpretation of 
SDM throughout this thesis. The model of ‘collaborative deliberation’ describes five 
propositions for collaborative clinical communication processes: 1) constructive 
interpersonal engagement; 2) recognition of alternative actions; 3) comparative learning; 4) 
preference construction and elicitation; 5) preference integration.(15) Fundamentally, all 
models of SDM recognise that there are two experts in the healthcare consultation: the 
clinician and the patient. Only when the two types of expertise are combined does SDM 
truly take place. The shift from paternalism to SDM indicates how we have moved, at least 
conceptually, from a position where ‘doctor knows best’, to the patient perception that 
‘nobody knows me better than me’. Although this conceptual transition has taken place, 
this thesis will address current deficiencies in realising this in routine practice.   
1.2 Supporting patients to participate in SDM – the 
implementation context 
Decision support interventions, also known as decision aids, have been developed to help 
individuals participate in healthcare decisions that involve weighing the benefits and harms 
of treatment options, often with scientific uncertainty, or equipoise.(16) They support the 
SDM process with a clinician by providing patients with information about the health 
condition, describing the features of the options, the likely outcomes, and supporting the 
patient to compare the options in relation to their personal values. Pioneer decision aids 
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appeared around 30 years ago, in the form of consultations structured by decision 
analysis,(17) preference elicitation techniques,(18) and the more common SDM 
programmes.(19) Since this time the number of decision support interventions that have 
been developed has increased exponentially, covering a wide range of formats (e.g. paper, 
video, web-based, face-to-face) and over 45 clinical decisions.(16) 
The Cochrane systematic review of decision aids for patients facing health treatment or 
screening decisions now includes 115 randomised controlled trials evaluating the 
effectiveness of decision support interventions.(16) Results show that these tools result in 
increased knowledge, more accurate risk perceptions, greater congruence between 
preferences and option chosen, lower decisional conflict, reduced passivity, and greater 
uptake of conservative treatment options. These tools are widely available, and attempts 
have been made by various healthcare provider organisations, across the world, to integrate 
these into routine clinical practice.  For example, Health Dialog, the USA based healthcare 
service provider, has created a suite of decision support interventions that is available to 
over 13 million of their customers.(20) In the UK, NHS Right Care have over 30 tools 
available in a web-based format to NHS patients.(21)   
In recent years, a supportive policy context has emerged in the UK for the implementation 
of SDM. Following the formation of the Coalition Government in 2010, patient-centred 
care was prioritised in healthcare policy reform, and a number of healthcare strategies have 
outlined their ambitions for more patient-centred healthcare services in the UK (NHS). In 
2010, the UK Government published its White Paper ‘Equity and Excellence: Liberating 
the NHS’.(22) They state a number of key aims in relation to placing patients at the heart 
of the NHS, including giving patients ‘access to the information they want, to make choices 
about their care’, and making ‘shared decision-making the norm: no decision about me 
without me’.  In 2012, the Health and Social Care Act (England)(23) introduced a duty on 
commissioners to promote the involvement of patients in decisions about their care and 
treatment. It is important to note that responsibility for healthcare is devolved to the four 
nations of the UK, and the strategies discussed relate specifically to England. However, 
there is evidence that the healthcare reforms established in England are being replicated 
around the UK, especially with regards to supporting patients with long-term conditions to 
become more involved in self-management of their condition.(24-26) Further, whilst the 
policy context in the UK clearly supports the integration of SDM into routine care, at least 
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at a strategic level, this support is also being demonstrated in other countries, such as the 
USA(27) and Canada.(28)  
In addition to UK healthcare policies promoting SDM, The NHS Constitution(29) sets out 
what patients, the public and staff can expect from the NHS, and what the NHS expects 
from them in return. Importantly, it states key rights as a patient of the NHS, which 
include: the right to make choices about NHS care and to information to support these 
choices; the right to be involved in discussions and decisions about healthcare, and to be 
given information to enable you to do this; and the right to be given information about 
proposed treatments in advance, including any signiﬁcant risks and any alternative 
treatments which may be available, and the risks involved in doing nothing. Royal Colleges, 
such as the Royal College of General Practitioners, the Royal College of Physicians, and the 
Royal College of Nursing, are also exploring how they can support care planning, self-
management and SDM. The General Medical Council, the regulatory body for doctors in 
the UK, have also stated in their Good Medical Practice Guidelines (2013)(30) the 
importance of listening to patients’ preferences, providing information to patients in a way 
they can understand, and respecting a patient’s right to be involved in the decision process. 
The National Institute for Health and Care Excellence (NICE) develop quality standards, 
which are designed to drive measurable quality improvements within specific areas of 
health or care in the UK. They also publish quality statements, and whilst these are not 
mandatory indicators with set targets, they still aim to improve quality of care. One of their 
quality statements is to ensure ‘patients are actively involved in shared decision-making and 
supported by healthcare professionals to make fully informed choices about investigations, 
treatment and care that reflect what is important to them’. (31) This quality statement is 
accompanied by various structural, process and outcome measures that can be used to 
assess quality in this domain.  
Significantly, whilst the rationale for doing SDM once rested upon propositions that the 
approach was ethically correct, it is increasingly being recognised that SDM is also a 
fundamental component in patient safety. Mulley and colleagues(2) discuss the problem of 
‘preference misdiagnosis’, which occurs when patients are not fully informed about the 
options available and they would choose a different option should they be informed.  They 
propose that ‘preference misdiagnosis’ is comparable to the more accepted ‘medical 
misdiagnosis’, and make a compelling case for why SDM is essential for providing safe and 
effective healthcare. Further, SDM has an equally compelling economic imperative. With 
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constrained resources and healthcare systems reaching a state of ‘allocative efficiency’ (i.e. 
unable to make someone better off without making someone worse off), SDM has the 
potential to guide population-level decisions about which services should be commissioned 
or decommissioned, and which should be increased or decreased.(32)  
1.3 Implementation of SDM: have we forgotten that it takes 
‘two to tango’? 
In the current healthcare climate, very few healthcare workers and policy developers argue 
against the principle of involving patients in their own healthcare decisions. Recent 
healthcare policy reforms, outlined above, promote the notion of ‘patients as partners', and 
have also provided a more supportive context for those who wish to implement SDM in 
their organisation. A large number of tools that can help to involve the patient in the SDM 
process exist, and their effectiveness has been demonstrated repeatedly.(16) Despite this, 
SDM does not appear to be happening routinely in NHS settings in the UK, or anywhere 
else in the world.  
A key unanswered question was whether decision support interventions (‘tools’) were 
sufficient on their own to embed SDM into routine clinical care, and to encourage most 
patients to actively participate in the SDM process.  Several implementation projects 
attempted to address this question, including the UK-based Making Good Decisions in 
Collaboration (MAGIC) programme.(33) MAGIC was commissioned by The Health 
Foundation to establish what worked, and what did not work, in embedding SDM into 
primary and secondary care settings. Using quality improvement methodology,(34) the 
MAGIC teams in Cardiff (Wales) and Newcastle (England) worked directly with clinical 
teams across the care spectrum to design and test interventions. These clinical areas 
included, primary care, breast cancer, head and neck cancer, prostate cancer, maternity, 
chronic kidney disease, and paediatric ears, nose and throat.  
Key learning from the programme emphasised the importance of four broad areas: 
engagement, training, tools, and measurement / feedback.(33, 35-37)  Organisational level 
engagement is key to driving cultural change. Senior local health organisation members 
driving SDM as an organisational initiative was important for the MAGIC programme. 
Senior members included the Chief Executive, the Medical Director, and the Director of 
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Patient Experience at the Cardiff and Vale University Health Board. Instead of being seen 
as a University based project that they were being asked, or told, to do, the work was seen 
as a health organisation programme that fitted in with the organisation’s mission statement 
and objectives. This also reinforced the importance of the work to the clinical teams that 
were taking part. Clinical team level engagement and support are also critical if the 
approach is to be adopted and accepted, as is ownership over the interventions that are 
being used; the teams that are still routinely using the interventions, post-implementation 
phase, are those that were heavily involved in the initial design and testing. A dedicated 
SDM facilitator worked directly with the clinical teams, within their clinics, to support and 
motivate the teams through the SDM implementation process. The teams were involved in 
intervention conception, design, and testing, using quality improvement methodology.(34)  
The SDM skills training package delivered to clinicians was a key driver in changing 
clinicians’ attitudes towards patient involvement, and equipped them to work together with 
patients. Significantly, it moved a large number of clinicians from saying ‘we do this already’, 
to saying ‘we could do this better’. The effectiveness of decision support interventions is 
well established,(16) but it became clear during the intervention design phase of the 
MAGIC programme that large, outside-consultation tools, were unlikely to be used by the 
teams, and questions arose over their ability to affect the discussion between the patient 
and clinician in a consultation. In response, the team developed brief in-consultation tools 
called Option Grids.(36) These present the key features of the options against the things 
that matter most to patients; they are designed to support patients to think about their 
options in relation to their own preferences and to encourage dialogue with the clinician. 
Finally, routine measurement (Decision Quality Measure) embedded into the teams also 
motivated clinicians to use the SDM approach, as it gave real-time feedback and enabled 
them to use the information to directly improve patients’ care. 
A key learning point from the MAGIC programme was ‘skills trump tools, but attitudes 
trump skills’. In a follow-up paper, Lloyd et al discuss the challenges of changing the team 
culture and the clinicians’ attitudes.(35) This showed that skills training and decision 
support tools were important interventions, but if you cannot change the attitudes of the 
individuals who are delivering the approach, SDM is unlikely to become embedded, or 
sustained, routinely. It is clear that this implementation programme invested a huge amount 
of energy in trying to understand the clinician and organisational barriers, and developing 
interventions that address these. However, this, and other, implementation programmes 
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have paid little attention to what patients’ feel helps or stops them from being involved in 
healthcare decisions. 
There is good evidence that patients’ attitudinal barriers are hindering progress in 
implementing SDM, and this is a further crucial barrier yet to be overcome.  Even when 
patients are well educated and well informed, many still find it difficult to use this 
knowledge to participate meaningfully in decisions about their healthcare.(38)  The Francis 
report into failings at Mid Staffordshire Trust revealed that patients often feel prohibited 
from speaking up, even when they are extremely concerned about safety or the quality of 
care they are receiving.(39)  Online blogs, publications, and social media campaigns (such as 
#hellomynameis)(40) show that even doctors are not immune to the power imbalance 
when they become patients, feeling that they represent a disease rather than that they are an 
individual, and aware of a pressure to be compliant and passive.(40-42)  How then can we 
expect people to express their preferences about treatment options–especially when they 
often observe doctors assuming that they can act in their best interests, displaying 
unquestioned confidence?  
To exemplify the importance of addressing patients’ attitudes, in addition to clinicians’ 
attitudes and organisational barriers: a decision support tool could exist for every clinical 
decision, in a variety of accessible formats; a SDM discussion could be initiated in every 
relevant consultation by a clinician who is receptive to the approach, who has undergone 
the relevant skills training, and has access to these decision support tools; and the clinician 
initiating SDM could work in an organisation that fully endorses the implementation of 
SDM, by aligning incentives to this approach and ensuring structural barriers are minimal 
e.g. sufficient time available in the consultation for this process. However, if the patient has 
long-standing beliefs, based on experiential experience and perceived social norms, that 
‘doctor knows best’ and that it is not part of a patients’ role to become involved in their 
healthcare decisions, then it will be difficult to engage that patient in the decision-making 
process. It is likely that many patients will still defer the decision-making to the perceived 
‘expert’; the clinician. The information that the patient is given might increase their 
knowledge about their options, but if they do not value the expertise that they bring to the 
decision process and believe they can become involved in making the decision, true SDM is 
unlikely to take place; instead the process will resemble information transfer.  
Various models propose that health literacy is an action-orientated concept, whereby it is 
both a process and an outcome.(43, 44) The Health Literacy Pathway Model(43) describes 
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how health literacy develops in patients over time, moving along a trajectory from 
becoming informed about their condition, learning skills to become more involved, toward 
a point where they become active partners in decision-making process. As patients move 
through this pathway, they also become more empowered. In parallel with the Health 
Literacy Pathway Model,(43) SDM could be seen as a skill that develops, rather than an 
intellectual capability. Patients will become informed about their own specific health 
condition and their options (via information provision, verbal or decision support 
interventions), they will be supported by a clinician to become involved in the process and 
to develop the skills to do so (by considering personal preferences in relation to their 
options), and they will then actively participate in the decision-making process. However, I 
propose that the first essential step in this iterative process is to become aware of what 
SDM is, and what the process involves. This is just as important as, and should precede, 
information provision about treatment options and deliberation, as outlined in the SDM 
model for clinical practice.(1) If the patient does not understand what it means to be 
involved in SDM, and does not accept this approach (e.g. due to perceived social norms 
about involvement), the latter stages of information provision, preference elicitation, and 
active involvement in decision-making are unlikely to take place, or be effective in 
supporting SDM in that person.  
Research suggests that patients with limited health literacy might become ‘disempowered’ 
in a consultation;(43) the same might be true for patients with limited understanding of the 
SDM process. If we offer the opportunity to become involved in SDM during a healthcare 
consultation, without preparation, this affords little time for attitudinal change among 
patients who believe that a paternalistic approach is ‘normal’; in other words, patients are 
being ‘thrown in at the deep end’. If the patient-perceived barriers are not also considered 
during SDM intervention development and implementation, it is unlikely to become the 
norm for most patients, or an approach that becomes embedded into the fabric of 
healthcare organisations. This thesis aims to understand patient-perceived barriers, and to 
develop an intervention that addresses these.  
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1.4 Developing and evaluating theory-based complex 
interventions 
The Medical Research Council (MRC) has produced detailed guidance for the development 
of complex interventions.(45) This framework will be used to guide the development and 
feasibility testing of the intervention that will be described during this thesis. A complex 
intervention is defined as having several interacting components; complexity might relate 
to the range of possible outcomes, their variability in the target population, or the number 
of elements in the intervention package. The framework outlines four key stages involved 
in the systematic development – evaluation – implementation process of a complex 
intervention. The key stages of include: (1) development; (2) feasibility / piloting; (3) 
evaluation; and (4) implementation (see Figure 1.1 for further detail). The developers 
highlight the interactions between the stages and point out that the process will unlikely be 
linear in nature.  
Figure 1.1 Key stages of the MRC framework for developing complex interventions 
 
 
 
 
 
 
 
 
Adapted from Craig et al(45) 
This thesis will focus on the development stage (Chapters 2, 3, 4, and 5) and the feasibility 
/ piloting stage of the framework (Chapter 6). Each stage is described in more detail in the 
relevant thesis chapters. Recently, the MRC published guidelines for process evaluations of 
complex interventions.(46) A process evaluation is defined as a study that aims to 
Feasibility / piloting 
1.  Testing procedures 
2.  Estimating recruitment / retention 
3.  Determining sample size 
Implementation 
1.  Dissemination 
2.  Surveillance and monitoring 
3.  Long-term follow-up 
 
Development 
1.  Identifying the evidence base 
2.  Identifying / developing theory 
3.  Modelling process and outcomes 
  Modelling process and 
Evaluation 
1.  Assessing effectiveness  
2.  Understanding change process 
3.  Assessing cost-effectiveness 
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understand the functioning of an intervention, by examining implementation, mechanisms 
of impact, and contextual factors. The MRC process evaluation framework was used to 
guide the feasibility / piloting stage (see Chapter 6). 
1.5 Thesis aims and objectives 
The aim of this thesis is to develop and pilot-test a patient-targeted complex intervention 
designed to prepare patients for SDM with clinicians, using the MRC frameworks for 
developing and evaluating complex interventions.(45, 46) The objectives of this thesis are:  
1. Identify and describe patient reported barriers to participating in SDM with 
clinicians 
2. Identify previously developed interventions that aim to prepare patients for SDM 
and evaluate if they address patient-reported barriers and facilitators 
3. Develop a theory-based intervention designed to prepare patients for SDM using 
the Behaviour Change Wheel  (BCW) Guide(47) and the MRC Framework for 
developing complex interventions(45)   
4. Pre-test the prototype intervention with lay users and clinicians / organisational 
representatives 
5. Pilot-test the intervention in a Breast Care Centre to assess the potential impact of 
the intervention, using a process evaluation method(46) 
1.6 Thesis overview 
This thesis contains seven further chapters. With the exception of Chapters 7 and 8, each 
chapter contains four main sections: background, methods, results, and discussion.  
Chapter 2 – Patient reported barriers and facilitators to shared decision-making: a 
systematic review and thematic synthesis 
The first key step in developing a complex intervention is to identify the evidence base. 
Chapter 2 systematically reviews patient-reported barriers and facilitators to patient 
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involvement in healthcare decisions. A thematic synthesis identified key barriers and 
facilitators that will need to be addressed by the patient-targeted complex intervention. A 
taxonomy of patient-reported barriers and facilitators is presented.  
Chapter 3 - A review and critical evaluation of patient-targeted interventions designed 
to prepare patients for SDM: do they address patient-reported barriers and 
facilitators?  
Chapter 3 builds on the evidence base from Chapter 2. It presents a literature review of 
existing interventions that aim to prepare patients for SDM. The included interventions 
were evaluated to determine if they address the key patient-reported barriers and facilitators 
identified in Chapter 2.  
Chapter 4 – Using the Behaviour Change Wheel Guide to develop a patient-targeted 
intervention designed to prepare patients for shared decision-making 
The next stage in developing a complex intervention is to identify appropriate theory. 
Chapter 4 describes the development of a theory-based intervention that aims to prepare 
patients to participate in SDM. It outlines the stages of the BCW Guide(47) that guided the 
development of the intervention. The resultant prototype intervention is an 8-page booklet 
entitled, ‘Your Health, Your Choice’.  
Chapter 5 – Pre-testing the prototype ‘Your Health, Your Choice’ intervention with 
patients and clinicians: a qualitative study 
Chapter 5 presents the results of the pre-testing qualitative study. Following the 
development of the prototype booklet, interviews were conducted with lay users and 
healthcare representatives (clinicians / organisational representatives) to assess reactions to 
the booklet’s content, design, readability, usability, and implementation. The results 
informed refinements to the booklet and implementation process that was used during the 
pilot-testing (Chapter 6).  
Chapter 6 – Pilot-testing the ‘Your Health, Your Choice’ intervention: a process 
evaluation 
Chapter 6 presents the pilot-testing of the ‘Your Health, Your Choice’ intervention, using a 
process evaluation method. The pilot-testing was conducted with women who had been 
referred to the Cardiff and Vale University Health Board Breast Care Centre.  
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Chapter 7 – Further research plans 
Chapter 7 presents further research proposals that have arisen from the work that has been 
completed in Chapters 2 through 6, which are beyond the remit of this thesis. Several 
proposals are presented relating to the further development and evaluation of the ‘Your 
Health, Your Choice’ intervention. This culminates with the key research proposal; a 
cluster-randomised controlled trial and process evaluation of the ‘Your Health, Your 
Choice’ intervention, embedded in a SDM clinical pathway.  
Chapter 8 – General discussion 
Chapter 8 presents an overview of the thesis including a summary of key findings, a 
discussion of the strengths and weaknesses, and the clinical implications of the work.  
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Chapter 2 
Patient-reported barriers and facilitators to 
SDM: a systematic review and thematic 
synthesis
‘Let me repeat: choosing what risks to take is not a medical decision. You 
will be qualified to make choices about how you wish to face these risks. 
After all, it is you who, for better or worse, will be cured, become sicker and 
suffer side effects…That decision should be the patients’ choice because the 
trade-offs are personal value judgments, NOT medical science. All medicine 
can do is tell us the numbers – probabilities – but to make the choice is the 
patient’s right.’ 
Stephen H. Schneider, cancer patient, extract from ‘The Patient From Hell’ (2006) 
In the field of medical shared decision-making (SDM), Mr Schneider might be considered 
the ‘ideal patient’. He recognises that there is uncertainty surrounding different treatment 
options and that the patient plays a critical role in deciding which risks are acceptable to 
them.  Most importantly, he acknowledges the valuable expertise that a patient can 
contribute to the discussion of treatment options: knowledge about their own body and 
mind; awareness of their current and future personal circumstances; their personal and 
family’s values.  Medical experts can use their training, experience, and evidence based 
knowledge to present the options that are appropriate to the patient, and the possible 
outcomes of those options. However, medical expertise must be considered in conjunction 
with personal expertise to ensure that patients’ decisions are truly informed. But what does 
it take to get to this point: years of experience; adequate information provision; high levels 
of self-efficacy; supportive medical staff who encourage patient participation? The aim of 
this chapter is to systematically review and thematically synthesise those factors that 
prohibit or enable patients to become more involved in their healthcare decisions, in order 
to inform the development of a complex intervention to support this behaviour.  
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2.1 Introduction 
SDM is viewed as fundamental to safe and effective healthcare. (2) ‘No decision about me 
without me’(22, 48) encapsulates the ambition of a more patient-centred healthcare system, 
and policies that support this ambition are emerging in the UK(23, 49, 50) and 
elsewhere,(51-54) but it is yet to be realised routinely in healthcare settings. Sufficient 
background work has assessed clinician-reported barriers and facilitators to implementing 
SDM,(55-58) and recent implementation studies report some successes, but 
implementation efforts still face considerable difficulties.(33, 59) Much of the 
implementation work to date is driven by a focus on embedding decision support tools into 
clinical pathways and the distribution of these tools (60-64), and considering factors that 
affect clinician (57, 65, 66) and organisational buy-in.(64) Surprisingly, implementation 
work has not considered the patient perspective in any detail. This review examines what 
patients think helps or hinders them from being involved in making healthcare decisions.  
The relative lack of attention afforded to the patient perspective in implementation work 
does not mean that these data are not available. An initial search of the literature indicates 
that many studies have attempted to understand the factors that promote or hinder patients 
becoming more involved in healthcare discussions.(38, 67-69) What has not been achieved 
to date is a comprehensive synthesis of the data arising from these studies, many of which 
are qualitative, which could be used to complement the well-cited taxonomy of barriers and 
facilitators from the clinicians’ perspective.(57) As discussed, much of the implementation 
work in this field has focused on understanding and overcoming clinician and 
organisational barriers to SDM, and whilst this work is also critically important, SDM is 
unlikely to become widespread and sustainable in practice, or the ‘norm’ in healthcare, if 
we do not also address the patient-reported barriers.  
To exemplify this point: a decision support tool could exist for every decision, in a variety 
of accessible formats; a SDM discussion could be initiated in every relevant consultation by 
a clinician who has undergone the relevant skills training and has access to these decision 
support tools; and the organisation could fully endorse the implementation of SDM by 
aligning incentives and ensuring structural barriers are minimal e.g. time available in 
consultations for the process. However, if these interventions/initiatives do not address the 
patient perceived barriers, whether these are experienced or anticipated, the promotion of 
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patients being actively involved in their healthcare decisions will still not be an accepted 
practice that becomes embedded into the fabric of healthcare organisations.  
Referring back to our ‘ideal patient’, Mr Schneider, we would anticipate that there are many 
barriers that need to be addressed in order to enable other patients to adopt this viewpoint. 
The fact that Mr Schneider refers to himself as ‘the patient from hell’, because of his desire 
and ability to be involved in his healthcare discussions, suggests that patients believe the 
active patient role is somewhat frowned upon by the medical profession. It also emphasises 
the potentially powerful influence of long-standing cultural beliefs of what behaviour is 
appropriate in the doctor-patient interaction. Further anecdotal evidence from working in 
this field also highlights patients’ fears of being involved: ‘I don’t want my card marked as 
one to them patients’ (Diabetes patient, 60+ years, personal correspondence). All of the 
enabling factors listed above could be in place, but if patients feel that they do not have 
permission to be involved, or should not be involved, changing clinicians’ attitudes and 
decision support provision alone is not going to result in the attitudinal and behavioural 
change needed to engage these patients in SDM. 
A critical first step in developing a complex intervention is to understand the audience that 
you are targeting and those factors that might impact, positively or negatively, on achieving 
the desired behaviour.(45) The key aim of the complex intervention being developed in this 
thesis is to increase active patient participation in the decision-making process during their 
healthcare consultations. When I refer to active patient participation in healthcare 
decisions, I do not refer simply to the receipt of a SDM tool such as a decision aid; I refer 
to a demonstrable impact on the decision-making dialogue between the patient and the 
clinician during a healthcare consultation. As such, a necessary step in the intervention 
development is to understand patients’ motivations for actively taking part in SDM 
discussions with their clinician, and the factors that prevent them from so doing.  
Previous reviews have identified the factors that might influence patients’ preferences for 
involvement in medical decision-making.(70) However, most studies included in this review 
are based on univariate and multivariate associations between patient characteristics (e.g. 
age, education, prognosis, coping style) and desired levels of involvement. Thus, most 
studies are not based on the actual views of patients. Benbassat and colleagues(71) reported 
that demographic and personal characteristics such as age, illness severity, education and 
gender, only explain 20% or less of the variability in preferences. This supports the need to 
examine factors that might influence patient involvement through direct enquiry with 
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patients. It is likely that there will be some overlap between the factors used in correlational 
analyses and the patient-reported factors, but direct enquiry will allow us to examine why 
the particular factor is viewed as a facilitator or barrier by the patient. Further, whilst the 
previous review(70) provides useful insight into factors affecting the desire to be involved, 
preference is a precursor to involvement; this current review aims to build on previous 
work by also assessing those factors that affect actual involvement.  
The aim of this chapter is to systematically review and thematically synthesise patient-
reported barriers and facilitators to SDM and to develop a taxonomy of patient-reported 
barriers that could be considered during theory-based intervention development and 
implementation work. These data will be considered against the clinician-reported data, and 
both will form part of the theoretical foundation for intervention development (see 
Chapter 4).  
2.2 Methods 
2.2.1 Search strategies 
To identify patient-reported barriers and facilitators to SDM, a systematic literature review 
was conducted. Nine electronic databases were searched (from database inception), with no 
language restrictions: ASSIA (1987>); CINAHL (1982>); British Nursing Index (1985>); 
Embase (1947>); Medline (1946>); Medline in Process; PsycINFO (1806>); Scopus 
(1966>); Web of Knowledge (1981>). Search strategies used a combination of free-text 
words and MeSH (Medical Subject Headings), or database equivalent, derived from the 
following broad topic areas: decision-making; barriers/facilitators; patient-reported. Free 
text words and MeSH used in the Medline search strategy were modified to search the 
remaining bibliographic databases (Search strategies for all electronic databases can be 
viewed in Additional Appendix 2.1 on included CD).  
Follow-up searches included manual searches of the reference lists of papers included for 
full text analysis (see Figure 2.1) and of the contents lists of the most frequently cited 
journals of these papers (Health Expectations, Journal of General Internal Medicine, 
Patient Education and Counselling, and Social Science and Medicine). To ensure a 
thorough review of the field, including in-press articles, authors/researchers in the field of 
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SDM were contacted via known interest groups (e.g. Facebook, SDM listserve) and 
personal email to identify completed and on-going work. 
2.2.2 Selection criteria 
A study was eligible for inclusion in the review if: (i) it reports empirical data; (ii) 
participants were patients (or patient data could be separated from other types of 
participants e.g. clinicians); (iii) it reported patients’ perceptions (barriers/facilitators, 
attitudes, experiences/expectations, preferences) of their involvement in decision-making 
about their healthcare (more general) or involvement in the decision-making process during 
a healthcare consultation (more specific); (iv) results were based on direct enquiry with 
patients (patient-reported); (v) published in a peer reviewed journal. The term patient is 
used to refer to anyone who is a potential recipient of healthcare; they do not have to be 
currently undergoing treatment/management or in the process of making a decision about 
their healthcare.  
Studies were excluded if their results focused solely on any of the following: (i) factors that 
influence preferences for involvement in decision-making, rather than actual involvement; 
(ii) hypothetical scenarios/simulated patients; (iii) patient-reported barriers to involvement 
in other aspects of their healthcare (e.g. participation in clinical trials, health service 
planning, adherence to medication/treatment, daily care activities), or involvement in 
someone else’s healthcare decision-making (unless they are the surrogate decision maker); 
(iv) outcomes of decision support interventions, without direct enquiry of the value of the 
intervention in facilitating SDM (e.g. studies that correlate use of decision support tools 
with increased self-reported involvement in decision-making). If the results presented in 
exclusion criteria (i)-(iv) formed only part of the overall data presented, and these data 
could be differentiated from data that were of interest to this study (see inclusion criteria), 
the study was included, but only data relevant to inclusion criteria were extracted. 
Studies were not excluded on the basis of their design, method, language or principal aim. 
Thus, all studies that could provide usable data to make a judgment of patient perceived 
barriers and facilitators to SDM were included, regardless of whether this was the principal 
aim. When the same data from a single study was described in more than one publication, 
the most recent publication was included. When new and complementary data from a 
single study were described in more than one publication, all publications were included.  
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2.2.3 Study identification and data extraction 
The title and abstract of all references identified were screened for relevance. Full text 
articles of potentially relevant studies were obtained for detailed evaluation. Relevant 
information for data extraction was agreed and data extraction forms were piloted. Data 
were extracted under the following headings for all studies meeting the inclusion criteria: 
study characteristics (first author, year, title, publication details, country, language, principal 
aim, study design, methodological approach, data collection methods); participant 
characteristics (number, population, patient status, participant recruitment, 
inclusion/exclusion criteria, demographics, response rate); study context (setting, health 
condition, specific decision considered, based on self/surrogate and 
experiential/anticipated decision-making); operationalisation of healthcare involvement; 
theoretical base/conceptual framework used to assess barriers/facilitators; summary of 
main findings.  
Study findings/results for each included paper were extracted verbatim and entered into 
QSR International’s NVivo 10 software.(72) To our knowledge, there is no taxonomy of 
assessing patient-reported barriers/facilitators to involvement in SDM. As such, we 
conducted inductive thematic synthesis and did not use a priori codes. Additionally, we did 
not restrict our assessment to those barriers/facilitators explicitly identified by study 
authors. Data were examined independently and a judgment was made regarding aspects of 
the patient-reported data that could provide insights into the barriers and facilitators 
encountered, or perceived, by patients. Thematic synthesis(73) was conducted by two 
independent reviewers (NJW and AE or GE) to identify consistent codes across the 
studies. Discrepancies between coders were resolved during iterative discussions, or with a 
third reviewer. Most salient codes, descriptions, and the relationships between them were 
identified and aggregated into descriptive themes, followed by analytical themes. 
Descriptive data regarding the frequency of codes across the studies were also recorded.  
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Studies identified from 
electronic searches 
(13.08.12-15.08.12) 
 
n = 3305 (duplicates) 
 
ASSIA      422 
BNI      520 
CINAHL     126 
EMBASE     408 
Medline      534 
Medline IP     2 
PsycINFO     684 
Scopus      115 
Web of Knowledge  494 
2901 imported into 
EndNote (404 duplicates 
removed). Title & abstract 
assessed. 
 
51 potentially 
relevant articles 
identified via 
reference lists of 
articles included 
for full-text 
analysis identified 
from electronic 
searches 
 
3 potentially 
relevant articles 
identified via 
contents lists of 
most frequent 
journals of 
articles included 
for full text 
analysis 
identified from 
1 potentially 
relevant article 
identified via 
known authors 
in the field of 
shared decision 
making 
 
 
2667 excluded 
 
 
289 articles retrieved for more detailed 
evaluation (n = 234 electronic searches, n = 55 
follow-up searches). Full text assessed. 
 
  Electronic  Follow-up 
Definite  30  5 
Probable  49  4 
Possible  155  46 
Total  234  55 
 
53 articles thought to meet inclusion / 
exclusion criteria for data extraction (n = 41 
identified via electronic searches, n = 10 
follow-up searches). 
 
45 articles included for final analysis 
 
236 articles excluded (n = 
193 identified via electronic 
searches; n = 43 follow-up 
searches). 
 
8 articles excluded: 
duplicate data presented in 
2 articles, most recent 
included (n=1); unable to 
distinguish patient reported 
data (n=1); focus on actual 
treatment choice (n=1); 
focus on role preference 
(n=1); focus on role 
designation (n=1); data 
saturation not met (n=1); 
influences on 
compliance/non-
compliance (n=1); not 
patient reported. 
 
Figure 2.1  -  Flowchart of progress through the systematic review 
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2.3 Results 
2.3.1 Included studies 
Electronic and follow-up searches yielded 2956 unique references; 289 full-text articles 
were retrieved for detailed evaluation. Forty-five articles from 44 unique studies met 
inclusion criteria.  Two articles presenting additional, but distinct data were from the same 
study;(74, 75) data were extracted from each article. Figure 2.1 describes the progress 
through the systematic review, including details of electronic database search outputs, 
articles identified via follow-up searches, the stages at which articles identified were 
assessed (title and abstract, full text) and excluded or underwent data extraction, and the 
final articles included in the analysis.  
2.3.2 Study characteristics 
Study characteristics are presented in Table 2.1. All studies were published in English. 
Studies originated from 15 different countries (in order of frequency; alphabetically): 
UK,(68, 76-87) USA,(8, 38, 74, 75, 88-93) Sweden,(69, 94-98) Canada,(99-101) 
Australia,(102, 103) Iran,(104, 105) Belgium,(106) China,(107) Finland,(108) Germany,(109) 
Indonesia,(110) Japan,(111) Norway,(112) South Korea,(113) The Netherlands(92, 114); 
one study was conducted in The Netherlands and the USA.(92) One study recruited 
patients from 11 European countries (Austria, Belgium, Denmark, France, Germany, 
Israel, The Netherlands, Portugal, Slovenia, Switzerland, UK).(106) This means the data set 
reports views of patients from a total of 22 different countries.  The earliest published 
study was 1994;(76) 70% of studies were published between 2005 and 2012.  
Study designs and data collection methods for each article can be viewed in Table 2.1. The 
most common study method was qualitative (n=38),(8, 38, 67-69, 74-91, 93-95, 97-103, 
105, 106, 108-112, 114) followed by quantitative (n=5)(92, 96, 104, 107, 113); no studies 
identified barriers/facilitators using a mixed-methods design. Nine studies also included 
clinicians in the sample,(8, 90, 93, 100, 105, 107, 110, 113, 114) but patient-reported data 
were analysed separately.
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Table 2.1  -  Description of included articles that identified barriers / facilitators (n=45) 
First 
author, 
Year of 
publication, 
Country of 
origin, 
Citation 
Principal objective of the study Reporting 
focus 
(barriers 
and/or 
facilitators)  
Operationalization of involvement  
 
Conceptual 
framework 
for barriers/ 
facilitators 
assessment 
Design/methods 
of study within 
which barriers 
and facilitators 
elicited 
 
Setting(s) 
 
Health condition(s) 
 
 
Participant 
characteristics 
Aasen, 
2011, 
Norway 
(112) 
 
 
To explore how elderly patients with 
end-stage renal disease who are 
undergoing treatment with 
haemodialysis perceive patient 
participation in a dialysis unit. 
Facilitators Participation in the healthcare decision-making 
process.  
Yes(84)  Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care, 
outpatient.  
 
End Stage Renal 
Disease.  
11 patients. 
64% male, 36% 
female. Age 
range 74-90. 
 
Adler, 1998, 
USA(88) 
 
 
To focus on aspects of patient 
behaviour, specifically assertiveness, to 
examine how they influence patient-
physician communication. 
Barriers & 
facilitators 
Patient-physician communication and patient 
activation.  
No Cross-sectional, 
Qualitative, Focus 
groups (n=4). 
Secondary care, 
outpatient.  
 
Breast cancer.  
29 female 
patients. Age 
range 63-85. 
Agard, 
2004, 
Sweden(94) 
 
 
Explore patients' knowledge of heart 
failure and their attitudes toward 
medical information (prognostic 
information in particular) and to assess 
different patient-related factors that 
might hamper the improvement of 
patient's knowledge. 
Barriers Information disclosure to patients. No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care, 
outpatient. 
 
Chronic heart 
failure. 
40 patients. 
62% male, 38% 
female. Age 
range 60-80 (75 
mean). 
 
 
Anoosheh, 
2009, 
Iran(104) 
To investigate nurse-patient and 
environment-related communication 
barriers perceived by patients and nurses 
in Iranian nursing. 
Barriers Communication between nurses and patients. 
Communication is the application of words and 
conduct for making, transmitting and interpreting 
messages. Communication involves an interaction 
between the speaker and subject, and the 
environment influences this process. These three 
factors co-influence the communication outcome, 
and any barriers to them can results in ineffective 
communication. 
Pos Cross-sectional. 
Quantitative. Self-
administered 
questionnaire/ 
investigator 
administered 
questionnaire. 
Secondary care, 
inpatient.  
 
No specific health 
condition. 
61 patients. 
48% male, 52% 
female. Age not 
reported.  
Avis, 1994, 
UK(76) 
Examine the patients' perspective on 
making choices about treatment in a day 
surgical unit through the use of 
qualitative methods.  
Barriers Patient participation and making choices about 
treatment. 
No Cross-sectional. 
Qualitative.  
a) Observations  
b) Interviews 
Secondary care, 
inpatient & 
outpatient. 
 
Hernia repair. 
20 patients. Age 
range 15-70. 
a) 12 male 
patients 
b) 10 patients. 
90% male, 10% 
female. 
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Barnard, 
2007, 
UK(77) 
 
 
 
To assess whether using a computerised 
touch screen assessment tool before 
outpatient consultation makes patients 
more active in consultations. 
Barriers & 
facilitators 
Patient centred care: eliciting the patients’ concerns 
and activating the patient to contribute more to the 
consultation [using interactive education]. 
 
No Cross-sectional. 
Qualitative. Self-
administered 
questionnaire 
(open-ended 
questions). 
Secondary care, 
outpatient.  
 
Diabetes. 
53 patients. No 
further details 
reported for 
sub-set of 
patients who 
completed 
open-ended 
questions.  
Bastiaens, 
2007, 
Belgium* 
(106) 
Explore the views of people aged over 
70 years on involvement in their 
primary health care in 11 different 
European countries. 
Barriers & 
facilitators 
Patient involvement: enabling people to take an 
active role in deciding about and planning their 
care.  
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
 
Primary care. 
 
No specific health 
condition.  
406 patients. 
45% male, 55% 
female. Age 
range 70-96 (79 
mean). 
Beaver, 
2005, 
UK(87) 
To explore patient views on 
participation in treatment, physical care 
and psychological care decisions and 
factors that facilitate and hinder patients 
from making decisions. 
Barriers & 
facilitators 
Shared decision-making – participation in treatment 
decisions and care decisions. 
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
 
Secondary care. 
 
Colorectal cancer. 
41 patients. 
46% male, 54% 
female. Age 
range 37-84 
years (62 
mean). 
Belcher, 
2005, 
USA(89) 
To explore views of older adults 
regarding participation in medication 
decision-making. 
Barriers & 
facilitators 
SDM is a model for the way in which the physician 
and patient participate in treatment decision-
making. One of the core assumptions of this model 
is that the patient brings to the decision information 
that the physician cannot know without engaging 
the patient in the decision-making process. In this 
model, the physician and patient share information 
with each other. The physician provides 
information, or acknowledges uncertainty, 
regarding the harms and benefits of available 
treatment options and the patient provides 
information regarding beliefs and preferences; both 
Pos Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
 
Primary & 
community care. 
 
Multiple chronic 
conditions. 
 
51 patients. 
37% male, 63% 
female. Age 
range 65-89.  
                                                 
* Lead author from Belgium. Study recruited participants from 11 countries: Austria, Belgium, Denmark, France, Germany, Israel, The Netherlands, Portugal, Slovenia, Switzerland, UK 
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participate in the decision-making process, 
although in different aspects. 
Bhavnani, 
2009, 
UK(68) 
 
 
To examine patients' views about a 
variety of decision aids for different 
conditions (heart disease, osteoporosis, 
osteoarthritis and breast cancer) in order 
to inform a strategy to introduce them 
into general practice. 
Barriers Patient decision aids are interventions designed to 
help those people facing treatment or screening 
decisions make choices by providing information 
on the management options available and the 
possible health outcomes. 
No Cross-sectional. 
Qualitative. Focus 
groups (n=12). 
Primary care. 
 
Heart disease and 
stroke, 
osteoarthritis, 
osteoporosis & 
breast cancer.  
77 patients. 
19% male, 81% 
female. Age 
range 42-83 (66 
mean). 
Caress, 
2002, 
UK(79) 
To explore preferred treatment decision-
making roles, and rationales for role 
preference, and to identify perceived 
facilitators and barriers to attaining 
preferred role. 
Barriers & 
facilitators 
Participation in treatment decision-making.  No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Primary & 
secondary care.  
 
Asthma. 
32 patients. 
53% male, 47% 
female. Age 
range 18-84 (47 
mean).  
Caress, 
2005, 
UK(78) 
Explore preferred and perceived levels 
of involvement in treatment decisions, 
rationales for role preference, perceived 
facilitators/barriers to involvement and 
the interrelationship of role preference 
and demographic variables in a sample 
of patients with asthma. 
Barriers & 
facilitators 
Participation in treatment decision-making. No Cross-sectional. 
Qualitative. 
Structured 
interviews. 
Primary care & 
secondary care. 
 
Asthma. 
230 patients. 
42% male, 58% 
female. Age 
range 19-94 (52 
mean). 
Charles, 
1998, 
Canada(99) 
 
 
Exploratory study focusing on three 
related issues: 1) the extent to which 
women with early stage breast cancer 
perceived they had treatment options; 2) 
their understanding of the risks and 
benefits associated with different 
treatment options, and 3) the role they 
wanted for themselves and for their 
oncologists in the treatment decision-
making process. 
Barriers & 
facilitators 
Patient participation in treatment decision-making: 
patients’ being provided with information about 
their disease and treatment options, as well as 
opportunities to actively participate in treatment 
decision-making.  
No Cross-sectional 
case study. 
Qualitative. 
Interviews.   
Secondary care. 
 
Early stage breast 
cancer. 
20 female 
patients. Age 
range 42-78 (56 
mean). 
Claramita, 
2011, 
Indonesia 
(110) 
Explore the perceived ideal 
communication style for doctor-patient 
consultations and the reality of actual 
practice in a Southeast Asian context. 
Barriers The informed and SDM between doctors and 
patients is the substantial issue in the ideal style. 
No Cross-sectional. 
Qualitative. 
Interviews.  
Primary, secondary 
and community 
care.  
 
16 patients. No 
further details 
reported.  
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Various medical 
conditions. 
Clover, 
2004, 
Australia 
(102) 
 
 
Explore patients' understanding of their 
discussions about end-of-life care with 
nurses in a palliative care setting. 
Barriers & 
facilitators 
Patient participation in discussions about end of life 
care and negotiation of preferences.  
No Cross-sectional. 
Qualitative. 
Interviews. 
Secondary care, 
inpatient.  
 
Terminal illness.  
11 patients. 
64% male, 36% 
female. Age 
range 57-85 (74 
mean). 
Cohen, 
2003, 
UK(80) 
 
 
 
To gain an in depth understanding of the 
perspectives of men recently diagnosed 
with localised prostate cancer, and to 
explore the value of decision-making 
models in the setting of NHS practice. 
Barriers SDM: interchange of both information and attitudes 
between both parties.  
No Before and after. 
Qualitative. Semi-
structured 
interviews.  
Primary & 
secondary care.  
 
Localised prostate 
cancer. 
19 male 
patients. Age 
range 58-88.  
Curtis, 
1997, 
USA(90) 
 
 
Identify barriers and facilitators to 
communication about end-of-life care 
for patients with AIDS and their 
physicians. 
Barriers & 
facilitators 
Patient-physician communication about end-of-life 
care. 
No Cross-sectional. 
Qualitative. Focus 
groups (n=6). 
Community care.  
 
AIDS. 
47 patients. 
66% male, 34% 
female. Age 
range 23-58 (38 
median). 
Decker, 
2007, 
USA(91) 
 
 
Describe cardiac patients' preferences 
for involvement in decision-making, and 
their informational needs, in the context 
of the myocardial infarction event 
continuum. 
 
Barriers & 
facilitators 
Two theories prevail in the patient involvement 
literature – SDM and informed choice. SDM is the 
more popular model and involves the patient and 
clinician ‘sharing’ in the decision-making process 
as opposed to decisions being made by the clinician 
only (paternalistic model) or the patient only 
(informed patient model).  
Pos Cross-sectional. 
Qualitative. Focus 
groups.  
Secondary care.  
 
Myocardial 
infarction. 
19 patients. 
79% male, 21% 
female. Age 
range 38-70 (61 
mean males; 
44.5 mean 
females) 
Doherty, 
2005, 
UK(81) 
To identify what involvement patients 
want in clinical decision-making and 
explore the underlying factors 
influencing that choice, thus identifying 
aids and barriers to increasing patients' 
involvement in decision-making. 
 
Barriers & 
facilitators 
Preferences for involvement in clinical decision-
making. Three models described: the paternalistic 
model where the clinician decides what treatment 
to implement with the patient being given the 
amount of information that the clinician considers 
the require; the shared model where the patient and 
clinician share decision-making throughout the 
process with a two-way exchange of information, 
and the informed model where the clinician’s role 
is to provide the patient with enough information in 
order that the patient can make his own choice of 
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care.  
 
Various 
medical/surgical 
conditions. 
20 patients. 
55% males, 
45% females. 
Age range 18-
79 (66 mean).  
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treatment option.  
Ekdahl, 
2010, 
Sweden(95) 
To deepen the knowledge of frail elderly 
patients' preferences for participation in 
medical decision-making during acute 
hospitalisation. 
 
Barriers & 
facilitators 
Patient participation in decision-making: MeSH 
defines patient participation as ‘involvement in the 
decision-making process in matters pertaining to 
health.’ 
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care.  
 
No specific health 
condition.  
15 patients. 
34% male, 66% 
female. Age 
range 75-96 (84 
mean).  
Ekdahl, 
2011, 
Sweden(96) 
To investigate the preferred and actual 
degree of control i.e. the role elderly 
people with co-morbidities wish to 
assume and actually had with regard to 
information and participation in medical 
decision-making during their stay in 
hospital. 
Barriers  Patient participation in decision-making.  No Cross-sectional. 
Quantitative. 
Telephone 
administered 
questionnaire. 
Secondary care.  
 
No specific health 
condition.  
156 patients. 
49% males, 
51% female. 
Age range 76-
98 (83 mean). 
Eldh, 2006, 
Sweden(69) 
To explore conditions for patients' 
experiences of participation and non-
participation in their health care. 
Barriers & 
facilitators 
Patient participation and non-participation in health 
care: the foremost perspective of patient 
participation is that it represents taking part in 
decision-making. Note that patients' notion of 
participation is closer to dictionary definition 
'whereby, patients contribute by sharing their 
unique knowledge'.  
No Cross-sectional. 
Qualitative. Self-
administered 
questionnaire 
(open-ended 
questions). 
Secondary care, 
inpatients and 
outpatients.  
 
No specific health 
condition.  
212 patients. 
40% males, 
60% females. 
Age not 
reported.  
Entwistle, 
2008, 
UK(86) 
To investigate the meaning of 
involvement in treatment decision –
making for people with diabetes 
Barriers & 
facilitators 
Patient involvement in treatment decision-making. No Cross-sectional. 
Qualitative. Semi-
structure 
interviews. 
Primary & 
secondary care. 
 
Diabetes. 
18 patients. 
55% male, 45% 
female. Age 
range 20-79. 
Farahani, 
2011, 
Iran(105) 
Explore communication barriers [health 
care] from perspectives of nurses, 
physicians and patients who were 
hospitalised, in cardiac care settings 
with either unstable angina or for 
evaluation of suspected acute 
myocardial infarction and their family 
members. 
Barriers Nurse-patient communication, for the purpose of 
patient education. 
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews.  
Secondary care, 
inpatient.  
 
Cardiac disease. 
9 patients and 4 
family 
members. 64% 
male, 36% 
female (58.7 
mean). 
Fraenkel, 
2007, 
USA(67) 
To gain a more complete understanding 
of the essential elements, or the 
prerequisites, critical to active patient 
participation in medical decision-
Barriers & 
facilitators 
SDM: where patients play an active role in 
decisions related to their health care.  
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care, 
outpatient.  
 
Osteoporosis.  
26 patients. 4% 
male, 96% 
female. Age 
range 49-76 (61 
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mean). 
Frosch, 
2012, 
USA(38) 
To arrive at a better understanding of 
how patients perceive these 
communication tasks, specifically when 
considering clinical decisions that are 
sensitive to patients' preferences.  
 
Barriers & 
facilitators 
SDM.  Yes (115, 
116) 
Cross-sectional. 
Qualitative. Focus 
groups (n=6). 
Primary care.  
 
No specific health 
condition.  
48 patients. 
38% male, 62% 
female. Mean 
age 65.  
Henderson, 
2002, 
Australia 
(103) 
To explore and describe the 
phenomenon of patient participation 
within the context of hospital nursing in 
Western Australia. 
Barriers & 
facilitators 
Patient participation: being allowed to become 
involved in a decision-making process or in the 
delivery and evaluation of a service, or even simply 
being consulted on an issues of care such as 
activities of daily living, pain management or 
treatment options.  
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews & 
observations.  
Secondary care, 
inpatient (after 
discharge). 
 
Various acute 
medical, surgical, 
extended care.   
32 patients. 44 
% male, 56% 
female. Mean 
age 59.  
Janssen, 
2011, The 
Netherlands 
& USA(92) 
To compare quality of patient-clinician 
communication about end-of-life care, 
and endorsement of barriers and 
facilitators to this communication in the 
Netherlands and the USA. 
Barriers & 
facilitators 
Patient-clinician communication about end-of-life 
care.  
No Cross-sectional 
(baseline data 
from 3 datasets†). 
Quantitative. Self-
administered 
questionnaire.   
 
Secondary care.  
 
Chronic Obstructive 
Pulmonary Disease 
(COPD). 
122 Dutch 
patients (62% 
males, 38% 
females; mean 
age 67) and 391 
USA patients 
(92% males, 8% 
females; mean 
age 68).  
Kawabata, 
2009, 
Japan(111) 
To reveal factors affecting the 
physician-patient relationship regarding 
patient participation in medical 
encounters in primary care. 
Barriers & 
facilitators 
Patient participation in medical encounters.  No Cross-sectional. 
Qualitative. Focus 
group (n=1). 
Primary care.  
 
No specific health 
condition.  
 
5 female 
participants 
(patient 
representatives). 
Age range 45-
59 (53 mean).   
                                                 
† Baseline data analysed included data from one longitudinal study. However, only baseline data considered, so overall design cross-sectional. 
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Kelsey, 
2007, 
UK(82) 
To explore young people's perceptions 
of their involvement in healthcare 
decisions affecting their management of 
care. 
Barriers & 
facilitators 
Involvement in healthcare decisions affecting the 
management of care. 
No Cross-sectional. 
Qualitative. 
Interviews & 
patient audio 
diaries.  
Secondary care, 
inpatient.  
 
Various 
medical/surgical 
conditions.   
10 patients. 
60% male, 40% 
female. Age 
range 13-16.  
Larsson, 
2011, 
Sweden(97) 
To explore barriers for patient 
participation in nursing care with a 
special focus on adult patients with 
experience of inpatient physical care. 
Barriers Participation in nursing care: active patient 
involvement in all aspects of own care. 
No Cross-sectional. 
Qualitative. Focus 
groups (n=6). 
Secondary & 
community care.  
 
No specific health 
condition.  
26 patients. 
69% male, 31% 
female. Age 
range 32-87.  
Lown, 2009, 
USA(8) 
To explore how patients and physicians 
describe attitudes and behaviours that 
facilitate SDM.  
Facilitators SDM: interaction between patients and physicians 
when both parties wish to participate in making a 
decision about health care tests or treatments, and 
in which both physician and patient are both 
involved in the process, both shared information 
and express preferences, and both agree about the 
decision plans.  
Pos Cross-sectional. 
Qualitative. 
Research work 
groups (n=4). 
Primary care.  
 
Various chronic 
conditions.  
 
44 patients. 32% 
male, 68% 
female. Age not 
reported.  
Newsome, 
2012, 
USA(93) 
To examine the use of decision aids and 
uncover barriers to greater decision aid 
utilisation in primary care. 
Barriers SDM: involvement of both the patient and the 
doctor, a sharing of information by both parties, 
both parties taking steps to build a consensus about 
the preferred treatment, and reaching an agreement 
about which treatment to implement.  
No Cross-sectional. 
Qualitative. Focus 
groups.  
Primary care.  
 
Various conditions. 
37 patients. 
Gender & age 
not reported.  
Nordgren, 
2001, 
Sweden(98) 
To describe patients' perceptions of how 
self-determination finds expression in 
the context of care. 
Barriers & 
facilitators 
Self determination: within health care, self 
determination has been described in terms of 
patient participation in decisions concerning their 
own lives without a controlling involvement from 
others.  
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews.  
Secondary care, 
inpatient.  
 
Various 
surgical/medical 
conditions.  
 
17 patients. 
65% male, 35% 
female. Age 
range & mean 
not reported.  
O’Brien, 
2011, 
Canada(100) 
To identify patients' and physicians' 
perceptions of physician-related verbal 
and nonverbal facilitators and barriers to 
patient involvement in treatment 
decision-making, during encounters for 
women with early stage breast cancer. 
Barriers & 
facilitators 
Involvement in treatment decision-making.  Pos Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care.  
 
Early stage breast 
cancer.  
40 female 
patients.  
Phase 1: Age 
range 40-70 (62 
mean).  
Phase 2: Age 
range 48-79 (61 
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Park, 2005, 
South 
Korea(113) 
Investigate the communication barriers 
perceived by older hospitalised patients 
and nurses in Korea, with the aim of 
identifying disparities between the two 
parties. 
Barriers Communication between patients and nurses: 
Communication involves an interaction between 
the speaker and the subject and the environment 
influences this process.  
No Cross-sectional. 
Quantitative. Self-
administered 
questionnaire.  
Secondary care, 
inpatient.  
 
Various 
medical/surgical/oph
thalmology 
conditions.  
100 patients. 
59% male, 41% 
female. Mean 
age 68.  
Peek, 2009, 
USA(75) 
To explore barriers and facilitators to 
SDM among African-Americans with 
diabetes. 
Barriers & 
facilitators 
SDM: a process where both patients and physicians 
share information, express treatment preferences 
and agree on a treatment plan. 
Yes (12, 117-
119)  
Cross-sectional. 
Qualitative.  
a) Focus groups 
(n=5)  
b) Semi-structured 
interviews 
Primary care.  
 
Diabetes.  
51 patients 
overall. 18% 
male, 82% 
female. Mean 
age 62.  
a) 27 patients 
b) 24 patients 
Peek, 2010‡, 
USA(74) 
To explore barriers and facilitators to 
SDM among African-Americans with 
diabetes. 
Barriers & 
facilitators 
SDM models contain three domains: information 
sharing, deliberation/physician recommendation, 
and decision-making.  
Yes (12, 117-
119)  
Cross-sectional. 
Qualitative.  
a) Focus groups 
(n=5)  
b) Semi-structured 
interviews 
Primary care.  
 
Diabetes.  
51 patients 
overall. 18% 
male, 82% 
female. Mean 
age 62.  
a) 27 patients 
b) 24 patients 
Ruan, 2008, 
China(107) 
Identify the major communication 
barriers (nurse-related, patient-related, 
environment-related) perceived by both 
nurses and elderly patients and to 
determine the perceived differences in 
the level of importance of the 
communication barriers between nurses 
Barriers Nurse patient communication: communication is 
the use of words and behaviours to construct, send 
and interpret messages. It is a process by which one 
individual may affect another through written, 
verbal and non-verbal means. 
No Cross-sectional. 
Quantitative. 
Investigator 
administered 
questionnaire.  
Secondary care, 
inpatient.  
 
Various conditions.  
56 patients. 
64% male, 36% 
female. Age 
range 69-88 (79 
mean).  
                                                 
‡ Peek 2010 and Peek 2009 use same sample, but Peek 2010 reports additional data obtained from additional questions/prompts used during focus groups and semi-structured interviews. 
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and elderly patients. 
Sainio, 
2001, 
Finland 
(108) 
Explore the views and experiences of 
adult cancer patients about patient 
participation in care and decision-
making and the preconditions for this 
participation. 
Barriers & 
facilitators 
Active patient participation in decision-making and 
care. 
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews.  
Secondary care, 
inpatient.  
 
Various cancer 
diagnoses.  
34 patients. 
53% male, 47% 
female. Age 
range 24-54 (44 
mean).  
Simon, 
2006, 
Germany 
(109)  
Investigate depressed patients' 
perceptions of the treatment decision 
process with general practitioners (GPs). 
Barriers Involvement in the treatment decision-making 
process. In SDM at least two individuals are 
involved in partnership to share the process of 
making a treatment decision.  
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Inpatient and 
outpatient. 
 
Depression. 
40 patients. 
40% male, 60% 
female. Age 
range 18-70 (43 
mean).  
Skea, 2004, 
UK(83) 
To explore women's views of decision-
making relating to hysterectomy. 
Barriers & 
facilitators 
Various aspects of decision-making relating to 
hysterectomy.  
No Cross-sectional. 
Qualitative. Semi-
structured 
interviews. 
Secondary care.  
 
Hysterectomy.  
20 female 
patients. Age 
range 36-53).  
Thompson, 
2007, 
UK(84) 
Examine the views and preferences of 
citizens, as patients, members of 
voluntary groups, or neither, on 
involvement in health care delivery (role 
they wish to play and their conceptual 
meanings behind them). Develop a 
taxonomy based on this. 
Barriers & 
facilitators 
Patient involvement and participation in health care 
consultations.  
No Cross-sectional. 
Qualitative.  
a) Semi-structured 
interviews 
b) Focus groups 
(n=36) 
c) Workshops 
(n=12) 
Primary and 
community care.  
 
Various health 
conditions, 
including chronic 
conditions.  
355 patients 
overall.  
a) 44 patients 
b) 190 patients 
c) 121 patients 
Gender & age 
not reported.  
Thorne, 
2012, 
Canada(101) 
To contribute to the evolving dialogue 
on optimising cancer care 
communication through systematic 
analyses of patients' perspectives. 
Barriers & 
facilitators 
SDM. No Longitudinal. 
Qualitative. 
Interviews.  
Secondary care.  
 
Various cancer 
diagnoses.  
 
100 patients. 
28% male, 72% 
female. Age 
range 23-83 
(65% between 
50-69) 
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First 
author, 
Year of 
publication, 
Country of 
origin, 
Citation 
Principal objective of the study Reporting 
focus 
(barriers 
and/or 
facilitators)  
Operationalization of involvement  
 
Conceptual 
framework 
for barriers/ 
facilitators 
assessment 
Design/methods 
of study within 
which barriers 
and facilitators 
elicited 
 
Setting(s) 
 
Health condition(s) 
 
 
Participant 
characteristics 
Van Staa, 
2011, The 
Netherlands§
(114) 
To integrate findings of mixed methods 
research (MMR) into preferences and 
competencies for communication during 
consultations of adolescents with 
chronic conditions, in order to 
demonstrate the added value of MMR 
for health communication research. 
Barriers & 
facilitators 
Triadic communication during healthcare 
consultations.  
No Cross-sectional. 
Qualitative.  
Semi-structured 
interviews.   
Secondary care.  
 
Various chronic 
conditions.  
31 patients. 
52% males, 
48% females. 
Age range 12-
19 (15 mean).  
 
 
 
 
                                                 
§ Mixed methods study – reported barriers and facilitators derived from one method only so logged as qualitative/quantitative (as appropriate) for the purposes of this review. 
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Table 2.1 provides details on the study aim and reporting focus e.g. barriers and/or 
facilitators. The principal aim of 30 studies was to identify patient-reported 
barriers/facilitators to involvement in decision-making (determined by the reported 
primary objective or by existence of direct questioning during data collection).(8, 38, 67, 69, 
74, 75, 78, 79, 81, 86, 88-90, 92-94, 96, 97, 100, 103-109, 111, 113, 114) Thirteen 
publications reported barriers only,(68, 76, 80, 93, 94, 96, 97, 104, 105, 107, 109, 110, 113) 
two reported facilitators only,(8, 112) and 30 reported both barriers and facilitators.(38, 69, 
74, 75, 77-79, 81-86, 88-92, 95, 98-103, 106, 108, 111, 114).  
2.3.3 Barriers & facilitators - main themes  
Key descriptive themes were grouped under two broad analytical themes: (1) ‘how is the 
healthcare system organised?’ (i.e. factors that are largely outside of patients’ and clinicians’ 
control, such as time, continuity of care, workflow and the healthcare setting) and (2) ‘what 
happens during the decision-making interaction?’ (i.e. factors more influenced by the 
participants taking part in the decision-making interaction, such as predisposing factors, 
interactional influences, preparation for the SDM encounter, and preparation for the SDM 
process). The two analytical themes will be discussed in turn, including the main descriptive 
themes and sub-themes that emerged. The number of studies in which each theme/sub-
theme was identified as a factor affecting participation is presented in parentheses (See 
Table 2.2 for an overview of the main themes and sub-themes, including the number of 
studies each theme was identified as a barrier/facilitator and their associated references). 
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Table 2.2  -  Patient reported barriers & facilitators to SDM: overview of analytical, descriptive & sub-themes (no. of studies / 44 identified as 
factor) (no. of references identified as a factor) 
 
How is the healthcare system organised? (27) 
Analytical theme 
Descriptive themes 
(a) Time (20) 
 (38, 67, 68, 74, 78, 79, 81, 83, 85, 86, 89, 95, 98, 100, 106, 108, 
110-113) 
(b) Continuity of care (15) 
(74, 78, 79, 81, 83, 86, 87, 89, 92, 95, 97, 101, 104, 106, 108) 
(c) Workflow (9) 
(67, 68, 79, 81, 86, 93, 100, 108, 111) 
(d) Characteristics of the healthcare setting (7)  
(67, 69, 81, 83, 89, 107, 113) 
 Clinicians are too busy (38, 67, 81, 83, 86, 87, 89, 95, 98, 106, 
108, 110-113) 
 Lack of time during consultation (38, 67, 78, 79, 83, 89, 
98, 106, 108, 111) 
 Adequate time in the consultation (fac) (74, 78, 83, 
89, 100, 106, 112) 
 
 Inability to choose clinician to do SDM with (89) 
 Too many clinicians involved in care (81, 86, 87, 89, 
92, 95, 97, 104, 106, 108) 
 Lack of continuity in the informational flow 
between clinicians (97) 
 Clinician does not know the patient (83, 86, 106) 
 Being known by the clinician (fac) (78, 79, 89, 101, 
106) 
 
 Distributing SDM among different clinicians 
e.g. nurse takes part in SDM with patient (fac) 
(79, 81, 108, 111) 
 System does not offer multiple-consultation 
model that may be needed for SDM (68, 93, 100) 
 Appropriate consultations for SDM (fac) (67) 
 
 Inadequate environmental conditions e.g. noisy, lack of 
privacy (81, 83, 107, 113) 
 Not paying for healthcare (bar)  / paying for healthcare 
(fac) (67) 
 Overspecialization of doctors (89) 
 Lack of reimbursement for clinician undertaking SDM (69, 
89) 
What happens during the healthcare consultation? (44) 
Analytical theme 
Descriptive themes 
(a) Predisposing factors (33)  
(74, 76, 78-82, 84-86, 88-92, 94-97, 100, 102-114) 
(b) Interactional context factors (39)  
(8, 38, 67-69, 74, 76, 78-82, 85, 86, 88, 89, 92-95, 97-100, 102-108, 110-113) 
(c) Preparation for a SDM encounter 
(32)  
(8, 38, 67-69, 74, 76, 78-84, 86-89, 92, 95, 97-103, 106, 108, 109, 112, 114) 
(d) Preparation for the SDM process (36)  
(8, 67-69, 74, 76-84, 86-89, 93, 95-103, 105-109, 111-113) 
Patient characteristics (29)  
(74, 76, 78, 79, 81, 82, 84, 85, 88-90, 92, 94-97, 103-114) 
 Being in poor health (78, 79, 81, 82, 89, 95-97, 106, 108, 109, 
113) 
 Being in good health (fac) (108) 
 Cognitive / physical impairments (78, 79, 97, 106, 107, 
113)  
 Prior exposure to illness / decision-making 
Power imbalance in the patient-clinician 
relationship (36)  
(8, 38, 67-69, 74, 76, 78-86, 88, 89, 93-95, 97-103, 106-108, 110-114) 
Presumptions about the patient role  
 Expectation of the clinician making the 
decisions (67, 68, 74, 76, 78-81, 84, 88, 89, 94, 96, 98, 102, 103, 112) 
 Desire to act like a ‘good’ patient driven by a 
fear of consequences (38, 67, 68, 74, 76, 80, 88, 97, 98, 101-
Perceived need for preparation (30)  
(8, 38, 67-69, 74, 76, 78-84, 86-89, 92, 95, 98-102, 106, 108, 109, 112, 114) 
 Patient is not entitled to a choice (67, 76, 78, 82, 87, 88, 
92, 98, 100, 102, 109) 
 Patient is not explicitly offered a choice or it is 
presented in a biased way (80, 83, 86, 87, 101, 102, 112) 
 ‘Doing nothing’ is not an option (80, 83, 87, 99) 
 Patient does not want to or need to participate 
Providing information about options (27)   (67, 69, 74, 76, 
78-84, 86-89, 95, 97-103, 106, 108, 111, 112) 
 Insufficient information about condition, options and 
outcomes (69, 74, 76, 78, 80, 81, 83, 86, 87, 89, 95, 97, 98, 100-103, 111, 112) 
 Sufficient information about condition, options and 
outcomes (fac) (67, 69, 74, 78, 79, 81, 82, 84, 86-88, 95, 100, 101, 106, 108) 
 Clinician does not explain the options and outcomes (67, 69, 
74, 80, 82, 83, 86, 87)   
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point (fac) (74, 92) 
 Age (older/younger) (78, 79, 88, 95, 103, 106, 108, 111, 114) 
 Ethnicity (74, 88) 
 Lower level of Education (79, 94, 106, 110) 
 Poor articulation (76, 78, 81, 106, 107) 
 Difference in personal characteristics (95-97, 104, 
105)  
 Health condition – stigma / discrimination (84, 86, 
90, 104) 
 Long term patient (bar(112) & fac (78, 79)) 
Decision characteristics (18)  
(78, 80-82, 84-86, 90-92, 100, 102, 103, 105, 106, 108, 109, 111, 114) 
 Timing along the illness trajectory (bar & fac) 
(84, 85, 91, 102, 103, 111) 
 Major decisions (bar (78, 81) & fac (78, 81, 108)) 
 Minor decisions (bar (81) & fac (78, 81)) 
 Embarrassing or sensitive topics (90, 105, 106) 
 Shock of receiving diagnosis (80, 84, 86) 
 Time to come to terms with diagnosis (fac) (80, 
100) 
 
103, 106, 108, 112) 
 Perceived acceptability of asking the clinician 
questions (bar (38, 74, 76, 78, 80, 82, 86, 88, 89, 95, 99, 102, 103, 
111) & fac (8, 67, 74, 82-84, 86, 88, 89, 95, 98, 100, 103, 106, 108, 110, 
111)) 
 Belief that clinicians do not want patients 
involved (38, 67, 68, 85, 86, 88, 89, 95, 98, 101, 106, 111-113) 
 Clinician reinforces passivity by rewarding this 
behaviour (80, 102, 106, 107) 
 Not having explicit ‘permission’ to participate 
in SDM (38, 67, 74, 82, 83, 89, 93, 98, 100, 103, 110, 114) 
 Having explicit ‘permission’ to participate in 
SDM (fac) (8, 67, 69, 74, 78, 86, 89, 100, 101, 103, 106, 108) 
 
Patients undervalue their expertise relative to 
clinicians 
 ‘Doctors know best’ and patients’ have 
‘inferior’ knowledge (38, 67-69, 74, 76, 78-85, 
88, 89, 94, 95, 97-99, 102, 103, 106, 108, 110-
112, 114) 
 Patients are not capable of understanding 
medical/technical information (76, 85, 94, 97, 114) 
 Recognize that there are two experts in the 
medical encounter (fac) (8, 67, 74, 78, 79, 81, 82, 84, 86, 88, 
89, 99, 101, 102, 110) 
Interpersonal characteristics of the 
clinician(s) (35)  
(8, 38, 67, 69, 74, 76, 78-84, 86, 88, 89, 92, 95, 97-108, 110-114) 
 Authoritarian clinicians (38, 74, 83, 89, 97, 98, 103, 106, 112, 
113) 
 Equal relationship (fac) (8, 38, 69, 74, 78, 79, 84, 86, 88, 89, 
98, 99, 101, 110) 
 Clinician does not listen to patient’s concerns 
(38, 69, 74, 78, 79, 81, 82, 84, 89, 97, 98, 100, 102, 103, 106, 107, 110, 112, 
113) 
 Clinician listens to patient’s concerns (fac) (8, 69, 
74, 78, 79, 86, 89, 98, 101, 106) 
 Clinician with poor interpersonal skills (38, 74, 78, 
79, 81, 83, 86, 89, 97, 101, 102, 104-108, 113) 
 Clinician with positive interpersonal skills (fac) 
(74, 79, 83, 86, 100, 101, 106, 108) 
 Good relationship with clinician (fac) (8, 67, 74, 78, 
79, 81, 84, 86, 92, 98, 101, 108) 
 Poor relationship with clinician (108) 
 Lack of individualized approach and not asked 
about preferences (38, 69, 80, 81, 86, 89, 97, 108, 111, 112)  
 Individualized approach where clinician seeks 
in SDM (68, 69, 76, 80-82, 84, 88, 89, 92, 95, 98, 101, 106, 114) 
 Accepting responsibility to be involved in 
decision-making (fac) (8, 38, 67, 78, 79, 82, 84, 86-89, 99, 
101, 106, 108, 114) 
 Not knowing what to expect from the SDM 
consultation (74, 81, 83, 92) 
Expectations of the outcome of being 
involved in SDM (21)  
(67, 68, 74, 76, 80, 83, 84, 86, 87, 89, 92, 95, 97, 99, 101-103, 106, 108, 109, 114) 
 Perceiving that there are ‘right’ and ‘wrong’ 
decisions (not wanting responsibility for wrong 
decision) (68, 76, 80, 84, 87, 89, 95, 97, 99, 102, 103, 106, 114) 
 Recognizing equipoise and uncertainty (fac) (67, 
83, 89, 101, 106, 108) 
 Fear of accepting reality of diagnosis (68, 74, 84, 87, 
89, 92, 97, 102, 106, 108, 109) 
 
 Clinician explains the options and outcomes (fac) (67, 78, 82-84, 
86, 87, 89, 99-101, 106) 
 
Terminology used by HCPs (17) 
 (67, 69, 74, 76, 78, 81, 82, 84, 87, 89, 95, 97, 98, 105, 107, 109, 113) 
 Clinician uses medical terminology (67, 74, 76, 78, 81, 84, 89, 96-98, 
105, 107, 109, 113)  
 Clinician uses simple terminology (fac) (69, 74, 82, 84, 87, 89) 
Decision support (8)  
(8, 68, 77, 83, 89, 93, 100, 111) 
 Lack of written decision support (bar) (83, 100, 111)/ written 
decision support (fac) (68, 77, 100) 
 Purpose of the decision support tool is unclear (93) 
 Decision support from others e.g. family, other clinicians 
(fac) (8, 83) 
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patient’s preferences (fac) (8, 69, 78, 84, 86, 89, 92, 98, 100, 
101, 106) 
 Clinician does not address patient directly (82, 97, 
114) 
Trust (24) (8, 67, 68, 74, 76, 78-81, 84, 86-89, 92, 94, 95, 97-99, 102, 
106, 107, 112) 
 Trust in clinician (bar (67, 68, 78-81, 84, 87-89, 94, 95, 97, 98, 
102, 112) & fac (8, 67, 74, 86, 89, 92, 97, 106)) 
 Lack of trust in clinician (bar (74, 89, 107) & fac (67, 
78, 84)) 
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2.3.3.1   How the healthcare system is organised 
Four key themes relating to the way in which the healthcare system is organised were 
identified by patients as either facilitating or hindering participation in SDM (see Table 2.2). 
Most of these factors are potentially modifiable, but would require significant organisational 
level change, rather than change at the individual level.  
a) Time (20/44 studies) 
Some patients feel that the limited time allocated for consultations is insufficient for SDM. 
Limited time is a barrier to becoming informed, processing information received, and 
discussing issues with the clinician. For instance, in a study by Frosch et al(38), men felt that 
insufficient time with their physicians was a barrier to asking questions and voicing concerns, 
as well as a barrier to processing and reflecting on information given during a visit. Patients 
in Fraenkel et al’s(67) study believed lack of time was a barrier to providing effective 
healthcare and reported that there ‘doesn’t feel like there’s ever room in the system anymore 
for real dialogue’. Conversely, adequate time for discussion can facilitate involvement in 
SDM.(78, 83, 100, 106) Patients in Peek et al’s study(74) also felt that adequate time afforded 
opportunities for relationship building, which was deemed important for effective 
communication with the clinician. Patients frequently reported that clinicians seemed too 
busy and hurried (85, 86), and they did not want to bother them. Interestingly, patients were 
often sympathetic to clinicians’ high workloads, felt guilty about taking up their time,(38) pity 
because they are so busy,(112) and terminated consultations more quickly when waiting 
rooms were busy. (106, 110)  
b) Continuity of care (15/44) 
Some patients believe that a lack of continuity in their care is a barrier to SDM.  For 
instance, patients in Belcher et al’s(89) study felt that inability to choose a doctor with whom 
to actively participate in decisions affected their participation, whilst other patients feel that 
there are too many clinicians involved in their care to participate.(81, 108) Other patients feel 
that the lack of continuity in the informational flow between clinicians was a barrier (e.g. 
sub-optimal handovers)(97) and some felt it was difficult to participate when the clinician did 
not know them personally.(83, 85, 106) Conversely, patients in several studies perceived 
continuity in care as a facilitator, especially being known by the clinician. (78, 79, 89, 101, 
106) 
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c) Workflow (9/44) 
Although not a predominant theme, patients identified how workflow processes could be 
amended to facilitate greater involvement, such as distributing the SDM process between 
different clinicians. Some patients believe that nurses play an important role in explaining the 
information provided by doctors, and they also provide greater support in listening to 
patients’ preferences and concerns.(79) Patients refer to the nurses as ‘mediators’ or 
‘intermediaries’ who can explain information provided by doctors to the patients, (81, 111) 
and provide the doctors with important information about the patient’s preferences. This 
therefore somewhat contrasts with the view that lack of continuity is a barrier to 
involvement. In terms of barriers, some patients suggest that the healthcare system is not 
set-up for the multiple consultation model needed to support SDM e.g. to receive the 
decision support tool, have time to think about options, have the opportunity to ask 
clarifying questions at a later date. Having appropriate appointments for SDM, e.g. longer 
appointment times available for those situations, would support and encourage involvement.  
d) Characteristics of the healthcare setting (7/44) 
Poor environmental conditions, such as a noisy environment,(107, 113) lack of privacy,(81) 
and requiring physical examinations(83) were not conducive to involvement in decision-
making. Some patients believe that their right to participate in SDM depends on whether 
they pay for their healthcare or not.(67) Other healthcare setting-related barriers reported by 
patients include overspecialisation of doctors and lack of reimbursement for clinicians 
undertaking SDM.(89)  
2.3.3.2   What happens during the decision-making interaction 
Ten key elements relating to the decision-making interaction were identified by patients as 
either facilitating or hindering participation in SDM. These are grouped under four 
descriptive themes: (see Table 2.2) 
a) Pre-disposing factors (33/44) 
(i) Patient characteristics (29/44) 
Various patient characteristics have been cited as either facilitating or hindering patient 
involvement in SDM. Some characteristics are non-modifiable, as their presence or absence 
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could not be influenced by interventions designed to promote SDM.  Non-modifiable 
barriers include the presence of cognitive impairments(79, 97, 110) and being in poor health; 
(78, 81, 89, 106, 108, 113) patients in several studies reported that they were happy to 
relinquish decision-making control when they felt very ill.(82, 95-97) Non-modifiable 
facilitators include being in good health,(108) and prior exposure to the illness or decision-
making point.(74)  
Most patient characteristics are, however, potentially modifiable.  Age is reported by patients 
to influence involvement in SDM. Whilst age per se is not modifiable, most barriers related 
to age were linked to attitudinal issues or prejudices that could be addressed. Patients in 
several studies report that being in an older age group restricted their involvement, citing 
various reasons for this: some older patients report that they are less interested in their own 
life than they were when they were younger;(95, 108) some feel that they receive 
discriminatory treatment or they are not listened to because they are old;(88, 103) whilst 
some believe that they are part of an age cohort which accepts the authority of the clinician 
and should not question this authority.(106, 111) However, some studies have shown that 
being in a younger age group can also limit involvement, mainly because of the triadic 
relationship children and adolescents encounter. In these situations, some young people feel 
that they do not need to be involved because their parent will adopt the decision-making 
role, some felt that they were not capable of representing themselves or were not interested 
in taking part, whilst some felt that their parents’ interference restricted discussion.(114)  
Two studies looked specifically at issues of ethnicity in SDM, and similar modifiable 
attitudinal issues have been identified.(74, 75) Patients in these studies reported that the 
power imbalance in the relationship between patient and clinician was exacerbated by ethnic 
difference. They believed that African-Americans were more likely to defer to authority, less 
likely to experience information exchange, and were less likely to have their concerns 
validated by the clinician. Having poor articulation,(76, 78, 106, 107) a lower level of 
education,(79, 94, 106) and differences in personal characteristics between the patient and 
the clinician (e.g. dialect/accent, age, sex)(95-97, 104, 105) were also reported as barriers to 
SDM. In some studies, patients report that the nature of their health condition impacts 
negatively on their level of involvement because of stigma and discrimination, for example, 
infectious diseases,(104) drug addiction,(90) alcoholism.(84) Asthma patients in two studies 
believe that having the condition for a long time facilitated involvement;(78, 79) however, 
patients in another(112) study believe that being a long-term patient is a barrier to 
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involvement as it is more difficult to obtain information and the healthcare team has lost 
interest or forgotten about them.  Again, whilst these characteristics are unchangeable (e.g. 
we cannot change a patient’s level of education, health condition, length of time with 
condition), they are modifiable if we provide alternative ways to support these patients and 
focus on attitudinal change at the levels of patient, clinician and organisation.  
(ii) Decision characteristics (19/44) 
Several decision characteristics were identified as barriers to SDM. Patients in 
Thompson’s(84) and Clover et al’s(102) studies reported that not everyone aspires to be 
involved at all times and in all situations and patients use different approaches depending on 
the decision being made, suggesting involvement in SDM is contextually dependent. Acute 
myocardial infarction patients in Decker et al’s(91) study were asked to describe preferred 
involvement and information needs along the continuum of myocardial infarction care. 
Results indicate that involvement in decision-making progresses from the acute event to 
recovery and is influenced by time; progressing from active when seeking emergency care, to 
passive when hospitalised and receiving treatment, back to active when making decisions 
about rehabilitation and recovery. Significant decisions were identified as both a barrier and 
facilitator to involvement: some patients in Doherty et al’s(81) study report that they would 
like to be more involved in major decisions (e.g. cancer) than minor decisions (e.g. asthma), 
whilst others preferred less involvement when a major decision had to be made. These issues 
are non-modifiable; it is logical that patients in, for example, an emergency situation, will not 
be involved in decision-making, and we cannot change the severity of the disease or a 
patient’s stated preference of involvement in relation to this; however, it is possible that 
these factors could change over time.  
However, most decision characteristics reported as barriers are potentially amenable to 
change. For example, Farahani et al(105) reports how embarrassing topics can be a barrier to 
discussion; a patient was not told that sexual impotence was a potential side effect of 
prostate cancer treatment because of the cultural stigma associated with discussing sexual 
problems. There is also some evidence that patients might be less inclined to participate in 
decisions about sensitive issues, such as end-of-life discussions and advanced directives.(92) 
Again, the focus here is on attitudinal change, either at the individual belief or subjective 
norm level. 
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Timing of the decision can also act as a barrier or facilitator to involvement. For instance, 
men diagnosed with prostate cancer in Cohen et al’s(80) study reported that the consultation 
was ‘overshadowed’ by the shock of receiving the threatening news. As such, they could not 
absorb any information that they were given after the diagnosis and they could not attend to 
a decision-making discussion, even if this had taken place. Having time to come to terms 
with the diagnosis before option presentation was felt to facilitate involvement in the 
decision-making process,(85) as was having time to go away and think about the decision, 
especially when the clinician reinforced that the decision did not need to be made that 
day.(83, 100) However, it is worth noting that one breast cancer patient felt that the time 
between diagnosis and start of treatment was too short and did not facilitate the use of 
decision aids as a means to provide decision support.(68) Timing barriers are potentially 
modifiable for most situations, if we can reconsider where SDM fits in the clinical pathway 
or patient’s disease trajectory, and provide time before considering options after a diagnosis, 
if feasible.  
b) Interactional context factors (39/44) 
(i) Power imbalance in the patient-clinician relationship (36/44) 
 Presumptions about the patient role  
Several modifiable barriers relating to patients’ presumptions of the ‘normal’, expected 
patient role were identified. Many patients believe that ‘normal’ patients are passive and 
expect clinicians to make decisions.(76, 78, 81, 95, 98, 112)  For example, a patient in 
Bhavnani et al’s(68) study reports that she would not go to the doctor having read a 
decision aid and highlight what treatment she would like; she believes you go to the 
doctor to be asked questions, provide answers to those questions, and to be told what 
treatment to have. In many studies, it is clear that patients have an expectation of being 
told what to do by the clinician.(76, 78, 81, 95) The use of terms such as ‘accept’, ‘trust’, 
and ‘should’ indicate that patients are quite often accepting of this role, but sometimes 
they perceive they have no option to be involved, even if they wanted to. For example, 
patients in Nodgren et al’s(98) study perceived that they had no other choice but to 
comply with the treatment put forward by staff. A patient in Aasen et al’s(112) study 
stated, ‘even if we wanted to decide…it doesn’t mean we could. You must listen to those 
who are supposed to help you or else it won’t work’.  
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Many patients’ desire to act like a ‘good’ patient is driven by a fear of bad consequences if 
they step outside of this traditional patient role. For example, palliative care patients in 
Clover et al’s(102) study reported concern that staff labelled them as inflexible, 
troublesome, and hard to manage when they made their preferences clear. Similarly, 
patients in Frosch et al’s(38) study feared that questioning behaviour would result in them 
receiving a long-term reputation as a difficult patient.  The fear of being described as a 
difficult patient is frequently accompanied by a fear of retribution; patients feel that being 
labelled difficult is in someway associated with poorer quality care or avoidance from 
medical staff.(38, 67, 103) Wanting to be a ‘good’ patient even resulted in patients 
undertaking covert work to inform themselves, as they did not want to ‘rock the 
boat’.(38) The desire to be a ‘good’ patient is also driven by the perceived benefits that 
might arise, such as lack of conflict in the encounter,(38, 103) and having the clinician ‘on 
your side’ at a time of great need.(88)  
Perceived unacceptability of asking the clinician questions and raising options can act as a 
barrier to SDM. Patients frequently reported that they should not ask their doctors 
questions or make attempts to be involved. Some patients believe that hospital is a place 
where you do not ask questions(76) and medical staff do not want to be questioned, (86, 
89) even using phrases like ‘dare ask’.(95, 102) The perception that you cannot, or should 
not, ask questions is discussed in relation to how it would undermine the skills of the 
clinician,(38, 76) show a sign of distrust,(38, 99) or a lack of respect(78, 80, 88). Linked to 
this barrier is the belief that clinicians do not want patients involved in their 
healthcare.(86, 89, 111, 112) For example, patients in Ekdahl et al’s(95) study felt that 
doctors and consultants, who are at the top of a hierarchical system, believe they do not 
need to communicate with patients.(95) A patient in Nordgren et al’s(98) study described 
how the healthcare team just did things to them without asking, deciding the course of 
action beforehand. Sometimes, passive behaviour is directly reinforced by clinicians e.g. 
where compliant, non-questioning individuals are called ‘easy’ or ‘best’ patients.(88)  
Not having explicit ‘permission’ or encouragement to be involved in decision-making is 
another barrier commonly cited by patients. Patients in Peek et al’s(74) study, for 
example, believed that they do not have ‘the right’ to be involved in healthcare decisions. 
Other patients note that because the doctor did not ask how they felt about the treatment 
option, they could not initiate that dialogue.(38) Adolescents in van Staa’s(114) study, 
who participated in triadic consultations, report that the clinician did not tell them to play 
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a more active role, and thus they did not think it was necessary. On the other hand, 
explicit encouragement from clinicians with a positive attitude to patient involvement is 
frequently cited as a facilitator to being more active in the consultation.(67, 74, 82, 86, 89, 
103, 108, 110) Bastiaens et al’s(106) study of older people reports that a key facilitator to 
involvement was a doctor who willingly encouraged patients to ask questions and take 
part in decisions; patients in this study believed that part of the doctor’s role was to 
initiate SDM.   
 
 Patients undervalue their expertise relative to that of the clinician 
Many patients believe ‘doctor knows best’, and that their own knowledge is superfluous 
to the decision-making process, being trumped by medical expertise and experience. 
Patients in several studies repeatedly state that they rely on the clinician to make the 
decision because they are the ones who have had many years of medical training, who 
know about the illness and the treatments, and who have years of clinical experience; they 
are the ‘experts’, ‘professionals’, ‘specialists’, and ‘skilled technicians’.(74, 76, 78-81, 84, 
87, 88, 94, 98, 99, 102, 103, 106, 112) There is an expectation that the clinician should 
know what they are doing, and they are therefore in the best position to make a decision 
because patients are not educated in the field of medicine. As a patient in Henderson et 
al’s(103) study expressed: ‘I am an engineer and I know my area of work, the nurses and 
doctors know theirs’. When patients discuss their knowledge relative to the clinicians’, 
they often talk about themselves, or their knowledge, as being inferior to the ‘gods in 
white’.(89, 106) They undervalue their contribution using sentences such as ‘what do I 
know’(88), ‘I don’t think anyone would take me seriously enough’,(89) ‘the average lay 
person knows nothing you know’,(67) and ‘they know more about it than I do’.(84) Some 
patients also perceive that they are not capable of understanding the ‘complex and 
technical’ information needed to make a decision, even if they are offered it.(76, 94) As 
such, some patients make no attempt to attain a higher level of knowledge(76, 94).  
When a patient undervalues their own expertise compared to the clinician, whether that 
be their level of medical knowledge or their failure to recognise the complementary 
expertise they can bring to the decision-making process, this acts as a barrier to 
involvement. On the contrary, when patients do recognise that there are two experts in 
the decision-making encounter, and that the patient is an expert in their own body, mind, 
and social circumstances, this acts as a facilitator to SDM.(67, 74, 79, 81, 82, 86, 87, 89, 
   44 
99, 101, 102) For example, a patient in Caress et al’s study states: ‘Obviously I haven’t 
got…the range or depth of knowledge to make a decision on my own…but it’s my body, 
so I should have a very big say in what happens. So a balance is probably best’.(78) Other 
patients talk about wanting to be told the treatment options available by the medical 
experts, but then making ‘the other half’ of the decision.(74) One patient highlights the 
complexity of their personal belief system noting that it has taken a lifetime to build up, 
so they would never consider letting anyone else telling them what to do.(101)  
Clearly, factors relating to how patients perceive their role in the patient- clinician 
relationship and belief in their own ability to participate are potentially modifiable; many of 
the cited barriers could be addressed through attitudinal change at the level of the patient 
and the clinician, possibly at the organisational level, and complemented by the promotion of 
self-efficacy in patients.  
(ii) Interpersonal characteristics of the clinician(s) (35/44) 
Patients report various attitudes and behaviours exhibited by clinicians that might facilitate 
or restrict involvement in decision-making. It is likely that many of these are not directly 
linked to participation in SDM, but negative attitudes and behaviours displayed by doctors 
will impact on general patient-doctor communication, which is an essential precursor to 
SDM. The most frequently cited barrier was encountering authoritarian clinicians who 
dominate the decision-making encounter. Patients in several studies report how clinicians 
with an authoritarian, superior, dominating, overbearing, and intimidating manner restrict 
their level of involvement.(38, 86, 87, 89, 97, 103, 113) One patient describes how patients 
are at a disadvantage and they have to struggle and ‘take a beating mentally’.(98) However, 
when patients feel that they are in an equal relationship with the clinician and their opinion is 
respected, this acts as a facilitator to involvement. For one patient in Thompson’s study, 
being part of a team that respects the patient and values their opinions is key to 
involvement.(84) Others describe how the decision-making interaction with a clinician 
should be more like a discussion with a friend, where both of the participants are equals. (74, 
110)  
Some patients believe that the presence of an advocate in the consultation can support their 
involvement in decision-making.(8, 38, 74, 81, 89, 106, 108)  For some, the support can help 
to overcome practical barriers, such as forgetfulness or inability to remember all of the 
information by oneself, but for others it is seen as a form of social support or back up that 
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may help to redress the power imbalance, especially for those patients who lack confidence. 
Two studies report not having a family member or caregiver in the consultation as a barrier 
to participation.(107, 113) Patients cite authoritative clinicians as a barrier to SDM, but some 
patients believe that the whole hospital or healthcare unit is an institution of power and 
control that restricts involvement.(84, 95, 98, 112) They refer to the hospital as a ‘jail’(112) 
and as having certain rules and regulations that you have to follow.(98) 
Another frequently cited barrier is when clinicians do not listen to the patient’s concerns.(69, 
74, 78, 79, 82, 89, 108, 110) Patients in various studies report situations whereby the clinician 
was dismissive of their concerns, many of which related to the treatment being received. For 
example, a patient in Claramita et al’s(110) study reports how a doctor continued to 
prescribe a drug, even though the patient has told them on several occasions that they have 
an adverse reaction to that drug. Breast cancer patients in O’Brien et al’s(100) study believed 
that their involvement in the decision-making process was compromised when the 
physicians did not appear interested in their concerns about the disease or the treatment. 
When genuine concerns are not acknowledged or are ‘called into question’ by clinicians, 
patients feel as though they have lost their self-determination.(98) Some elderly patients feel 
that the staff treated them like children, or ‘silly old ladies’, and did not value their opinions 
or respect the elderly.(103, 107) This perceived unwillingness to listen to the patient’s 
concerns, and to acknowledge the patient’s expertise in their own body, is seen as an 
important barrier to involvement. Conversely, listening to the patient and respecting their 
views is frequently cited as helping patients to become involved in their care.(69, 78, 79, 86, 
89, 98, 106) Some patients believe that having health concerns ‘heard’ and validated by the 
clinician creates a sense of partnership, which in turn facilitates SDM.(74) 
Clinicians with poor interpersonal skills are frequently reported as inhibiting participation. 
Negative verbal and non-verbal communication behaviours displayed by clinicians made 
patients feel that they could not be involved. They use phrases such as ‘abrupt’,(89) 
‘aggressive’(104), ‘arrogant’,(108) ‘dismissive’,(89) ‘uncaring’,(97) ‘bossy’,(102) 
‘unfriendly’(107), and ‘lack of empathy’(105) to describe the attitudes and behaviours of 
these clinicians. Thorne et al(101) describe how the tone, or atmosphere set by clinicians’ 
non-verbal behaviours can impact on the verbal communication that follows. Other patients 
describe how the ‘general kind of atmosphere’ created by clinicians with poor interpersonal 
skills can restrict them from feeling able to ask questions.(106) On the other hand, clinicians 
who display positive interpersonal skills facilitate involvement. Being ‘friendly’, ‘positive’, and 
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‘genuinely concerned’ are seen as important factors in encouraging involvement.(108) Peek 
et al(74) report how interpersonal skills were deemed essential for establishing a good 
relationship with the professional and for creating a positive environment where patients felt 
comfortable participating in the decision-making dialogue.(74) Patients in several studies 
viewed having a good relationship with the clinician as an important facilitator to patient 
involvement.(8, 67, 78, 79, 81, 108) Some patients felt that it was easier to talk about 
treatment preferences when you have built up a relationship, sometimes over many 
years.(74) Patients in one study reported that a poor relationship with the clinician would 
restrict participation in decision-making.(108) It is likely that the ability to establish a ‘good’ 
relationship is linked with the interpersonal skills both of the patient and the clinician.  
An individualised and tailored approach, whereby the clinician seeks to understand the 
patient’s needs and preferences, is another important facilitator to involvement.(69, 78, 92, 
101, 106) Patients in Eldh et al’s(69) study were asked to report the essential conditions for 
participation in healthcare; making a decision based on own knowledge and needs and being 
regarded as an individual were two of the key conditions. Patients value having their own 
perspective and insight acknowledged, and emphasise the need to be treated as a person who 
has goals, rather than a disease. Patients in Thorne et al’s(101) study describe ‘being 
recognised for the uniqueness as central to their ability to operate within somewhat foreign 
relationships with the professionals…’. When patients are not asked about their preferences, 
and thus not regarded as individuals, this is seen as a barrier to participation.(69, 80, 89, 97, 
111, 112) Patients in several studies describe how this impacted on their ability to become 
involved in the consultation. In these situations, patients describe being treated as an ‘object’ 
or a ‘disease’.(69, 89, 108) The focus on treating individual diseases and numbers was 
perceived to impede patient participation in medication decision-making in some cases.(89) 
For some patients, maintaining a good quality of life was more important than maximising 
their life span, but they struggled to have their preferences heard by the medical team and 
were sometimes scolded for these decisions.(112)  
Although not a key barrier, patients report that participation in decision-making is 
compromised when the clinician does not address the patient directly. This was specifically 
identified in situations of triadic communication e.g. consultations with children/adolescents 
and their parents.(82, 114) The young people expressed frustration that the clinician 
addressed the parent, rather than them directly. Another study reports how a patient was 
faced with ‘secretiveness’ when the nurse discussed issues with their relatives ‘behind their 
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back’. Again, most factors related to interpersonal characteristics of the clinician are 
modifiable, with a focus on addressing clinicians’ attitudes towards patient involvement and 
improving the way in which they communicate and interact with patients.  
(iii) Trust (24/44) 
Trust is a complex issue where both the presence and absence of trust can be a facilitator or 
a barrier to participation respectively, depending on the individual. Some patients report that 
trust in the healthcare team leads them to act more passively in the medical encounter, and 
often refer to ‘leaving their lives in the hands of the professionals’ because they trust them. 
Patients in several studies reported that they trust the clinicians because they are the experts 
with the knowledge and have had many years of training.(78, 79, 84, 94, 102) Some patients 
report a ‘blind trust’ in the clinician, having faith that they will act in their best interests.(68, 
79, 80, 89, 95) Patients in these studies use phrases such as ‘if he tells me this is good for me 
then I believe them’,(89) ‘they do what they think they have to do…what they think is best 
for me’,(95) ‘trust…in the doctor means you should accept what the doctor says’.(89) 
Patients in Nordgren et al’s(98) study report that they trust the clinician like they trust their 
parents, again indicating an unconditional trust. For other patients, trust is something that is 
based on positive past experience with the clinician or having a good reputation. (67, 79, 88) 
Some patients refer to a ‘need’ to trust the clinicians as a way of coping: a patient in Charles 
et al’s(99) study describes how she had to trust the physician to make the decision as that 
was the only way she could live with the decision.  
Patients also cite trust as a facilitator to greater involvement in healthcare decisions. Patients 
in several studies report that a trusting relationship with the clinician would make them more 
willing to ask questions, share personal information, and discuss their personal concerns.(8, 
67, 74, 89) Patients in Peek et al’s(74) study refer to trust in the physician’s medical 
knowledge and skills as a facilitator: patients would be more likely to discuss treatment 
options, because they believe the options would be based on evidence based information.  
Similarly, patients have cited lack of trust as a barrier to involvement.(74, 89, 107) 
Interestingly, lack of trust also appears sometimes to encourage involvement in decision-
making, and inadvertently act as a facilitator. Patients in Fraenkel et al’s(67) study report that 
they would ask questions in a consultation if they did not trust their doctor. Whilst question 
asking is not the same as SDM, it does suggest that these patients are more inclined to 
engage in discussion with the doctor, which is essential for SDM. Patients with a negative 
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past experience who do not trust clinicians stated they wanted to be more involved, as did 
patients who did not trust the medical profession more generally, because of the control they 
are perceived to try to exert on patients.(84)  
Clearly trust is a complex issue, especially when trust and lack of trust are both barriers and 
facilitators to SDM. Trust is an essential component of any effective relationship, but it can 
make patients act more passively. Clearly, I would not advocate promotion of distrust to 
increase levels of participation in these patients; instead, interventions should focus on 
promoting trusting relationships between the patient and clinician (e.g. via more open 
communication) in conjunction with promoting positive attitudes among patients towards 
involvement, reinforced by clinicians who encourage this behaviour. As such, issues related 
to trust are modifiable, but cannot be addressed in isolation due to its complexity.   
c) Preparation for a SDM encounter (32/44) 
This theme differs from the next (‘preparation for a SDM process’), as it identifies the 
preparation needed for a patient to have opportunity to participate in SDM, rather than 
participation in the actual SDM process. 
(i) Perceived need for preparation (30/44) 
Perceiving there is no decision to be made is a barrier to SDM and can arise for several 
reasons. Sometimes, patients believe that they are not entitled to a choice, or they were not 
offered a choice, and therefore did not make any attempts to be involved as there was no 
(perceived) decision to be made.(67, 76, 82, 98, 102) However, the perception of ‘no choice’ 
is also related to the way in which the clinician presents the options e.g. if they indicate a 
clear preference or present them in a biased way.(80, 83, 86, 87, 102, 112) For some patients, 
the options available determine whether they perceive there is a decision to be made. For 
example, breast cancer patients in one study believed that ‘doing nothing’ was not an option, 
and a choice is only made when there are meaningful treatment options with equal value, as 
perceived by the patient, to choose from.(99)   
Patients’ acceptance of the SDM patient role will also influence their readiness to share 
decision-making. Feeling that you do not want to be involved in healthcare decisions is an 
important barrier. Various different reasons indicating why patients do not want to be 
involved have been reported, including: general preference for passivity and wanting to be 
told what to do;(76, 84, 89, 95) not wanting to receive or understand the information;(68, 
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101, 106) medical information is too distasteful;(76, 81, 88) involvement in decision-making 
may delay treatment.(68) One patient described how some people like ‘happy talk’ and to be 
‘kept in the dark’ and some people like the ‘facts’, with the former being less likely to 
participate.(101)  
Perceiving that you do not need to be involved is another, related barrier. Some patients 
presume that everything will get done for them, and thus they do not need to be prepared to 
play an active role in decision-making.(88) This was found to be the case in a study of 
adolescents where they felt involvement was not necessary, as their parents would take on 
that role.(114) On the other hand, recognising the SDM patient role, and accepting the 
responsibility to be involved is a key facilitator. As we would expect, the greater emphasis 
the patient puts on him or herself as the person responsible for making decisions, the more 
likely they are to be involved. Patients talk about a desire to be involved in their own 
healthcare in a sense that they are accepting responsibility.(67, 79, 86-89, 106) Some patients 
refer to this as wanting to have ‘control over your own destiny’(78), and some believe that 
having control over a situation is important when you are ill, and active involvement is key to 
this.(84) A patient in Frosch et al’s(38) study shows how responsibility to be involved 
sometimes goes beyond receiving options and discussing them; they believed that they had a 
responsibility to educate themselves and carry out their own research.  
Some patients were unsure about what it is they can expect from a SDM consultation and do 
not know what to prepare for. If they have never encountered SDM before, and thus do not 
know what it is they should be involved in, they do not know what information and support 
they can expect to receive ahead of making a decision.(74, 81) It therefore seems important 
to address patients’ expectations by explaining to them ahead of time what it is they can, and 
should, expect from a SDM consultation.  
(ii) Expectations of the outcome of being involved in SDM (21/44) 
When patients perceive that there are ‘right’ and ‘wrong’ decisions, this acts as a barrier to 
SDM. Some patients use the term ‘right’ to describe decisions that are made by their doctor. 
(80, 99, 103, 106) Patients report that they do not want to be involved in the decision-
making process because they do not want responsibility for a ‘wrong’ decision,(76, 80, 87, 
99, 103) suggesting that they want to avoid any potential regret. Some patients talk about 
being able to ‘blame’ clinicians for ‘bad’ outcomes if they are not active participants in the 
decision-making process.(99) On the other hand, when patients recognise that there are no 
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right or wrong decisions in situations of equipoise, just ‘decisions that are right for me’, this 
acts as a facilitator to involvement. This acceptance of uncertainty, and recognition that 
certain decisions are based on personal values, encouraged patient involvement (67, 83, 89, 
101) 
For some patients, a fear of accepting the reality posed by the diagnosis (e.g. diabetes,(74) 
cancer(108)) is a barrier to involvement. They may have anxiety towards certain 
examinations or treatment,(106) or they may feel unable to cope with the diagnosis that they 
have been given.(89, 102) Patients in Peek et al’s(74) study described how fear and denial are 
important barriers in SDM, with several patients reporting that they would rather not know 
the truth, and thus do not want information about the diagnosis or the likely outcomes of 
the different options. In the context of advanced care planning (e.g. end of life decisions) 
some patients would simply rather not think about the future: ‘I would rather concentrate on 
staying alive than talking about death.’(92) 
Overall, most factors related to preparation for a SDM consultation are modifiable, and can 
be addressed by seeking to change attitude or subjective norm beliefs e.g. clearly outlining 
the concept of equipoise, emphasising patients’ roles/responsibilities and the need to 
participate, outlining what is involved in the SDM process. However, some factors will 
remain non-modifiable by an intervention to encourage involvement e.g. the shock after 
receiving a cancer diagnosis.  
d) Preparation for a SDM process (36/44) 
(i) Information provision about options (27/44) 
Many patients feel they cannot be involved in decisions when they do not have information 
about the specific condition, when they are unaware of the options and what they entail, or 
do not know the possible outcomes. For example, Nodgren et al(98) described how patients’ 
self-determination in the care context was limited, because they lacked knowledge about 
their disease and the available treatments. One patient noted, ‘I don’t think I had received 
enough information about the risks to be able to make a decision about the operation’(98). 
Skea et al (83) explored women’s views of decision-making relating to hysterectomy, and 
similarly found that limited information provision, especially about the possible treatment 
outcomes, restricted patients’ abilities to participate in the decision-making process.  
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Equally, provision of sufficient information to address individual information needs was a 
key facilitator. Eldh et al(69) explored conditions for patient participation in healthcare by 
asking patients to describe previous situations in which they participated, or did not 
participate, and to explain the reasons why.  Being informed according to individual needs 
was one of the main conditions for participation cited by patients in this study.  Peek et 
al(74) explored barriers and facilitators to SDM among African-Americans with diabetes. 
They found that informed patients reported more self-efficacy, not only in participating in 
decision-making with their physicians, but also in their confidence to ask questions about the 
various treatment options, thus actively participating in the dialogue. Similarly, Thorne’s(101) 
study of cancer patients highlighted how patients felt better prepared to engage effectively in 
consultations when they were appropriately informed according to their individual needs. 
Earlier provision of information, e.g. before consultations, was reported by some patients as 
an important factor in being prepared for a SDM process.(83) 
The way in which clinicians present the available options was another frequently cited barrier 
and facilitator. When the clinician did not take time to explain each option, patients found it 
difficult to participate in the decision-making process. For instance, hysterectomy patients in 
Skea et al’s(83) study described how they were not given sufficient information about the 
alternative options available to be able to make a shared decision. One patient reported that 
she was given very little information regarding how the laser treatment option would work 
compared to the surgical option, and she did not know what the possible side effects or 
outcomes of the laser treatment would be. Another patient reported a similar situation 
regarding the medication options; she received no information about how these options 
worked compared to the surgical options. Additionally, she received no information about 
the possible disadvantages of any of the options, leaving her unsure as to whether there were 
any disadvantages of surgery, and thus unable to make an informed decision.   
Conversely, when the clinician clearly presents the available options and discusses what the 
options entail (e.g. procedure, possible outcomes), patients feel much better prepared to take 
part in medical decision-making. Most early stage breast cancer patients in the first phase of 
O’Brien et al’s(100) study felt that the surgeon helped them to be involved in treatment 
decision-making when they discussed their surgical options. Individual patients commented 
on the helpfulness of being presented with the personalised outcome data and the 
opportunity to view the ‘stats’ to make a judgement on the outcomes of each option e.g. 
highest possibility of recovery. Survey respondents in Caress et al’s(78) study of asthma 
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patients indicated that active participation was linked to how much patients felt they knew 
about their condition and the available treatments. Participants in Thompson’s(84) study 
were asked to describe what happens in their healthcare consultations, and to identify factors 
that helped or hindered the process. Patients described situations of being involved as being 
told your diagnosis and having somebody take the time to explain the available options, 
along with the side effects. Significantly, the patients refer to their involvement as being part 
of a ‘team’, within which their opinions are valued.  
(ii) Terminology used by clinicians (17/44) 
Patients feel that it is difficult to be involved in the decision-making process when clinicians 
use medical jargon instead of simple terms that patients can understand.(81, 87) Doherty et 
al(81) describe a situation whereby a patient who wanted to participate in SDM felt unable to 
do so because they were intimidated by the doctors’ use of medical terminology during ward 
rounds. Further studies highlight this problem, whereby patients feel that the clinicians are 
‘talking another language’(98) or ‘talk so far over patients’ heads’.(67) In some situations, 
unexplained medical terminology can lead patients to misinterpret the procedures that are 
being offered, and thus hinder their ability to make reasoned decisions about them. In 
Farahani et al’s(105) study, one patient described how many patients thought that an 
angiography was a dangerous operation with the possibility of dying, as opposed to a type of 
x-ray.  
On the other hand, patients frequently cited the use of simple, non-technical language as a 
facilitator to involvement in the decision-making process. Patients in Eldh et al’s(69) study 
discussed the importance of being informed according to personal needs, but they also 
highlighted the importance of receiving this information in a way that the patient could grasp 
it. Patients’ quotes indicate that the use of ordinary language and alternative information 
presentations, such as diagrams, facilitated involvement. Similarly, patients in Peek et al’s(74) 
study stressed the importance of discussing medical problems in ‘layman terms’, which could 
also be facilitated through the use of diagrams. Patients in this study talk about bringing the 
doctor down to the level of the patient, or the doctor bringing the patient up to their level, 
suggesting a compromise whereby each participant in the SDM encounter attempts to ease 
the information exchange process: clinicians use simple terms and they also help patients to 
become more informed in the medical terminology. Importantly, Kelsey et al’s(82) study of 
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hospitalised young people highlighted the impact of providing information at an appropriate 
level for perceived, and possibly real, empowerment and autonomy in the young people.  
(iii) Decision Support (8/44) 
Lack of written decision support can act as a barrier to involvement, because it is difficult to 
remember the information presented.(100, 111) Barnard et al(77) showed that patients 
valued decision support materials as they helped them to remember information, focus on 
points of concern, think about issues they wish to discuss in the consultation, and thus 
facilitated SDM. Decision aids are also seen as a good starting point to promote discussion 
with clinician, and thus involvement in the SDM dialogue.(68) However, it is important to 
note that whilst some patients view decision support materials as helpful, others felt that 
they make the consultation feel impersonal and false, and they favoured the direct 
information exchange from the doctor(68, 77) The facilitative potential of decision support 
materials is reduced if patients feel that the purpose of the tool is unclear,(93) and patients 
also commented on the difficulty of ‘keeping up’ with rapidly evolving medical information. 
(89) Decision support also refers to the support that the patient is offered from alternative 
sources e.g. family, friends, other patients, non-doctors; patients in two studies highlighted 
the importance of discussing your treatment options with other people.(8, 83)  
The factors related to preparation for the SDM process are modifiable; many of the listed 
barriers could be addressed through adequate information provision about the options 
available (whether this be decision support tools or from the clinician), a balanced 
presentation of options, and use of non-medical terminology by the clinician when 
discussing the options.  
2.4 Discussion  
The results suggest that most patients currently can’t participate in healthcare, due to various 
structural, pre-disposing, interactional, and preparatory factors, rather than the more 
common view among clinicians that patients won’t participate because they don’t want to. 
Patient-reported barriers and facilitators to SDM relate to how the healthcare system is 
organised (i.e. time available, continuity of care, organisation of workflow, and the setting 
itself) and to what happens in the consultation (i.e. predisposing factors such as patient 
characteristics, interactional influences including the power imbalance between patient and 
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clinician, and preparation for the SDM encounter and the process itself, including knowledge 
gain). These need to be considered alongside clinician-reported factors(57) during 
intervention development and implementation. Predominant themes were patients’ 
knowledge and the power imbalance in the clinician-patient relationship. Significantly, most 
patient-reported barriers and facilitators are potentially modifiable, and many can be 
addressed by attitudinal changes at the levels of patient and clinician/health care team, or 
cultural change at the organisational level.  
An ‘informational paradox’ 
An important information paradox has been identified. Unsurprisingly, the principal enabler 
to SDM is having informational needs met at an appropriate level for the individual. 
However, we cannot consider this in isolation from other relevant factors because of their 
complex interactions. Patients report that they need to have their informational needs met in 
order to participate, but they also undervalue their ability to acquire this knowledge, and 
undervalue any knowledge gain relative to that of the clinician. The prevailing view is that 
‘doctors know best’. Patients feel that they are unable to acquire the complex medical 
information that doctors own, and any knowledge they acquire will always be trumped by the 
doctors’ expertise; thus inevitably patients tend to defer medical decisions to the clinician. 
Patients place physicians on a pedestal with regard to their ‘superior’ knowledge, and there is 
some evidence that patients feel more comfortable when they perceive their doctor to be ‘all-
knowing’. A recent article found that patients derogate physicians who use a clinical decision 
support, as they deem them less capable than those who do not use a tool to aid 
diagnosis.(120) A contributing factor is that patients also place much emphasis on medical 
information provided, but do not recognise, or undervalue, the complementary expertise that 
they can bring to the SDM encounter i.e. personal preferences and circumstances. This 
suggests that the only expertise patients recognise as legitimate in the healthcare consultation 
is the medical expertise.  
Therefore, information provision alone appears insufficient for SDM; patients need to be 
supported so they feel that they are capable of acquiring and understanding knowledge about 
the available options, and so that they value their personal knowledge contribution in this 
process. In relation to Nutbeam’s levels of health literacy (functional, critical, interactive),(44) 
the focus for interventions should be on developing interactional health literacy, which 
encourages the development of personal skills so that people can actively use the knowledge 
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acquired, as opposed to functional health literacy, where the focus is on transmission of 
factual information.   
‘Covert contracts’ in the patient-clinician relationship 
Interacting with this informational paradox are the ‘covert contracts’ that patients develop 
with clinicians, usually physicians, which are not typically acknowledged. Many patients enter 
into an unspoken contract with the clinician, adopting the role of a ‘good patient’, 
characterised by passivity and compliance. This chapter does not elucidate the reasons why 
these contracts exist (e.g. socialisation to patient role, previous experience, social/cultural 
norms, the media).(121) Nonetheless, presumptions about the ‘normal’ patient role emerged 
as an important barrier, with many patients believing that they should not or cannot be 
involved.  In Foulcaudian terms,(122) we may be able to change discursive practices 
regarding expected patient roles if patients experience discursive practices regarding where 
they are encouraged to avert the traditional ‘clinical gaze’, by considering their own 
preferences and developing skills of self-representation. Therefore, implementation attempts 
should also focus on providing patients with explicit permission to change these ‘contracts’ 
and promote their self-efficacy, or confidence, in achieving this.  
This approach would reflect a generative ‘asset’ model of health literacy,(43, 44) where it is 
proposed that health literacy skills, which are needed to engage in SDM,(43) are an asset that 
develops over time. As outlined in the Health Literacy Pathway Model,(43) health 
knowledge, or a basic understanding of the health information, is just the first of five stages 
in being able to participate in SDM: there are other skills that the patient needs to develop, 
or enhance, in order to appraise this information and to engage in a discussion with the 
clinician. As such, once patients have been given this permission to participate, we will need 
to support the development of the necessary skills, and promote their self-efficacy in 
participating.    
Knowledge does not equal power 
As we have seen, knowledge provision, acquisition, and expectation to contribute personal 
preferences are done in the context of a power imbalance between clinicians and patients. 
Therefore, information provision and values clarification exercises (e.g. in decision support 
tools) alone are unlikely to promote SDM for most patients. We must also address the power 
imbalance that exists so that people feel that they can and want to use this knowledge. 
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Contrasting the well-known phrase, it would appear that knowledge does not equal power 
(Sir Francis Bacon, 1597), at least in the discourse of medical decision-making: patients need 
knowledge and power in order to participate in SDM. Individual capacity to participate is 
linked to how much knowledge a patient has (i.e. knowledge about treatment options and 
knowledge about their own personal circumstances) and how much power they have, or 
perceived capacity to influence the decision-making encounter (e.g. having permission to 
participate, confidence in own knowledge, having necessary skills, and self-efficacy in using 
these skills). All other factors (e.g. interpersonal characteristics of the clinician, patient 
characteristics, time) will promote or inhibit this capacity depending on their presence or 
absence (see Figure 2.2) Again, this approach has parallels with action orientated models of 
health literacy,(43, 44) in which there is a focus on motivational aspects, and not just 
intellectual capacity: it is about getting patients to actually use the information that they are 
given, by understanding and promoting the motivating factors and skills that will enable 
them so to do.  
Comparison with clinicians’ views 
The three most commonly cited clinician-reported barriers are time, lack of agreement with 
the applicability of the approach to the patient, and lack of agreement with the applicability 
of the approach to the clinical situation,(57) suggesting clinicians presume that many patients 
will not benefit from SDM, or do not wish to take part. Whilst patient characteristics such as 
desire to participate emerged as factors in this review, factors other than desire were much 
more prominent (e.g. knowledge, power imbalance, interpersonal characteristics of the 
clinician). This supports Legare’s suggestion that interventions should be patient-focused, 
encouraging patients to take a lead in decision-making, in order to avoid clinicians making 
sometimes erroneous, a priori judgements about lack of ability or desire for involvement. 
However, it also highlights the importance of understanding the patient-reported barriers, as 
they are distinct from the clinicians’ barriers literature. This again lends more support to the 
view that patients currently can’t participate, rather than they won’t participate because they do 
not want to.
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Preparation for what?  
Another important distinction that emerged concerned the different types of preparation 
needed for SDM: preparation to participate in the decision-making process itself, but also 
the attitudinal preparation needed to present a patient with the opportunity to participate in 
SDM. To date, it appears that many of the interventions designed to encourage patients to 
participate in SDM focus on preparation for the decision-making process.(16) In fact, the 
barriers cited in relation to process, such as lack of information about options and use of 
medical terminology, have largely been addressed by these interventions; thus the use of 
these would help to overcome these specific barriers. However, it appears that interventions 
have largely overlooked the attitudinal preparation that is also needed, which interacts with 
the power imbalance evident in the patient-clinician relationship. Power imbalance and the 
associated attitudes towards patient involvement were a key barrier; if attitudinal preparation 
to address beliefs and perceived social norms about the passive patient role does not take 
place before information provision, it is unlikely that that patients will change their 
behaviour and actively engage in the decision-making discussion.  
2.4.1 Implications 
The discussion above pertains to the key themes and interactions that have emerged from 
this review; there are many additional barriers and facilitators that have been identified 
through other literature (e.g. clinician perspectives)(57) that will also need to be considered 
during intervention development, and these will be discussed in further detail in Chapter 4. 
However, it is clear from this review that many of the patient-reported barriers are 
attitudinally based, and are therefore potentially modifiable. Given the significance of 
patients’ beliefs and normative attitudes towards SDM, behaviour change theories are an 
appropriate guide for intervention development and evaluation. Many behaviour change 
theories include these concepts as key drivers of behaviour, including the BCW Guide.(47) 
This is discussed further in Chapter 4.  
It should be acknowledged that many behaviour change theories account for change at the 
individual level. Therefore, it is critical that a behaviour change intervention is embedded 
within the wider implementation context. First, I have identified ‘pre-disposing’ factors 
relevant to the patient and the decision, which will determine the relevance (or not) of SDM 
to that situation e.g. preference-sensitive decision, emergency situation, health-literacy level, 
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perceived self-efficacy, patient with cognitive impairment. These need to be considered when 
initiating a SDM interaction, but the modifiable nature of some of these factors suggests that 
they should not necessarily act as a barrier to offering SDM (e.g. ‘age’ as a barrier might be 
related to subjective norms about what it means to be a ‘good’ patient, rather than age per 
se). Second, I have identified clinician-related attitudinal and behavioural factors that will 
facilitate or impede SDM depending on their presence or absence: this is in addition to the 
published taxonomy of clinician reported barriers/facilitators.(57) Third, I have identified 
organisational factors that might also impact on patients’ ability to participate in SDM e.g. 
time.  
An intervention may be successful in changing attitudes and subjective norms, so that a 
patient intends to carry out SDM, but patients might be incapable of carrying out the 
intended behaviour if, for example, the doctor has a negative attitude towards involvement 
or they are not afforded the time need to engage in the process. What is clear from this 
current review is that organisational and clinician attitudinal/behavioural changes alone will 
not support SDM: as such, an intervention focused on patient attitudinal/behavioural 
change, implemented in the context of these wider changes, should be used to guide 
intervention development as it addresses the attitudinal and behavioural changes needed at 
the patient level.  
2.4.2 Strengths and weaknesses 
To my knowledge, this is the first systematic review to focus exclusively on patient-reported 
barriers and facilitators to SDM, and direct enquiry with patients in the primary studies is a 
significant strength of this study. This review does not focus on characteristics that are 
correlated with a greater desire to be involved, or greater actual involvement; it examines 
what patients have reported to be significant factors in helping them or stopping them from 
being more involved in their healthcare consultations. Direct enquiry might miss more subtle 
barriers and facilitators that are not directly obvious to patients (e.g. coping style), but I am 
confident that the key factors influencing participation have been identified, supported by 
their consistency across a large number of studies using various research methodologies.  
Although systematic searches were used, this is not a well-indexed field of research and 
researchers have varying interpretations of SDM: as such some articles might have been 
missed in this review. Synthesising qualitative data derived from the systematic review 
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approach is also an emerging field of research, whereby the methodologies are not as well 
defined as, for example, systematic reviews of effect sizes using randomised controlled 
trials.(123) However, this review has used a well-documented approach developed by the 
ESRC for analysing the qualitative data from our review(73), and the process has been 
described.  I used an inductive approach to analysing the data because no pre-existing 
taxonomy of patient-reported barriers/facilitators to SDM existed, which ensures that key 
themes were derived directly from the data. The resultant taxonomy of patient-reported 
barriers and facilitators can be used to complement the clinician taxonomy.(57) 
In this review, some patients have said that they do not want to be involved in decision-
making. However, it is not clear from our review if these patients have made an ‘informed’ 
decision not to be involved; in other words, these patients may state that they do not want to 
be involved because they have never been afforded the opportunity to be, and thus do not 
know what it means to be involved. It is possible that many of the ‘do not’ want to 
participate individuals are actually ‘cannot’ participate individuals, because their participation 
is limited by their lack of knowledge of what it is to be involved. This fits with findings from 
Longo et al’s discrete choice experiment study, whereby patients placed greater value on 
SDM consultations once they had experienced them.(124) This highlights the importance of 
informing all patients about what a SDM consultation involves and offering them the 
opportunity to participate; a patient-targeted guide to a SDM consultation could help 
patients to make more informed choices about whether or not they want to participate.  
2.4.3 Conclusion 
This review found that patients need knowledge and power to participate in SDM. One of 
the most significant barriers to SDM was inadequate information provision.** To date, 
researchers appear to have ‘picked off’ the most prominent patient-reported barrier to 
involvement, that being inadequate information provision, and have perhaps wrongly 
assumed that they can address this barrier in isolation from the many other interacting 
factors: as demonstrated by a focus on developing patient decision aids(16) and the content 
and development process for these.(125, 126) Decision aids are successful at supporting 
patients in the SDM process, but they fail to address the essential first step of ‘preparing for 
                                                 
** This chapter forms the basis of two published articles in Patient Education and Counseling and the BMJ.  These can be viewed in 
Appendix 2.2 and Appendix 2.3, respectively.  
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the SDM encounter’, including perceiving the opportunity and personal ability to be 
involved. Knowledge provision and encouragement to think about personal values alone are 
unlikely to support actual involvement in SDM for a large number of people. Power 
imbalance in the clinician-patient relationship and perceived acceptability of patient 
involvement are also key barriers. These must be addressed too if patients are to change their 
long-established behaviours and actively engage in decision–making discussions. 
In one of the earliest papers published in this field, Charles and colleagues wrote about what 
it means to be involved in SDM.(12) Fundamentally, at least two participants, a clinician and 
patient, need to be involved. Attempts to develop tools to support this interaction have been 
successful, but SDM researchers and implementers seem to have forgotten that ‘it takes at 
least two to tango’ when conducting implementation work.  The focus on addressing 
clinician and organisational factors has meant that little value has been afforded to what 
patients actually think about implementing this approach; what do they think helps or stops 
them from taking part? This Chapter has taken steps to explore this and Chapter 4 will 
ensure that this viewpoint is integrated with existing implementation literature to form a 
strong theoretical foundation for developing a complex intervention to support SDM. 
However, SDM researchers and implementers must remember that patient-reported factors 
cannot be addressed by focusing on patients alone: significant structural and attitudinal 
changes at the organisational and clinician level are still needed, and clinicians will have a 
valuable contribution to changing the subjective norms of patients.  
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Chapter 3 
A review and critical evaluation of patient-targeted 
interventions designed to prepare patients for 
SDM: do they address patient-reported barriers 
and facilitators? 
3.1 Introduction 
 ‘Doctor knows best’ is perhaps one of the most clichéd terms used to describe patients 
perceptions of the doctor-patient relationship, but the consequences of this view on patients’ 
capacity to participate in shared decision-making (SDM) should not be underestimated. As 
highlighted in Chapter 2, patients need knowledge and power to participate in SDM. 
Attitudinal factors, such as perceived social norms about appropriate behaviour in the 
doctor-patient interaction and not having ‘permission’ to participate, were key patient-
reported barriers to participation. Significantly, the results indicated that providing decision 
options and knowledge to patients does not empower them to participate in SDM if they do 
not know what to do with the knowledge, or feel that they cannot do anything with that 
knowledge. It was concluded that an intervention designed to promote patient participation 
in SDM should focus in the first instance on addressing patients’ attitudinal factors, before 
information provision about options. This review aims to identify and critically evaluate 
existing interventions that focus primarily on attitudinal change and preparing patients to 
engage in a SDM discussion.  
A Cochrane Review of patient decision aids now includes over 100 randomised controlled 
trials of interventions that focus primarily on information provision and values clarification; 
most of these trials show favourable outcomes for patients, including improved knowledge 
and more realistic perceptions of treatment outcomes.(16) Implementation programmes 
have also focused on integrating decision support interventions into clinical pathways and 
distributing these tools.(60-64) The considerable number of decision aids that exist for 
various healthcare decisions, and the integration of these into clinical systems, indicates that 
researchers have focused on addressing one of the key patient-perceived barriers to SDM - 
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knowledge. However, researchers have paid less attention to ‘entry-level’, or ‘gatekeeping’ 
factors that will determine whether patients actually engage in a SDM discussion, and use 
their acquired knowledge. In other words, interventions have focused on addressing the 
‘knowledge’ deficit, as opposed to the ‘power’ or attitudinal barriers (e.g. having ‘permission’ 
to participate, perceiving the patient role as active in the decision-making process, belief in 
own knowledge and ability to acquire knowledge about the options).  
For many patients, participation in SDM signals a significant attitudinal and behavioural shift 
from what they are used to (e.g. expectation of being passive and being told what to do by 
the clinician). When we look at health-related behavioural change literature, there is a focus 
on understanding the motivations and barriers for conducting positive health behaviours, in 
order to understand how negative health behaviours can be changed (e.g. (116, 117) Whilst 
SDM is not typically viewed as a health behaviour, not participating in the decision-making 
process could be viewed as a negative health behaviour that has potential negative outcomes 
e.g. decisions misaligned with the patient’s preferences, receiving treatment that you do not 
want or need, or outcomes that you did not expect.  
If a clinician were faced with a long-term smoker, it is unlikely that they would hand them an 
intervention (e.g. nicotine patches, medication) with some information about how they are 
used, and expect them to change their attitudes and behaviours to smoking immediately. 
They would need to make sure that the smoker was ready to participate in the behaviour 
change first, understand their motivations and barriers for doing so, and offer support to 
change their attitudes about the negative health behaviour. On the other hand, decision 
support tools are handed out to patients, which provide the necessary tools and knowledge 
to become involved, without first making sure that the patient is ready or prepared to be 
involved. Implementation researchers have also tended to neglect patients’ motivations and 
barriers for becoming involved in SDM, and therefore have little understanding of what 
factors will actually lead to a behavioural change: a perspective that Chapter 2 has 
synthesised. A taxonomy of patient-reported barriers and facilitators to SDM was proposed 
(see Figure 2.2, Chapter 2),(127) which allows us to understand the patient-perceived 
motivating and impeding factors that must be addressed in order to change attitudes about 
SDM among patients, and subsequently behaviours. Interventions should consider these in 
conjunction with clinician-perceived factors and organisational perspectives.(33, 57)  
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A key step in developing a complex intervention is to understand the existing evidence base 
and available interventions.(45) Given the abundance of interventions designed to address 
the knowledge barrier, this chapter focuses on interventions that prepare patients for a SDM 
encounter by addressing attitudinal and normative factors, before information provision. 
The decision specific interventions addressing knowledge (i.e. decision aids) should be used 
as adjuncts to the attitudinal interventions, but results from Chapter 2 indicate that they are 
unlikely to promote SDM for most people in isolation from such attitudinal 
interventions.(127) The aim of Chapter 3 is to identify, describe and critically evaluate 
patient-focused interventions that aim to prepare patients for a SDM encounter by primarily 
focusing on attitudinal and normative factors. Specifically, I will assess: 
a) Characteristics of included interventions 
b) To what extent the identified interventions address patient-reported barriers and 
facilitators to SDM 
c) Evaluations of effectiveness of these interventions, focusing primarily on patient 
reported and health outcomes 
3.2 Methods 
3.2.1 Search strategies 
Targeted literature and online follow-up searches were used. Previous Cochrane Reviews 
have been conducted that identify the following: decision aids for people facing health 
treatment or screening decisions;(16) interventions before consultations for helping patients 
to address their information needs;(128) SDM interventions for people with mental health 
conditions;(129) and interventions for improving older patients’ involvement in primary care 
episodes.(130) Broadly, these reviews identify patient-focused interventions that have been 
designed to promote active patient participation in SDM during healthcare consultations. 
Specifically, these may include some interventions that have been delivered before 
consultations that explicitly aim to prepare patients to take part in a SDM by focusing on 
attitudinal change.   
Each previous review has used inclusion and exclusion criteria that are relevant to their 
specific aim e.g. interventions delivered before the consultation(128) or interventions for 
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patients with mental health conditions.(129) Additionally, Cochrane Reviews tend to employ 
stricter criteria regarding study design e.g. only randomised controlled trials are considered 
(see Additional Appendix 3.1 on included CD for full details of inclusion/exclusion criteria 
used in previous reviews). Cochrane guidelines state that the associated publication should 
report studies that were excluded from the review, as well as those studies that were 
included.(131) Therefore, for the purposes of the current review, publications noted as 
included and excluded in each review were considered. Publications noted in the reference 
lists as ‘awaiting assessment’, as they are on going, were also consulted. An update of one of 
the reviews was being conducted at the time of this work(128), so the results of this update 
were also considered (available via personal communication).   
Targeted follow-up searches were conducted to complement the searches of previously 
published reviews. These included: consulting websites and publications of organisations 
known to promote patient involvement or healthcare improvement (e.g. Informed Medical 
Decision Making Foundation, Expert Patients Programme); consulting health related 
Government websites and policy documents; consulting departmental/organisational 
websites of authors from the book ‘Shared Decision Making in Health Care: Achieving 
Evidence Based Patient Choice’;(132) examining abstracts from the 2013 International 
Shared Decision Making Conference (Peru, June 2013); and manual searches of the reference 
lists of papers included for full text analysis (see Figure 3.1). 
3.2.2 Selection criteria 
A study/intervention was eligible for inclusion in this review if:  
(i) the intervention was patient-focused, or focused on the patient and their 
representative e.g. carer, surrogate decision maker, partner; 
(ii) the intervention is delivered before a consultation (in which the decision is 
discussed); 
(iii) the intervention aims to prepare patients for a SDM encounter with a 
clinician (i.e. increasing readiness to participate) by focusing on attitudinal 
change towards patient involvement in SDM (i.e. a patient’s 
beliefs/expectations about being involved in the SDM process).  
Evidence of this intention could include, for example:  
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 highlighting the active patient role in decision-making as accepted and expected; 
explaining what SDM is/outlining the process; 
 outlining the patient role in the SDM process; 
 promoting favourable attitudes towards participation in SDM.  
For inclusion, the attitudinal change tasks must be followed-up by information provision 
about the available options and preference clarification tasks, but attitudinal change tasks 
must be distinct from and precede information provision/values clarification support. This 
is based on results from Chapter 2, which indicate that attitudinal change acts as a potential 
gatekeeper to actual engagement with information about treatment options and exploration 
of personal values.  Also, knowledge about the available options is essential if a patient is to 
fully engage in the decision-making process.  
Studies were excluded if the intervention: 
(i) aimed to improve general communication and information exchange in the 
healthcare consultation, without specific focus on the decision-making 
processes i.e. those that do not intend to impact on the decision-making 
dialogue between the patient and the clinician(s); 
(ii) is provided during or after a consultation; 
(iii) solely provides information about treatment options and/or promotes values 
clarification, in the absence of attitudinal preparation, or if attitudinal tasks 
do not precede information provision/preference clarification tasks; 
(iv) only encourages patients to consider treatment options away from the 
consultation (promoting autonomous rather than SDM); 
(v) is targeted solely at clinicians (e.g. skills training) or for individuals attending 
group consultations/activities (e.g. antenatal classes).  
Interventions were also excluded if they aimed to promote any of the following: treatment 
adherence; compliance with a certain option; informed consent; patient involvement in other 
aspects of healthcare (e.g. service design, clinical trial participation); general involvement in 
self-management/self-care. Interventions were excluded if the intervention description, 
content and process of delivery, was not sufficient enough (after contact with 
author/developer) to determine if the intervention aimed to prepare patients for a SDM 
encounter by focusing on attitudinal change. Studies/interventions were not excluded on the 
basis of study design, method or language. When the same intervention is described in more 
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than one publication, the original development publication was included, or the earliest 
publication describing intervention format/use/evaluation in the absence of a 
developmental publication. All additional papers were considered as background papers 
during data extraction for details on intervention content, use, and effectiveness etc.  
3.2.3 Intervention identification and data extraction 
The title and abstract of all references identified through reference lists of previously 
published reviews(16, 128-130) were screened for relevance. Full text articles/full 
intervention details of potentially relevant studies/interventions were obtained for detailed 
evaluation. When sufficient information was not provided in associated publications, 
intervention developers were contacted to obtain a copy of the intervention, information 
regarding its development, and information on its current use and implementation in 
healthcare settings.  Relevant information for data extraction was agreed and data extraction 
forms were piloted. Data were extracted under the following headings for all interventions 
meeting the inclusion criteria (data derived from main development publication and/or 
background publication(s)): intervention characteristics (developer, year, country of origin, 
language, name/title, aim, intervention description, format, method of delivery, timing/point 
of delivery, target audience/healthcare setting, generic versus decision specific intervention); 
development process/formative research; theoretical base/conceptual framework used; 
evaluation process/plans.  Additional data were also extracted regarding the associated 
publications i.e. those publications that described either the development, pilot-testing, 
implementation or effectiveness of the intervention, including: author, year of publication, 
country, publication details, principal aim, study design, methodological approach, data 
collection methods, setting, participant details, and outcomes.  
3.2.4 Intervention evaluation 
The included interventions were assessed against the patient-reported barriers and facilitators 
to SDM identified in Chapter 2 (see Table 2.2) in order to examine the extent to which the 
interventions addressed the identified factors. Interventions were assessed against each 
barrier/facilitator using the following question: to what extent could the intervention, or the 
way in which the intervention is used, address the barrier/facilitator? A 4-point Likert-like 
scale was used: 1 = not at all; 2 = very little; 3 = moderately; 4 = to a great extent. An 
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‘unsure’ option was also available, if it was felt that there was not enough information 
available regarding the intervention or the way in which it is used to make a judgment. 
Details regarding the exact component(s) of the intervention and/or the intervention 
implementation process that addressed the barrier/facilitator were also extracted. When the 
intervention was not available after contact with the developer/author, scores were based 
solely on the associated publications. Interventions were not evaluated against non-
modifiable barriers and facilitators that could not be influenced by any intervention (e.g. 
patient-targeted, clinician-targeted, organisational change intervention). These include: being 
in poor health, being in good health, cognitive impairments, prior exposure to the illness / 
decision-making point, difference in personal characteristics between the patient and the 
clinician.  After the interventions were scored using the 4-point Likert-like scale, a ‘traffic 
light’ system was used to categorise the barriers/facilitators as follows:  
a) Green indicates that the barrier/facilitator has been addressed sufficiently by 
interventions; 
b) Amber indicates that the barrier/facilitator has been addressed to some extent, but 
there are areas for improvement; and  
c) Red indicates that the barrier/facilitator has not been addressed sufficiently by 
previous interventions.  
A further category (grey) was assigned when a barrier/facilitator had not been addressed, but 
it was felt that either a patient-targeted intervention would have little direct influence on that 
factor, or the factor is only relevant in very specific situations. The effectiveness of the 
interventions was determined by assessing evaluation methods and impact on decision 
outcomes.  
3.3 Results 
3.3.1 Included interventions 
Searches of previously published reference lists(16, 128-130) (including unpublished update, 
available via personal communication) yielded 446 unique references; 215 full-text 
articles/intervention details were retrieved for detailed evaluation. Seven interventions were 
included from electronic (n=5)(17, 133-137) and follow-up (n=2)(33, 138) searches. One 
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intervention has been evaluated in two separate trials. (17, 135) Three additional 
background/evaluation papers were included for the Sepucha(137) intervention.(139-141) 
Figure 3.1 describes the progress through the review, including details of 
articles/interventions identified via reference lists of previously published reviews, 
articles/interventions identified via follow-up searches, the stages at which 
articles/interventions were assessed (title and abstract, full text) and excluded or underwent 
data extraction, and the final articles/interventions included in the analysis.
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Figure 3.1  -  Flowchart of progress through literature review 
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3.3.2 Intervention and study characteristics 
Seven different interventions were evaluated in the review (17, 33, 133, 134, 136-138), and 
four additional papers that describe the evaluation of included interventions were 
included.(135, 139-141) Three out of the seven interventions were developed in Australia, 
(133, 134, 138) three in the USA, (17, 136, 137) and one in the UK. (33) The earliest 
intervention was published in 1985; (17) the most recent were made available in 2012. (33, 
138) Two interventions are now publicly available campaigns, (138, 142) whilst five 
interventions have been developed and tested solely in a research setting. (17, 133, 134, 136, 
137) All of the interventions are generic (i.e. they can be used for any health condition), but 
three of the interventions contain disease specific elements (e.g. algorithms, question prompt 
lists). (17, 134, 136) The interventions have been used in various settings, including: cancer, 
(33, 134, 137) diabetes, (135, 136) female cancer, (33, 133, 137) maternity,(33) 
musculoskeletal,(33) paediatric ears nose and throat,(33) peptic ulcer disease,(17) primary 
care,(33, 137) renal,(33) reproductive and sexual health, (138) and urology.(33) Full details of 
intervention characteristics can be found in Table 3.1.  A brief summary of each intervention 
is provided below.  
3.3.2.1 Ask 3 Questions (33)  
Ask 3 Questions is a patient activation marketing campaign, designed to increase patients’ 
awareness of SDM and to change their expectations about patient involvement. It is 
intended to ‘activate’ patients before healthcare consultations by encouraging them to ask 
three key questions about their healthcare options:  
1) What are my options?  
2) What are the possible benefits and risks of those options? 
3) How can we make a decision together that’s right for me? / how likely are the 
benefits and risks of each option to occur?  
The questions are reinforced with the statement, ‘we want to know what’s important to you’, 
in order to emphasise the importance of patients’ preferences. Originally from 
Australia,(143) the campaign was further developed in the UK (Cardiff and Newcastle) as 
part of an SDM implementation programme called MAGIC,(33) which used a quality 
improvement methodology; subsequently, local level testing and adaptation led to variations 
of the campaign questions. Various promotional materials were developed to display the 
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three questions, including posters, booklets (explaining the rationale for SDM and 
promoting active patient role) and a promotional video for use in waiting rooms.  
It is used as both an intervention to be handed out to patients ahead of their consultation 
(with appointment letter or on arrival at appointment) and a general awareness campaign 
used across the local healthcare organisations. The campaign was implemented as part of a 
range of packages including, SDM skills training for clinicians, organisational engagement 
strategies and decision support tool development (e.g. Option Grids).(35) Ask 3 Questions 
has since been made publicly available for use or adaptation by other healthcare or voluntary 
organisations.(142, 144)  
3.3.2.2 Ask Share Know (ASK) (138) 
Ask Share Know (ASK) is a patient targeted campaign designed to encourage and empower 
people to be involved in decisions about their health. It has three main components, Ask, 
Share, and Know, but also explains and provides a rationale for SDM. The Ask component 
encourages patients to ask three key questions when they are given healthcare options:  
1) What are my options? (one option will always be wait and watch); 
2) What are the possible benefits and harms of those options? 
3) How likely are each of those benefits and harms to happen to me? 
The Share component encourages patients to share personal information with the clinician, 
so that they are aware of the patients’ individual lifestyle preferences and needs. The Know 
component emphasises the importance of knowing all of the information you need to (e.g. 
possible outcomes, likelihood of outcomes, personal preferences) in order to make an 
informed decision. This section also contains a patient consultation summary tool to help 
structure the consultation around ASK. Various promotional materials have been developed 
including a website, video clips and magnets (with the website details). These materials are 
distributed to patients immediately before their consultation. ASK was originally developed 
as part of a research program, but it is also publicly available online (138) and the materials 
have been distributed by various patient organisations.  
3.3.2.3 Cancer Consultation Preparation Package (CCCP) (134) 
The Cancer Consultation Preparation Package (CCPP) contains several interventions, which 
aim to provide patients with a conceptual framework of evidence based SDM, and to inform 
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patients about their potential role in that process. The aim is to change patients’ behaviour 
by making them more active in the consultation, with the intention of changing clinicians’’ 
behaviours. The package consists of the following:  
1) An eight page booklet titled ‘How Treatment Decisions are Made’, which outlines 
the principles of evidence based medicine and the importance of patient involvement 
and preferences in the decision-making process 
2) A brochure titled ‘Your Rights and Responsibilities as a Patient’, which outlines the 
legal rights of patients in Australian hospitals; 
3) A cancer specific Question Prompt List, which provides 19 suggested questions. 
The package was developed for use in a research setting, and is delivered to patients at least 
48 hours before their initial consultation.  
3.3.2.4 Greenfield 1985 Intervention (17) 
The intervention developed by Greenfield and colleagues in a research setting is designed to 
alter the traditional patient role in the patient-clinician relationship. The intervention is 
coach-led, whereby a clinic assistant works together with the patient during a 20-minute 
session through several key tasks, including:  
1) a review of the most recent visit in the medical record; 
2) a treatment algorithm (disease specific), which helps to identify relevant medical 
decisions that are likely to arise during the consultation; and  
3) coaching patients to overcome common barriers to involvement, including 
embarrassment, fear of appearing foolish, forgetting to bring up an issue, or 
intimidation by the clinician. The patient is also encouraged to focus on treatment 
issues that could be affected by their lifestyle preferences.  
The intervention is delivered directly before the scheduled appointment. Upon completion, 
the patient proceeds directly to their appointment, and receives a copy of their record and 
treatment algorithm at the end of the appointment to take home.  
3.3.2.5 ‘How Treatment Decisions are Made?’ booklet plus videotape (133) 
The intervention developed by Brown and colleagues is designed as an ‘advanced organiser’, 
which provides a framework for patients’ understanding of the structure of the decision-
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making process. It consists of two key components: an eight-page booklet titled ‘How 
Treatment Decisions are Made’ and a 15-minute videotape. The booklet has also been used 
as part of a different intervention included in this review: Cancer Consultation Preparation 
Package (see above). (134) The booklet outlines the principles of evidence-based medicine, 
the importance of patients’ preferences in the decision-making process, and encourages 
patients to play an active role in their healthcare consultations. The videotape portrays eight 
experienced medical oncologists discussing treatment options with patients. It is designed to 
model different patient styles, and to demonstrate that physicians are comfortable with both 
active and passive styles. The intervention is delivered immediately before a scheduled 
consultation.  
3.3.2.6 Rost 1991 Intervention (136) 
The intervention developed by Rost and colleagues is a coach-led intervention, which aims 
to enhance patient information seeking and decision-making during hospitalisation. It is 
adapted from the intervention developed by Greenfield et al (also included in this review; see 
above), (17) and consists of two key parts: the 45-minute individual session delivered the day 
before planned discharge and a 1-hour instructional package delivered at home after 
discharge. The first part of the intervention is almost identical to the Greenfield intervention 
listed above,(17) but it takes 45-minutes instead of 20-minutes to deliver, and the coach (i.e. 
nurse) also elicits examples where the patient has taken an active role in influencing the 
course of their care with positive results, and examples of past difficulties with 
communicating with physicians. The one-hour instructional package, delivered at home after 
discharge before the next outpatient visit, addresses and reinforces skills introduced in the 
earlier session. It includes a self-assessment of three question asking skills that patients can 
use to effectively communicate with their physicians (question construction, question 
introduction, and question clarification), and is followed by three modules that teach these 
skills. It is also delivered as part of a comprehensive 3-day evaluation and education 
programme, which constitutes usual care, but no further details are provided. Unlike the 
other interventions, this intervention is designed specifically for inpatients before discharge.  
3.3.2.7 Consultation Planning Template (CPT) (137) 
The intervention developed by Sepucha and colleagues is coach-led, and aims to prepare 
patients for their consultation by using the Consultation Planning Template (CPT). A nurse 
(or other trained facilitator) uses the guide to elicit and record patients’ questions and 
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concerns for upcoming medical consultations. The structured outline includes prompts for 
the patient to generate decision-focused agendas for their consultation. The main sections 
include: Process Issues (goals for consultation, desired participation, timeline); Diagnosis and 
Prognosis (Test result, further testing, baseline prognosis); Treatment Choices (treatment 
spectrum, complementary therapy, treatment interactions); Treatment Implications (benefits 
and harms, impact on daily life, ranking the treatments), Values and Preferences (trade-offs, 
treatment goals, hopes, and fears, thoughts and feelings); and Next Steps (treatment 
selection, action items, barriers and resources). The sub-topics can be adapted for the 
specific clinical setting. The intervention is delivered immediately before a scheduled 
consultation. Following the session (which last approximately 35 minutes), the facilitator 
organises the agenda to produce the Consultation Plan for the patient, which they can then 
take to their consultation.
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Table 3.1  -  Characteristics of interventions included for evaluation 
                                                 
†† Publication that describes the development of the intervention or earliest publication describing intervention format/use/evaluation in the absence of a developmental publication 
Intervention 
title                   
(key 
reference)††  
Developers/
Authors, 
Year, 
Country, 
References  
Decision 
specific / 
generic  
Intervention 
aim 
Intervention description & format  Intervention use & evaluation Healthcare 
setting(s)  
Development process & 
theoretical/ conceptual 
base 
Ask 3 
Questions (33) 
The Health 
Foundation 
(Cardiff 
University, 
Cardiff & 
Vale 
University 
Health Board, 
Newcastle 
University, 
Newcastle 
upon Tyne 
Hospitals 
NHS 
Foundation 
Trust), 2012, 
UK (33, 142, 
144-146)  
 
Generic To raise 
awareness 
among patients 
about their role 
in SDM and 
encourage them 
to ask three key 
questions about 
their health and 
healthcare 
options 
Patient-targeted awareness raising campaign promoting patient 
involvement in SDM, consisting of 3 questions (two versions).  
Version 1: 1) what are my options?; 2) what are the possible risks 
and benefits of those options?; 3) how likely are the risks and 
benefits of each option to occur? Version 2: 1) what are my 
options?; 2) what are the possible risks and benefits?; 3) how can 
we make a decision together that’s right for me? Both versions 
reinforced with statement: ‘We want to know what’s important to 
you.’ 
Questions provided to patients in various formats, including: 
posters (in public areas and consultation rooms), A5 flyers (also 
contain blank list for patient’s own questions), business cards, 
booklets (describes briefly: rationale for 3 questions campaign, 
why decisions and options are available in healthcare, importance 
of personal values in making decisions, examples of 
patients/clinicians who have found intervention helpful, that 
clinicians want patients to be involved in decisions and want to 
understand what is important to patients). Accompanying websites 
available with similar information (adapted for different audiences 
and the version used). Promotional video, intended for use in 
waiting rooms, and video vignettes with patient and clinician views 
of the campaign.   
Designed primarily to be delivered 
ahead of a decision-making 
consultation (e.g. with appointment 
letter or by reception staff when 
attending clinic). Generally 
delivered ahead of a consultation as 
part of a clinical pathway (various 
according to setting), but also used 
as a general awareness raising tool 
across healthcare organisations and 
patient groups.  
Designed to be used and adapted by 
healthcare/voluntary organisations 
(e.g. AQuA adapted original 
materials.( 144) Different versions 
of questions used in different 
locations. Format of 3 question 
materials  (e.g. posters, booklets, 
flyers) generally consistent across 
locations, design varies.  
 
Used in implementation / quality 
improvement programmes. Not 
tested in research study. No formal 
evaluation available.  
Reported as used 
in various 
settings, 
including: breast 
cancer, paediatric 
tonsillectomy, 
head and neck 
cancer, urology, 
maternity, primary 
care, renal, 
musculoskeletal. 
Intervention 
available free for 
use and adaptation 
across NHS 
England & Wales 
via The Health 
Foundation – 
might also be used 
in other settings 
with different 
format, use etc. 
Developed as part of an 
implementation / learning 
programme using a quality 
improvement (PDSA) 
methodology. Involved clinical 
teams, research teams and 
patient groups. 
3 questions based on questions 
originally developed by 
Shepherd et al 2011.( 143) 
No theoretical model specified 
by developers. Original 
questions based on principles 
of decision analysis. (147) 
Ask Share CemPED, Generic To encourage Online patient-targeted awareness raising campaign promoting Designed for use ahead of decision- Reproductive and Developed by a team based in 
   77 
Know (ASK)   
(138) 
Sydney 
University & 
Family 
Planning 
NSW, 2012, 
Australia 
(138, 143, 
148)  
and empower 
people to be 
involved in 
decisions about 
their health, by 
helping people 
to get the 
information 
they need to 
share medical 
decisions with 
clinicians. 
patient involvement in SDM. 3 distinct components to the 
interventions: ‘Ask’, ‘Share’ & ‘Know’.  
Ask - encourages patients to ask 3 questions: 1) what are my 
options? (one option will always be wait and watch); 2) what are 
the possible benefits and harms of those options? 3) how likely are 
each of those benefits and harms to happen to me? A brief 
explanation of each question is provided to the patient.  
Share: encourages patients to share personal information with the 
clinician i.e. personal preferences and values. Emphasises that 
there are two experts in a consultation and the complementary 
knowledge patients can contribute. Highlights importance of 
medical history, individual risk factors, & lifestyle preferences in 
decision-making. Also describes what lifestyle preferences and 
needs are, and how they can impact on the decision made (with 
examples).  
Know: emphasises the importance of knowing the information that 
you need to make an informed decision e.g. outcomes, likelihood 
of outcomes, personal preferences, and general information given 
by clinician. Provides examples of strategies / tools that help 
patients to remember the information. Also provides ‘consultation 
summary’ worksheet – patient can log answers to 3 questions, 
what they shared with the clinician, and what they know / decided 
to do with the information.  
Also on website: description of and rationale for SDM; statement 
that medical decisions are a combination of professional’s 
knowledge and patient’s knowledge; examples of typical 
healthcare decisions; explanation of and rationale for ‘wait and 
watch’ option; description of individual lifestyle preferences and 
needs; video clips displaying 3 questions in action.   
making consultations. In feasibility 
study, video-clip, consultation 
summary worksheet and magnet 
with website details given to patient 
immediately before a consultation.  
The intervention is also currently 
available as an online public 
awareness campaign. Possible those 
resources are not only used 
immediately ahead of a specific 
consultation. Resources also 
distributed by various patient 
advocacy groups.  
 
The 3 questions element of ASK 
have been tested in a cross-over 
trial with trained actors, but not 
with real patients.( 143)  
ASK has been evaluated in a 
feasibility study (unpublished)  
examining demand, implementation 
and practicality of the intervention 
being distributed before a 
consultation (video clip, 
consultation summary & magnet 
with website details).  
 
sexual health.  
 
Intervention also 
publically 
available – likely 
to be used in 
various settings.   
 
Australia from a West 
Australian consumer advocacy 
program (Patient First 
Program) and a consumer 
health advice book, ‘Smart 
Health Choices’. (148) 
3 questions tested with trained 
actors in family practice 
setting, Sydney.( 143) 
3 questions and the ‘know’ 
element of the intervention are 
based on principles of decision 
analysis. (147) When combined 
with the ‘share’ element, which 
enables patients to integrate the 
information with their own 
preferences, the intervention 
promotes aims of evidence-
based SDM. (149) 
 
Cancer 
Consultation 
Preparation 
Package 
(CCPP) (134) 
 
 
 
Butow et al, 
2004, 
Australia, 
English (133, 
134, 150) 
Generic / 
Specific 
(Question 
Prompt 
List) 
To inform 
patients of their 
rights, prosing 
questions that 
they might 
choose to ask, 
and outlining 
evidence based 
decision-
making. It aims 
to change 
patient 
The Cancer Consultation Preparation Package (CCPP) consists of 
3 main components, designed to provide a conceptual framework 
for patients about evidence based clinical decision-making and to 
inform patients about their potential role in decision-making.   
1. Booklet - How Treatment Decisions are Made (see Brown 2004 
below for full description).  
2. Brochure: ‘Your Rights and Responsibilities as a Patient’. The 
brochure presents the legal rights of patients in an Australian 
hospital, and avenues for resolving complaints and disputes.  
3. Question Prompt Sheet (QPL): endorses question asking and 
includes 19 suggested question and a recommendation to prepare a 
list of questions for the consultation.  
Delivered at least 48 hours before 
the initial oncology consultation.  
 
Evaluated in 2-arm RCT.  
Cancer patients 
attending first 
oncology 
consultation. 
Development of booklet (‘How 
Treatment Decisions are 
Made’) outlined above (Brown 
2004). Development of 
brochure ‘Your Rights and 
Responsibilities as a Patient’ 
not reported (existing 
publication developed by 
another institution). 
Development of QPL reported 
in Brown 1999.( 150) The 
questions were derived from a 
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behaviour, and 
through these 
changes, change 
physician 
behaviour 
CCPP also includes the control booklet, which informs patients 
about the physical and spatial characteristics, staffing and 
procedures of the Sydney Cancer Centre (Sydney, Australia).      
content analysis of 20 taped 
consultations and consultation 
with four experts: two medical 
oncologists and two 
psychologists experienced in 
cancer research. These 
questions were grouped 
according to their content using 
a method of categorization.  
 
No theoretical / conceptual 
base reported. Knowledge 
based solution strategies in 
medical reasoning referenced in 
previous publication detailing 
the booklet, ‘How Treatment 
Decisions are Made’.( 151) 
Greenfield 
1985 (17) 
Greenfield et 
al, 1985, 
USA, English 
(17, 135) 
Generic, 
used in 
conjunction 
with 
disease 
specific 
algorithms 
Designed to 
alter the 
traditional 
patient role in 
the physician-
patient 
interaction 
The intervention is designed to both inform patients about the logic 
of the medical care process and to improve their information 
seeking skills so they would interact more effectively with their 
physicians. 
20-minute session conducted by clinic assistant included:  a review 
of the patient's medical record; a review of a treatment algorithm 
for chronic ulcer disease; and a behaviour change strategy 
designed to increase patient involvement in the physician-patient 
interaction.   
The clinic assistant reviews the most recent visit recorded in 
medical record with patient. They use an algorithm to help the 
patient identify relevant medical decisions in their care that are 
likely to arise during the current visit. The patient is encouraged to 
focus on treatment issues that could be affected by their lifestyle 
and preferences. Patients are explicitly encouraged to ask 
questions, recognise relevant medical decisions, and to share 
decision-making with the physician.  
Assistants coach patients to overcome common barriers to 
involvement including embarrassment, fear of appearing foolish, 
forgetting to bring up an issue, and intimidation by the physician.                                                                                      
Goal is to teach recognition of relevant medical decisions and to 
reinforce assertive behaviours during visits with physicians. At 
conclusion, patient proceeds to scheduled consultation. At the end 
of the consultation they are given a copy of their medical record 
Delivered during a 20-minute 
session immediately prior to a 
scheduled consultation. 
 
Evaluated in two RCTs: peptic ulcer 
disease(17) and diabetes(135) 
Peptic ulcer 
disease and 
diabetes. 
Not reported in detail. 
Developed as part a 
randomised controlled trial.  
 
Theoretical / conceptual basis 
not reported.  
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and the treatment algorithm. 
How Treatment 
Decisions are 
Made 
(+videotape) 
(133) 
 
 
Brown et al, 
2004, 
Australia, 
English (133, 
134) 
Generic To promote 
SDM. To 
operate as an 
‘advanced 
organiser’ that 
lays the 
framework for 
the patients’ 
understanding 
of the overall 
structure of the 
decision-
making process. 
Designed to 
provide a 
structuring of 
knowledge 
regarding 
clinical 
decision-
making and 
sufficient cues 
to activate the 
learning 
achieved in the 
context of the 
consultation.   
8-page booklet - describes decision-making in the context of 
evidence based medicine, treatment options, and patient 
preferences. It describes: a) the importance of evaluating 
treatments before they are widely used; b) different stages of 
research that are conducted to evaluate the safety and efficacy of 
new treatments; c) levels of evidence; d) how the Doctor decides 
which treatments to recommend, including a synopsis of factors 
other than evidence that may influence these options; e) the 
importance of patient involvement in treatment decision-making, if 
that is desired; f) a list of suggested questions to ask the Doctor 
about treatment options; g) explicit encouragement of active 
patient involvement.  
15-minute videotape also part of the package – portrays eight 
experienced medical oncologists discussing treatment options with 
patient. Designed to model different patient styles and demonstrate 
that oncologists were comfortable with both active and passive 
styles.  
 
Delivered immediately before a 
scheduled consultation (patients 
asked to turn up 30 minutes earlier).                   
 
Booklet and videotape evaluated in 
2-arm randomised controlled trial 
(RCT). Booklet also evaluated as 
part of a different package in Butow 
2004 (134) (see below) 
Female cancer 
patients (any site, 
any stage). 
 
 
Developed in consultation with 
an international panel of 
experts in the fields of 
evidence-based medicine, 
psych oncology, and consumer 
involvement. Piloted with 24 
female cancer patients for 
acceptability, salience and 
clarity. Also provided to panel 
of experts (2 patient advocates, 
2 experts in evidence based 
medicine, 2 oncologists, 2 
psycho oncologists). Field-
tested with 164 cancer patients 
before first oncologist meetings 
as part of a range of 
interventions in another study. 
(134)  
No theoretical / conceptual 
base specified explicitly by 
authors, but they reference 
knowledge based solution 
strategies in medical reasoning. 
(151) 
Rost 1991 
(136) 
 
Rost et al, 
1991, USA, 
English (17, 
136) 
Generic, 
used in 
conjunction 
with 
disease 
specific 
algorithms 
To enhance 
patient 
information 
seeking and 
decision-
making during 
hospitalisation 
Two key components: 
1st component:  45-minute individual session between patient and 
nurse day before planned discharge. Nurse reviews physician’s 
admission notes and laboratory values with the patient and 
introduces decision tree, which indicates treatment choices in 
managing various problems related to diabetes. Nurse elicits 
examples where patients have taken active roles in influencing the 
course of their care with positive results, and examples of past 
difficulties in communicating with physicians. Common obstacles 
to active patient participation and strategies to overcome these 
obstacles are discussed. The nurse closes the session by requesting 
that patient write down questions for the physician and suggesting 
that they review the decision diagram to identify treatment 
Delivered the day before planned 
discharge consultation.  
 
Evaluated in randomised trial (136) 
Insulin-dependent 
and non-insulin-
dependent 
diabetic patients 
Adapted from Greenfield 1985 
(see above) (17). Notes that 
package was piloted and 
revised before the trial, but not 
clear which elements were 
piloted.  No further information 
about intervention development 
provided. 
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decisions they would like to influence.  
2nd component: 1-hour instructional package the patient 
independently completes at home before their next outpatient visit 
(after discharge). Addresses skills introduced in the earlier 
intervention session. Includes self-assessment of 3 question asking 
skills patients can use to effectively communicate with their 
physicians: question construction, question introduction, question 
clarification. Self-assessment followed by three modules that teach 
the skills.        
Delivered as part of a routine comprehensive 3-day evaluation and 
educational programme (received by controls); no further details.                                                                                                                                                             
Consultation 
Planning 
Template 
(CPT) (137) 
 
 
 
 
 
 
 
 
Sepucha et al, 
2003, USA, 
English(139-
141) 
Generic Nurses use the 
Consultation 
Planning 
Template (CPT) 
to help prepare 
patients for their 
consultations 
The CPT consists of a structured outline that prompts patients to 
generate decision-focused agendas for their meetings with 
healthcare providers. The main sections include: Process Issues, 
Diagnosis and Prognosis, Treatment Choices, Treatment 
implications, Values and Preferences, and next steps. In each 
section the subtopics can be tailored to the clinical setting where 
the template is being used.  
Trained facilitators (nurses, patient navigators, or resource centre 
staff members) use the CPT as a guide to elicit and record patients' 
questions and concerns for upcoming medical consultations. The 
consultation plan can be structured as a table, structured outline, or 
flowchart. During consultation planning sessions, facilitators use 
the focused questions from the CPT, as well as open-ended follow-
up questions, to elicit patients' agendas for medical visits. 
Facilitators then organise and format the agenda to produce a 
consultation plan. They do not provide medical information - they 
focus on eliciting and organising what the patients know and the 
key questions they have.  
Last approximately 35 minutes. Patient given a copy of the CP and 
one attached to medical records for physician to see. 
Delivered before a consultation 
within which treatment options will 
be presented. 
 
Evaluated in 3 studies. (139-141)  
Generally used 
with breast cancer 
patients; also used 
with other cancer 
patients and in a 
community setting 
Developed originally as part of 
doctoral thesis. The authors 
translated standard meeting 
facilitation processes that have 
been well validated in the 
business community to the 
medical consultation.( 152, 
153)  
Then the developers 
qualitatively integrated 
decision analysis to structure 
the discussion about treatment 
decisions and action science to 
promote open communication. 
(154-158)  
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Table 3.2  -  Intervention evaluation: the extent to which interventions address the patient-reported barriers and facilitators to SDM‡‡ 
                                                 
‡‡ 4-point rating scale (1=not at all, 2=very little, 3=moderately, 4=great extent). Green = barrier/facilitator sufficiently addressed by previous interventions, Amber = barrier/facilitator addressed to 
some extent, Red = barrier/facilitator not sufficiently addressed, Grey = not applicable. The following interventions were not available from the developer/author and scores were based on the 
information provided in the associated publications: Cancer Consultation Preparation Package, How Treatment Decisions are Made + videotape. 
Patient-reported barriers 
& facilitators (descriptive themes & sub-
themes) 
 
Ask 3 
Questions (33) 
Ask Share 
Know (138) 
Cancer 
Consultation 
Preparation 
Package 
(CCPP) (134) 
Greenfield 
1985 (17) 
How 
Treatment 
Decisions are 
Made + 
videotape (133) Rost 1991 (136) 
Consultation 
Planning 
Template 
(CPT) (137) 
How the healthcare system is organised 
Time 
Clinicians are too busy 
 
3 2 3 1 1 1 1 
Inadequate/ adequate time in the consultation 
(bar / fac) 
 
3 3 3 3 3 3 3 
Continuity of 
Care 
Inability to choose a clinician to do SDM with 
 
1 1 1 1 1 1 1 
Too many clinicians involved in care 
 
1 1 1 1 1 1 1 
Lack of continuity in informational flow 
between clinicians 
 
1 1 1 1 1 1 1 
Clinician does not know / knows the patient (bar 
/ fac) 
 
1 2 1 1 1 1 1 
Workflow 
Distributing SDM among different clinicians 
(fac) 
 
1 1 1 2 2 3 3 
System does not offer multiple-consultations 
model that may be needed for SDM / appropriate 
consultations for SDM (bar / fac) 
 
Unclear Unclear Unclear 4 Unclear 4 3 
Characteristics 
of healthcare 
setting 
Inadequate environmental conditions  
 
Unclear Unclear 4 4 Unclear Unclear 3 
Not paying / paying for healthcare (bar / fac) 
 
1 1 1 1 1 1 1 
Overspecialisation of doctors 
 
1 1 1 1 1 1 1 
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Lack of reimbursement for clinicians 
undertaking SDM 
 
1 1 1 1 1 1 1 
What happens during the decision-making encounter? 
Predisposing factors 
 
Patient 
characteristics 
Age (older / younger) 
 
3 1 1 1 1 1 1 
Ethnicity 
 
3 1 1 1 1 1 1 
Lower level of education 
 
2 2 2 1 2 1 1 
Poor articulation 
 
2 2 2 3 2 3 3 
Health condition – stigma / discrimination 
 
1 1 1 1 1 1 1 
Long term patient (bar / fac) 
 
1 1 1 2 2 2 2 
Physical impairments 
 
1 1 1 1 1 1 1 
Decision 
characteristics 
Embarrassing or sensitive topics 
 
1 1 1 2 2 2 2 
Shock of receiving diagnosis (bar)  / time to 
come to terms with diagnosis (fac) 
 
Unclear Unclear 3 3 3 3 Unclear 
Interactional context factors  
Power 
imbalance in the 
patient-clinician 
relationship 
Presumptions about the patient role 
Expectation of the clinician making the 
decisions 
 
3 4 3 3 3 3 3 
Desire to act like a ‘good’ patient driven by a 
fear of consequences 
 
2 2 2 2 2 2 2 
Perceived acceptability of asking the clinician 
questions (bar / fac) 
 
4 4 3 4 4 4 4 
Belief that clinicians do not want patients 
involved 
 
4 4 3 3 4 3 3 
Clinician reinforces passivity by rewarding this 
behaviour 
 
1 1 1 1 1 1 1 
Having (fac) / not having explicit permission to 
participate in SDM (bar) 
 
4 3 3 4 3 4 3 
Patients undervalue their expertise 
relative to clinicians 
 
‘Doctor knows best’ & patients’ have ‘inferior’ 
knowledge (bar)/ recognise that there are 2 
 2 4 2 2 2 2 2 
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experts in medical encounter (fac) 
Patients are not capable of understanding 
medical/technical information 
 
1 2 2 1 2 2 3 
Interpersonal 
characteristics 
of the clinician 
Authoritarian clinician 
 
1 1 1 1 1 1 1 
Equal relationship (fac) 
* 
3 3 3 3 3 3 3 
Clinician does not listen to patient’s concerns 
(bar) / clinician listens to patient’s concerns (fac) 
 
2 2 2 2 2 2 2 
Clinician with poor interpersonal skills  (bar) / 
clinician with positive interpersonal skills (fac) 
 
1 1 1 1 1 1 1 
Good relationship (fac) / poor relationship with 
clinician (bar) 
 
1 1 1 1 1 1 1 
Lack of individualised approach & not asked 
about preferences (bar) / individualised approach 
and asked about preferences (fac) 
* 
3 3 3 3 3 3 3 
Clinician does not address patient directly 
 
1 1 1 1 1 1 1 
Trust 
Trust in clinician (bar / fac) 
 
1 1 1 1 1 1 1 
Lack of trust in clinician (bar / fac) 
 
1 1 1 1 1 1 1 
Preparation for the SDM encounter 
 
Perceived need 
for preparation 
Patient is not entitled to a choice 
 
 
4 4 4 3 3 3 3 
Patient is not explicitly offered a choice / 
presented in biased way by clinician  
* 
3 3 3 3 3 3 3 
Patient does not want or need to participate in 
SDM 
 
2 2 2 1 1 1 1 
Accepting responsibility to be involved in 
decision-making (fac) 
* 
1 2 3 3 3 3 3 
Not knowing what to expect from the SDM 
consultation 
 
3 3 3 3 4 4 4 
Expectations of 
the outcome of 
being involved in 
SDM 
Perceiving that there are ‘right’ & ‘wrong’ 
decisions, not wanting responsibility for a wrong 
decision) (bar)/ recognising equipoise and 
uncertainty (fac) 
 
2 2 2 1 2 1 1 
Fear of accepting reality of diagnosis   
1 1 1 1 1 1 1 
Preparation for a SDM process  
Providing 
information 
Insufficient (bar) / sufficient information about 
condition, options, & outcomes (fac) 
* 
3 3 3 3 3 3 3 
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about options Clinician does (fac) / does not explain options & 
outcomes (bar) 
 
Unclear  Unclear Unclear Unclear Unclear Unclear Unclear 
Terminology 
used by clinician 
Clinician uses medical terminology (bar) / 
clinician uses simple terminology (fac) 
 
1 1 1 1 1 2 1 
Decision support 
Written decision support (fac) / lack of written 
decision support (bar) 
 
Unclear  Unclear 1 2 1 2 3 
Purpose of decision support tool is unclear  
Unclear Unclear 1 1 1 1 Unclear 
Decision support from others e.g. family, other 
clinicians (fac) 
 
3 3 1 2 1 2 2 
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3.3.3 Intervention evaluation 
3.3.3.1 To what extent do the interventions address patient-reported barriers and 
facilitators to SDM? 
The interventions and associated documentation detailing the use and/or evaluation of the 
interventions were examined to assess the extent to which they could potentially address the 
patient-reported barriers and facilitators identified in Chapter 2 (see Table 2.2). Table 3.2 
provides an overview of the scores awarded to each intervention against each 
barrier/facilitator. Two of the interventions were unavailable for review, after contact with 
the developers, so the scores are based on the information available in the associated 
publications.(133, 134) The interventions were assessed against 51 different 
barriers/facilitators in total (27 barriers, four facilitators, and 20 combined 
barriers/facilitators). However, only 18 of the 51 factors were deemed appropriate for a 
patient-targeted intervention focusing on preparing patients for a SDM consultation to 
address in isolation, and this is used as the denominator when assessing how many 
barriers/facilitators were addressed.  
Due to the relative homogeneity of scores across interventions, the ‘traffic light’ system was 
used to categorise at the barrier/facilitator level. Using the traffic light system, six of the 18 
barriers/facilitators were categorised green (addressed well by previous interventions), two 
were categorised amber (have been addressed to some extent by previous interventions, with 
room for improvement), and ten were categorised red (not been sufficiently addressed by 
previous interventions).  
Thirty-three of the total 51 barriers and facilitators were deemed as not appropriate for a 
patient-targeted intervention to address in isolation.  However, interventions were scored 
against these factors to assess whether they have been addressed. Twenty-eight of the 33 
factors were categorised as grey; these are factors that were not addressed well, but I would 
not necessarily expect a patient-targeted intervention to directly influence. A further five of 
the 33 barriers/facilitators I would not expect a patient-targeted preparation intervention to 
address were categorised as amber, because they were thought to address the factor to some 
extent (these are indicated with an asterisk in Tables 3.2 and 3.4). 
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Table 3.3  -  ‘Green’ barriers/facilitators: factors that have been addressed 
sufficiently by previous interventions 
Barriers / Facilitators 
Intervention Score (1 – 4 or unsure) 
Ask 3 
Questions 
(33) 
Ask Share 
Know (138) 
Cancer 
Consulta-
tion 
Preparat-
ion 
Package 
(134) 
Greenfield 
1985 (17) 
How 
Treatment 
Decisions 
are Made 
+ 
videotape 
(133) 
Rost 1991 
(136) 
Consulta-
tion 
Planning 
Template  
(137) 
Sub-theme: 
Presump-
tions about 
the patient 
role 
Perceived 
acceptability 
of asking the 
clinician 
questions (bar 
/ fac) 
4 4 3 4 4 4 4 
Expectation 
of the 
clinician 
making the 
decision 
3 4 3 3 3 3 3 
Belief that 
clinicians do 
not want 
patients 
involved 
4 4 3 3 4 3 3 
Having / not 
having 
permission to 
participate in 
SDM (bar / 
fac) 
4 3 3 4 3 4 3 
Sub-theme: 
Perceived 
need for 
preparation 
Patient is not 
entitled to a 
choice 
4 4 4 3 3 3 3 
Not knowing 
what to 
expect from 
the SDM 
consultation 
3 3 3 3 4 4 4 
 
Six of the 18 barriers/facilitators have been sufficiently addressed by existing interventions, 
with most interventions receiving a score of 3 or 4 for these factors (see Table 3.3 above). 
Four of these factors relate to patients’ ‘presumptions about their role in the medical encounter’, and 
two relate to patients’ ‘perceived need for preparation’. The factor receiving the highest score 
across all interventions was the ‘perceived acceptability of asking the clinician questions’. All but one 
intervention(134) received a score of 4 for this factor, indicating that this is an area previous 
interventions address well. When patients feel that it is acceptable and appropriate to ask 
clinicians questions, this facilitates involvement in SDM. All interventions directly encourage 
patients to ask questions in the healthcare consultation, and use various techniques to 
achieve this: two interventions coach patients to overcome common barriers to asking 
questions, such as forgetfulness and embarrassment; (17, 136) four interventions provide 
patients with lists of questions that they can use if they are given treatment options (two 
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generic,(33, 138) two condition specific (17, 136)); two interventions include video clips 
demonstrating patients asking the clinician questions during a consultation;(133, 138) the aim 
of the CPT is to elicit patients questions about the decision-making process;(137) the Ask 3 
Questions intervention includes statements from clinicians that have found this approach 
useful and uses the strapline ‘we want to know what’s important to you’.(33) All of these 
techniques indicate that it is acceptable for patients to ask questions about their options, and 
that clinicians are receptive to this.  
Another barrier that has been addressed well is the ‘expectation of the clinician making the decision’. 
All the interventions emphasise the importance of patient involvement in decision-making 
and encourage patients to take part in the decision-making process, thus indicating that the 
clinician does not necessarily make the decisions. Some address this issue directly: The ASK 
intervention explicitly states repeatedly that patients should be involved in healthcare 
decisions together with clinicians;(138) two interventions describe how medical professionals 
have changed from being more paternalistic, to now expecting patient involvement;(33, 138) 
two interventions use an algorithm to help patients to identify decisions about their care that 
they may wish to discuss with the clinician in the subsequent appointment.(17, 136)  Some 
also address this issue more implicitly: the Ask 3 Questions intervention(33) encourages 
patients to get the answers to three questions and highlights the importance of personal 
values, the CPT process involves patients creating an agenda for their decision-making 
appointment,(137) whilst another intervention includes video clips portraying patients who 
are actively involved.(133) These indicate that the patient can be involved in the decision-
making process, without explicitly stating that patients should make decisions together with 
clinicians.  
Interventions have also addressed patients’ ‘belief that clinicians do not want patients involved’ in the 
decision-making process. The Ask 3 Questions intervention achieves this by using the 
strapline ‘we want to know what’s important to you’ (where ‘we’ represents the 
clinician/team/organisation) and stating ‘your healthcare professional needs you to tell them 
what’s important to you’.(33) The ASK intervention encourages patients to be involved and 
states that clinicians will share the decision-making with patients.(138) The intervention 
developed by Brown et al provides video examples of consultations where the patient is 
either active or more passive, making it clear that the clinician is comfortable with both types 
of consultation.(133) The remaining interventions do not address this barrier directly, but the 
   88 
fact that the patient is being encouraged to become more involved, and sometimes even 
coached, suggests that the clinicians are receptive to the approach.  
Another barrier addressed particularly well by existing interventions is ‘not having permission to 
participate in SDM’. In three of the interventions, ‘permission’ to be involved in SDM comes 
directly from the clinicians involved in the patient’s care. For example, Ask 3 Questions 
includes the message ‘we want to know what’s important to you’, and displays the materials 
in the waiting areas and consultations rooms.(33) Three interventions are delivered by 
coaches, who are members of the healthcare team, and they provide direct verbal 
encouragement to be involved in decision-making.(17, 136, 137) Two of the interventions 
use language that promotes patient involvement in their written materials and use video clips 
displaying patients who are active in the decision-making process.(133, 138) These three 
interventions were awarded a score of 3 as the ‘permission’ to be involved was not as explicit 
and did not come directly from the clinicians involved in the patient’s care.  
All interventions have taken steps to address the following barrier: ‘patient is not entitled to a 
choice’. Three of the interventions directly address this issue by emphasising that patients will 
sometimes be faced with choices about their healthcare, thus they are entitled to make 
decisions together with clinicians.(33, 134, 138) The remaining four do not explicitly state 
this entitlement to choice, but the fact that the interventions either encourage patients to 
actively identify relevant decision points(135, 136) or provide a framework of patient 
involvement in the decision-making process(133, 137) indicates that patients are entitled to 
choice.  
Some patients report that ‘not knowing what to expect from a SDM consultation’ is a barrier to 
involvement. All of the interventions provide at least a brief outline of what a patient can 
expect from a SDM consultation, including the key SDM components e.g. presentation of 
choice, options available, a discussion of options in relation to the patient’s preferences etc. 
However, this is sometimes done quite briefly and it is not always presented in a way that 
might be easy to understand (e.g. interventions use text rather than diagrammatic 
presentation of the process). Two interventions have addressed this barrier to a greater 
extent by presenting patients with video examples of SDM consultations, and were awarded 
a score of 4.(133, 136)  
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Table 3.4  -  'Amber' barriers/facilitators: factors that have been addressed to some 
extent, with room for improvement 
Barriers / Facilitators 
Intervention Score (1 – 4 or unsure) 
Ask 3 
Questions 
(33) 
Ask Share 
Know (138) 
Cancer 
Consulta-
tion 
Prepara-
tion 
Package 
(134) 
Greenfield 
1985 (17) 
How 
Treatment 
Decisions 
are Made 
+ 
videotape 
(133) 
Rost 1991 
(136) 
Consulta-
tion 
Planning 
Template 
(137) 
Sub-theme: 
Time 
Inadequate / 
adequate time 
in the 
consultation 
(bar / fac) 
3 3 3 3 3 3 3 
Sub-theme: 
Patient 
characteristi
cs 
Poor 
articulation 
2 2 2 3 2 3 3 
Sub-theme: 
Interpersonal 
Characteris-
tics clinician 
Equal 
relationship* 3 3 3 3 3 3 3 
[Lack of] 
individualised 
approach & 
[not] asked 
about 
preferences 
(bar / fac)* 
3 3 3 3 3 3 3 
 
Sub-theme: 
Providing 
information 
about options 
Insufficient / 
sufficient 
information 
about 
condition, 
options & 
outcomes (bar 
/ fac)* 
3 3 3 3 3 3 3 
 
Sub-theme: 
Perceived 
need for 
preparation 
Patient is not 
explicitly 
offered a 
choice or it is 
presented in a 
biased way* 
3 3 3 3 3 3 3 
Accepting 
responsibility 
to be involved 
in decision-
making (fac)* 
1 2 3 3 3 3 3 
 
Two of the 18 barriers/facilitators have been addressed to some extent by the existing 
interventions. A further five barriers/facilitators that I would not expect a patient-targeted 
preparation intervention to address were also categorised amber, as they addressed the factor 
to some extent (total of eight categorised amber). These are marked with an asterisk in Table 
3.4 above. All of the interventions received a score of 3 for the barrier/facilitator ‘adequate 
time in the consultation’ as they are delivered ahead of the main consultation with a clinician. 
This could potentially reduce pressure on the time available in the actual clinical consultation 
by preparing patients to engage in the SDM process before they are asked to discuss the 
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options. However, as will be discussed below, these interventions do not address the barrier 
that ‘clinicians are too busy’; they increase the burden on overall time available to clinical teams, 
especially the coaching interventions that take 20-45 minutes to administer.(135-137).  ‘Poor 
articulation’ has been cited as a barrier to participating in SDM. None of the interventions 
were designed specifically for this group, but three of the seven interventions provide 
coaching, which might help patients with poor articulation.(135-137) The coaches help 
patients to identify and rehearse questions that they want to ask about their options, and to 
overcome issues of embarrassment and forgetting. Poor articulation could also be addressed 
by the use of pre-set question prompt lists or encouragement to develop a list of questions, 
as used in the other interventions,(33, 133, 134, 138) but it is unlikely to be as effective as 
direct coaching, and thus received lower scores.  
Patients have reported that ‘accepting responsibility to be involved in decision-making’ is a facilitator 
to SDM. All of the interventions encourage involvement, but there is no direct assessment as 
to whether the patient has actually accepted the role. Therefore, proxy measures, such as 
preference to be involved, increased involvement in the consultation (e.g. question asking), 
improved decision quality, and likelihood of stating treatment preferences were used. Four 
of the interventions provide clear evidence of their impact via pilot studies, controlled 
studies or randomised controlled trials (RCTs) (See Table 3.6 for full details on intervention 
effectiveness): Greenfield et al found a significant difference in involvement preferences 
between the intervention and control group in two RCTs;(17, 135) intervention patients 
were significantly more likely than control patients to report involvement and treatment 
preferences for two of the interventions;(133, 134) Rost found a significant difference in the 
number of questions asked during the consultation between the intervention and control 
groups, indicating that intervention patients are more likely to become involved;(136) studies 
evaluating the CPT found higher decision quality scores compared to controls,(141) higher 
satisfaction in patients using the CPT,(139, 140) and decreased communication difficulties 
with clinicians. 
Some of the barriers/facilitators identified by patients are dependent on the way in which the 
clinician interacts with the patient and uses the intervention, thus we could not expect the 
identified interventions to address the barrier/facilitator in isolation (marked with asterisk in 
Table 3.4). However, despite this reliance on clinicians’ attitudes and behaviours, the 
included interventions scored reasonably well on the following barriers/facilitators: ‘equal 
relationship’, ‘insufficient information about the condition, options and outcomes’, ‘lack of individualised 
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approach and not asked about preferences’, and ‘not explicitly offered a choice or choice being presented in a 
biased way’. The interventions would have no direct impact on whether the clinician made the 
patient feel that they are in an equal relationship, as this is also dependent on the 
interpersonal skills and behaviour of the clinician. However, all of the interventions highlight 
the importance of patients’ contribution to the decision-making process, which may go 
someway to reassuring the patient that the clinician wants the patient’s involvement, and 
there is a more even distribution of power.  
Similarly, the interventions included in this review do not tend to focus on information 
provision because they are focusing on preparing patients for a SDM consultation, ahead of 
the decision-making process. However, they all introduce the notion of options and potential 
outcomes, which should indicate to patients that there will be information available; some 
interventions directly encourage patients to ask for this information (e.g. Ask 3 
Questions(33) and ASK(138) both encourage patients to obtain this information from the 
clinician) and one is designed to be used in conjunction with in-consultation decision 
support tools.(33) The interventions would have scored higher if it were clear that they are 
consistently used by a clinician trained in SDM skills, who may or may not use a decision 
support tool for information provision. Another related barrier is ‘not being explicitly offered a 
choice or choice being presented in a biased way’. Again, this factor can depend on the individual 
clinician and how they frame choice and the options available. However, the interventions 
do go some way to addressing this barrier by highlighting that there are clear and legitimate 
options available to patients, which have the potential to reduce the likelihood of biased 
presentation. The barrier ‘lack of individualised approach and not being asked about personal 
preferences’ will also depend on the clinician’s behaviour in the consultation, but the 
interventions scored relatively well on this factor. All of the interventions encourage patients 
to consider their individual preferences when making decisions, which might reduce the 
likelihood that the patient perceives that they are not receiving an individualised approach 
and being treated as a ‘disease’. 
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Table 3.5  -  'Red' barriers/facilitators: factors that have not been sufficiently 
addressed 
Barriers / 
Facilitators 
Intervention Score (1 – 4 or unsure) 
Ask 3 
Questions 
(33) 
Ask Share 
Know (138) 
Cancer 
Consulta-
tion 
Prepara-
tion 
Package 
(134) 
Greenfield 
1985 (17) 
How 
Treatment 
Decisions 
are Made + 
videotape 
(133) 
Rost 1991 
(136) 
Consulta-
tion 
Planning 
Template  
(137) 
Sub-theme: 
Time 
Clinicians 
are too 
busy 
3 2 3 1 1 1 1 
Sub-theme: 
Patient 
Characteris
-tics 
Age (older / 
younger) 3 1 1 1 1 1 1 
Ethnicity 
3 1 1 1 1 1 1 
Lower level 
of 
education 
2 2 2 1 2 1 1 
Sub-theme: 
Presumptio
ns about the 
patient role 
Desire to 
act like a 
‘good’ 
patient; fear 
of 
consequen-
ces  
2 2 2 2 2 2 2 
Sub-theme: 
Patients’ 
undervalue 
their 
expertise 
relative to 
clinicians 
‘Doctor 
knows best’ 
& patients 
have 
‘inferior’ 
knowledge 
/ recognise 
that there 
are two 
experts in 
the medical 
encounter 
2 4 2 2 2 2 2 
Patients are 
not capable 
of 
understand-
ing 
medical/ 
technical 
information 
1 2 2 1 2 2 3 
Sub-theme: 
Perceived 
need for 
preparation 
Patient 
does not 
want or 
need to 
participate 
in SDM 
2 2 2 1 1 1 1 
Sub-theme: 
Expecta-
tions of the 
outcome of 
being 
involved in 
SDM 
Perceiving 
that there 
are ‘right’ 
and 
‘wrong’ 
decisions 
(not 
wanting 
responsibil-
ity for a 
wrong 
decision) 
2 2 2 1 2 1 1 
Sub-theme: 
Decision 
support 
Decision 
support 
from others 
e.g. family, 
3 3 1 2 1 2 2 
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carer, other 
clinicians 
(fac) 
 
Ten of the 18 barriers/facilitators that I would expect a patient-targeted pre-consultation 
intervention to cover have not been addressed well by previous interventions. Most of the 
interventions were awarded low scores for the barrier ‘clinicians are too busy’. As discussed 
above, interventions received higher scores for the barrier ‘lack of adequate time in the 
consultation’ because the interventions are delivered before the main clinical consultation. 
This prepares patients ahead of the discussion about options, which could potentially reduce 
the time needed during the consultation. However, the interventions still increase the 
workload of clinical teams as a whole, and they do little to address the fact, and patients’ 
perceptions, that clinicians are too busy. This is especially true for coaching 
interventions(135-137) and interventions that require patients to view a video before the 
consultation.(133, 138) Only two interventions scored 3 on this barrier as they are relatively 
simple, self-administered interventions, which require little resource from clinical teams to 
administer.(33, 138) 
Under the sub-theme ‘patient characteristics’, all but one of the interventions were awarded a 
score of one for the barriers ‘age’ and ‘ethnicity’.(33) Results from Chapter 2 indicate that these 
barriers are largely related to attitudinal issues; for example, people of an older age group 
believe that they are part of an age cohort that should not question the authority of clinicians 
and some young people feel that they do not need to be involved because their parent will 
make the decision for them. The Ask 3 Questions intervention(33) goes some way to 
addressing these attitudinal issues; the promotional materials include character illustrations 
that represent different age groups and ethnic backgrounds, intended to indicate that SDM is 
an approach that can be used by everyone. However, the interventions do not directly 
address these attitudes towards involvement held by some people in older and younger age 
groups. None of the interventions were designed specifically for groups with ‘lower levels of 
education’ and do not report testing in this group; therefore they received low scores for this 
barrier. Some of the written materials for two of the interventions were developed for 
reading age ten, and so address this barrier to some extent, but not sufficiently.(133, 134) 
Two of the interventions include an algorithm component, which might be difficult to 
understand, so they were awarded the lowest score. (135, 136)  
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The ‘desire to act like a ‘good’ patient’, due to a fear of the consequences of stepping outside this 
traditional patient role, is a frequently cited patient-perceived barrier to participation in SDM. 
All of the interventions encourage patients to become involved in the decision-making 
process, and some highlight the move away from paternalistic approaches in healthcare,(33, 
138) but none of the interventions directly address the fear of retribution. For many patients, 
it is fear of the negative outcomes, such as reduced quality of care or being labelled a 
‘difficult’ patient, which drives this desire to act like a ‘good’ patient. None of the 
interventions take steps to reassure patients that the quality of treatment that they receive 
from the healthcare team will not be affected in a negative way, should they make the 
decision to participate.  
A sub-theme of barriers that has not been addressed well is ‘patients undervaluing their expertise’.  
This was a significant factor that emerged from the systematic review of patient-reported 
barriers and facilitators, as it impacts on patients’ perceived levels of influence on the 
decision-making process, and thus their individual capacities to participate. This sub-theme is 
made up of two key factors: patients perceiving that ‘doctor knows best’ because they have 
inferior knowledge and patients believing that they are ‘not capable of understanding ‘complex’ 
medical information about the options’. With the exception of the ASK intervention, all of the 
interventions were awarded low scores for the first of these two factors. The interventions 
highlight the importance of patients’ personal values and preferences, and encourage patients 
to let the clinician know about these and consider them during the decision-making process. 
However, they do not explicitly emphasise that patients’ expertise (about personal 
preferences) is just as important as medical professionals’ expertise (about the options 
available). The ASK intervention, on the other hand, addresses this factor well by explicitly 
describing how both the patient and the clinician are experts in their own right, and that 
both types of expertise are of equal value in the decision-making process.(138)  
All of the interventions received a low score for the second of these two barriers. Patients 
frequently report that they feel incapable of understanding ‘complex’ information about the 
treatment options, and thus defer the decision to experts. Although some of the 
interventions make attempts to support patients to overcome barriers such as 
embarrassment and forgetfulness, none of the interventions contain components that 
specifically promote patients’ self-efficacy in understanding information about the options 
available. Question prompt lists are useful tools for promoting assertiveness and information 
exchange in a consultation, but they do not necessarily mean that the patient will feel capable of 
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understanding the information that they are given. Even when the interventions are designed 
for use in conjunction with a decision support tool that focus on information provision 
about options (e.g. decision aid), this does not equate to patients feeling that they are able to 
understand the information that they will be given. The interventions lack motivational or 
cognitive elements that encourage patients to believe that they are capable of understanding 
the information, before being given the information (by the professional or via a decision 
support tool). Such elements could help to ensure that patients do not make a decision to 
not be involved and defer the decision to the clinician based on the belief that they are 
incapable of understanding the information. Further, the interventions do not provide 
reassurance that clinicians will present the information in a way that the patient can easily 
understand, or reassure patients that it is acceptable to ask clinician to explain the 
information in a different way if they do not understand.  
None of the interventions explicitly address the barrier ‘patients do not want to or need to 
participate in SDM’. All of the interventions encourage involvement and highlight the 
importance of patients’ preferences in the decision-making process. These therefore go some 
way to highlighting patients’ responsibility to be involved in decision-making about their 
own healthcare. One intervention includes a component entitled ‘your rights and 
responsibilities as a patient’, but this appears to focus on patients’ legal rights in hospital, and 
avenues for complaints and disputes.(134) None of the interventions provide an explicit 
rationale for being involved in the SDM process in a way that might challenge those patients 
who feel that they do not need to be involved. Obviously, there will also be patients who 
state that they do not want to be involved in SDM, and this should be accepted if it is an 
informed decision. However, there will be patients who state that they do not want to be 
involved, who actually feel that they cannot be involved. The interventions do little to ensure 
that patients are making an informed decision about whether to be involved in the decision-
making process, after understanding what involvement in the decision-making process 
entails.  
When ‘patients perceive that there are ‘right’ and ‘wrong’ decisions’ and they do not want to accept 
responsibility for a wrong decision, this can act as a barrier to SDM. On the other hand, 
when ‘patients recognise equipoise and uncertainty in medical decision-making’, this facilitates SDM. 
The importance of patients’ values in the decision-making process is emphasised throughout 
all of the interventions, which implies that there may not necessarily be a clinically preferable 
option available.  However, equipoise is an unfamiliar concept for many patients, and none 
   96 
of the interventions explicitly or sufficiently cover what this means, and why patients are 
being offered healthcare options. Further, none of the interventions reinforce that neither 
the patient nor the clinician will be ‘blamed’ for the outcomes of the decision, especially as 
these cannot always be predicted. One intervention uses the phrase ‘decision that is right for 
you’, which does imply that there are no right and wrong decisions but decisions that are 
best for the patient, but it also uses the phrase ‘make the right decision’, which conflicts with 
this idea.(33) The final factor that has not been addressed sufficiently by previous 
interventions is the ‘facilitative role of decision support from others’, such as family members, carers, 
or other clinicians. Two of the interventions suggest that family members and carers might 
also have questions if the patient is asked to make a decision, but they do not explicitly 
encourage the patient to consider involving them in the decision-making process.(33, 138)  
The remaining interventions do not refer to the support that other people can offer the 
patient when they are asked to make a decision.(159) 
Twenty-eight of the total 51 barriers/facilitators were categorised as grey. These are factors 
that I would either not expect a patient-targeted intervention to address in isolation from 
interventions targeting clinician attitudes/behaviours or organisational structures, or they are 
only relevant to very specific situations that do not apply to most patients. Interventions 
were still scored against these factors to determine if they had been used in conjunction with 
other interventions that could potentially address such factors e.g. a SDM skills training 
package for clinicians using the patient-targeted interventions (factors that have been 
addressed in this way are marked by an asterisk in Tables 3.2 and 3.4). The full list of factors 
categorised as grey can be viewed in Table 3.2. In summary, these factors relate largely to 
improving continuity of care, adapting workflow processes so that there are appropriate 
appointments for SDM discussions (i.e. multiple consultations), fixed patient characteristics 
(e.g. the presence or absence of a long term condition or cognitive impairments such 
dementia), and attitudes and behaviours of the clinician (e.g. authoritative, poor interpersonal 
skills, use of medical terminology, reinforcement of passive behaviour). There are also some 
factors that are relevant only in specific circumstances, including whether a patient pays for 
their healthcare, stigma and discrimination associated with certain diseases/conditions, and 
poor environmental conditions during physical examinations for SDM.   
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3.3.3.2 What is the effectiveness of existing interventions? 
Four of the seven interventions were evaluated in randomised controlled trials.(17, 133, 134, 
136) ASK (138) has been evaluated in a feasibility study(160) and the CPT has been 
evaluated in pilot and controlled studies.(139-141) Ask 3 Questions(33) has not been 
formally evaluated. Table 3.6 summarises the evaluation of each intervention, including study 
design, sample, outcome measures, and key findings. 
Table 3.6  -  Effectiveness of included interventions 
Intervention 
(study 
references) 
Study 
design / 
intervention 
Outcome measures Key findings 
Ask 3 
Questions (33) 
Not formally 
evaluated 
- - 
Ask Share 
Know (ASK)   
(138) 
Cross-over 
feasibility 
trial. 123 
patients 
attending 
family 
planning 
clinic  
 Use of the ‘Ask’ component 
during the consultation 
 Whether patient had made a 
decision 
 Information & involvement 
preferences 
 Recall of questions used in 
‘Ask’ component 
Limited info available - only conference abstract 
available and feasibility study (no comparison group) 
 Questions 1, 2 and 3 (of the ASK component) were 
asked in 66, 63 and 51 consultations respectively.  
 Most participants found questions helpful (72%) and 
would recommend them to others (94%). 50% reported 
recalling questions two weeks after consultation.  
Cancer 
Consultation 
Preparation 
Package (134) 
 
 
 
Two-arm 
randomised 
controlled 
trial (RCT). 
164 cancer 
patients. 
Before consultation 
 Satisfaction with the 
intervention 
 Information & role preferences 
During consultation 
 Patient information seeking 
behaviour (self-report & coded 
transcripts) 
 Physician behaviour (coded 
transcripts) 
After consultation 
 Achievement of role 
preferences 
 Patient satisfaction with the 
consultation 
 Patient and physician 
satisfaction with the decision-
making process 
Before & after consultation 
 Anxiety 
 Depression 
 
 Regarding 10 active patient behaviours coded, patients 
in the intervention group asked significantly more 
questions (P = .009) & challenged information 
significantly more often (P = .05) than control group. 
No significant difference between groups for other 
behaviours, or when behaviours were summed. 
 No significant difference between groups in reported 
involvement and achievement of role preference, but 
results suggest trend that patients receiving intervention 
were less likely to achieve role preference (P = .06). 
 No significant impact of intervention on: patient or 
physician satisfaction with decision-making process,  
patient satisfaction with consultation, physician 
behaviour, or post consultation anxiety / depression 
scores. 
Greenfield 
1985 (17) 
Greenfield 
1985(17) 
Two-arm 
RCT. 45 
patients with 
peptic ulcer 
disease. 
Greenfield 
1988(135) 
Two-arm 
RCT. 59 
diabetic 
patients. 
Greenfield 1985 
 Patient interaction indicators 
 Role preference 
 Knowledge of disease 
 Patient satisfaction with care 
 Physical & role limitations due 
to health status 
 Pain 
 
 
 
 
 
Greenfield 1988 
 Patient interaction indicators 
 Diabetes control 
 Disease severity 
 Health-related quality of life 
 Changes in treatment regimen 
Greenfield 1985 
 Patients in the intervention group were significantly 
more effective at information seeking than controls (P < 
0.001), significantly more likely to prefer an active role 
in decision-making (P < 0.001), and had better 
knowledge of disease (P < 0.01). 
 Intervention patients reported significantly fewer 
physical and role limitations than controls (P < 0.05). 
Difference between groups related to ulcer pain was in 
same direction, but not significant.  
 No significant difference between groups in levels of 
patient satisfaction. 
 
Greenfield 1988 
 Patients in the intervention group report significantly 
fewer functional limitations (P < 0.01), had 
significantly better blood sugar control (P = 0.001), and 
were significantly more active during their visit than 
controls (P < 0.05).  
 No significant difference between groups in knowledge 
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 Patient satisfaction 
 Knowledge of diabetes 
 
of disease or patient satisfaction.  
How 
Treatment 
Decisions are 
Made 
(+videotape) 
(133) 
 
 
Two-arm 
RCT. 65 
female cancer 
patients.  
Before consultation 
 Information & role preferences 
During consultation 
 Patient & physician behaviours 
during consultation 
After consultation 
 Achievement of information & 
role preferences  
 Patient satisfaction with the 
consultation 
 Patient & doctor satisfaction 
with decision-making 
 Decisional conflict 
Before & after consultation 
 State anxiety 
 Depressive symptoms 
 Regarding active patient behaviours, interventions 
participants were significantly more likely than controls 
to declare their perspectives on the costs & side-effects 
(P = 0.04) and benefits (P = 0.03) of treatment,  
 Intervention participants were more likely than controls 
to declare their preferences for information (P = 0.09) 
and treatment during the consultation (P = 0.10), 
although this was not significant. The intervention had 
no impact on other patient behaviours, including stating 
role preference or asking questions.  
 Doctors tended to introduce more themes in the 
intervention group, but this was not significant (P = 
0.06). 
 No significant impact of intervention on: post-
consultation involvement and information preferences; 
patient & doctor satisfaction with decision-making; 
patient satisfaction with the consultation; decisional 
conflict; post consultation depressive symptoms / 
anxiety. 
 
Rost 1991 
(136) 
 
Two-arm 
RCT. 61 
patients with 
diabetes 
mellitus.  
 Frequency of patient 
information seeking and 
decision-making behaviours 
 Patient satisfaction 
 Perceptions of specific doctor-
patient behaviours 
 Patient recall of medication 
and self-care recommendations 
 Physician’s satisfaction with 
the patient’s hospitalisation  
 Patient’s physical and 
psychological functioning 
 Intervention patients asked significantly more questions 
at discharge than control patients (P < 0.001). 
 No significant difference in patient–reported 
involvement in information seeking and decision-
making at discharge.  
 No significant impact of the intervention on: patient 
recall of medication or self-care recommendations; 
patient satisfaction. 
 Intervention participants reported significantly better 
physical functioning than controls (P = 0.02) 
 Trend for interventions physicians to report more 
dissatisfaction with the context of care than physicians 
in the control group, although not significant (P = 0.09) 
 
Consultation 
Planning 
Template 
(CPT) (137) 
 
 
Sepucha 2000 
Pilot study 
(with control 
group). 24 
patients with 
early stage 
breast cancer. 
 
 
Sepucha 2000 
Before intervention 
 Decision Quality  
After Consultation Planning  
 Decision Quality  
After consultation 
 Satisfaction with consultation 
 Decision Quality (+ 
physicians agreement with 
this) 
 
Sepucha 2000 
 Patients in intervention group achieved significantly 
higher decision quality scores compared with control 
patients (P = .008) and significantly higher level of 
intersubjective agreement with their physicians about 
decision quality (P = <.0001). 
 
 
 
 
 
 Sepucha 2002 
Controlled 
trial. 94 breast 
cancer 
patients. 
 
 
Sepucha 2002 
Before intervention 
 Scale of communication 
barriers 
After Consultation Planning 
 Scale of communication 
barriers 
 Satisfaction with interview 
After consultation 
 Patient-doctor Interaction 
 Physician satisfaction with the 
consultation 
 
Sepucha 2002 
 Patients in both intervention and control group 
reported significant reduction in communication 
barriers after sessions (P = < .001). 
 Patients in the intervention group reported 
significantly higher satisfaction than the control group 
 
 
 
 
 
 
 Belkora 2006 
Retrospective 
descriptive 
study. 67 
patients 
(breast cancer 
and unknown 
cancer 
diagnosis)  
 
Belkora 2006 
After Consultation Planning / 
consultation  
Patient satisfaction with 
intervention 
Belkora 2006 
 Patients were highly satisfied with CPT consultations 
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3.4 Discussion 
This review identified seven interventions that prepare patients for a SDM discussion with a 
clinician. Of the 18 barriers/facilitators that I would expect a patient-targeted preparation 
intervention to address, six have been adequately addressed by previous interventions, two 
have been addressed to some extent with room for improvement, and 10 have not been 
adequately addressed. Five additional factors were categorised as amber (total of eight factors 
categorised amber); these were factors that I would not expect a patient-targeted preparation 
intervention to address, but they have been addressed to some extent by the included 
interventions.  Of the total 51 barriers/facilitators identified by patients that are potentially 
modifiable, 28 were deemed unfeasible for a patient-targeted preparation intervention to 
address in isolation, or they are only relevant to highly specific situations. Trial outcomes 
suggest that these interventions have a positive impact on patient engagement in the 
consultation,(17, 133-137, 139, 141) but only one of the interventions provides evidence of 
use in routine clinical practice, outside the research setting.(33)  
Analysis indicates that there is scope to develop a patient-targeted preparation intervention 
that addresses all, or more, of these barriers and facilitators more comprehensively. 
Interventions also need to be grounded in behaviour change theory in order to address 
patient attitudinal factors identified in Chapter 2. Interventions tend to be more effective 
when theoretically grounded;(161) lack of theoretical basis impedes the possibility of 
understanding behaviour change, and the processes that underlie effective interventions.  
The large number of factors that could not be addressed by a patient-targeted preparation 
intervention in isolation also highlights the need to develop such interventions as part of a 
‘SDM bundle’, where they are implemented in the context of organisational support and 
alongside complementary interventions targeting clinician attitudes and behaviours (e.g. 
SDM skills training), and knowledge provision (e.g. decision support interventions).  
In Chapter 2, I showed that individual capacity to participate in SDM depended on two key 
factors: knowledge and power. In the decision-making context, power refers to the patients’ 
perceived capacity to influence the decision-making encounter including factors such as 
valuing one’s own knowledge and its contribution to the decision-making process, and self-
efficacy in one’s ability to acquire medical knowledge about the condition or options. 
Without perceived power, provision of information about options is unlikely to support 
SDM in a large number of patients. One of the key unaddressed gaps identified in the 
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current review relates to patients undervaluing their expertise relative to that of the clinician. 
The two factors related to perceived power in the consultation have not been sufficiently 
addressed by previous interventions – these are patients perceiving that ‘doctor knows best’ 
whilst they have ‘inferior knowledge’ and patients believing that they are not capable of 
understanding ‘complex’ medical information about the options. Only one intervention 
explicitly states that patients’ knowledge is just as important as medical expertise,(33) and 
none of the interventions sufficiently promote patients’ self-efficacy in understanding the 
knowledge about treatment options, before being given the information. Given the 
significance of these factors in determining individual capacity to participate in SDM, this is 
an important gap that needs to be addressed. Future interventions will need to ensure 
patients are adequately prepared and feel that they are capable of understanding the information 
about their options, before attempts to provide this information. If patients do not feel 
capable at the point of being presented with this information, it is likely that they will be less 
willing to make attempts to understand the information and more likely to defer the 
decision-making to the clinician. Interventions could also benefit from explicitly explaining 
the rationale for and the importance of the patients’ personal contribution (i.e. about 
preferences), rather than simply stating that the medical and patient expertise is of equal 
value. 
Another key factor identified in Chapter 2 relates to the ‘covert contract’ that patients 
develop with clinicians, mainly physicians. Many patients feel that they need to adopt the role 
of a ‘good patient’, which is characterised by passivity and compliance. Attempts to 
encourage patients to move away from this perception of the ‘good patient’ role and to 
become more active in the decision-making process can be hampered by patients’ fear of 
retribution. This key barrier has not been sufficiently addressed by previous interventions, as 
indicated by the low scores awarded.  The interventions encourage patient involvement, and 
some even acknowledge the move away from the traditional passive patient role, but none of 
the interventions directly address the fear of retribution, which is often driving compliance 
with the traditional role.(38)  If fear of negative consequences is stopping patients from 
adopting a more active role in decision-making, future interventions need to reassure 
patients that the quality of treatment that they receive from the medical team will not be 
affected in a negative way should they decide to participate, and they will not be perceived 
negatively by the team (e.g. they will not be perceived as a ‘difficult’ patient). Attempts 
should be made to normalise the active patient role so that patients perceive that it is 
expected and accepted by clinicians and other patients.  
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Failure to address the above barriers is important, given their significance in the review of 
patient-reported barriers and facilitators to SDM (Chapter 2).(127) However, several other 
factors were also not addressed well and will also need to be covered by future interventions. 
These include: overcoming the perception that there are ‘right’ and ‘wrong’ decisions for 
certain medical conditions or procedures, and explicitly and clearly describing to patients 
what equipoise means; reinforcing that SDM is suitable for everyone, and should not depend 
on, for example, your age, ethnic background, or level of education; changing patients’ 
perceptions that they do not ‘need’ to participate in SDM; and disentangling those patients 
who have made an informed decision not to participate, from those who have not, or those 
who actually feel that they cannot participate because of various factors.(121)   
In addition to the clear gaps identified by the review, Table 3.3 includes those 
barriers/facilitators that have been addressed well by previous interventions. In summary, 
these factors relate to patients’ presumptions about the patient role and their perceived need 
for preparation. The interventions provide patients with permission to participate and 
indicate that clinicians want patients involved, they emphasise patients’ entitlement to choice, 
they highlight the acceptability of asking clinicians questions, and they help patients to 
understand what they can expect from the SDM process. Although most patient-reported 
factors relating to presumptions about the patient role are covered adequately, fear of 
retribution has not been covered, as outlined above. Therefore, even if all of the other 
factors related to perceptions of the patient role are addressed adequately by an intervention, 
it is possible that patients will still be apprehensive to become involved until they are 
reassured that there will not be negative consequences. This highlights the importance of 
comprehensively addressing as many of the barriers/facilitators as possible in an 
intervention.  
It should also be noted that whilst all of the interventions scored highly on these factors, the 
same interventions scored lower on the barriers related to time. Two of the interventions 
include a coaching element ranging from 30-45 minutes in duration,(17, 136) two of the 
interventions include video clips that are viewed directly before the consultation,(133, 138) 
and two interventions include video clips on accompanying websites.(33, 138) Whilst these 
interventions addressed the above factors well, coaching sessions and video clips are time 
and cost intensive interventions that will place additional burden on already busy clinical 
teams. Therefore, the feasibility of these interventions in routine clinical practice is 
questionable, and we need to find alternative ways to address these elements in future 
   102 
interventions so that they also address organisational barriers such as time and clinical 
workflow.   
A large number of factors identified as barriers and facilitators relate to attitudinal change at 
the level of the patient. In the SDM field, researchers have invested a lot of time and effort 
into developing and delivering SDM skills training programmes for clinicians. Person-
centred care is also becoming incorporated into the medical and nursing curriculum at 
several centres (e.g. Cardiff University, University of Ottawa). SDM implementation 
programmes highlight the importance of both changing clinicians’ attitudes towards SDM 
and providing the tools to support SDM. However, SDM is more complex than delivery of 
patient decision support interventions alone.(35) Further, implementation research has 
shown that normalisation of SDM in clinical teams requires considerable effort, engagement 
and facilitation, especially to achieve the attitudinal shifts among clinicians necessary to 
support this work.(35) Unfortunately, the same level of investment in attitudinal change at 
the patient level has not been recognised. It takes considerable effort to move clinicians from 
thinking SDM is something they do already, to seeing it as different to current practice and 
something that they could do better.(35) Among some of the more resistant clinicians, who 
have long-standing beliefs about appropriate roles in the doctor-patient relationship, 
significant attitudinal shift is required before they accept that SDM is the correct way to 
approach decision-making with patients.(35)  
A SDM consultation is considerably different to the consultations that many patients are 
used to, and may even be comfortable with, yet they are just expected to ‘get it’ and change 
their usual and long established behaviours when they are presented with an opportunity to 
participate in the decision–making process. Patients are presented with the decision support 
tools that support the decision-making process before we are certain that they are ready to 
be presented with this opportunity. Researchers and implementers have invested a large 
amount of time in making sure clinicians have undergone the necessary attitudinal shift for 
SDM to take place, with variable success, and that they are provided with the necessary tools 
to support the process, but we have not invested the same effort in preparing patients 
attitudinally for this different way of engaging with the healthcare system. Instead, 
researchers have focused on providing the tools to support the process, as evidenced by the 
large number of knowledge based tools included in the Cochrane review of patient decision 
aids.(16) These are of course valuable for patients to participate in SDM, but they are 
unlikely to support SDM for the large number of patients unless ‘entry-level’ attitudinal 
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factors are addressed first.(127) It is acknowledged that structured training programmes are 
available that support patients to become more involved in their healthcare management 
(such as the Expert Patient Programme), but these tend to be targeted at patients with long-
term conditions, and not the general patient population who are asked to make discrete 
medical decisions.  
The relatively few interventions that have attempted to prepare patients for the SDM 
encounter have not addressed the patient-identified barriers/facilitators comprehensively. A 
significant finding from this review was the number of barriers/facilitators against which we 
could not assess a patient-targeted preparation intervention. Many of these factors were 
related to organisational structures (e.g. creating systems that accommodate SDM pathways) 
or the attitudes and behaviours of clinicians. It would be unrealistic to expect a patient-
targeted intervention preparing patients for a SDM consultation to address these in isolation, 
and scores on these factors would depend largely on whether the interventions had been 
used with complementary interventions that target clinicians’ attitudes and behaviours, and 
whether wider organisational change and support had also been initiated. This highlights the 
challenge of addressing the wide range of patient-reported factors.(127) Further, even if an 
intervention were to address the 20 patient-reported barriers/facilitators that I would expect 
it to cover, there are still a large number of patient-reported factors that will not be 
addressed, and this is before the wider literature on clinician and organisational barriers is 
considered.(33, 35, 57)  
The theoretical basis of existing interventions is unclear (not reported). If interventions are 
not theoretically grounded, this impedes the possibility of understanding the behaviour 
change processes that underlie effective interventions i.e. the active and effective ingredients. 
Due to the absence of explicitly reported theoretical models, it is difficult to determine 
which components of the existing interventions might be effective, or less effective. The 
results from Chapter 2 suggest that attitudinal and behavioural change appears to be a key 
factor in increasing patient involvement in decision-making. As such, it is important that the 
intervention is theory-based and systematically developed. This will ensure that the 
determinants of the target behaviour(s) are identified, and that the intervention components 
addressing each determinant are explicitly stated, which allows the potential to explore 
associations between these intervention components and intervention effects.   
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The results of this review emphasise the need for a holistic approach to intervention 
development that addresses multiple levels of barriers/facilitators simultaneously. To date, 
most patient-targeted preparation interventions have been developed in isolation and tested 
in controlled trial settings. We need to move away from this approach and develop patient-
targeted preparation interventions as part of a ‘SDM bundle’. These bundles will include a 
range of complementary interventions including, but not exclusive to, patient decision 
support interventions and SDM skills training for clinicians. They will be implemented in the 
context of wider clinical team engagement and organisational support. The development 
process that will lead to the development of the intervention will need to consider the 
patient-reported factors(127) in conjunction with clinician-reported(57) and organisational 
factors(33, 35) to ensure that as many factors as possible are considered. These may apply to 
the content of the intervention, the way in which it is implemented, or the wider context 
within which it is implemented.  
3.4.1 Strengths and Weaknesses  
I did not conduct a systematic review using new search strategies. However, the results have 
been derived in part from previously conducted Cochrane systematic reviews, which adhere 
to strict guidelines,(131) and the review has been supplemented by vigorous follow-up 
searches of academic and non-academic institutions that are involved in shared decision-
making work. Given the scope of the previous reviews, I am confident that the interventions 
suitable for this review would be a sub-set of those identified previously. The relative 
homogeneity of scores across interventions at the barrier/facilitator level confirms the 
significance of key gaps identified by this review; when a barrier has not been addressed well 
by one intervention, it tends to have not been addressed well by other interventions.  
However, since my review was carried out (August 2013), two further Cochrane Reviews 
have been published, which could have served to identify interventions.(162, 163) My review 
of existing interventions preceded and informed the intervention development phase (see 
Chapter 4); as such, it was not feasible to repeat the literature review of interventions when 
the new reviews were identified. However, I did examine the two reviews to identify if there 
are any studies / interventions that meet the inclusion criteria, which were not included in 
my original review conducted in August 2013.    
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From the Legare et al review,(66) two of the included studies meet the inclusion criteria of 
my review. One has already been included in my review,(134) the other was not included (or 
identified from my search strategies).(164) This intervention is delivered in the waiting area 
before a consultation and explains what a decision is, it prompts patients to select a topic of 
focus for the current healthcare visit, and to list / prioritise questions for their healthcare 
professional. A quick examination of this intervention suggests that its inclusion in the 
review would not change the results of the review: there is still scope to develop a more 
comprehensive intervention that addresses the key patient barriers identified in Chapter 2, 
ahead of consultations (ideally before patient arrives at appointment).  
From the Coulter et al review,(162) no further studies met the inclusion criteria of my 
review. Many of the interventions focus on changing health behaviours related to the 
person’s long-term condition (e.g. lifestyle, exercise habits, diet), goal-setting, and general 
information exchange during a consultation. Whilst the promotion of self-efficacy and goal 
setting might impact on SDM during a consultation, the specific aim of the intervention was 
not to change attitudes regarding patient involvement in SDM. Many are also delivered 
during a consultation, rather than before, they are not patient-focused (e.g. skills training of 
the clinical team), and they are delivered in a group setting.  
A large number of factors were included in the evaluation that I would not necessarily expect 
a patient-targeted preparation intervention to address in isolation. This is acknowledged in 
the results presentation, and their inclusion serves to highlight the importance of a holistic 
approach to the development of future interventions. It is also acknowledged that a duplicate 
study selection and data extraction process was not used for the current review. However, 
the purpose of the review is to describe and evaluate features of existing interventions, rather 
than prediction of the effect of interventions. It was therefore deemed appropriate for one 
reviewer experienced in the evaluation of SDM interventions (i.e. International Patient 
Decision Aids Standards Instrument rater),(126, 165) who developed to the taxonomy of 
patient-reported barriers/facilitators, to conduct the evaluation.  
3.4.2 Conclusion 
Previously developed patient-targeted interventions designed to prepare patients for a SDM 
discussion do not adequately address patient-reported barriers and facilitators. Neglect of 
‘entry-level’ factors such as attitudinal change among patients, a focus on information 
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provision about options, and the development of patient-targeted interventions in isolation 
from other interventions may explain why SDM implementation attempts are still facing 
considerable roadblocks. Previous interventions lack theoretical basis, thus making it difficult 
to delineate the intervention components that might be most effective. The gaps identified 
by the evaluation indicate that there is scope to develop a theory-based intervention that 
more comprehensively addresses these barriers so that we can adequately prepare patients 
for a SDM discussion. Significantly, patient-targeted preparation interventions only form one 
piece of a very complex puzzle. The intervention that will be developed in Chapter 4 will 
need to be developed and implemented as part of a ‘SDM bundle’, within a context of wider 
organisational engagement and support.
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Chapter 4 
Using the Behaviour Change Wheel Guide to 
develop a patient-targeted intervention designed to 
prepare patients for SDM   
4.1 Introduction 
This chapter outlines the theoretical development of a patient-targeted intervention designed 
to prepare patients and increase patient involvement in shared decision-making (SDM). 
Chapter 2 identified various patient-reported barriers and facilitators to SDM: power 
imbalances in the clinical encounter (perceived or real) and the view that ‘doctor knows best’ 
were key factors hindering involvement, even when informational needs were met. Chapter 2 
concluded that a patient-targeted intervention designed to promote patient participation in 
SDM should focus in the first instance on addressing patients’ attitudinal factors.  
Chapter 3 reviewed current interventions to establish whether they addressed patient-
reported barriers and facilitators, especially attitudinal factors related to power imbalances. 
Chapter 3 highlights a number of factors that current interventions fail to address, and a 
number of ways in which future interventions could be improved. First, key barriers relating 
to power imbalances and social norms about acceptable patient behaviour need to be 
addressed more effectively. These include perceptions that ‘doctor knows best’ and that 
patients have inferior knowledge (i.e. failure to recognise that there are two ‘experts’), beliefs 
that ‘good’ patients are passive, and lack of confidence in being able to understand the 
information about options.  
Second, whilst some existing interventions have addressed many of the barriers / facilitators, 
they are cost and time-intensive. Some are delivered directly before a consultation, which 
leaves little time for attitudinal / behaviour change, and / or they lack a systematic 
distribution model (e.g. posters in waiting room). The intervention proposed in this thesis 
will need to be cost-effective and fit into current clinical pathways with minimum disruption, 
to ensure that it is feasible. It should also be delivered before patients attend for clinical 
appointments, to maximise the potential for attitudinal change. Third, existing interventions 
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tend to be developed and implemented in isolation from other interventions, or in controlled 
trial settings. The proposed patient-targeted intervention will need to be implemented in 
real-life clinical settings, in conjunction with a range of complementary interventions that 
tackle factors that are not related to patients’ attitudes (e.g. skills training for clinicians, 
decision support tools for information provision). 
Finally, the theoretical basis of existing interventions is unclear (not reported). The current 
intervention will be a behaviour change intervention, which are defined as ‘coordinated sets 
of activities designed to change specified behaviour patterns’.(166) Behaviour change 
interventions tend to be complex, involving many interacting components,(166) and tend to 
be more effective if interventions are based on evidence-based principles of behaviour 
change (theoretically grounded).(161) If interventions are not theoretically based, this 
impedes the possibility of understanding the behaviour change processes that underlie 
effective interventions i.e. the active and effective ingredients.  Therefore, the development 
of the current intervention will be grounded in behaviour change theory.  
The UK Medical Research Council (MRC) guidance for developing complex interventions 
informed by theory has been used to guide the development of this intervention,(45) but it 
does not provide detailed guidance on which theory to use. A large range of behaviour 
change theories exist, such as the Theory of Planned Behaviour(117) and the Health Belief 
Model.(167) However, selecting one or two theories or approaches to guide the intervention 
development will not cover the full range of possible influences, and thus key determinants 
of behaviour might be missed.(166) In a review of nineteen behaviour change frameworks 
that classify behaviour change interventions, Michie et al(166) concluded that none of the 
existing frameworks were comprehensive or conceptually coherent. As a result, they 
developed an integrated framework, which combines 33 theories and 128 theoretical 
constructs of behavioural change: the Behavioural Change Wheel Guide.(47, 166) This 
framework has also been designed for use in clinical implementation settings.  
4.1.1 Developing a theory-informed intervention: the Behavioural Change 
Wheel Guide 
The Behavioural Change Wheel Guide(47) proposes a systematic approach to theory-based 
intervention development, using a combination of four behaviour change ‘technologies’: 
1. The COM-B model of behaviour;(47, 166) 
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2. The Theoretical Domains Framework (TDF);(168, 169) 3)  
3. The Behaviour Change Wheel (BCW);(47, 166) and 
4. The Behaviour Change Techniques Taxonomy (v1.0).(170)  
These behaviour change technologies are used to answer the following questions during the 
design process: 
1. What behaviour are you trying to change and in what way? 
2. What will it take to bring about the desired change? 
3. What types of intervention are likely to bring about the desired change?; and 
4. What should be the specific intervention content? 
The guide is based on the ‘COM-B’ model of behaviour, which proposes that behaviour is 
dependent on the interaction between three necessary conditions: capability, opportunity, 
and motivation (Figure 4.1).(166) Capability is defined as the individual’s physical or 
psychological ability to enact the behaviour, and includes having the necessary knowledge 
and skills (psychological capability being the capacity to engage in the necessary thought 
processes). Motivation is defined as the reflective and automatic mechanisms that activate or 
inhibit behaviour. Reflective processes involve evaluations and plans (conscious decision-
making), and automatic processes involve emotions and impulses that arise from associative 
learning and/or innate dispositions. Opportunity relates to factors that lie outside the 
individual’s control that enable or prompt the behaviour. This is sub-divided into the 
physical opportunity afforded by the environment, and social opportunity afforded by the 
social environment that influences how we think about things. The model highlights 
potential influences between the different components: both opportunity and capability can 
influence an individual’s motivation; all three components can influence the enactment of a 
behaviour; and enacting a behaviour can in turn alter capability, motivation and 
opportunity.(166)  
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Adapted from Michie et al, 2011(166) 
 
 
This COM-B model of behaviour also provides a basis for designing interventions aimed at 
behaviour change, as it may help to identify the theoretical domains that are likely to be 
important in changing behaviour. The TDF is an elaboration of the COM-B model, and was 
developed in order to make the COM-B model more usable for implementation researchers 
designing and evaluating behaviour change interventions.(168, 169) Through a consensus 
process, the integrative framework was developed from 33 theories and 128 theoretical 
constructs of behavioural change.(169) The refined framework comprises 14 domains of 
theoretical constructs: knowledge; skills; social/professional role and identity; beliefs about 
capabilities; optimism; beliefs about consequences; reinforcement; intentions; goals; memory, 
attention, and decision processes; environmental context and resources; social influences; 
emotion; and behavioural regulation.(168) Table 4.1 provides a description of each domain 
and illustrates how the domains map to the COM-B components.  
Capability 
Psychological / Physical 
 
Motivation  
Reflective / Automatic 
 
Opportunity 
Social / Physical 
 
Behaviour 
Figure 4.1  -  The COM-B system - a framework for understanding behaviour 
   111 
Table 4.1  -  Mapping the COM-B model to the TDF domains 
 
COM-B 
Component 
 TDF Domain Description 
Capability Psychological  Knowledge An awareness of the existence of something 
 
 
Cognitive & 
interpersonal skills 
An ability or a proficiency acquired through practice 
Memory, attention 
& decision 
processes  
The ability to retain information, focus selectively on 
aspects of the environment and choose between two or 
more alternatives 
Behavioural 
regulation 
Anything aimed at managing or changing objectively 
observed or measured actions 
Physical  Physical Skills An ability or a proficiency acquired through practice 
Opportunity Social Social influences 
Those interpersonal processes that can cause individuals 
to change their thoughts, feelings, or behaviours 
 Physical 
Environmental 
context & resources 
Any circumstance of a person’s situation or environment 
that discourages or encourages the development of skills 
and abilities, independence, social competence, and 
adaptive behaviour 
Motivation Reflective 
Social/professional 
role & identity 
A coherent set of behaviours and displayed personal 
qualities of an individual in a social or work setting 
  
Beliefs about 
capabilities  
Acceptance of the truth, reality, or validity about an 
ability, talent, or facility that a person can put to 
constructive use 
  Optimism 
The confidence that things will happen for the best or that 
desired goals will be attained 
  
Beliefs about 
consequences 
Acceptance of the truth, reality, or validity about 
outcomes of a behaviour in a given situation 
  Intentions 
A conscious decision to perform a behaviour or a resolve 
to act in a certain way 
  Goals 
Mental representations of outcomes or end states that an 
individual wants to achieve 
 Automatic Reinforcement 
Increasing the probability of a response by arranging a 
dependent relationship, or contingency, between the 
response and a given stimulus 
  Emotion 
A complex reaction pattern, involving experiential, 
behavioural, and physiological elements, by which the 
individual attempts to deal with a personally significant 
matter or event 
 
The COM-B model and the TDF sit at the centre of the integrated BCW (Figure 4.2). 
Around this central hub are nine intervention functions (each includes one or more 
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behaviour change techniques) and seven policy categories (that could enable or support these 
interventions to occur) (see Table 4.2 for definitions of interventions and policies). Put 
simply, interventions are those activities that are designed to change behaviours, and policies 
are decisions made by authorities concerning interventions.(166) The authors emphasise that 
it is not a linear system, but one where components of the behaviour system at the hub 
interact with each other, as do the functions within the intervention layer and the categories 
within the policy layer. 
 
 
 
Figure 4.2  -  The Behaviour Change Wheel 
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Table 4.2  -  Definitions of interventions and policies 
Interventions Definitions 
Education Increasing knowledge or understanding  
Persuasion Using communication to induce positive or negative feelings to stimulate action 
Incentivisation Creating an expectation of reward 
Coercion Creating an expectation of punishment of cost 
Training Imparting skills 
Restriction Using rules to reduce the opportunity to engage in the behaviour (or to increase 
behaviour by reducing opportunity to engage in competing behaviours) 
Environmental 
restructuring 
Changing the physical or social context 
Modelling Provide an example for people to aspire to or emulate 
Enablement Increasing means or reducing barriers to increase capability (beyond education or 
training) or opportunity (beyond environmental restructuring) 
Policies Definitions 
Communication 
/marketing 
Using print, electronic, telephonic, or broadcast media 
Guidelines Creating documents that recommend or mandate practice. This includes all changes 
to service provision 
Fiscal Using the tax system to reduce or increase the financial cost 
Regulation Establishing rules or principles of behaviour or practice 
Legislation Making or changing laws 
Environmental / 
social planning 
Designing and/or controlling the physical or social environment  
Service provision Delivering a service 
 
This chapter describes how the Behavioural Change Wheel Guide(47, 166) has been used, in 
conjunction with MRC Guidelines for complex interventions,(45) to systematically develop a 
theory-based intervention designed to prepare patients for a SDM consultation with a 
clinician.  
4.2 Methods 
Using the BCW Guide, a four-step approach was used (see Table 4.3): 
1. Identifying the problem (what behaviour are you trying to change, and in what way?) 
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2. Assessing the problem (what are the barriers/facilitators, and what will it take to 
bring about the desired change?) 
3. Forming possible solutions (what types of intervention are likely to bring about the 
desired change?); and  
4. Deciding on the specific intervention content (using a taxonomy of behaviour 
change techniques).  
The fifth step involves ‘planning the intervention evaluation’ (how can behaviour change be 
measured and understood?). The focus of the current chapter is on intervention prototype 
development; Chapter 5 describes pre-testing and refinement of the intervention, Chapter 6 
describes pilot-testing using a process evaluation, and details regarding the intervention 
implementation plan and proposed evaluation (or Step 5) can be found in Chapter 7. 
Table 4.3  -  Steps used to develop intervention content 
 
STEP KEY TASKS 
STEP 1: Identifying the 
problem – what behaviour are 
you trying to change, and in what 
way? 
 Identify the evidence-practice gap 
 Specify the behaviour change needed to reduce the 
evidence-practice gap 
 Specify the group whose behaviour needs changing 
STEP 2: Assessing the problem 
–    what are the 
barriers/facilitators, and what will 
it take to bring about the desired 
change?  
 Review potential barriers and facilitators to the behaviour 
 Use the TDF and COM-B model to identify the pathway(s) 
of change to the behaviour 
STEP 3: Forming possible 
solutions – what types of 
intervention are likely to bring 
about the desired change?  
 Use the BCW to identify potential behaviour change 
techniques (intervention and policy level) to overcome the 
barriers and enhance the facilitators 
 Use the APEASE criteria to select those intervention 
functions and policies that are most appropriate 
STEP 4: Deciding on specific 
intervention content – using a 
taxonomy of behaviour change 
techniques  
 Use the Behaviour Change Techniques taxonomy to select 
specific intervention content and mode of delivery  
 Use the APEASE criteria to select those behaviour change 
techniques that are most appropriate 
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4.2.1 Step 1: Identifying the problem – what behaviour are you trying to 
change, and in what way? 
First, the target behaviour was selected and specified in detail by asking the following 
questions: What is the behaviour (or series of linked behaviours) that you will change? Who 
performs the behaviour(s)? What do they need to do differently to achieve the change? 
When, where and in what contexts do they perform the behaviour? Who do they perform 
the behaviour with? Behaviour is defined as: 
 ‘Anything a person does in response to internal or external events. Actions 
may be overt (motor or verbal) and directly measurable, or covert (activities 
not viewable but involving voluntary muscles and indirectly measurable). 
Behaviours are physical events that occur in the body and are controlled by 
the brain.’(171)  
Candidate behaviours were listed, and considered in terms of the following: likely impact on 
outcome if the behaviour was changed; how easy it is to change; effects of changing the 
behaviour (positive or negative) on other behaviours; and whether it can be measured. 
4.2.2 Step 2: Assessing the problem – what barriers and facilitators need 
to be addressed? 
Patient-perceived barriers and facilitators to increased involvement in SDM were reported in 
Chapter 2, and have been published elsewhere.(127, 172) A behavioural analysis was 
conducted to understand how the reported barriers/facilitators might affect performance of 
the target behaviour (active participation in SDM by the patient) and potential pathways of 
change. The behavioural analysis involved retrospectively coding patient-reported 
barriers/facilitators according to the domains of the TDF, which map to the COM-B model 
(See Table 4.1). This coding was checked and ratified in discussion with supervisors.  It was 
possible for individual barriers/facilitators to be coded under multiple TDF 
domains/components of the COM-B model. This coding exercise helped to identify the 
pathways of change that were likely to influence the target behaviour, and informed the 
selection of intervention components and policies in Step 3.  
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4.2.3 Step 3: Forming possible solutions - which intervention components 
could overcome the modifiable barriers and enhance the 
facilitators? 
Following the TDF/COM-B coding exercise in Step 2, the BCW (see Figure 4.2) was used 
to identify which of the nine intervention categories and seven policy categories could 
potentially overcome the barriers and enhance the facilitators. An intervention function 
matrix (see Table 4.4) was used to determine the most appropriate intervention functions for 
each component of the COM-B model. For example, if a barrier was coded as ‘Psychological 
Capability’ in the TDF /COM-B coding exercise, the intervention function matrix suggests 
that ‘Education’, ‘Training’, or ‘Enablement’ would be suitable intervention components. 
 
Table 4.4  -  COM-B Intervention Function Matrix 
 
Model of 
Behaviour: 
sources 
Intervention Functions 
Education Persuasion Incentivisation Coercion Training Restriction Environmental 
restructuring 
Modelling Enablement 
Physical 
Capability 
     
    
Psychological 
capability 
     
    
Physical 
opportunity 
     
    
Social 
opportunity 
     
    
Automatic 
motivation 
     
    
Reflective 
motivation 
     
    
 
Each source of behaviour can be addressed by more than one intervention function, and it 
would not be feasible to use all of the intervention functions to address a given 
barrier/facilitator. Therefore, I made a judgement about the most appropriate functions 
using the BCW APEASE criteria:  
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 Affordability – can it be delivered to budget? 
 Practicability – can it be delivered as designed?  
 Effectiveness and Cost-effectiveness – does it work (ratio of effect to cost)? 
 Acceptability – is it judged appropriate by relevant stakeholders (publicly, 
professionally, politically)? 
 Side-effects/safety – does it have any unwanted side-effects or unintended 
consequences? 
 Equity – will it reduce or increase the disparities in health/wellbeing/standard of 
living?  
The most appropriate intervention functions were selected for each barrier and recorded. 
The policy categories matrix (see Table 4.5) was then used to identify how policy categories 
map to the intervention functions; using the APEASE criteria, a decision was made about 
which polices would support the delivery of the intervention. Policy categories relate to the 
way in which the interventions are implemented.  
 
Table 4.5  -  COM-B Policy Categories Matrix 
 
Policy 
Categories 
Intervention Functions 
Education Persuasion Incentivisation Coercion Training Restriction Environmental 
restructuring 
Modelling Enablement 
Communication/ 
Marketing 
     
    
Guidelines 
 
     
    
Fiscal 
 
     
    
Regulation 
 
     
    
Legislation 
 
     
    
Environmental/ 
social planning 
     
    
Service 
provision 
     
    
   118 
4.2.4 Step 4 - Deciding on the specific intervention content – using the 
Behaviour Change Techniques Taxonomy 
Step 3 identifies the broad level intervention functions and policy functions that will be used 
and addressed by the intervention e.g. education will be provided to patients about the 
benefits of SDM, and local health board communication channels will be used to deliver the 
message. Step 4 focuses on establishing the specific behaviour change techniques that will be 
used, the exact content of the intervention, and the specific mode of delivery. The Behaviour 
Change Techniques Taxonomy (v1.0)(170) comprises 93 hierarchically-clustered techniques, 
clustered into 16 groups: 1) Goals and planning; 2) Feedback and monitoring; 3) Social 
support; 4) Shaping knowledge; 5) Natural consequences; 6) Comparison of behaviour; 7) 
Associations; 8) Repetition and substitution; 9) Comparison of outcomes; 10) Reward and 
threat; 11) Regulation; 12) Antecedents; 13) Identity; 14) Scheduled consequences; 15) Self-
belief; 16) Covert learning.  
The taxonomy was developed using a Delphi-exercise in response to the under-reporting 
and inconsistency of reporting content in behaviour change interventions.(170) The 
taxonomy was used to guide the selection of specific intervention content that could 
potentially address each barrier/facilitator. Again, the APEASE criteria were used to ensure 
selected techniques were locally relevant, feasible, and could be delivered as a cohesive 
intervention. When the specific content for each barrier/facilitator was agreed, the taxonomy 
was used to code the content. This standardised framework ensured consistency of labelling 
the techniques used to address different barriers/facilitators, and the ability to identify if 
there was overlap in the techniques used. It also helps to specify the active ingredients of the 
intervention, which is essential when planning intervention evaluation (for further details, see 
Chapter 6), and useful for intervention replication.  
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4.3 Results 
4.3.1 Step 1: Identifying the problem – what behaviour are you trying to 
change, and in what way? 
Previous chapters have shown that most current SDM interventions have been 
clinician/organisation targeted or dependent, and/or are delivered during or after clinical 
encounters e.g. patient-targeted decision support tools(16). The results of Chapter 2 
demonstrate that patients’ attitudes are a significant barrier to SDM,(127) and Chapter 3 
concluded that patient-targeted preparation interventions delivered before SDM encounters 
show promise for changing patients’ attitudes and behaviour. Based on this, the patient was 
chosen as the target for behaviour change: the patient-targeted intervention that is being 
developed will be used within a wider SDM implementation programme (MAGIC),(33, 35) 
which has focused on changing clinicians’ attitudes / behaviours and restructuring the 
organisational environment.  
The target behaviours for the intervention arose from models and definitions of SDM,(1, 15, 
118) as well as questionnaires that aim to determine if SDM has taken place during a clinical 
encounter.(173, 174) These models / definitions / questionnaire items were examined to 
establish key behaviours that need to happen for SDM between a patient and a clinician to 
take place. There are many different ways that patients could be more involved in healthcare 
decisions, but target behaviours were selected on the basis that they were observable and/or 
measurable. Behaviours that indicated that a patient had actively participated in the decision-
making process with a clinician were selected: 
 Display positive and receptive behaviours towards involvement in the decision-
making process when offered treatment choice by the clinician 
 Communicate personal preferences (things that matter most to the patient) to the 
clinician(s), during and/or after the clinical encounter (e.g. during a follow-up home 
visit with a nurse)  
 Use of the intervention (booklet) before, during, or after the next clinical 
appointment with a clinician e.g. use of the notepad / checklist 
I chose these target behaviours because they had strong supporting evidence (i.e. that 
performance of these behaviours leads to outcomes associated with SDM, such as increased 
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knowledge, integration of preferences, congruence between personal preferences and 
choice), were potentially modifiable at the patient level, and were unlikely to have a negative 
impact on other behaviours e.g. clinicians’ behaviour in the consultation.  
4.3.2 Step 2: Assessing the problem – what barriers and facilitators need 
to be addressed? 
In Chapter 2, a total of 44 unique barriers/facilitators were identified by the systematic 
review of patient-perceived factors.(127) The 44 barriers/facilitators were coded against the 
TDF/COM-B model (Table 4.6). Frequencies of barriers/facilitators coded under the 
TDF/COM-B model are: Knowledge (10); Cognitive & interpersonal Skills (7); Memory, 
attention and decision processes (6); Behavioural regulation (3); Physical skills (0); Social 
influences (15); Environmental context and resources (43); Reinforcement (6); Emotion (6); 
Social/professional role and identity (11); Beliefs about capabilities (9); Optimism (1); Beliefs 
about consequences (15); Intentions (5); Goals (3). 
The coding exercise revealed that certain pathways of change were more significant than 
others (in terms of frequency). The key areas for change relate to: provision of knowledge 
about options; social norms about acceptable behaviour in a clinical encounter and 
participation of certain groups (e.g. older age group); how patients perceive clinicians’ and 
their own role and identity in a clinical encounter; beliefs about ability to be involved in a 
decision-making process; beliefs about the potential negative consequences of being 
involved (e.g. retribution); and, clinician-related attitudinal factors. 
For the purposes of the current coding exercise, all barriers/facilitators were coded against 
the TDF/COM-B model. However, it would not be feasible to address all 44 
barriers/facilitators identified with a patient-targeted intervention; for example, some of the 
factors are non-modifiable, and others can only be addressed by a clinician-targeted 
intervention. In the results section of Chapter 3, several different categories were established, 
which indicated the potential modifiability of the barriers and facilitators. Using these 
categories, and the APEASE criteria, factors that would have the biggest influence on 
behaviour/attitudinal change in patients (i.e. attitudinal factors about social norms) and that 
could be addressed by a patient-targeted intervention, were selected as targets for the 
intervention (see Table 4.6 for list of selected factors). 
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The remaining factors were organised according to several sub-categories, and are also 
presented in Table 4.6: non-modifiable patient/decision related characteristics, beyond remit 
of current intervention; factors that can be addressed by complementary patient-targeted 
intervention; factors that can be addressed by complementary clinician-targeted intervention; 
and, organisational factors beyond scope of patient-targeted intervention (but to be 
considered during implementation).  
4.3.3 Step 3: Forming possible solutions - which intervention components 
could overcome the modifiable barriers and enhance the 
facilitators? 
Forty-four barriers/facilitators were identified by the review in Chapter 2 and were coded 
against the TDF/COM-B model. Nineteen factors were selected to be addressed by the 
intervention. The remainder were considered either non-modifiable or contextual factors, 
not significant factors determining patients’ behaviour or factors that need to be addressed 
by complementary interventions e.g. clinician skills training (see Table 4.6). 
Following the coding exercise in Step 2, the intervention matrix (Table 4.4) was used to 
identify the range of suitable intervention functions that could be used to address the 
selected barriers/facilitators. Table 4.6 indicates how selected barriers and facilitators were 
mapped to the COM-B model and TDF in Step 2 (column A&B), the range of possible 
intervention functions, as suggested by the intervention mapping matrix (column C), and the 
selected intervention functions (column C, indicated in bold). The possible and selected 
intervention functions in column C are grouped according to how the map to the COM-B 
model e.g. restriction maps to Opportunity-social and Opportunity-physical.  
Selected intervention functions were agreed using the APEASE criteria, in discussion with 
supervisors. For example, one of the patient-perceived barriers was ‘patients perceiving that 
there are ‘right’ and ‘wrong’ decisions and not wanting responsibility for wrong decisions’. 
This barrier was mapped to the domains ‘knowledge’ (Capability-psychological) and ‘beliefs 
about consequences’ (Motivation-reflective). The intervention matrix (Table 4.4) suggests 
that these domains could be addressed by education/training/enablement and 
education/persuasion/ incentivisation/coercion, respectively. Using the APEASE criteria, it 
was deemed that this barrier would be best addressed by ‘education’ and ‘enablement’. This 
is reported in bold in column C of Table 4.6. 
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The policies that would support the delivery of the intervention were then considered. The 
four key intervention functions selected were (in order of frequency), Persuasion (Per), 
Education (Edu), Environmental Restructuring (Env R), and Enablement (Enb). Using the 
Policy Categories Matrix (Table 4.5), these intervention functions map to the following 
policy categories:  
 Communication / marketing: Edu, Per 
 Guidelines: Edu, Per, Env R, Enb 
 Fiscal: Edu, Per, Env R, Enb 
 Regulation: Edu, Per, Env R, Enb 
 Legislation: Edu, Per, Env R, Enb 
 Environmental / social planning: Env R, Enb 
 Service provision: Edu, Per, Enb 
Using the APEASE criteria, I considered communication /marketing, guidelines, and service 
provision to be the policies that would be most likely to have an impact. The key aim of the 
intervention that is being developed is to change patients’ attitudes towards patient 
involvement in healthcare decision-making. The key areas for change identified by the 
coding exercise related to challenging social norms about patient involvement, redefining the 
patient role in healthcare consultations, emphasising clinician approval of patient 
involvement, and reassuring patients that there would not be negative repercussions of 
involvement. These key messages would be best suited to text-based materials, using 
principles of social marketing, such as a branded booklet that could be given to patients 
ahead of their consultation. 
Addressing the Service Provision category would also have an impact on the implementation 
of the intervention. If I change the way in which the service is provided, to incorporate 
SDM, I could integrate the intervention into the clinical care pathway with relative ease. 
Similarly, by addressing the Guidelines category, I could change the clinical care pathways of 
the teams that are involved, to mandate that every eligible patient is sent the intervention 
ahead of their consultation with the consultant / nurse specialist. Some categories could help 
to support the implementation of the intervention, but they are too broad for the initial 
pilot-testing stage, and would not be practicable. Regulation (i.e. establishing rules or 
principles of behaviour in practice) is possible in the long term (e.g. implementing the 
intervention at a whole health care organisation level), but it is beyond the remit of pilot-
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testing. Legislation at a national healthcare policy level would also be beneficial, but it is 
again not practicable at the team-level pilot-testing stage.  Further, the fiscal measures 
category (e.g. using the tax system to reduce or increase the financial cost) would not be 
relevant to the current intervention
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Table 4.6  -  Barriers / facilitators mapped to TDF / COM-B model, selected intervention components and behaviour change techniques used 
by the intervention 
A B C D E 
Barriers/ 
Facilitators 
Which theoretical 
domains / COM-B 
constructs do they 
map to? 
Possible / selected 
intervention components 
(selected in bold) 
Content description 
Behaviour Change 
Techniques coding 
BARRIERS / FACILITATORS TO BE ADDRESSED BY INTERVENTION  
Predisposing factors 
Age (older / younger) O-So Social Influences; 
O-Ph Environmental 
context & resources; M-
Re Social/prof role & 
identity; M-Re Beliefs 
about capabilities 
Restriction (O-So/O-Ph), env. 
restructuring-So/O-Ph), modelling 
(O-So), enablement O-SO/O-Ph), 
training (O-Ph), restriction O-SO/O-
Ph), education (M-Re), persuasion (M-
Re), incentivisation (M-Re), coercion 
(M-Re) 
Characters who range in age have been used in the booklet. This will indicate that SDM is 
for patients of all ages (for example, Page 3 depicts an older female patient, and page 6 
depicts characters from older age, middle age, and younger age groups).   
 
A quote from a patient in an older age group has been included. This quote indicates that it 
is okay for patients (including older patients) to change the way that they interact with 
clinicians, and to work together with them (see quote on Page 3 accompanied by older 
female patient character: ‘we want to get the message out there that it’s okay to interact 
differently with healthcare workers…we can work together with them as part of a team.’   
6.2    Social comparison 
6.3    Information about 
others’ approval 
 
Ethnicity O-So Social influences; 
M-Re Social/prof role & 
identity; O-Ph 
Environmental context & 
resources 
Restriction (O-So/O-Ph), env. 
restructuring (O-So/O-Ph), modelling 
(O-So), enablement (O-So/O-Ph), 
education (M-Re), persuasion (M-Re), 
incentivisation (M-Re), coercion (M-
Re), training (O-Ph), restriction (O-Ph) 
Characters from a range of ethnic backgrounds have been included to promote inclusivity 
for all ethnic backgrounds (for example, see characters on Page 3, Page 5, and Page 6).  
6.2    Social comparison 
 
Lower level of education C-Ps Cognitive & 
interpersonal skills; O-
Ph Environmental 
context & resources; M-
Re Beliefs about 
capabilities 
Education (C-Ps/M-Re), training C-
Ps/O-Ph), enablement (C-Ps/O-Ph), 
restriction (O-Ph), env. restructuring 
(O-Ph), persuasion (M-Re), 
incentivisation (M-Re), coercion (M-
Re) 
The booklet’s content has been written in a clear and concise manner. The Flesch Reading 
Ease Score is 80/100, and the Flesch Reading Grade is 5.  
 
N/A Not associated with a 
behaviour change technique.  
Poor articulation C-Ps Cognitive & 
interpersonal skills; C-Ps 
Memory, attention & 
decision processes 
Education (C-Ps/M-Re), training (C-
Ps), enablement (C-Ps), persuasion 
(M-Re), incentivisation (M-Re), 
coercion (M-Re) 
Tools that encourage patients to: a) write down any questions before the appointment, b) 
write down what is important to them and what they think about each option (see ‘What can 
help me get more involved section’, Page 7). 
Encouragement to share the questions and/or what is important to them with other people 
1.4    Action planning  
2.3    Self monitoring of 
behaviour 
3.1    Social support 
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e.g. clinician, family, and friends (see ‘what matters to me?’ section in Table, ‘What will I 
have to do?’ section, Page 6). 
Reminder that they can bring a family member/friend to the appointment if it would help 
them to communicate their questions/preferences ‘Don't forget, you can always bring 
someone along to your appointment with you’, Page 7. 
(practical) 
4.1    Instruction on how to 
perform the behaviour 
12.5  Adding objects to the 
environment 
 
Long term patient (bar/ 
fac) 
C-Ps Knowledge; C-Ps 
Cognitive & 
interpersonal skills; C-Ps 
Behavioural regulation; 
O-So Social influences; 
O-Ph Environment 
context & resources; M-
Re Social/prof role & 
identity; M-Re Beliefs 
about capabilities; M-Re 
Beliefs about 
consequences 
Education (C-Ps/M-Re), training (C-
Ps/O-Ph), enablement (C-Ps/O-Ph), 
restriction (O-So), env. restructuring 
(O-So/O-Ph), modelling (O-So), 
persuasion (M-Re), incentivisation 
(M-Re), coercion (M-Re) 
Persuasive language to emphasise that SDM is for everyone, regardless of whether you have 
a long term condition or not (see page 2, ‘It doesn't matter if you have along term condition, 
if you are making an important decision for the first time, or if you are simply deciding 
which medicine to take - everyone can be more involved when they have healthcare 
choices.’) 
6.3     Information about 
others' approval 
9.1     Credible source 
Interactional context factors 
Expectation of the 
clinician making 
decisions 
C-Ps Behavioural 
regulation; O-So 
Social influences; M-
Re Social/prof role & 
identity 
Education (C-Ps/M-Re); training (C-Ps), 
enablement (C-Ps/O-So); restriction (O-
So), env. restructuring (O-So);  
modelling (O-So); persuasion (M-Re); 
incentivisation (M-Re); coercion (M-Re).  
Information about the expected patient and clinician role is provided. This emphasises why 
the clinician cannot make the decision on their own, without the patient's input. Challenge 
existing beliefs about passive patient role (see ‘Why should I get involved?’ section, Page 
4). Provide rationale for involvement (see ‘Let's work together...so we can provide care 
that's right for you’ section, Page 3).  
A guide on how to take part in a SDM consultation, and what to expect, is provided in a 
table (see ‘What will I have to do?’ section, Page 6).  
Present common barriers to SDM stated by patients and challenge these perceptions; one 
includes perception that clinicians should make the decision (see ‘Doctor knows best, what 
do I know’ quote, ‘I'm still not sure...’ section, Page 5). Acknowledge that the role may not 
be what patients are used to (see opening paragraph ‘I'm still not sure...’ section, Page 5). 
Patient quote emphasising that patients should/can work together as a team with clinicians 
(see quote from asthma patient, ‘We want to get the message out there that it's okay to 
interact differently with healthcare workers...we can work together with them as part of a 
team’, Page 3). 
Present numbers of other patients who would prefer SDM, over clinician/patient making the 
decision (see infographic, bottom of Page 2) 
Information throughout booklet framed from perspective of local health board clinicians - 
provides confirmation that clinicians want patients to be more active in the decision-making 
process. 
4.1     Instruction on how to 
perform the behaviour 
6.2     Social comparison 
6.3     Information about 
others' approval 
9.1     Credible source 
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Desire to act like a good 
patient driven by fear of 
consequences 
O-So Social 
influences; O-Ph 
Environmental context 
& resources; M-Au 
Reinforcement; M-Re 
Beliefs about 
consequences 
Restriction (O-So/O-Ph); env. 
restructuring (O-So/O-Ph/M-Au), 
modelling (O-So); enablement (O-So/O-
Ph/M-Au); training (O-Ph/M-Au); 
persuasion (M-Au/M-Re); 
incentivisation (M-Au/M-Re); coercion 
(M-Au/M-Re); education (M-Re)  
Information about the expected patient and clinician role is provided. Challenges existing 
beliefs about passive patient role (see ‘Why should I get involved?’ section, Page 4).  
Information in booklet framed from perspective of local health board clinicians - provides 
confirmation that clinicians want patients to be more active in the decision-making process. 
Gives patients 'permission' to be involved (e.g. see quotes ‘...we need you to share, so we 
can provide better care’, Page 4).  
Challenges patients' perceptions of potential negative outcomes if they do take part in SDM 
(see quote ‘I don't want to be a difficult patient & annoy the doctor’ and ‘I don't want to be 
responsible for a wrong decision’, ‘I'm still not sure...’ section, Page 5).  
Emphasise benefits of being involved in the decision-making process (see ‘Some benefits of 
being involved...’, ‘Why should I get involved?’ section, Page 4) 
4.1     Instruction on how to 
perform the behaviour 
5.1     Information about 
health consequences 
5.2     Information about 
emotional 
consequences 
6.3     Information about 
others' approval 
9.1     Credible source 
 
Perceived acceptability 
of asking the clinician 
questions 
O-So Social 
influences; O-Ph 
Environmental context 
& resources; M-Au 
Reinforcement; M-Re 
Beliefs about 
consequences 
Restriction (O-So/O-Ph); env. 
restructuring (O-So/O-Ph/M-Au), 
modelling (O-So); enablement (O-So/O-
Ph/M-Au); training (O-Ph/M-Au); 
persuasion (M-Au/M-Re); incentivisation 
(M-Au/M-Re); coercion (M-Au/M-Re); 
education (M-Re) 
Convey the message that question asking is acceptable behaviour and that clinicians are 
happy to respond to patients' questions when they have them (see quote ‘If you're not sure 
why you have a choice, just ask' and ‘If you don't understand the options, just ask’, Table in 
section ‘What will I have to do?’, Page 6). 
Present common barriers to SDM stated by patients and challenge these beliefs; one 
includes perception that patient will annoy clinician if they get involved/ask questions (see 
‘I don't want to be a difficult patient and annoy the doctor’ quote, ‘I'm still not sure...’ 
section, Page X).  
Tools that encourage patients to ask specific questions about their options and to write down 
any questions before the appointment (see ‘What can help me get more involved section’, 
Page 7 and Appointment Checklist, Page 8). 
Information in booklet framed from perspective of local health board clinicians - provides 
confirmation that clinicians want patients to be more active in the decision-making process. 
1.4     Action planning 
4.1     Instruction on how to 
perform the behaviour 
6.3     Information about 
others' approval 
9.1     Credible Source 
12.5   Adding objects to the 
environment 
Belief that clinicians do 
not want patients 
involved 
O-So Social 
influences; O-Ph 
Environmental context 
& resources; M-Au 
Reinforcement; M-Re 
Social/prof role & 
identity 
Restriction (O-So/O-Ph); env. 
restructuring (O-So/O-Ph/M-Au), 
modelling (O-So); enablement (O-So/O-
Ph/M-Au); training (O-Ph/M-Au); 
persuasion (M-Au/M-Re); 
incentivisation (M-Au/M-Re); coercion 
(M-Au/M-Re); education (M-Re) 
Use of persuasive language throughout booklet, framed from perspective of local health 
board clinicians, that they do want patients involved In their healthcare decisions  
(See the following quotes/content: ‘A patient's guide to becoming more involved in 
healthcare decisions - written by patients and healthcare workers for you’, Page 1; ‘Let's 
work together, so we can provide care that’s right for you’ heading, Page 3’; ‘…we need 
you to share, so we can provide better care’, Page 4; ‘I don't want to be a difficult patient 
and annoy the doctor’ quote, Page 5).  
 
Information about the expected patient and clinician role is provided. This emphasises why 
the clinician cannot make the decision on their own, without the patient's input. Challenge 
existing beliefs about passive patient role (see ‘Why should I get involved?’ section). 
6.3     Information about 
others' approval 
9.1     Credible source 
Not having explicit 
permission to participate 
O-So Social 
influences; O-Ph 
Environmental context 
& resources; M-Re 
Beliefs about 
Restriction (O-So/O-Ph); env. 
restructuring (O-So); modelling (O-
So/O-Ph); enablement (O-So/O-Ph); 
training (O-Ph); education (M-Re); 
persuasion (M-Re); incentivisation (M-
Persuasive language used throughout the booklet conveying the message that patients have 
the right to participate in their decisions - this will act as 'permission' to become involved, 
framed from the local health board clinicians. (See the following quotes/content: ‘A 
patient's guide to becoming more involved in healthcare decisions - written by patients and 
healthcare workers for you’, Page 1; ‘Let's work together, so we can provide care that’s 
right for you’ heading, Page 3 ‘; ‘…we need you to share, so we can provide better care’, 
6.3   Information about 
others' approval 
7.1   Prompts/cues 
9.1   Credible source 
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consequences Re); coercion (M-Re) Page 4; ‘I don't want to be a difficult patient and annoy the doctor’ quote, Page 5).  
Checklist indicates that patients are expected to participate and have permission to check 
that they have been involved (see Appointment Checklist, Page 8). 
‘Doctor knows best’, 
patients have ‘inferior’ 
knowledge (bar) / 
Recognise that there are 
two experts in the 
medical encounter (fac) 
C-Ps Knowledge; O-
So Social influences; 
O-Ph Environmental 
context & resources; 
M-Re Beliefs about 
capabilities 
Education (C-Ps/M-Re); training (C-
Ps/O-Ph); enablement (C-Ps/O-So/O-
Ph); restriction (O-So/O-Ph), env. 
restructuring (O-So); modelling (O-So/O-
Ph); persuasion (M-Re); incentivisation 
(M-Re); coercion (M-Re) 
Describe the different, but complementary knowledge that patients and clinicians have, 
which is needed for the decision-making process. Emphasise the importance of patients' 
knowledge and explain that there are ‘two experts’ in healthcare consultations (see ‘Why 
should I get involved?’ section, Page 4). 
Present common barriers to SDM stated by patients and challenge these perceptions; one 
includes perception that the doctor has superior knowledge (see ‘Doctor knows best, what 
do I know’ quote, ‘I'm still not sure...’ section, Page 5). 
6.3   Information about 
others approval 
9.1   Credible source 
 
Patients are not capable 
of understanding 
medical/ technical 
information 
C-Ps Cognitive & 
interpersonal skills; C-
Ps Memory, attention 
& decision processes; 
O-So Social 
influences; M-Re 
Social/prof role & 
identity; M-Re Beliefs 
about capabilities 
Education (C-Ps/M-Re); training (C-Ps); 
enablement (C-Ps/O-So); restriction (O-
So); env. restructuring (O-So); modelling 
(O-So); persuasion (M-Re); 
incentivisation (M-Re); coercion (M-Re) 
Use persuasive language to encourage the patient to believe that they are capable of 
understanding the information about options. Emphasise that SDM is for ‘everyone’ (see 
opening section, Page 2 ‘...everyone can be more involved when they have healthcare 
choices’). 
Present common barriers to SDM stated by patients and challenge these perceptions; one 
includes perception that patients are not capable of understanding the information if they are 
given it (see ‘I can't understand medical jargon’ quote, ‘I'm still not sure...’ section, Page 5).  
Reassure patient that the clinician will take time to explain the information, and it is okay to 
ask if they do not understand it first time/would prefer a different format (see ‘What will I 
have to do?’ section, Page 6).  
Provide tools to help make patients feel more capable of understanding the information (see 
‘What can help me get more involved?’ section, Page 7, and Appointment Checklist, Page 
8). 
 
6.3     Information about 
others approval 
9.1 Credible source 
15.1   Verbal persuasion 
about capability 
12.5   Adding objects to the 
environment 
Preparation for the SDM encounter 
Patient is not entitled to 
a choice 
O-So Social 
influences; M-Re 
Social/prof role & 
identity  
Restriction (O-So); env. restructuring (O-
So); modelling (O-So); enablement (O-
So); education (M-Re); persuasion (M-
Re); incentivisation (M-Re); coercion (M-
Re) 
Use persuasive language throughout booklet to emphasise that patients are entitled to a 
choice about their healthcare decisions (e.g. see quote ‘…everyone can be more involved 
when they have healthcare choices’, opening section, Page 2; ‘...but, most of the time you 
will have choices’, Page 3; ‘...you can choose the option that fits best with what you prefer’, 
Page 3).  
Acknowledge that many patients are surprised when they are offered a choice because it is 
not what they are used to (see opening paragraph, ‘I'm still not sure...’ section, Page 5).  
Present numbers of other patients who would prefer SDM, to the clinician/patient making 
the decision (see infographic, bottom Page 2). 
6.2      Social comparison 
6.3     Information about 
others' approval 
9.1     Credible source 
‘Doing nothing’ is not an 
option 
C-Ps Memory, 
attention & decision 
processes; O-So Social 
influences; M-Re 
Beliefs about 
consequences  
Education (C-Ps/M-Re); training (C-Ps); 
enablement (C-Ps/O-So); education (C-
Ps/M-Re); env. restructuring (O-So); 
persuasion (M-Re); incentivisation (M-
Re); coercion (M-Re) 
Explain that inaction (doing nothing) is sometimes an appropriate action when making 
healthcare decisions (see diagram ‘What will I have to do?’ section, Page 6). 
9.1     Credible source 
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Patient does not want to 
or need to participate in 
SDM 
O-Ph Environmental 
context & resources; 
M-Au Reinforcement; 
M-Re Social/prof role 
& identity; M-Re 
Beliefs about 
consequences; M-Re 
Intentions 
Training (O-Ph/M-Au); restriction (O-
Ph); modelling (O-Ph/M-Au); enablement 
(O-Ph/ M-Au); persuasion (M-Au/M-
Re); incentivisation (M-Au/M-Re); 
coercion (M-Au/M-Re); env. 
restructuring (M-Au); education (M-Re)  
Use persuasive language throughout booklet to promote positive attitudes towards patient 
involvement in SDM and to establish patient involvement as the norm.  
Emphasise benefits of being involved and highlight potential negative outcomes of not 
being involved (see ‘Why should I get involved?’ section, page 4’). 
Describe the different, but complementary knowledge that patients and clinicians have, 
which is needed for the decision-making process. Emphasise the importance of patients' 
knowledge and explain that there are ‘two experts’ in healthcare consultations (see: ‘Why 
should I get involved?’ section, Page 4;  ‘Doctor knows best, what do I know’ quote, ‘I'm 
still not sure...’ section, Page 5). 
Present numbers of other patients who would prefer SDM, to the clinician/patient making 
the decision (see infographic, bottom Page 2). 
5.1      Information about 
health consequences 
6.2      Social comparison 
6.3      Information about 
others' approval 
9.1      Credible source 
 
Accepting responsibility 
to be involved in SDM 
M-Re Intentions Education, persuasion, incentivisation, 
coercion (all M-Re) 
Provide a description of a typical SDM consultation using a table explaining how patients 
can get involved, when they accept the role (see Table ‘What will I have to do?’ section, 
Page 6).  
Tools that are designed to be completed before/during/after a consultation; completion 
would indicate that the patient has accepted that responsibility (see ‘What can help me get 
more involved?’ section, Page 7, and Appointment Checklist, Page 8). 
4.1     Instruction on how to 
perform the behaviour 
7.1     Prompts/cues 
12.5   Adding objects to the 
environment 
Not knowing what to 
expect from the SDM 
consultation 
C-Ps Knowledge, M-
Re Beliefs about 
consequences; M-Re 
Intentions; M-Re 
Goals 
Education (C-Ps/M-Re); training (C-Ps); 
enablement (C-Ps); persuasion (M-Re); 
incentivisation (M-Re); coercion (M-Re) 
Provide a description of a typical SDM consultation using a diagram, allowing patients to 
know what to expect if they are offered healthcare choices (see diagram, ‘What will I have 
to do?’ section, Page 6).  
Provide an appointment checklist, listing key elements of a SDM process/consultation, and 
encouraging patients to make sure they were involved (see ‘Appointment Checklist’, page 
8).  
 
1.4     Action planning 
4.1     Instruction on how to 
perform the behaviour 
7.1      Prompts/cues 
Perceiving that there are 
‘right’ & ‘wrong’ 
decisions/ recognising 
equipoise & uncertainty  
C-Ps Knowledge; M-
Re Beliefs about 
consequences  
Education (C-Ps/M-Re), training (C-Ps), 
enablement (C-Ps); persuasion (M-Re); 
incentivisation (M-Re); coercion (M-Re) 
Explain 'equipoise' to patients and provide a rationale for choice, and also highlight 
situations when there may not be choices (see  ‘Let's work together...so we can provide care 
that's right for you’ section, Page 3).  
Emphasise that there are no right or wrong decisions in situations of equipoise; the decision 
will depend on personal preferences. Highlight the potential positive outcomes of being 
involved, and the potential negative outcomes if not involved (see ‘Why should I get 
involved?’ section, Page 4). 
Present common barriers to SDM stated by patients and challenge these perceptions; one 
includes perception that there are right and wrong decisions (see ‘I don't want to be 
responsible for a wrong decision’ quote, ‘I'm still not sure...’ section, Page 5). 
5.1      Information about 
health consequences 
5.3      Information about 
social and 
environmental 
consequences 
9.1       Credible source 
Preparation for the SDM process 
Decision support from 
others  
O-So Social influences Restriction, env. restructuring, 
modelling, enablement (all O-So) 
Remind patients that they can bring a family member / friend to an appointment if they 
want. This could be for emotional or practical social support (see ‘What can help me get 
more involved?’ section, page 7).  
Encourage patients to discuss their decision and what's important to them with a family 
3.2      Social support 
(practical) 
3.3      Social support 
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member / friend / other clinician (see ‘What will I have to do?’ section, page 6). (emotional) 
12.2    Restructuring the 
social environment 
NON-MODIFIABLE PATIENT / DECISION CHARACTERISTICS, BEYOND REMIT OF CURRENT INTERVENTION OR UNLIKELY TO HAVE SIGNIFICANT IMPACT (NOT KEY BARRIER / 
FACILITATOR) 
Poor / good health (fac) C-Ps Cognitive & 
interpersonal skills; O-
Ph Environmental 
context & resources; 
M-Au Emotion 
   
Cognitive impairments C-Ps Cognitive & 
interpersonal skills 
   
Physical impairments O-Ph Environmental 
context & resources 
   
Prior exposure to illness 
/ decision-making point 
(fac) 
C-Ps Knowledge, C-Ps 
Cognitive & 
interpersonal skills; C-
Ps Behavioural 
regulation; M-Re 
Social / prof role & 
identity; M-Re Beliefs 
about capabilities; M-
Re Beliefs about 
consequences; M-Re 
Intentions; M-Re 
Goals 
   
Difference in personal 
characteristics  
O-Ph Environmental 
context, M-Re Social / 
prof role and identity 
   
Embarrassing or 
sensitive topics  
O-So Social 
influences; O-Ph 
Environmental context 
& resources; M-Au 
Emotion 
   
Health condition stigma / 
discrimination 
O-So Social 
influences; O-Ph 
Environmental context 
& resources; M-Re 
Social / prof role and 
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identity 
Timing along the illness 
trajectory 
O-Ph Environmental 
context and resources 
   
Major (bar/fac) / minor 
(bar/fac) decisions 
C-Ps Memory, 
attention & decision 
processes; M-Au 
Emotion; M-Re 
Beliefs about 
capabilities; M-Re 
Beliefs about 
consequences 
   
Shock of receiving 
diagnosis / time to come 
to terms with diagnosis 
(fac) 
C-Ps Memory, 
attention & decision 
processes; O-Ph 
Environmental context 
& resources; M-Au 
Emotion 
   
Fear of accepting reality 
of diagnosis 
M-Au Emotion; M-Re 
Optimism; M-Re 
Beliefs about 
consequences 
   
BARRIERS / FACILITATORS THAT CAN BE ADDRESSED BY A COMPLEMENTARY PATIENT-TARGETED INTERVENTION (e.g. decision support intervention) 
Insufficient/ sufficient 
information about 
condition, options & 
outcomes/ clinician 
does/does not explain the 
options/ outcomes 
C-Ps Knowledge; O-
Ph Environment 
context & resources 
   
Written decision support 
(or lack of) 
C-Ps Knowledge; C-Ps 
Memory, attention & 
decision processes; O-
Ph Environmental 
context & resources 
   
Purpose of the decision 
support tool is unclear 
C-Ps Knowledge    
BARRIERS / FACILITATORS THAT CAN BE ADDRESSED BY A COMPLEMENTARY CLINICIAN-TARGETED INTERVENTION (e.g. SDM skills training) 
Clinician reinforces 
passivity by rewarding 
O-Ph Environment 
context & resources; 
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behaviour  M-Au Reinforcement 
Authoritarian clinicians  O-Ph Environmental 
context & resources 
   
Equal relationship (fac) O-Ph Environmental 
context & resources 
   
Clinician does not listen 
to patients’ concerns 
O-Ph Environmental 
context & resources; 
M-Re Optimism; M-
Re Beliefs about 
consequences 
   
Clinician with poor (bar) 
/ positive (fac) 
interpersonal skills) 
O-Ph Environmental 
context & resources 
   
Good (fac) / poor (bar) 
relationship with 
clinician  
O-Ph Environmental 
context & resources; 
M-Au Reinforcement  
   
Individualised approach 
& asked about personal 
preferences (fac; or lack 
of, bar) 
O-Ph Environmental 
context; M-Re Beliefs 
about consequences 
   
Clinician does not 
address patient directly 
O-Ph Environmental 
context & resources 
   
Patient is not explicitly 
offered a choice, or it is 
presented in a biased 
way 
O-Ph Environmental 
context & resources 
   
Clinician does (fac) / 
does not (bar) explain 
the options & outcomes 
C-Ps Knowledge; O-
Ph Environmental 
context & resources 
   
Clinician uses medical 
terminology (bar) / uses 
simple terminology (fac) 
O-Ph Environmental 
context & resources 
   
ORGANISATIONAL FACTORS BEYOND SCOPE OF PATIENT-TARGETED INTERVENTION – TO BE CONSIDERED DURING IMPLEMENTATION OF INTERVENTION 
     
Time available in the 
consultation 
O-Ph Environmental 
context & resources 
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Inability to choose 
clinicians to do SDM 
with 
O-Ph Environmental 
context & resources 
   
Too many clinicians 
involved in care 
O-Ph Environmental 
context & resources 
   
Lack of continuity in 
informational flow 
between clinicians 
O-Ph Environmental 
context & resources 
   
Being know (fac) / not 
being know (bar) by the 
clinician 
O-Ph Environmental 
context & resources 
   
Distributing SDM 
among different 
clinicians (fac) 
O-Ph Environmental 
context & resources 
   
Appropriate, multiple 
consultations for SDM 
(fac; or lack of, bar) 
O-Ph Environmental 
context & resources 
   
Inadequate 
environmental 
conditions  
O-Ph Environmental 
context & resources 
   
Paying (fac) / not paying 
(bar) for healthcare 
O-Ph Environmental 
context & resources 
   
Overspecialisation of 
doctors 
O-Ph Environmental 
context & resources 
   
Lack of reimbursement 
for clinicians doing 
SDM 
O-Ph Environmental 
context & resources 
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4.3.4 Step 4 - Deciding on the specific intervention content using the 
Behaviour Change Techniques Taxonomy (v1.0)  
4.3.4.1 The prototype intervention 
The results of Step 3 included selecting the broad intervention / policy categories (column 
C). Using the Behaviour Change Techniques Taxonomy (V1) as a guide (see Additional 
Appendix 4.1 on included CD), the exact format of the intervention and the content were 
selected. The exact content of the prototype intervention (including location in the 
intervention) is reported in Table 4.6 (column D). This table shows how the intervention 
content maps to the intervention categories selected.  
 The prototype intervention is an 8-page A5 booklet (see Figure 4.3 for front cover; see 
Appendix 4.2 for full booklet). This would be accessible to a larger number of patients, cost-
effective, and could be easily integrated into current clinical pathways.  The booklet will be 
sent to patients ahead of their clinical appointments (preferably at least one week before the 
appointment). During the pre-testing stage (see Chapter 5) participants’ views on alternative 
formats were explored. For feasibility, a booklet was chosen for the pilot-testing, with scope 
to develop additional formats with the same content at a later date e.g. tablet app, phone 
app, website. 
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Draft content was developed with supervisors. This was circulated for comment to members 
of the Healthcare Communication and Quality Research Group, based in Cardiff 
University’s School of Medicine. The nine respondents included a mix of researchers 
(offering a ‘patient’ perspective) and clinical members of staff. Comments were sought on 
the purpose of the booklet (e.g. to prepare patients to take part in SDM), the textual content 
(e.g. readability), and proposed specific elements (e.g. prompt and space for patients to write 
down what is important to them). All suggestions for appropriate use and improvement were 
integrated into the next draft, and / or considered during implementation planning (see 
Chapter 6).  
In August 2014, a graphic designer / illustrator was commissioned to develop the booklet, 
integrating the agreed content with graphic and character design. The initial version was 
received, and further feedback was sought from the Healthcare Communication and Quality 
Group. Feedback focused specifically on the layout, various design elements (e.g. colour 
scheme, style), character design, and usability. Three iterations were produced in order to 
incorporate the feedback. The final prototype version that was used in pre-testing (see 
Chapter 5) was received mid-August 2014.  
Figure 4.3  -  Front cover of ‘Your Health, Your Choice’ booklet 
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The draft title for the prototype booklet is ‘Your Health, Your Choice’. There are seven key 
sections to the booklet.  
1. This leaflet explains…(page 2) 
This section (see Figure 4.4) explains what the booklet will cover i.e. why patients 
have healthcare choices, what they can expect from a SDM consultation, and how 
they can work together with clinicians. It emphasises that SDM is something that 
everyone can take part in. The infographic highlights the number of patients that said 
that they would share decision-making with a clinician, compared to those who 
would rather make the decision by themselves, or let the clinician make the decision. 
This provides an element of social comparison for patients, where they can see what 
other patients have chosen to do in a similar situation. They can see that most other 
patients preferred to share the decision, and this also provides confirmation that 
other people approve of the behaviour.  
 
2. Let’s work together…(page 3) 
This section (see Figure 4.4) provides the rationale for patients becoming more 
involved in healthcare decisions. It makes comparisons to other day-to-day decisions 
that most people would be familiar with and comfortable making, and parallels 
healthcare decision-making to these ‘normal’ decisions.  This section begins to 
challenge patients’ perceptions of clinicians’ and patients’ roles in the healthcare 
consultation. At a high-level, it highlights that patients can be involved in decision-
making about their healthcare.  This section also includes a quote from an older 
female asthma patient, which emphasises that patients and clinicians can work 
together as part of a team. This challenges social norms that patients cannot be 
involved, thus normalising SDM, whilst providing social support and evidence of 
others’ approval.  
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Figure 4.4  -  Pages 2 & 3 of the ‘Your Health, Your Choice’ booklet 
Figure 4.5  -  Pages 4 & 5 of the ‘Your Health, Your Choice’ booklet 
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3. Why should I get involved? (Page 4) 
This section (see Figure 4.5) provides the rationale for SDM and patient involvement 
in healthcare decisions. It emphasises that there are two ‘experts’ and explains the 
different types of expertise that the patient and the clinician contribute to the 
decision-making process. This section challenges the common patient-perceived 
barrier that ‘doctor knows best’ and it explains why patients’ personal preferences are 
just as important as medical expertise. The right hand column highlights some of the 
benefits of participating in SDM, and the bottom paragraph highlights the potential 
downsides to not being involved i.e. receiving treatments the patient did not want, or 
outcomes that they did not expect.  
 
4. I’m still not sure… (Page 5) 
This section (see Figure 4.5) focuses on directly challenging the key patient-reported 
barriers that arose in Chapter 2. It presents four of the key barriers, framed from the 
patient perspective, and presents four responses to these barriers, framed from the 
clinician perspective. These four barriers include: ‘doctor knows best, what do I 
know?’ (Patients undervaluing the importance of their own expertise); ‘I can’t 
understand medical jargon!’ (Perceiving that patients are not capable of understanding 
information about options); ‘I don’t want to be a difficult patient’ (fear of the 
repercussions of being an active patient); ‘I don’t want to be responsible for a wrong 
decision’ (perceiving that there are right and wrong decisions, rather than equipoise). 
It emphasises that other patients often feel the same (social comparison). The 
clinicians’ responses provide reassurance to patients and attempt to change patients’ 
perceptions.  
 
5. What will I have to do? (Page 6) 
This section (see Figure 4.6) focuses on providing information to patients on how to 
perform the behaviour i.e. SDM. It outlines what to expect from a SDM consultation, 
or consultations. The section is formatted as a flowchart, which outlines three key 
stages of making a shared decision. Each heading is accompanied by a list of the key 
tasks that will be required during that stage. These headings relate to the three stages 
outlined in the SDM model for clinical practice.(1) This section is also written from 
the clinicians’ perspective, to provide confirmation that clinicians want patients to be 
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involved. It encourages patients to ask questions if they are not sure and to involve 
significant others in the decision-making process (social support).  
 
6. What can help me get more involved? (Page 7) 
This section (see Figure 4.6) focuses on enabling patients to become more involved in 
SDM by providing a tool to help prepare for the consultation and the decision-
making process. This page provides a notepad that patients can write on. Patients are 
encouraged to use the notepad to write down their questions for the clinician. They 
are also encouraged to write what they think about their options, should they be told 
they have them.  It also encourages patients to bring someone to their appointment if 
they wish (social support).  
 
 
 
 
 
 
 
 
7. Your appointment checklist…(page 8) 
The final page of the booklet (see Figure 4.7) includes an Appointment Checklist. 
Patients frequently report that they do not know what to expect from a SDM 
consultation, and this can act as a barrier to SDM. The aim of this page is to provide 
patients with a guide to the key features of an SDM consultation (picking up from the 
flowchart on page 6). The checklist acts as an aide memoire of the type of care 
patients should be receiving if they are faced with healthcare choices. The checklist 
Figure 4.6  -  Pages 6 & 7 of the ‘Your Health, Your Choice’ booklet 
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format allows patients to tick these off as and when they occur, if they so wish. Again, 
this page challenges attitudes that patients should not be involved; it ensures patients 
know that they can be actively involved and encourages them to check that they are.  
 
 
 
 
 
Figure 4.7  -  Page 8 of the ‘Your Health, Your Choice’ booklet 
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The colour scheme, layout, format and character design used throughout the booklet have 
been selected to ensure that the booklet is engaging and stands out from traditional patient 
information leaflets. It has also been designed in a way that will appeal to a variety of 
different age groups. Clear and concise language has been used throughout, and the content 
has a Flesch Reading Grade score of 5, making it accessible to a large number of people.  In 
order to make sure that patients perceive that the booklet is from a credible source, 
organisational logos have been included. The text is also framed as if written from the local 
health board’s and / or clinicians’ perspective. This will help patients to feel that they have 
permission from their clinician to take part in SDM.  
4.3.4.2 Behaviour Change Techniques Taxonomy coding exercise 
The results of the Behaviour Change Techniques Taxonomy coding are reported in column 
E. Full definitions of the behaviour change techniques used are available in Additional 
Appendix 4.3 (on included CD). 16 different behaviour change techniques were used in the 
intervention. Techniques were used from the following groups (number of techniques from 
each grouping included in parentheses): 3. Social support (2); 6. Comparison of behaviour 
(2); 12. Antecedents (2); 1. Goals and planning (1); 2. Feedback and monitoring (1); 5. 
Natural consequences (1); 4. Shaping knowledge (1); 7. Associations (1); 9. Comparison of 
outcomes (1). The four most frequently selected techniques were: 9.1 Credible source (12); 
6.3 Information about others’ approval (11); 4.1 Instruction on how to perform the 
behaviour (6); and 6.2 Social comparison (5).  
4.4 Discussion 
This chapter described how the BCW Guide(166) was used to develop a theoretical patient-
targeted intervention designed to prepare patients for a SDM clinical encounter. This guide 
offered a systematic approach to developing the resulting 8-page A5 booklet, ‘Your Health, 
Your Choice’. The four-step approach has combined theory and empirical research to select 
intervention components, moving through a process of identifying target behaviours, 
mapping barriers / facilitators to theoretical domains, selecting behaviour change techniques, 
and developing the intervention. The benefit of developing a theory-based intervention is 
the potential to explore associations between intervention components and intervention 
effects. The integrated framework, which covers various behaviour change theories, also 
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allows for a more comprehensive evaluation of the possible determinants of behaviour. 
Further, use of the Behaviour Change Techniques Taxonomy helps to specify the active 
ingredients for evaluation planning, and assists with intervention replication.  
It should be noted that this intervention focuses on the individual level i.e. the patient. 
Patient attitudinal factors are a significant barrier to increased involvement in SDM, as noted 
in Chapter 2. However, there are multiple other factors that will also need to be addressed in 
conjunction with patient-related attitudinal factors, if the intervention is to be successful 
(presented in Table 4.5). These include organisational factors (e.g. time in the consultation to 
do SDM; appropriate distribution models), clinician-related factors (e.g. displaying negative 
attitude towards patient involvement; encouraging patient passivity) and factors related to 
knowledge acquisition about options (e.g. provision of decision support tools). A single 
patient-targeted intervention such as the ‘Your Health, Your Choice’ booklet cannot address 
all of these factors. Therefore, the intervention will be implemented within a broader on-
going SDM implementation programme called MAGIC (MAking Good Decisions in 
Collaboration).  
MAGIC is a large-scale implementation programme taking place in Cardiff and Newcastle, 
commissioned by The Health Foundation, designed to embed SDM into routine clinical 
settings.(33, 37) In Cardiff, there have been three distinct phases to the MAGIC programme. 
Phase One (August 2010 – January 2012) was led by researchers at Cardiff University, and 
aimed to work collaboratively with various primary and secondary care teams to develop and 
test interventions within an implementation setting. Phase Two (February 2012 – August 
2013) was led by the Cardiff and Vale University Health Board, and focused on wider 
dissemination, implementation and sustainability of the successful interventions identified in 
Phase One. Phase Three began in December 2013, and is currently on going. This is an 
evaluation phase looking at three secondary care teams who have routinely embedded SDM 
into their clinical settings. These teams are the Breast Care Centre, Chronic Kidney Disease 
team, and the Paediatric Ears, Nose and Throat team.   
In addition to my PhD work, I have also been employed to work on the MAGIC 
programme since 2010. I was project manager during Phase One, and I was responsible for 
coordinating the development and implementation of SDM across four secondary care 
teams and four primary care teams. I worked closely with the dedicated SDM facilitators, 
and was responsible for collating the key learning from the different clinical areas.  I am also 
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involved in the SDM implementation evaluation for Phase Three of the programme. During 
Phase One, I took the lead on convening the Patient & Pubic Involvement panel for 
MAGIC; this involved meeting with the panel every other month to develop and refine 
SDM interventions, and making sure that they were consulted at all times when new 
developments arose. The ‘Ask 3 Questions’ campaign was developed with the panel 
(intervention included in Chapter 3 review), and this has helped with my understanding of 
patient perceived barriers and facilitators to SDM. This is one of the key reasons I decided 
not to conduct primary research with patients to explore barriers and facilitators; I was 
confident that the themes that emerged form the systematic review in Chapter 2 were 
reflective of the feedback I had heard from many patients throughout the MAGIC 
programme. The current intervention (‘Your Health, Your Choice) was not developed as 
part of the MAGIC programme, but my work on MAGIC has ensured I have a sound 
understanding of SDM implementation, which will assist with the development and 
implementation of my PhD work.  
The two key interventions that were most successful in Phase I were the advanced SDM 
skills workshops for clinicians and the brief in-consultation decision support tools (Option 
Grids): 
 SDM skills workshops: 1-3 hour skills training workshops framed around the SDM 
model for clinical practice,(1) using role play. The aim of the workshops is to help 
teams to understand the key steps in SDM and differentiate it from current ways of 
working.  
 Option Grids: brief one-page documents used within a consultation to facilitate 
discussion between patients and clinicians. They are designed to help people 
compare reasonable treatment or screening options for medical conditions. Using the 
grid, patients and clinicians can read and compare the answers to questions that 
patients frequently ask about each relevant option (see Figure 4.8) 
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These were implemented within the context of broader organisation and clinical team 
support, secured through various engagement activities with the Cardiff & Vale University 
Health Board members and clinicians. This included working directly with the Director of 
Patient Experience, securing support from the Chief Executive, and a dedicated SDM 
facilitator working directly with the clinical teams. This programme has ensured that the 
current intervention will be implemented in a supportive context, and that it can be delivered 
alongside complementary interventions that will address some of the barriers that could not 
Figure 4.8  -  Option Grid for breast cancer surgery 
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be addressed by the patient-targeted intervention alone.  For example, several of the barriers 
related to clinicians’ attitudes and behaviours (individualised approach, authoritarian 
clinicians, clinician does not explain the options) can be addressed by the SDM skills 
workshops, and also the team engagement activities that have taken place throughout 
MAGIC. Further, several of the barriers related to knowledge can be addressed by the 
provision of decision support tools, such as the Option Grids. The combination of different 
interventions and a supportive organisational context will maximise the impact of the ‘Your 
Health, Your Choice’ intervention, but it is proposed that this preparation is an essential 
component to promote SDM for the greatest number of patients.  
The next chapter (Chapter 5) describes the pre-testing process, whereby the prototype 
booklet was tested with members of the public, and clinicians / organisational 
representatives who will be integrating the booklet into their clinical pathways. 
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Chapter 5 
Pre-testing the prototype ‘Your Health, Your 
Choice’ intervention with users and clinicians: a 
qualitative study 
5.1 Introduction  
In relation to the MRC’s framework for the development and evaluation of complex 
interventions(45), Chapters 2 and 3 focused on the ‘theoretical phase’ of intervention 
development. That is, understanding the factors that will promote or inhibit patients 
becoming more involved in the healthcare decision-making process. The results from 
Chapters 2 and 3 formed the theoretical basis for the ‘Your Health, Your Choice’ 
prototype intervention. Chapter 4 reports how the BCW Guide(47) used the results from 
Chapters 2 and 3 to systematically develop the theoretically grounded intervention. The 
MRC stage of development used in the current chapter is known as ‘modelling’. This 
process involves delineating the actual intervention components, and examining how these 
active components may relate to outcomes. This stage also allows for refinements to be 
made to the design of the intervention, before embarking on a full-scale evaluation.  
Using the BCW Guide,(47) the active ingredients of the intervention were specified in 
Chapter 4 (see Table 4.6). In particular, the Behaviour Change Techniques Taxonomy(170) 
was used to specify the exact intervention components. Using the mapping process, 
assumptions were made about the components of the booklet that could address the key 
barriers and facilitators, and thus potentially change patients’ attitudes and behaviours.  An 
important stage in intervention development is ‘pre-testing’. This is the process of trying 
out the specific messages of the prototype intervention and the intervention materials with 
the intended participants before the final version is created.(175) This stage precedes the 
‘field-testing’, or pilot-testing, phase where the intervention is trialled as it will be 
implemented, with both the implementers (i.e. clinicians) and the intended participants (i.e. 
patients), before actual implementation (see Chapter 6 for details of the intervention pilot-
testing). Bartholomew and colleagues argue that the pre-testing phase is crucial to 
determine whether the planning up until this stage has resulted in an intervention that has 
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the potential to have the desired effect, is usable, and is likely to be implemented in the way 
intended.(175)  
The pre-testing phase provides reassurance that the assumptions made during intervention 
development are correct, or it identifies if changes are needed to address these 
assumptions.  Additionally, feedback from individuals who are involved in delivering the 
intervention and / or the broader organisational remit of patient-centred care, will allow us 
to make a judgement as to whether the intervention will fit with current practice.   
The aim of this chapter was to conduct pre-testing of the prototype intervention agreed in 
Chapter 4. Specifically, the chapter aimed to assess public users’ and clinicians’ reactions to 
the booklet’s content (or ‘active ingredients’), design, readability, usability, and potential 
implementation.   
5.2 Methods 
Pre-testing was conducted with two key groups: the general public and 
clinicians/organisational representatives. For ease of describing the methods and results, 
these groups will be referred to as the user group and the clinician group, respectively. A 
qualitative approach was used whereby participants were asked to take part in a structured 
interview. The interviews took approximately 45 minutes each, and were audio recorded. 
The study protocol and materials were reviewed and approved by the Cardiff University 
School of Medicine Research Ethics Committee, and a favourable ethical opinion was 
given in August 2014.  
5.2.1 User group – recruitment and analysis 
I aimed to recruit approximately six users, depending on data saturation. Potential 
participants had to be 18 years and over, and be able to read and speak English, but were 
not required to be a patient currently receiving care. Users were recruited via various 
routes. Involving People is part of Health and Care Research Wales. They encourage and 
support the active involvement of patients, carers and service users in health and social care 
research. Involving People were contacted, and a study opportunity form was completed, 
which outlined the requirements of participants and formed the basis of an advert that was 
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sent to the Involving People network members. Opportunistic sampling was also used to 
recruit users via social media websites (e.g. Facebook) and word of mouth.  
All individuals who indicated an interest in taking part in the study were sent the study 
information leaflet, a consent form and a study reply form, together with a self-addressed 
pre-paid envelope. Once the study reply form and consent form had been signed and 
returned, the individual was contacted in order to arrange a convenient time for the 
interview. When an interview had been arranged, participants were sent a copy of the 
intervention booklet and were encouraged to read the booklet before the interview, and to 
make notes if they wished.  
During the interview, participants were asked about their views on the booklet. The 
interview schedule was organised into two distinct sections: 1) questions based on the TDF 
(and key drivers of behaviour identified in Chapter 4); and 2) questions based on the 
booklet’s design elements, format and intended use (see Additional Appendix 5.1 on 
included CD for full interview schedule). The results of Chapter 4 indicated that certain 
pathways of change (TDF domains) were more significant, in terms of the frequency of 
barriers / facilitators being mapped to them. These key drivers of behaviour were: social 
influences; social and professional role and identity; beliefs about capabilities; beliefs about 
consequences; knowledge; and environmental context and resources. 
The mapping exercise in Chapter 4 ensured that the booklet content addressed these key 
barriers, and thus the key pathways of change e.g. the barrier ‘not knowing what to expect 
from a SDM consultation’, which mapped to the TDF domain ‘knowledge’, was addressed 
by including a section in the booklet on what to expect (‘What will I have to do?’ section). 
A key task of the pre-testing is to determine whether these specific elements of the 
intervention could potentially have the desired effect on the key drivers of behaviour e.g. 
does the section ‘What will I have to do?’ make users feel that they know what to expect 
from consultations where they are offered treatment options?  
All interviews were transcribed verbatim, and entered into NVivo qualitative analysis 
software.(72) Each transcript was thoroughly read, and the audio-recorded interview was 
re-listened to, to ensure familiarisation with the content of each interview. Using the key 
drivers of behaviour identified in Chapter 4 (see above), an initial set of codes were 
developed, each with a brief definition. This formed the initial analytical framework for the 
framework analysis,(176) which was used to code two of the transcripts. New codes that 
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did not fit with this initial framework were noted, and they were added to the revised 
framework. Codes that were redundant were removed or merged with other codes. The 
final framework was applied to each transcript using NVivo software (see Additional 
Appendix 5.2 on included CD for final analytical framework). Once all data had been 
coded using the analytical framework, the data were summarised in a separate matrix for 
each analytical theme (each matrix comprised one row per participant, and one column per 
code). Themes were generated from the data set by reviewing the matrices and making 
connections within and between participants and categories, influenced by the initial 
framework and new concepts that were generated inductively from the data.  
Content analysis, completed by hand, was also conducted to summarise feedback regarding 
the design elements, format, and text/graphic content (see Interview guide section B, 
Additional Appendix 5.1 on included CD). All requested changes were recorded, and sent 
to the designer to incorporate into the final version of the booklet used during pilot-testing 
(see Chapter 6). This feedback is summarised with the clinicians’ feedback in results section 
5.3.4. 
5.2.2 Clinicians – recruitment and analysis   
I aimed to recruit around six clinicians, depending on data saturation during qualitative 
analysis. The clinician group was recruited via known contacts that worked at either Cardiff 
and Vale University Health Board or Abertawe Bro Morgannwg University Local Health 
Board. Participants could either be clinicians or Health Board employees who are involved 
in the areas of patient experience or quality and safety. Potential participants were 
contacted via email in the first instance to gauge interest in taking part in an interview. All 
individuals who expressed an interest in taking part were sent the participant information 
leaflet, a consent form, and a study reply form, together with a self-addressed pre-paid 
envelope. Once the study reply form and consent form had been returned, the participant 
was contacted to arrange a convenient time and date for interview. Before the interview, 
participants were sent a copy of the booklet, and a covering letter that encouraged them to 
read the booklet and make notes.  
During the interview, the participants were asked about their views on the booklet. 
Specifically, they were asked about the following areas: overall purpose; format and design; 
views on the specific elements (see Additional Appendix 5.3 on included CD for full 
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interview schedule). Unlike the patient interview schedule, the focus was on the potential 
use of this booklet within a healthcare setting e.g. anticipated patients’ reactions, how could 
this fit into existing clinical pathways, and how does it fit with the organisation’s approach 
to patient-centred care? Using NVivo software, thematic analysis was conducted to analyse 
the feedback.(177) Framework analysis was not used for the clinician data; the framework 
was guided by the TDF (or the drivers of behaviour), and the focus of clinician interviews 
was on design / implementation feedback.  Content analysis by hand was also conducted 
to summarise suggested changes to the booklet’s design, format or text / graphic content. 
All requested changes were recorded, and sent to the designer to incorporate into the final 
version of the booklet used during pilot-testing (see Chapter 6).  This feedback is 
summarised with the users’ feedback in results section 5.3.4. 
5.3 Results 
Results have been organised into four key areas: (1) key themes emerging from the 
framework analysis of user data; (2) key themes emerging from the thematic analysis of 
clinician data; (3) implementation of the intervention (from user and clinician data); and (4) 
a summary of design and content changes (from user and clinician data).  
5.3.1 Sample 
Six participants (three male, three female) were recruited to the user group and interviewed. 
Two participants were recruited via the Involving People network (one male, one female). 
The four other participants included three females and one male. The age of the sample 
ranged from 21 – 74 years. Six participants were recruited to the clinician group (two male, 
four female), covering the following professions: Clinical Nurse Specialist (n=2), Patient 
Experience Facilitator (n=1), Investigation and Redress Manager (n=1), Senior Nurse in 
Quality and Safety (n=1), and People Centred Care Lead for Public Health Wales (n=1).  
Interviews lasted between 17 and 44 minutes (29 minutes average). For the participants’ 
convenience, two user participants were interviewed together (P9 and P10), and two 
clinician participants were interviewed together (C2 and C3). The transcripts for these two 
interviews were entered into NVivo twice, and each participant’s feedback was coded 
separately.  
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5.3.2 Patient sample - framework analysis using the TDF 
The initial analytical framework consisted of 23 codes, clustered across five categories. 
After coding two transcripts, one code was removed as it was not relevant to the interview 
transcripts (‘poor articulation or ability to communicate preferences’) and further codes 
were merged due to similarities in the coded content: ‘changing attitudes that good patients 
are passive and active patients are difficult’ was merged with ‘changing views on perceived 
acceptability of being involved in healthcare decisions (social norms)’; ‘overcoming 
perceived negative consequences’ was merged with ‘promoting perceived positive 
outcomes’; ‘knowledge of existence of choice’ was merged with ‘knowledge about 
rationale’.  Six new codes were added. The final analytical framework that was applied to 
the remainder of the transcripts consisted of 25 codes, clustered across six categories (see 
Appendix 5. 2)  
Data were then summarised into a matrix for each category in the analytical framework, 
with one row per participant and one column per code. Verbatim quotes were abstracted 
and entered into the corresponding cell. The following key themes emerged from 
examination of the data matrices:  
5.3.2.1 ‘This is the way that things are going to be’ – a shift in attitudes regarding 
patient involvement in healthcare decisions 
A key theme that emerged from the data related to social norms, or the perceived 
acceptability of patients’ participating in the healthcare decision-making process. A key 
barrier identified in the systematic review in Chapter 2 was patients perceiving that they 
cannot, or should not, be involved in decisions. Significantly, the booklet appears to have 
resulted in a positive change of attitude amongst most of the user participants; after reading 
the booklet, the users accepted that it is ‘okay’ for them to be more actively involved:    
 ‘I wouldn’t have even thought about it before to be honest with you…you 
go to the doctor…you’re always mindful you’re not going to be asking too 
much about the treatment or medication, but this message tells you now 
‘we’re offering a shared decision-making appointment – I’m meant to be 
offered it.’ [P6] 
 ‘Yeah definitely, I’d like to be more involved now after reading that…when 
going to the doctors, I know now I can have a choice in it, whereas before 
you’d go to the doctors for them to tell you what’s wrong and how to make 
you feel better.’ [P8] 
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The shift in attitudes towards active patient involvement in healthcare decisions was 
supported by personal stories from some of the participants, whereby they provided clear 
and detailed examples of situations where they had previously not been involved in SDM:  
‘You don’t want your doctor making decisions for you, well I don’t like it 
when I’m just told this is what’s happening, because when I went to my last 
appointment they were like ‘well you’re having this cream’ and I said ‘well 
I’ve had it before, that’s a really weak cream, you’re just giving me 
something now that isn’t going to work because I know it hasn’t worked 
before’. They’re not taking on board what’s happened, so yes it’s bad.’ [P8] 
‘Well, when I went to have my knees done, he wanted to do both knees at 
once. But that would have immobilised me for eight weeks, and I was like 
‘I’m not having that’, at some point I will have it done, but I was like ‘no, 
you’re not doing both knees’. So he was trying to get me to have two knees 
done, which would have been against me, which goes against what that 
[booklet] is sort of saying.’ [P9]  
The fact that the users discuss these situations in a negative light, in comparison to the 
SDM approach, suggests that they would have preferred to be more involved in the 
previous decisions, even if they did not realise this at the time of the original consultation.  
After reading the booklet, one participant saw SDM as an entirely new way of conducting 
most healthcare consultations, referring to them as a ‘new type of appointment’, but also 
recognised that some areas of healthcare do already promote the SDM approach: 
 ‘This is what’s going to be happening in the future…how this is going to 
evolve into these types of appointments. I think it would encourage you that 
this is the way that things are going to be, and that it’s okay to do it.’ [P6]  
‘I think already some departments have started encouraging people, as in 
maternity, you get asked what kind of birth plan you want, consultant led, or 
do you want the midwifery led unit?’ [P6] 
Interestingly, it seemed to be a case of participants not being able to know what they do 
not know; in other words, some felt that they had never been offered SDM before, or did 
not know what SDM was, but now that they know about it, they would want this type 
appointment: 
‘Probably because I didn’t have any knowledge about it, I didn’t know I 
could ask about it…but if they told me more, then I’d probably ask more 
questions and want to choose what cream I have.’ [P8] 
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‘Well it’s changed my views because I didn’t really know anything about if 
before, to be honest.’ [P6] 
Some users also believed that as other patients experience SDM, or become aware of SDM 
through the booklet, they would no longer wish to receive the ‘old type of appointment’:  
 ‘More people then will start expecting to have this, because once they know 
someone who has had a shared decision appointment, I suppose not many 
people would want the ordinary type of appointment. They would say ‘why 
can’t I have that appointment, my friend had an appointment where she was 
able to choose from the options…’.’ [P6] 
Generally, users felt that the elements of the booklet that made comparisons to other 
patients were helpful and reinforced positive social norms about SDM. This social 
comparison provided information about what other patients think about SDM, and it 
clarifies that others approve of it, thus providing reassurance about their own involvement 
in decision-making: 
 ‘It just showed how many actually want it, so it made me feel ‘well I want 
that now ‘cause 51 out of a 100 people like it, so it’s obviously got to be 
good.’ [P8] 
‘I like this bit, everyone else’s opinion, it asks the opinions from characters, 
and it made me feel like I can ask questions…I think going in now I’d be 
reassured.’ [P8] 
Users also felt that if they, or another individual that they knew, were prompted to speak to 
other people about the decision, such as family and friends, this would also encourage and 
support them to participate in SDM: 
 ‘It says here that you can share this with you doctor, nurse, or family, so 
the family becomes part of your treatment, whatever you’re going to do, the 
family become part of helping you to work together with your healthcare 
professional.’ [P6] 
 
5.3.2.2 ‘You know your life, better than the doctor knows your life’ – recognising 
the importance of patients’ contribution to decision-making 
Another key theme that emerged was users acknowledging that there are two experts in the 
healthcare consultation. One of the key patient-reported barriers identified in the 
systematic review in Chapter 2 was ‘doctor knows best’; in other words, patients placed a 
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significant emphasis on the medical knowledge from the clinician, and undervalued the 
importance of their own personal preferences in the decision-making process.  
The user interview data suggest that the booklet had a positive impact on helping patients 
to recognise the importance of both the clinician’s knowledge and the patient’s knowledge. 
It helped patients to understand that whilst clinicians know a lot about the diagnosis and 
the evidenced-based options that might help the patient, they do not know about the 
things that matter most to patients, and that the best decision for them would be made in 
collaboration with the clinician: 
‘A healthcare professional doesn’t know what would matter most to you and 
your family…[the booklet] would make you feel that it’s okay to do that and 
say ‘well actually I need to look after my mother, so I can’t go into hospital 
just yet, can I go in 3 months time and have a watchful waiting period?’’ 
[P6] 
‘I used to feel like they had to make a decision for me, so when I’d go to the 
doctors they’d prescribe the creams that they’d give me and the tablets, 
whereas now I’d probably feel like ‘well is this strong enough?’ [P8] 
 ‘…the two spectrums in a way, it’s like you know your side, you know 
yourself, and then they know the medical side of it, so it’s a joint effort. I 
want them there to be able to advise me on what’s available, but ultimately 
it’s me that it’s affecting, so it should be the choice is there for the patient.’ 
[P10] 
P6 saw patients as an extension of the clinical team that already work together: 
‘Already your healthcare professional would be working as part of a team 
at the hospital or surgery, so I think the patient would just become an 
extension of that team, and work together, it’s all about working together.’ 
[P6] 
In relation to the figure on page 2 of the booklet (See Appendix 4.2), which shows that 
23% of patients would like to make a decision on their own, P6 commented how she did 
not agree with this. This shows that the patient recognises the importance of both the 
patient and clinician contributions: 
‘23% saying they wanted to make a decision on their own, but I can’t see how 
that would ever be, because you need the information from the professional 
before, you can’t just make your own decisions on your health, it’s got to be a 
joint thing.’ [P6]  
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At the beginning of the interview, P9 noted that he felt clinicians knew best because ‘they 
are the ones with all the training’. However, during the interview he also provided examples of 
previous care that he had received, during which he was not asked about his personal 
preferences. Interestingly, whilst reflecting on this story, his viewpoint shifted to ‘you know 
your life, better than the doctor knows your life’.  
Several users referred to the ‘I’m still not sure section’ on Page 5 (see Appendix 4.2) of the 
booklet as being particularly helpful in addressing the issue of having two experts in the 
consultation, and challenging common barriers to involvement. All of the users could see 
the importance of their contribution to the decision-making process, and could understand 
the benefit to the patient of being involved, but some also viewed patient involvement as 
beneficial to clinicians too:  
‘I think it can only help the healthcare professional if the patient will engage 
properly in making these shared decisions…if they’ve got more than one 
option, it must be quite difficult for them to decide which is the best option for 
you, because they don’t know you like you know yourself.’ [P6]  
 ‘You can both say, ‘look we’ve both got the same checklist, I think this has 
been covered, and you do’, so I think that would help them from their side 
because they’d know you were happy with everything.’ [P10] 
 
5.3.2.3 ‘A standard appointment’ – knowing what to expect from a SDM 
consultation 
It is clear from the systematic review in Chapter 2 that many patients are not aware that 
they have options available to them, and many patients have had little previous experience 
of SDM.  Not knowing what to expect, or knowledge about the existence of options, was a 
key barrier to patient participation in SDM. The patients’ interview quotes above show that 
many patients did not know what SDM entailed before receiving the booklet; as such, it 
would be difficult for patients to actively participate or express a view in something that 
they do not know anything about.  
The third theme emerging from the patient interview data was knowing what to expect 
from a SDM consultation. The users reported that the booklet made it clear that there are 
sometimes healthcare choices to make, and it provided a clear rationale for this, for 
example:   
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‘I didn’t know a lot about it, but I think if you were sent this booklet you 
might be a bit more proactive in saying to your GP ‘I had a leaflet which 
said that I could take part in my appointment a bit more and help decide on 
my choices’.’ [P6]  
All users reported that the booklet provided clear guidance on what to expect if they were 
faced with healthcare options, and this prepared them to participate. The ‘what will I have 
to do?’ section on page 6 of the booklet and ‘your appointment checklist’ on page 8 were 
particularly helpful in outlining what to expect (see Appendix 4.2): 
‘Yeah, that was broken down quite well into ‘Do I have a choice?’, ‘What 
are my options?’, and ‘What matters to me?’ [P6] 
‘It [the flowchart on Page 6] shows you the steps you’d go through, like the 
process you’d go through, you have an option and talk about it, and then it 
tells you who you could talk to about it, like you doctor or family. I thought it 
was good.’ [P8] 
Users talked about using the checklist as a way of helping them know what to expect, and 
also as an in-consultation tool that helped them to make sure they received what they were 
expecting from an SDM appointment: 
 ‘If you took this with you then you can just check it off as you go, and let’s 
say they didn’t tell you about your possible outcomes, you’ve got that [the 
checklist] there with you and you can say ‘well why haven’t I been told the 
possible outcomes?’ It’s something you can refer back to and question your 
doctor or whoever.’  [P8]  
‘You’ve got your checklist, a standard appointment. ‘ [P9] 
P9 referred to the checklist as an ‘appointment control sheet’; this indicates that the user 
feels that they may have some control over how the consultation will go, and the checklist 
can help to ensure that it is a SDM appointment.  As well as being used by the patient to 
make sure that the checklist items had been covered, some users viewed the checklist as (in 
effect) a dyadic tool that they could complete together with a clinician, during a 
consultation:  
 ‘…with the healthcare professional, we could go through that [checklist], and 
we could see that everything from both sides was covered, and everything was 
clear to both of us. That I was clear with what the healthcare professional was 
saying, and he was clear with what I was trying to say.’ [P6]  
‘You can both say, ‘look we’ve both got the same checklist, I think this has 
been covered, and you do’, I think it would help from their side as well.’ [P10] 
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The notepad on Page 7 of the booklet helped to prepare users for a SDM appointment in 
various ways. Users can write down their health problem, concerns, or questions that they 
wanted to ask before the appointment, and it can act as an aide memoire of things that they 
wanted to cover with the clinician: 
‘I think it can prepare you before you go to the doctors as well, so if you know 
what’s wrong with you, you can write it down and say ‘this is what’s wrong, 
help me with my options’, and then you can say what you think about your 
options.’ [P8]  
‘I think it would help you, because sometimes you’re so nervous in a 
consultation, you could just look at that and go ‘oh hang on a minute’, and 
then spark your memory of something, something that you wanted to ask.’ 
[P8] 
Users felt that the notepad helped them to prepare for SDM, but it also helped to support 
the decision-making process after they had been given the options. P1 and P8 felt that the 
checklist was a useful tool to help them remember what was said during a consultation: 
‘…there were some things that [husband] said ‘oh he said this’ and I said ‘I 
didn’t hear him say that’ and it’s probably because your emotions are so up 
there aren’t they, and you don’t always take it in.’ [P1]  
‘If it was something about my skin, and I hadn’t taken my parents to the 
doctor that day, because normally they’d come, I’d write notes down.’ [P8] 
P8 also saw the notepad as a useful tool for recording their options, and facilitating 
discussion of these options with other people, such as family members: 
‘it prepares you before you go to the doctors, or after, you can even take it 
home and talk to your family about it…you could take it to an appointment 
with you, you could write down what they said if you didn’t want to make a 
decision there and then, and you can bring it home and say ‘this is what 
they’ve said’.’ [P8] 
P10 felt that if they completed the notepad, it would help to identify any gaps and issues 
that they wanted to discuss in further detail at the next appointment.  
‘And the space to write them…and even if you didn’t do it [make decision] 
there and then, if you took it home afterwards and had a little think about 
what you had, if there was a gap, whenever you were at your next 
appointment you could think ‘I want to discuss this…’.’ [P10]  
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Interestingly one user viewed the checklist as a monitoring tool that could be retained by 
the clinician, or a research team, and analysed to make sure that patients are receiving a 
SDM appointment.  
‘…it’s going to be completed at the end of the appointment with your 
GP…and that could be fed back as valuable information for the 
researchers, so that they can monitor progress, and how successful or not 
the appointments are.’ [P6]  
Overall, the booklet appeared to prepare users for the possibility of participating in SDM, 
provided useful tools that could help to ensure that they received SDM when offered 
healthcare options, and also tools that could support the SDM process.  
 
5.3.2.4 ‘It made me think it’s not so scary to make the decision about your 
healthcare’ - overcoming perceived negative outcomes 
The fourth theme that emerged from the data was overcoming the perceived negative 
outcomes of being involved in SDM.  The perception that active patients are difficult and 
the fear of the negative repercussions was a key patient-reported barrier identified in 
Chapter 2. The user interview data show that before reading the booklet, users felt that 
they would be classed as ‘difficult’ if they tried to be involved in the decision. However, 
now they feel that it is ‘okay’ to be involved, and there would not be negative 
repercussions, such as annoying the clinician or making a wrong decision.  
‘You would think prior to reading something like this that there could be 
negative repercussions if you went to your GP and started trying to have 
some involvement in the appointment, which has never been done 
before…this says it’s okay to take part, you’re not going to be penalised for 
trying to put your view over. Your health appointment isn’t going to be 
compromised because the doctor thinks, ‘I’m going to put them to the back 
of a list because they’re difficult, they want to know everything…’’ [P6] 
‘It sort of made me think it’s not so scary to make the decision about your 
healthcare.’ [P8]  
‘I don’t want to be a difficult patient, you feel like you’re nagging 
sometimes. Last time I went to the doctors I was asking and asking, and then 
you feel you better not ask again, I’ll just take what I’ve got and go, but if 
they give you the option to be involved, you’re not going to feel like a pain 
when you’re asking questions.’ [P8]  
‘Or I think the fears that you might have about making the wrong decision, 
this is quite informative that that can’t happen.’ [P1] 
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It was clear that the patients were able to focus on the benefits of being involved in the 
decision-making process, even if the diagnosis is not good: 
‘ With the pros and cons, it’s nice that you would get all of the information, 
because obviously you’re not always going to get good news, it’s not always 
going to be the news you want, but if you’re told the pros and cons…’ [P6]  
 
5.3.2.5  ‘If you think I should have the treatment, I’ll have it’  - the challenges of 
reaching certain patient populations 
The fifth theme that emerged related to the challenges of getting the key message of the 
booklet across to certain patient populations, such as the elderly. The users who were 
interviewed were largely supportive of the booklet’s concept and key messages, and 
indicated that they would now participate in SDM (age range 18-74 years). However, some 
users reported that they could foresee difficulties in patients of older age groups accepting 
that they should be involved in SDM. Sometimes this was anecdotal, based on the 
participant’s experiences with patients of this age group, and sometimes this was based on 
the general perceptions of this patient population.  
P1 talked about her experience of working with elderly patients located in the Valleys 
region of South Wales. Her work involved speaking to patients about their rights as a 
patient and encouraging patients to make sure that they are treated with dignity and respect 
in hospital. In this age group, perceptions of being a difficult patient were an important 
factor in their involvement, or lack of it: 
 ‘It says here, ‘I don’t want to be a difficult patient’, that’s a biggy, they all 
worry about that.’ [P1] 
P1 suggests that the attitudes of patients in these areas might be due to their social 
circumstances and the culture that they were brought up in more broadly, notably relatively 
deprived areas where people perceive that they have little choice in anything, let alone 
healthcare decisions, and where their opinions are not valued: 
 ‘…the older people up there, I don’t feel have ever had a choice. You know, 
they were brought up in the mining community, and the mines closed, 
poverty…I used to talk about human rights, if you go into hospital you should 
be treated with dignity and respect, and if you’re not, you must speak up. 
Maybe one in each group of forty would speak up…’  
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‘…I could tell they didn’t really understand, it wasn’t for them, I said ‘it is 
for you, we all got rights, our lives are important, we need to make choices’, 
and they said ‘oh what’s the point, nobody listens’.’ [P1]  
At an individual level, P1 refers to her experiences with her elderly mother of 94. P1 
reports that her mother was resistant to take part in decision-making or voice her opinion 
in hospital, mainly to avoid ‘rocking the boat’.  
 ‘There was a questionnaire that came around the ward on dignity and 
respect, and she said ‘oh don’t put my name now I don’t want any come 
backs!’, I said ‘mum I’m just giving my opinion, I’m not saying they’re not 
treating you with dignity and respect, I’m saying my opinion is it’s 
important to treat people with it…’. She said ‘but I don’t want to rock the 
boat’, I mean most of them in the ward were like it.’ [P1]  
Sometimes, lack of involvement is due to the elderly patient’s attitudes towards patient 
involvement, but sometimes lack of involvement is due to practical reasons:  
‘…my husband takes his mother, and she’s very deaf…she wouldn’t be able 
to cope without my husband being there, because she wouldn’t understand 
what the doctor was saying, not just because of the language, but because of 
her hearing….she won’t wear her hearing aid.’ [P1] 
P6 also noted that elderly patients might be less likely to participate in SDM as it is 
something that they are not familiar with. However, whilst it might be a challenge to 
change elderly patients’ attitudes, both P1 and P6 believe it is not impossible, if the booklet 
is delivered in the right way.  
 ‘‘Expert in their own lives’[reading from booklet]… well they might not 
think that for a while, they might think ‘well I’ve never had a decision to 
make’, with low self-esteem, so it would be quite good for a healthcare 
worker to sit with them and go through that.’ [P1]  
‘I think especially older people might be set in their ways about an 
appointment with their doctor, or somebody at the hospital, like a 
consultant, but I think it [the booklet] would encourage you that this is the 
way things are going to be, and that it’s okay to do it.’ [P6]  
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5.3.3 Clinician sample – key themes emerging from thematic analysis   
5.3.3.1 ‘We want you to be part of this’ - changing patients’ expectations 
The first key theme that emerged was changing patients’ expectations. The overarching 
feedback from the clinician sample was that the booklet gave a clear message that patients 
and clinicians should work together to make healthcare decisions, and that clinicians are 
supportive of this approach: 
‘I think the message is simple it’s just letting people know that you do have 
a choice, you should be involved. If I had my appointment letter and that 
was in it, I would feel far more encouraged that the health board, or the 
primary care provider is actually asking me to engage.’ [C6] 
‘What I like is the message that you can work as a team, or in conjunction 
with your clinician to try to make you better, it takes away the old ‘your life 
in their hands’ thing’ [C7] 
Participants felt that the booklet had the potential to change patients’ attitudes and 
expectations about their involvement in healthcare decisions; if patients read the booklet, 
they might come to an appointment with a different mind-set, expecting to be involved in 
healthcare decisions:  
‘Yeah, I think the first challenge is getting them to read it and understand it, 
and I think if they did and they do, then it would put them in a different 
place when they went to a consultation… if the reception was appropriate 
when they went to the consultation, then it would lead them to perhaps 
expect something different to happen.’ [C1] 
 ‘It would probably give me, if I was unsure, a bit more confidence to say 
what I wanted to say, in the consultation, or whatever, I’m not just sitting 
there sitting on my hands.’ [C7] 
C4 described the impact of the booklet when she gave it to a family member:  
‘I also gave it to my husband, because I’ve been working in the 
‘professional’ I might know, but I gave it to him and he said ‘oh I didn’t 
realise all of this’, ‘cause touch wood, as a family we don’t access health on 
a regular basis, and he found it really useful…he didn’t realise he had 
choices, now he knows from this booklet.’ [C4]  
Another participant referred to family members who manage a long-term condition, and 
the potential impact that the booklet might have:  
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‘There’s a lot of COPD in my family, and the best person to judge their 
current condition was the person suffering with the COPD...and very often 
they’ll go in and see a new clinician who would know nothing about their 
past medical history…it was very easy for their opinions’, to be overridden 
by a clinician on what they saw being presented, rather than what [the 
patient] felt. So I think if I was a patient and I had this prior to going to a 
consultation I’d definitely feel a bit more empowered to take control, or to 
maintain control of my illness and my treatment.’ [C7]  
Participants felt that the booklet clearly explained the SDM process to patients, and this 
helps the patient to know what to expect, and thus prepare:   
 ‘Well, I thought it’s been a long time coming…I’ve been doing my role 
now, patient experience, for fourteen years, and patients were saying about 
the lack of information on what they can do, and I thought it was really well 
explained, even from the first page, it gives the explanation on why you have 
choices, what you can expect, and how.’ [C4] 
‘And it is around that why, what, how, because that’s what people need to 
know…’cause it’s not always been joined up, people will say ‘oh you got 
choices’, but no explanation where they get the choices from, or who would 
give them the choices…but from the first page, it explains who, and why, 
and how it all works.’ [C1]  
Some of the participants felt that the comparison and references to other patients were 
useful and a familiar concept, and this would provide further reassurance to the patients 
reading it: 
‘Do you know, just thinking of our patients, they relate so well to other 
patients…there’s a little quote here from an asthma patients which is nice, 
patients relate very well to that, from experience’ [C2] 
The clinicians felt that the ‘I’m still not sure’ section of the booklet on page 5 (see 
Additional Appendix 4.3, on included CD) was particularly effective at challenging some of 
the common patient barriers that they have experienced with their own patients:  
‘I like this page here [page 5], ‘Doctors know best, what do I know’, ‘I 
don’t understand the medical jargon’. I think it’s very good, because I can 
just hear patients saying it, ‘Doctor knows best, what do I know better?’, 
and you can imagine them saying about the medical jargon, some patients 
are ‘umm, am I being a bit awkward if I’m asking…’.’ [C2]  
‘I like the bit about ‘don’t want to be responsible for a wrong decisions’, 
‘cause patients do think, ‘oh gosh, have I made the right decision now?’ 
[C4]  
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 ‘‘I don’t want to be a difficult patient’, yeah you know we’re in an NHS, 
free care, and a lot of us don’t, we think ‘oh well, we should be happy with 
our lot and I don’t want to cause problems’, so that’s definitely relevant.’ 
[C6] 
Although the clinician sample felt that the booklet would help to change patients’ attitudes 
regarding their involvement in healthcare decisions, they also recognised the challenges that 
might exist with certain patient populations. Again these included the elderly, the very ill, 
vulnerable patients, and patients from poorer backgrounds:  
Elderly: 
‘I felt that it’s saying ‘it’s okay to ask’, a lot of people don’t like to ask…my 
auntie, she’ll ring me up, and I’ll say ‘oh why didn’t you ask when you were 
there?’, ‘oh, I didn’t like to’, and I mean that’s a lot of the older people, and 
the majority of people we treat isn’t it, and they don’t ask.’ [C4] 
‘…it’s a generation thing as well…so I think that the older generation will 
probably say ‘what do I know, well doctors know best’. I don’t want to be 
too ‘generalistic’ about that, because obviously older patients question as 
well, but that’s just from my experience, whereas you find the younger 
generation who are more aware will use social media and internet to 
research things, they may have researched what they actually think is best 
for them and they happen to raise that.’ [C6]  
Ill /vulnerable patients: 
‘I think particularly with our patients, they would be pre-dialysis patients, 
you know their kidney function would be below 20%, which means that 
they’re fairly uremic, so their ability to take in and retain information is 
very poor at that stage…yes it’s something that they could refer back to, but 
I don’t know if they would sit there and read all of it straight away.’ [C3] 
‘From a personal perspective, I know that some more vulnerable family 
members are really frightened of choices…’ [C7] 
Socioeconomic background: 
‘We do tend to see quite a lot of patients in sort of the Merthyr area, the 
Valleys area, and again, not to stigmatise people but I think of the case load 
that one of our colleagues has, you know, I don’t know whether they would 
sit and read the booklet.’ [C2] 
 
However, whilst these patient groups might be difficult to reach, the clinicians did not feel 
it was impossible with the correct implementation approach e.g. distributing the booklet to 
patients with chronic kidney disease earlier in their care pathway (see section 5.3.4 for 
further details).  
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5.3.3.2  ‘Getting the most out of your consultation and treatment’ - benefits of 
SDM 
The second key theme was the perceived benefits of SDM. The clinician sample perceived 
clear benefits to patients if they were involved in SDM. They felt that that the booklet 
would encourage and enable patients to make sure that they were getting the most out of 
their consultation, and care or treatment that was right for them:  
‘…because it keeps things focused doesn’t it…people have written this at 
home, or maybe got a family member who will say ‘have you asked about 
such and such’, they can jot it all down there [notepad, page 7], so that 
when they’re in a consultation they’re getting the best out of it, from their 
perspective.’ [C4] 
‘the overall message is getting the most out of your time with the clinician, 
getting the most out of the consultation and the treatment, so it’s taking 
more control of you’re care…’ [C7] 
However, the participants also perceived that there were clear benefits to clinicians, or the 
organisation more broadly, if patients took part in SDM. Firstly, it helps the clinician to 
know what matters most to the patient:   
‘…if they’ve got the questions ready for the clinicians, you know it benefits 
both, it’s a partnership isn’t it, and the clinicians can only work on what the 
patient has told them…’ [C4] 
‘…but if the clinician’s had the same checklist as part of the consent form, 
or perhaps the documentation they use to write up the consultation, I think it 
would prompt them to ask the question, because I still don’t think the 
patient’s priorities are addressed.’ [C7] 
Some clinicians referred to the time pressures that they face, and felt that if the booklet 
encouraged the SDM approach among patients, it would be helpful in utilising their time 
more effectively: 
 ‘…from the clinical perspective, because the clinical person will know that 
they’ve covered everything that the patient wanted…it saves time, for the 
clinicians and the patients.’ [C4]  
‘…with the way the NHS is at the moment and the issues that the wards are 
facing in terms of acuity and staffing, I think anything that can help that 
short amount of direct patient care that the clinicians’ have can only 
help…direct care time percentages at the moment are around 30%, if 
something could improve the interaction between me and a patient in the 
very short time I had to spend with them, I would be happy.’ [C7] 
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C6 highlighted the importance of SDM in terms of downstream events that may result 
from poor communication, such as litigation cases and complaints against the health board: 
‘I come from the perspective of dealing with concerns…I see where things 
go wrong, the number one failure in all concerns is communication, we 
didn’t communicate well enough, we didn’t make people understand the 
consequences, didn’t really tell them what their options were, they didn’t 
think they had the option to say ‘no I don’t want that, thanks for all your 
advice, but I’m actually going to live with this because it’s my choice’.’ 
[C6] 
On the other side, from a risk management perspective, participant C6 believed that a 
record of patient involvement might also help the health board in cases where the patient 
experienced negative outcomes or side effects of the treatment:  
 ‘…from a risk management perspective, we may look to say ‘we really did 
make you fully aware of the potential consequences of something going 
wrong, or side effects, you told us you understood, and we’ve got 
documentation where you asked those questions, you were part of the 
decision…’ [C6]  
 
5.3.4  ‘How this is given out is key’ - implementation of the intervention 
Separate analysis of the user and clinician interview data found that implementation of the 
intervention was a key theme. Upon further analysis, feedback regarding intervention 
implementation was similar across the user and clinician sample. Therefore, both datasets 
are considered together for this theme.  
A booklet format was used for the prototype intervention as this was the easiest way to 
convey the key messages to the target audience, but it was also partly due to feasibility and 
cost considerations. Overall, the participants felt that the booklet would provide the easiest 
way to digest the information, but it was also the most accessible mode of delivery for 
most patients: 
 ‘It could go in other formats, but I think this is what’s easier to read for 
everyone…if you don’t catch the poster on the ward, you’ve got that there in 
your hand and you can just look through it.’ [P8] 
‘If it was virtual, those are the things people forget to look at, only those 
that really want it will go on there, a lot of this is about people who haven’t 
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thought about the fact they have a choice before, so if you’ve got it in your 
hand you’re more likely to look at it.’ [P10]   
‘If you’re going for the broadest penetration, given the age profile, the 
booklet is probably the lowest common denominator that would reach 
everybody…I think we’re still at booklet level for most people, to get to 
everybody.’ [C1] 
 ‘…a booklet format…I don’t know if you can do it any other way, we 
haven’t got enough people to do pre-appointment stuff…people haven’t got 
time to do it, the only way you’ve got to do it really is in booklet format.’ 
[C7]  
One participant noted the potential problems certain patient populations might have 
accessing the materials if they were in an online or phone / tablet app format: 
‘I know a lot of older people are not on the internet…when I worked with 
the older people in the Valleys, possibly 1% were on the internet…maybe 
it’s gone up since with the 50’s and 50’s [year olds] coming online 
more…it’s the modern thing isn’t it, you’ve got to modernise with the times, 
but I think the hard copy is excellent.’ [P1]  
During the interviews, participants’ perceptions on alternative modes of delivery were 
explored e.g. mobile phone / tablet app, website, social media accounts etc. Participants 
were not against the use of alternative formats per se, but they felt these would be 
additional items that would complement the booklet, which should be the main 
intervention: 
 ‘There are other ways of sending messages…you could have this [booklet] 
as the primary means of information, but then you could have links via 
Facebook, or Twitter, or email, you know, this could be the first step, but it 
could encourage you to visit these places to get more information.’ [C6] 
‘I’d say the booklet was the better option, but if I’d seen that on my phone, 
I’d probably download the app to have a quick nose at it…because you 
always have your phone on you…but I’d say the booklet is the way I’d look 
at it more.’ [P8] 
Participants also discussed how and when the booklet should be delivered to patients. 
Many participants felt that the main route of delivery should be via patient appointment 
letters. This will ensure that they receive the information before an appointment, and this 
would help patients to prepare for the possibility of being offered a choice: 
‘Before an appointment, yeah, ‘cause you can have a quick look…I think in 
a way it can prepare you before you go to the doctors.’ [P8] 
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‘I think with an appointment letter this could go out, so they are informed 
that there will be choices, or maybe choices, so if they’re faced with 
choices, they can already pre-empt…’what are my choices?’, and they can 
build their questions…’ [C4] 
Some of the responses addressed issues of permission, which is a key patient-reported 
barrier. The sense of ownership by the clinical team, or the organisation, was important; if 
the booklet went out with appointment letters then patients will feel that their clinical team, 
or the broader organisation, want them to be involved in SDM.  
‘One of the lessons we’ve learned along the way is ownership of a clinical 
team, it needs to be going from the surgeon or clinician or whoever, rather 
than the organisation…logistically that’s difficult, but this would probably 
need to be seen coming from the team they are seeing.’ [C1] 
 ‘You’ve almost missed the opportunity if you’re picking it up once you’re 
there, but if you want to get the message out there, the real message should 
be with your appointment letter…’well they’ve sent it to me, they obviously 
want me to read it, and they want me to come and engage.’ [C6] 
P6 also felt that the booklet should be delivered with appointment letters, and they 
emphasised the importance of a covering letter, from the clinical team, which explained 
that they would be conducting a ‘SDM appointment’, and encouraging patients to read the 
booklet. Again, this covering letter might act as some sort of ‘permission’ and direct 
encouragement from the team to engage:  
‘I think the booklet is great, but a booklet couldn’t explain that, I think an 
accompanying letter that explains that this type of appointment is now 
available at your GP practice, or hospital, is also needed.’ [P6]  
Interestingly, this participant talked about patients having to ‘opt out’ of receiving a SDM 
appointment, believing it would be easier for healthcare professionals to roll out this type 
of approach if patients had to consciously opt out. This indicates that they want to see 
SDM appointments as the norm that patients should expect.  
Some user participants also felt that the booklet would be appropriate at the point at which 
a diagnosis is made, or a condition has been identified. The key in such situations was 
allowing time to digest the diagnosis before being asked to make a decision. As such, the 
booklet would still be delivered before patients are asked to participate in making a 
decision, or being offered concrete options: 
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 ‘The worst thing is being told you’ve got cancer, your heads in a 
whirl…maybe they say ‘I’ll come to see you next week, in the meantime take 
this booklet, it might help you look at your health and your options, there’s 
a place here you can write some questions and we’ll talk next time.’ [P1] 
 ‘…it should be, ‘okay, I know you‘ve just had this news, this probably isn’t 
the time you want to think about it, but take this away so you know that you 
do have a choice, so if you have any questions the next time you see me, you 
have everything ready.’ [P10] 
Another idea that emerged from both datasets was the applicability of the booklet across 
primary and secondary care. Participants felt that it could be used either by primary care 
practices, or by hospital teams. Some emphasised the importance of using this booklet in 
primary care, as this is often the first port of call for many patients, and the place where 
most patients seek support most often: 
‘…the type of appointment [SDM] at either your GP or hospital…’ [P6]  
‘…and that’s where I think it starts really, in primary care, ‘cause that’s 
where you go before you start coming into secondary [care], so how would 
you want to be managed really…they’ve got a choice if they want to defer a 
bit, ‘can it be managed in primary care.’ [C4]  
Overall, the participants felt that a targeted approach was important, whereby the booklet 
was delivered to people who had appointments, or who would be facing treatment 
decisions; this made sure that the key messages were relevant to the patients. However, 
many participants felt that there was also scope for a broader public health campaign 
approach, as long as this followed on from, and accompanied, the targeted approach: 
‘I think you could do both, but the approach public health wise would be 
different…because I think people find it easier to get fixed on something if 
it’s got a purpose, as opposed to hypothetical ‘I might go into hospital at 
some point’, but some general awareness raising is good…in time it needs 
to be embedded into the organisation, and into the NHS in Wales, because 
that’s probably the level that you could make it spread across Wales.’ [C1]   
‘The more the better really, in case something slips through the net and they 
didn’t get it in their letter, I would put it into the main information areas 
within a hospital…people are always looking for information to read…it 
might not be for themselves, it can be knowledge for their families then, 
isn’t it?’ [C4] 
‘Perhaps an advertising campaign on radio…I myself hear lots of adverts 
like ‘have you been coughing for more than six weeks’, a message doesn’t 
have to be long, just hit you, like ‘do you know you can have a shared 
decision-making appointment at your surgery now?’.’ [P6] 
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Overall, there was scope for a broader public health campaign, but it was felt important the 
booklet should be targeted at patients who had an appointment in the first instance. This 
would ensure that the messages were relevant to the patient:  
‘I don’t think just sending it out is going to do anyone any good. ‘Cause 
we’re the worst for it, get a thing though the door and it goes straight in the 
bin, we don’t read it.’ [P10]  
P6 felt that adolescents and children, or ‘patients of the future’ would be an ideal target 
audience for the booklet; it would be easier to shape peoples’ perceptions about 
appropriate behaviour in a healthcare consultation before they had experience of them: 
‘…schools even, at that age they’re going to start going to the GP without 
their mum…it could be covered in pastoral lessons maybe? Teenagers, 
sometimes they’re a bit shy of going to the surgery, but there’s got to come 
a time why they start going on their own without their mums…this would 
help them know how things should be.’ [P6]  
The participants report that the booklet will be useful as it opens the door for patient 
involvement, and provides initial ‘permission’ to participate. However, they also note that it 
must be delivered in a supportive environment and initiated by clinicians with positive 
attitudes towards the SDM approach, the necessary SDM skills, and who can support 
patients through the process: 
 ‘…if you’re taking part in an appointment, the doctor would obviously 
speak to the person in a way they could understand exactly what was going 
on, pros, cons…’ [P6] 
‘Obviously, the surgery or hospital would have to be on board with this 
before you start offering these sorts of appointments, you can only assume 
that’s been discussed, and they’re happy…’ [P9] 
‘…if the reception was appropriate when they went to the consultation, then 
it would lead them to perhaps expect something different to happen.’ [C1] 
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5.3.5 Design, format and content changes 
Overall, both participant groups were positive about the booklet’s design and format. They 
liked the A5 format, and felt that eight pages was an appropriate length for the booklet. All 
participants felt that the overall design, colour scheme, and character drawings were 
appealing, and it would encourage them to read the booklet:  
‘First impressions when I literally opened the envelope and took it out, it 
was something that interested me, it was fun…you get so much junk mail 
through the post and it can be quite boring format, and this was something 
that sort of took my interest straight away…it sort of enticed me to look at it 
then and read on’ [P6] 
‘It’s very accessible from a patient point of [view]...you know I want to pick 
it up, I want to read it…I don’t normally look at literature you know…when 
I go for hospital appointments…but if that was sitting there, or if I had that 
prior to an appointment, I’d want to read it’ [C7] 
‘I think if I was in a waiting room, I would pick it up, I’d think ‘oh that’s 
colourful, that looks good’’ [P1] 
 ‘I mean, I thought it was really well laid out, I think it was about the right 
length that you could reasonably expect someone to look at and digest, 
although there is quite a lot of information in there, you know the design 
looked good. Easy to get through…space for people to make notes and 
things…so as a piece of work at that level I thought it was really good’ [C1] 
The booklet’s design was well received by a range of age groups, as reflected by the age 
range of the user and clinician sample, and also by statements made by participants: 
‘I would pick that up and read that quite happily and I think my son would 
pick that up and read that quite happily and I think some of my elderly 
relatives would do the same, so it has broad appeal’ [C7] 
‘Younger teenagers would look at this and think ‘oh I can read this easy’, 
and then older people as well would look at it and think the same’ [P8] 
‘…my Aunt is elderly, and I think she would understand it…because she 
does access health now, she’s of that age, she has a few health conditions, 
she wasn’t aware [of choice], I’ve not seen anything as plain English as 
this, so I’m sure she’d fine this useful.’ [C4] 
Using the feedback from users and clinicians, several changes were made to the booklet’s 
design, format and text or graphic content. Feedback and associated changes are listed in 
Appendix 5.4 and are summarised below.  
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Key changes related to the notepad and checklist tools on pages 7 and 8 of the booklet, 
respectively. Both users and clinicians were positive about the inclusion of such tools, but 
felt that there were some improvements that could be made to make them more useful for 
patients. First, the notepad needed to be larger so that there was more room to write. 
Second, the notepad required further guidance on how to use it i.e. before an appointment, 
to write down questions for the clinician, and / or after the appointment, to write down 
what they think about the options in relation to what is important to them. Third, the 
notepad could benefit from some example questions that patients might ask. All of these 
changes are detailed in Appendix 5.4 (see also, Figure 5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 - Page 7 after design, format and content changes 
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Finally, it was suggested that the checklist on page 8 would be better framed as a tool for 
preparing patients for an appointment, rather than solely as a post-hoc tool. Some 
participants pointed out that it is not always easy to schedule another appointment with the 
same clinician, should you realise after the appointment that they had not covered some of 
the checklist items e.g. in a secondary care setting, after an appointment with a consultant 
(see Figure 5.2 for changes; see also Figure 5.2): 
‘…so whilst there could be a checklist, you’ve almost, you’ve missed the 
boat to some degree, because if the answer to them is no…you’ve missed the 
opportunity really, because the consultation is gone…the reality is it doesn’t 
work like that and it could be months before you get to see the same person 
again…so maybe the checklist, maybe the questions could be in preparation 
for a consultation’ [C6] 
Another participant felt that the checklist could be improved by prompting patients to 
make sure that they know what will happen next; this has now been included (see Figure 
5.2). Several participants felt that pages 7 and 8 of the booklet could be perforated, so that 
they could tear off the notepad and the checklist and take it to a consultation; one patient 
referred to it as their ‘appointment control sheet’ [P9]. The updated version will 
incorporate this. 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 - Page 8 after design, format and content changes 
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Other key changes were made to the terminology used throughout the booklet. It was 
suggested that some of the terms used were ‘medical’ and not patient-friendly. For 
example, one user felt that the term ‘healthcare workers’ needed to be clarified: 
‘Healthcare workers, like again, is that nurses, doctors?...maybe say 
something like ‘your nurses, doctors and consultants are healthcare 
workers…a little example of who your healthcare worker is.’ [P1] 
A ‘call-out’ with text has been added to page 3 of the booklet changed to clarify who 
healthcare workers are.  
Several participants also did not like the use of the terms ‘pros, cons, and options’: 
‘This is what I wasn’t happy with, we will tell you what your options are 
and what they involve, we will describe the likely outcomes, including the 
pros and cons, I didn’t like that…maybe you need to think of some other 
way of asking that…umm, negative and positives I suppose…I didn’t feel it 
[pros and cons] was user friendly at all.’ [P1] 
‘Although I’m not an expert in terms of literacy levels, it was just 
occasionally I was reading it and thought outcomes, pros, cons, options, 
watchful waiting, still sounded a bit medical…we’ve used choice, so it could 
be choices…’ [C1] 
As a result, the terms ‘pros and cons’ have been changed to ‘positive(s) and negative(s)’ and 
the term ‘option(s)’ has been changed to ‘choice(s)’, throughout the booklet. 
Some participants felt that the booklet might only be applicable to secondary care, due to 
the use of the word ‘clinic’ on the front page of the booklet. It was also unclear whom the 
booklet was coming from, because the Cardiff and Vale University Health Board logo was 
on the back page of the booklet. To correct this, I have now used the terms ‘hospital’ and 
‘surgery’ on the front cover, to indicate that the booklet is relevant across primary and 
secondary care, and the Health Board’s logo has been moved to the front page.  
Feedback indicated that the booklet could benefit from providing some examples of 
healthcare decisions. These have now been included on page 3 of the booklet: 
‘I think the key message that I get is that it’s an encouraging leaflet to want 
you to ask questions, or to have choice…I think it could go a little further to 
explain what perhaps those choices could be e.g. maybe if surgery is being 
considered’[C6]   
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Changes were also made to the design of the booklet. Some users associated the red used 
for the leaflet and the building on the front cover of the booklet with negative 
connotations, or a ‘football red card’.  These have now been changed to green (See Figure 
5.3).  
5.3.6 The pilot-testing version of ‘Your Health, Your Choice’ 
The key changes to the booklet were presented in section 5.3.4 and in Appendix 5.4. There 
were no changes to key elements of the booklet in terms of additional or deleted sections / 
elements. As such, all of the booklet elements described in Table 4.6 (Chapter 4) stand for 
the latest version. Changes were only made to the design and / or content of these 
elements. This updated version of the booklet was used during pilot-testing, described in 
Chapter 6 (see Appendix 5.5 for full booklet).  
5.4 Discussion 
The aim of this chapter was to pre-test the ‘Your Health, Your Choice’ booklet with public 
users and clinicians to check reactions to the booklet’s content (key messages), design, and 
implementation. The booklet appears to be addressing the key patient attitudinal barriers to 
participation in SDM, identified in Chapter 2. Further, both users and clinicians were 
positive about the booklet’s design and format, and only minor changes were requested. A 
targeted approach to patients with upcoming appointments was suggested as the best 
distribution method, but this could be complemented over time by a larger scale public 
health campaign, delivered in various formats.   
From the systematic review of patient reported barriers / facilitators (Chapter 2) and the 
mapping exercise conducted in Chapter 4 (to the COM-B model of behaviour / TDF), the 
key drivers of behaviour were identified as social influences, social and professional role 
and identity, beliefs about capabilities, beliefs about consequences, knowledge, and 
environmental context and resources. Many of these key barriers are attitudinal in nature, 
and focus on patients’ perceptions of ‘normal’ patient behaviour in a consultation and 
perceived lack of influence over the SDM discussion (either due to lack of self-efficacy or 
fear of consequences).    
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From the framework analysis of user data, it appears that the booklet is addressing all of 
the key attitudinal factors identified, which might influence patients’ participation (or lack 
of) in healthcare decisions; this is key if the booklet is to be successful in changing patients 
attitudes, and their subsequent behaviour. A key barrier is patients’ perceiving that they 
cannot, or should not, be involved in decisions because it is not part of the patient role, 
and it is not socially accepted to be active; it is thought part of the clinician’s role to make a 
decision for the patient. Significantly, a key theme that emerged from the user interviews 
was a shift in users’ attitudes from expecting to be told what to do by a clinician, to 
perceiving that SDM is the best way to approach situations where there are healthcare 
options. Users felt that this key message was conveyed throughout the booklet, but the ‘I’m 
still not sure section’ (Page 5, Appendix 5.5) was particularly useful, as were the 
comparisons to what other patients would do and the ‘permission’ from the clinical team, 
as this reinforced positive social norms about patient involvement.  
Another key barrier to participation is patients failing to recognise their contribution to the 
decision-making process, and the importance of their own personal preferences. After 
reading the booklet, users recognised the importance of both the clinician and patient’s 
contribution, stating things such as ‘you know your life, better than the doctor knows your 
life’. This is in contrast to the prior belief that ‘doctor knows best’. Again, the ‘I’m still not 
sure section’ (Page 5, Appendix 5.5) was cited as being particularly helpful in forming those 
views, and providing reassurance, but it was also a key message presented throughout the 
booklet.  
Not knowing what to expect from SDM, or knowledge about SDM more broadly, is 
another key barrier to participation. The ‘what will I have to do?’ section (page 6), the 
notepad (page 7), and the appointment checklist (page 8), were all designed to help patients 
to know what to expect from a SDM consultation. They outline the process of being 
offered a choice, being told what the choices are, and being asked about what is important 
to the patient. They also encourage patients to prepare for this process by thinking about 
the choices in relation to their own personal preferences, and support patients to make a 
note of any questions / issues / concerns that they want to discuss. Users report that the 
booklet provided a clear rationale for healthcare options, and also provided clear guidance 
on what to expect if they were offered options. The checklist helped users to know what to 
expect, and it could also help users to make sure that they received a SDM appointment. 
The notepad could help patients to tailor the appointment to their concerns, facilitate 
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discussion of options with significant others, and also help to identify knowledge gaps that 
need further discussion with a clinician at a follow-up appointment.  Patients used phrases 
such as ‘standard appointment’ and ‘appointment control sheet’, indicating that they would 
now expect this as part of a consultation, and that they felt they had some influence over 
the process. This suggests that the tools promote self-efficacy in these patients to become 
more involved in the process.  
Fear of the perceived negative consequences of being involved is another key patient-
reported barrier. However, the booklet appears to have challenged these perceptions by 
providing reassurance that patient involvement is expected and valued, and by promoting 
the positive aspects of being involved. Users report that whilst they previously felt they 
were being a difficult patient if they asked questions, they now felt that it was okay to be 
involved and that it was not ‘so scary’. Again, the ‘I’m still not sure’ section (page 5, 
Appendix 5.5) was cited as being helpful in forming these views, specifically the quotes ‘I 
don’t want to be a difficult patient’ and ‘I don’t want to be responsible for a wrong 
decision’.  
From the thematic analysis of the clinician data, clinicians felt that the booklet’s key 
message was ‘we want you to be part of this’. They were positive about the booklet’s remit, 
and were encouraged that the message was that patients and clinicians should work 
together to make healthcare decisions.  In line with the users’ responses to the key 
messages, the clinician group felt that the booklet had the potential to change patients’ 
attitudes and their ‘mind-set’ towards being actively involved in healthcare decisions. The 
booklet provided the ‘permission’ to be involved, that they often witness their own patients 
needing. Clinicians also felt that the ‘I’m still not sure’ section (page 5, Appendix 5.5) was 
particularly useful in challenging common patient barriers to participation; many of the 
clinicians could relate to the quotes, stating that their own patients have said these things 
(e.g. ‘doctor knows best’, ‘I can’t understand medical jargon’).  
Significantly, both participant groups reported the benefits of SDM to both patients and 
clinicians. The primary intention of the booklet was to help patients to understand why 
they should be involved in decisions, and to help them perceive the positive benefits of 
being involved. All of the users could see the benefit to themselves and other patients, but 
some also recognised how this approach would help the clinicians to provide them with 
better care. They touched upon the difficulty that clinicians must face if they do not know 
what matters most to the patient, and were sympathetic to this. From the clinician 
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perspective, SDM was felt to have clear benefits to patients and the clinicians involved in 
their care, but the benefits of SDM to the organisation more broadly were also discussed in 
terms of risk management and reducing litigation. Clearly, SDM has numerous benefits to 
different people involved in the healthcare process, and how these are perceived will 
depend on the person; either way, the different benefits will provide motivation to the 
different agents involved in the healthcare process to participate in SDM.  
With regards to the booklet’s design, format, and content, users and clinicians were overall 
positive, and only minor changes were suggested. Both groups felt that the booklet was 
engaging, something that they would want to read, and that it would stand out from other 
materials. Key changes included replacing some of the ‘medical’ terminology (e.g. changing 
‘pros and cons’ to ‘positive and negative’ outcomes), and making the notepad (page 7) and 
the checklist (page 8; Appendix 4.2 for original) more useful for appointment preparation 
e.g. giving example questions, and encouraging patients to consider the checklist items 
during their appointment.  
It was agreed by both participant groups that a booklet format was the most accessible 
mode of delivery for most patients, and this would ensure the biggest reach. There was 
agreement between both groups that the booklet needed to be sent to patients ahead of 
their appointments. This would ensure that they had time to digest the information, and 
that they can also use the booklet to help them prepare. Importantly, all of the participants 
felt that the booklet needed to be sent to people who have a scheduled appointment with a 
clinician, or clinical team. Many saw scope for a broader public health campaign that built 
on the initial booklet, but, in the first instance, the booklet should be distributed as a 
targeted approach. This would ensure that the key messages of the booklet are relevant to 
the person it has been sent to, and it helps the individual to feel that they have ‘permission’ 
from the specific clinical team or clinician that they will be dealing with. Both of these were 
deemed very important for successful implementation.  
Whilst both participant groups were generally positive about the booklet, and believed that 
it had scope to change patients’ attitudes towards involvement, both groups also 
emphasised the potential difficulties of reaching certain patient populations. Sometimes 
this was based on the participants’ perceptions of these groups, and sometimes it was 
based on the participants’ own experiences of these groups. These hard-to-reach groups 
could include the elderly, the very ill, vulnerable patients, and patients from poorer 
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backgrounds. For example, the social norms about active patient involvement being 
unacceptable behaviour appear to be amplified in older patients.  Further, for patients who 
are very ill or who have lower levels of educational attainment, it might be difficult for 
them to understand the information in the booklet. Whilst the participants did not feel 
these were an impossible group to target, they acknowledged the challenges it posed. 
However, implementation strategies could help to overcome some of these challenges e.g. 
a clinician going through the booklet with an elderly patient to provide additional 
encouragement, or delivering the booklet at an earlier point in the care pathway of a long-
term patient, before the patient becomes acutely unwell.  
5.4.1 Strengths and weaknesses 
This iterative pre-testing approach included members of the general public, clinicians, and 
health board representatives; this ensured that feedback was sought from all parties who 
would be involved the implementation of the booklet. The pre-testing involved a small 
sample (six patients, six clinicians). However, this phase focused on initial testing of the key 
messages and design feedback, in order to refine the intervention, and implementation 
planning. The booklet will be tested with a larger number of real-life patients during the 
pilot-testing stage (see Chapter 6). The framework analysis conducted on the patient data 
enabled me to establish whether the booklet elements designed to address the key 
attitudinal barriers were likely to have the intended impact on patients’ attitudes. A graphic 
designer was commissioned to develop the booklet, and this ensured that the product was 
produced to the highest standard.  
The clinician sample consisted of clinicians who are currently involved in a large-scale 
SDM implementation programme, and individuals whose role focused on the 
improvement in patient care, whether that be from a patient experience, quality 
improvement, or investigation and redress perspective. Clearly these individuals are 
receptive to the idea of patient-centred care, and might be more responsive than 
individuals who are not directly involved in these areas of work. However, this booklet will 
be implemented in teams that practise SDM as part of everyday clinical practice, so I would 
expect the clinicians involved to be receptive to patient involvement; this will be discussed 
in further detail in Chapter 6 (Process evaluation) and Chapter 8 (Discussion).  
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The user group sample who volunteered to take part in the interviews are probably quite 
motivated individuals, who may be more likely to be actively involved in their care. This is 
particularly the case for the participants recruited via Involving People, who have a lot of 
experience of working on other research projects involving patient literature. Further, user 
participants recruited for pre-testing were not required to be patients currently receiving 
care, or currently faced with healthcare decisions. As such, their feedback is based on a 
hypothetical situation i.e. if they had treatment options. It is essential to know how this 
booklet will be received in a real-life clinical setting, where patients have received a 
diagnosis and are required to make a decision; this will be addressed during the process 
evaluation phase (Chapter 6).  
5.4.2 Conclusion 
Using a systematic and theoretically grounded development process (i.e. BCW),(47) I have 
been able to ensure that the intervention directly addresses some of the key attitudinal 
barriers and facilitators, which were identified in Chapter 2 of the thesis. This pre-testing 
process delineated the specific parts of the booklet that the participants found most useful, 
and it has provided reassurance that the booklet has the potential to change patients’ 
attitudes towards SDM, and possibly their behaviour. The process has also led to various 
design improvements, and has identified the most appropriate implementation strategy for 
use during pilot-testing. Pre-testing has provided an overview of users’ initial reactions to 
the booklet’s key messages in an artificial setting. The next step will be to pilot-test the 
‘Your Health, Your Choice’ booklet in a clinical team, using patients who are currently 
seeking healthcare, and who are likely to be faced with healthcare decisions (see Chapter 6). 
The pilot-testing will aim to further understand the functioning of an intervention, by 
examining implementation, mechanisms of impact, and contextual factors. 
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Chapter 6 
Pilot-testing the ‘Your Health, Your Choice’ 
booklet: a process evaluation 
6.1 Introduction 
The focus of Chapter 4 was the theoretical development of the prototype ‘Your Health, 
Your Choice’ intervention, using the Behaviour Change Wheel (BCW) approach.(47) The 
four key steps of the BCW Guide(47) used to develop the prototype intervention in 
Chapter 4 are listed in Table 6.1. In Chapter 5, the prototype version underwent pre-testing 
with lay members of the public, clinicians, and representatives from healthcare 
organisations.  The focus of Chapter 5 was to pre-test the booklet’s key messages, to refine 
the design and content, and to determine possible implementation strategies; an updated 
version of the booklet was then produced (see Appendix 5.5). The fifth step in the BCW 
approach to intervention development and evaluation is to plan the intervention’s 
evaluation; this step involves planning and testing how the behaviour change can be 
measured and understood. The aim of the current chapter is to pilot-test the ‘Your Health, 
Your Choice’ booklet, using a process evaluation, with real patients to determine if the 
booklet has the potential to result in the desired behaviour change (i.e. active participation 
in SDM with a clinician), before planning a full-scale evaluation.  
The target behaviours were specified in Chapter 4 as part of Step 1 (see Table 6.1 and 
Chapter 4). The aim of the intervention is to promote active patient participation in the 
decision-making process with a clinician. Step 2 identified various mediators of the target 
behaviour, and Steps 3 and 4 ensured that the intervention addressed these mediators. The 
fifth step of the BCW approach, addressed by this chapter, aligns with the feasibility and 
pilot-testing phase of the MRC framework for developing complex interventions.(47) 
According to the MRC framework, feasibility and pilot-testing should take place before a 
full-scale evaluation of intervention effectiveness. A full-scale evaluation (e.g. randomised 
controlled trial) would establish the booklet’s effectiveness, but testing feasibility before 
evaluation can provide important information about the design of the intervention and the 
proposed evaluation.(45) Specifically, it can identify weaknesses (intervention or process), 
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help to refine the intervention / implementation / evaluation plans, and determine if a full-
scale evaluation is warranted. 
Table 6.1 Steps used to develop and evaluate intervention content 
STEP KEY TASKS 
STEP 1: Identifying the 
problem – what behaviour are 
you trying to change, and in what 
way? 
 Identify the evidence-practice gap 
 Specify the behaviour change needed to reduce the 
evidence-practice gap 
 Specify the group whose behaviour needs changing 
STEP 2: Assessing the problem 
– what are the 
barriers/facilitators, and what will 
it take to bring about the desired 
change?  
 Review potential barriers and facilitators to the behaviour 
 Use the TDF and COM-B model to identify the 
pathway(s) of change to the behaviour 
STEP 3: Forming possible 
solutions – what types of 
intervention are likely to bring 
about the desired change?  
 Use the BCW to identify potential behaviour change 
techniques (intervention and policy level) to overcome the 
barriers and enhance the facilitators 
 Use the APEASE criteria to select those intervention 
functions and policies that are most appropriate 
STEP 4: Deciding on specific 
intervention content – using a 
taxonomy of behaviour change 
techniques  
 Use the Behaviour Change Techniques taxonomy to select 
specific intervention content and mode of delivery  
 Use the APEASE criteria to select those behaviour change 
techniques that are most appropriate 
STEP 5: Planning the 
intervention evaluation - how 
can the behaviour change be 
measured and understood? 
 Identify meditators of change to investigate the proposed 
pathways of change 
 Select appropriate outcome measures 
 Determine feasibility of outcomes to be measured in a trial 
 
At the feasibility and pilot-testing phase, a process evaluation plays a vital role in 
understanding the feasibility of the intervention, assessing acceptance, and optimising 
intervention design and evaluation. A process evaluation is defined as a study that aims to 
understand the functioning of an intervention, by examining implementation, mechanisms 
of impact, and contextual factors (See Figure 6.1).(46) The focus and depth of a process 
evaluation will vary according to the stage at which it is conducted (e.g. feasibility testing, 
evaluation of effectiveness etc.), but they assess three key areas: 
1. Mechanisms of impact – how intervention activities, and participants’ 
interactions with them, trigger change; 
2. Implementation – the structures, resources and processes through which delivery 
is achieved, and the quantity and quality of what is delivered; 
 181 
3. Context – how external factors influence the delivery and functioning of 
interventions 
The overall aim of the current chapter is to pilot test the ‘Your Health, Your Choice’ 
booklet, using the MRC guidelines for process evaluations.(46) The key objectives include 
examining: 
1. If the intervention produces change, and describe how it produces change; 
2. How delivery of the ‘Your Health, Your Choice’ intervention is achieved, and what 
is delivered to patients; 
3. Contextual factors that might affect process and outcomes. 
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Figure 6.1 Key functions of a process evaluation and relationships amongst them  
 
Adapted from Moore et al(46)  
6.2 Methods 
6.2.1 Clinical team and sample recruitment 
In Chapter 4, I stated that the ‘Your Health, Your Choice’ booklet forms part of a broader 
implementation strategy, and this is how it will be used during the pilot-testing phase. The 
booklet targets the individual level i.e. trying to change patients’ attitudes and behaviours. 
However, use of the intervention in isolation is unlikely to be effective, given the 
significance of clinician attitudinal barriers and the requirement of information about 
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treatment options. This means that the booklet needs to be implemented in a clinical team 
that is receptive and supportive of the SDM approach, and where clinicians have received 
SDM skills training. These teams might also routinely use patient decision support tools to 
assist with information exchange about the options, and to elicit patients’ preferences. With 
this in mind, the Cardiff and Vale University Health Board Breast Care Centre was selected 
for the pilot-testing phase.  
The Breast Care Centre has worked with the Institute of Primary Care and Public Health, 
Cardiff University, for five years on an on going SDM implementation programme 
(MAGIC), funded by The Health Foundation (see section 4.4, Chapter 4, for further details 
about this programme).(33, 37) During this implementation project, the Breast Care Centre 
has worked closely with researchers to design and test the best ways to embed SDM into 
their routine clinical practice. The team is supportive of the SDM approach, and also 
demonstrates senior level engagement in SDM (i.e. lead nurse, consultants/surgeons). 
During the period August 2010 – January 2012, the majority of the team (including nurses, 
clinical nurse specialists, and consultants), attended SDM skills training workshops. These 
skills workshops cover the model of SDM for clinical practice, developed by Elwyn and 
colleagues,(1) and use role-play scenarios to develop SDM skills. Learning reports from the 
MAGIC programme indicate that the skills workshops were effective in embedding SDM, 
and moved many of the clinicians from saying ‘we do this already’ to ‘we could do this 
better’.(33, 35, 37)  
The Breast Care Centre has also embedded a decision support tool (Option Grid) into 
routine clinical care (see Figure 4.8, Chapter 4). The Option Grid is designed to support 
women with early stage breast cancer to make a decision between lumpectomy with 
radiation or mastectomy.(178) It is used during the diagnostic consultation by the 
consultant, and sometimes the clinical nurse specialist, to outline the treatment options. It 
is then given to the patient to take home. The clinical nurse specialist also uses it during the 
follow-up home visit, approximately one week after diagnosis; it is used to describe the 
options in more detail and to elicit patients’ preferences. When they are not using specific 
decision support tools, the team have the necessary skills and experience to describe 
treatment options, including possible outcomes, and to incorporate patient’s preferences 
into the decision-making process.  
In addition, they have embedded a breast cancer decision quality measure (DQM) into 
their care pathway, and continue to collect routine data on patient decision quality to 
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inform their day-to-day care. Results from the DQM data indicate that patients’ average 
knowledge scores improve between the diagnostic consultation and the follow-up home 
visit (from 63% to 93%; based on data from October 2013 - February 2015). This supports 
the view that the SDM process used by the clinical nurse specialists is effective in 
increasing patients’ knowledge about the condition and the treatment options available. 
Further, since July 2011 (initiation of implementation programme, after SDM skills 
training), patients’ average knowledge scores on the DQM after the follow-up home visits 
have increased from 83% correct responses to 93% correct responses, demonstrating an 
improvement over time. This indicates that the team are providing adequate information 
about the treatment options available, and thus address the essential knowledge component 
of SDM.   
A brief outline of the Breast Care Centre referral and appointment process is provided in 
Figure 6.2. All new patients (males and females) referred to the Breast Care Centre between 
June 2015 and August 2015 were invited to take part in the study, to ensure a range of 
different decision-making circumstances. This includes: patients who are waiting for their 
initial appointment with the Breast Care Centre; patients not diagnosed with breast cancer 
at first visit who do not have current decisions, but who might have decisions to make in 
future; patients with a cancer diagnosis who have explicit treatment options available to 
them (e.g. early stage breast cancer); patients with a cancer diagnosis whose treatment 
options are less explicit (e.g. breast cancer recurrence that has spread).  
For this pilot and feasibility-testing phase, it was felt that the value lay in in-depth 
qualitative feedback with patients. This would allow a detailed understanding of the 
intervention functioning on a small scale, and an in depth understanding of causal 
mechanisms. Therefore, patients were invited to take part in a semi-structured interview 
(approx. 1 hour) with a researcher. All new patients referred to the breast cancer clinic 
between May - August 2015 were sent the ‘Your Health, Your Choice’ booklet, a covering 
letter from the clinical team inviting them to take part in an interview with a researcher, a 
patient information sheet, a study reply form, a consent form, and a pre-paid return 
envelope. Interviews were audio recorded and transcribed verbatim. The interview content 
is described in the following sections. Ethical approval was sought as part of the broader 
MAGIC evaluation project, and a favourable ethical opinion was granted on 19.03.14 
(14/WA/0036). 
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Figure 6.2  Referral and appointment process – Breast Care Centre 
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6.2.2   Assessing mechanisms of impact – does the intervention produce 
change, and how does it achieve this (objective 1) 
A key requisite for a good quality process evaluation is a clear description of the intended 
intervention and how it will be implemented.(46) The systematic BCW approach that has 
been used to develop the intervention has ensured that there is a clear description of the 
‘Your Health, Your Choice’ booklet content, and a description of how it is intended to 
work i.e. causal mechanisms.  
A detailed mapping process of patient-perceived barriers / facilitators to components of 
the COM-B Model / Theoretical Domains Framework (TDF) was conducted during Step 
3 and 4 of the BCW approach (see Chapter 4 for full details). Table 4.6 described how the 
barriers / facilitators map to the COM-B model / TDF, the selected intervention 
components, and the exact content of the intervention that has been designed to address 
the specified barrier / facilitator.  The key barriers / facilitators were mapped to the 
following TDF domains: knowledge; professional role and identity; beliefs about 
capabilities; beliefs about consequences; and social influences. Table 6.2 provides a 
summary of the key mediators of behaviour change, as mapped to the COM-B model / 
TDF (Columns A-C). 
Process evaluation outcome measures to assess mechanisms of impact were based on the 
TDF questionnaire developed by Huijg et al.(179) The questionnaire contains 32 items 
assessing 11 of the 14 TDF; it aims to measure TDF-based determinants of behaviours. 
Questions that related to the key domains were selected / adapted for use during one-to-
one patient interviews.  Additional questions were added to explore whether the booklet 
content was having the desired impact on patients’ intended future behaviours, and to 
assess perceived barriers / facilitators to involvement.  The questions used for the current 
study, based on the TDF questionnaire, are listed in Table 6.2 (Column D).  The full 
interview schedule, including intended future behaviour questions, can be found in 
Additional Appendix 6.1 (on included CD).  
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Table 6.2 Summary of the key mediators of behaviour, mapped to the COM-B Model / TDF and interview questions based on TDF questionnaire 
A 
COM-B 
Component 
B 
TDF 
Domain 
C 
Mediators of behaviour (key barriers and 
facilitators) 
D 
Interview guide, based on TDF questionnaire (questions used as a guide to facilitate 
discussion, and are adapted based on participants’ responses) 
Psychological 
capability 
Knowledge Knowledge about the existence of healthcare 
choices (generally); knowledge of the 
rationale for patient involvement in 
healthcare choices; knowledge about what to 
expect from a SDM encounter / process (i.e. 
when healthcare choices are available and are 
offered by a clinician).   
Note: Knowledge as a key mediator in achieving 
SDM also refers to knowledge about the 
treatment options available to the patient more 
specifically (i.e. what choices are available, and 
their likely outcomes). Information provision 
about treatment options is beyond the remit of the 
‘Your Health, Your Choice’ booklet (to be 
addressed by complementary interventions e.g. 
Option Grid). For the purposes of the interview, 
this domain focuses on knowledge of the 
existence of choice, rationale etc.  
1. Did the booklet help you to understand what it means to be involved in making a 
decision with a clinician?  
a. Can you describe what this means to you? 
2. Did the booklet explain why patients should become involved in healthcare 
decisions together with clinicians?  
a. Can you explain why you think it is important that patients are involved in 
their healthcare decisions? [What does the patient contribute?] 
3. Did the booklet explain what to expect if a clinician asks you to be involved in a 
healthcare decision? 
a. Can you describe the key steps a clinician might go through if you have a 
healthcare decision to make together? [process] 
4. Do you think the booklet enhanced your knowledge about shared decision-making, 
or was it something you already knew about? 
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5. After reading the booklet, do you feel that you know enough about shared 
decision-making to take part in future decisions?  If no, is there anything else you 
would like to know beforehand? 
Reflective 
motivation 
Professional / 
social role 
and identity  
Patients’ belief that they should not / cannot 
be involved in the decision-making process 
because it is not part of the patient role (it is 
part of the clinicians role to make decisions 
for the patient).  
1. Do you think it is part of the patient’s role to take part in decision-making? Why? 
a. To what extent has your view changed since reading the booklet? 
2. As a patient, do you feel that it is okay to ask the clinician questions? 
a. To what extent has your view changed since reading the booklet? 
 
 Beliefs about 
capabilities 
Patients’ belief that they are not capable of 
being involved in the decision-making 
process (e.g. due to lack of self-efficacy in 
ability to understand the information about 
choices); patients’ not recognising the value 
of their own expertise and capabilities (i.e. 
knowledge about their own personal 
preferences).  
1. For you personally, would you say it would be possible or impossible to make a 
decision together with a clinician? 
a. Did the booklet have any influence on how you feel?  
Thinking ahead to your next appointment with a doctor or nurse, if you were told that you 
had healthcare choices; 
2. How confident are you that you would be able to understand the information that is 
given to you about the choices?  
3. How confident are you that you can take part in the decision-making process with a 
clinician?  
4. Has the booklet helped you to feel more confident in any way? 
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 Beliefs about 
consequences 
Patients’ perceiving that involvement in the 
decision-making process might have negative 
repercussions (fear of consequences) 
1. How did the booklet make you feel about patients being involved in healthcare 
decisions with their clinicians? 
2. After reading the booklet, do you feel that there are benefits for patients who take part 
in their healthcare decisions? Can you describe these please?  
3. After reading the booklet, do you think that there are disadvantages for patients 
becoming more involved? Can you describe these please? 
4. After reading the booklet, do you feel that there are disadvantages for patients who do 
not take part in their healthcare decisions? Can you describe these please?  
5. For you personally, do you think that being involved in your healthcare decisions: 
a) would be a good thing, or a bad thing? Why?  
 
Social 
opportunity 
Social 
influences 
Patients’ belief that the active patient role is 
not socially acceptable (it is not ‘normal’ 
behaviour among patients), and the belief 
that clinicians do not want patients involved 
in the decision-making process.  
 
1. Do you think that most other patients would want to take part in a shared decision? To 
what extent has this view changed since reading the booklet? 
2. Do you think that most clinicians want patients to become more involved in decision-
making?  
a. To what extent has the booklet influenced how you feel about this? How? 
3. Do you think that the local health board more broadly wants patients to become more 
involved in decision-making? 
b. To what extent has the booklet influenced how you feel about this? How? 
4. As a patient, are there any other people that you would involve in your decision-
making? How would you involve them? How would this help you?  
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6.2.3  Assessing implementation, context & design issues (objectives 2 & 3) 
In addition to assessing mechanisms of impact, the process evaluation aimed to assess 
implementation of the intervention and consider the contextual factors that might influence 
delivery of the intervention. Open-ended interview questions were included in the interview 
guide to address the following: 
 Reach 
Questions assessing whether the patient came into contact with the intervention, and 
how they are interacting with it e.g. did they receive the booklet before the 
appointment, did they read the booklet straight away, did they share the booklet with 
anyone else, how long did it take to read, etc.?  
 Dose 
Questions assessing the quantity of the intervention received e.g. did the patient read 
all / part of the booklet, which parts did they read, did they use the tools e.g. 
checklist, etc.? 
 Context 
Questions assessing the patients’ context and the other external factors that might 
impede or strengthen the effects of the intervention e.g. stage in the care pathway, 
patient diagnosis, comorbidities, past experience (experiential or vicarious), the 
clinical care pathway and administrative processes of the Breast Care Centre.  
As this study is part of the pilot and feasibility stage of evaluation, patients were asked for 
feedback regarding the booklet’s design and future implementation. The full interview 
schedule including questions covering mechanisms of impact, implementation, and context 
can be found in Additional Appendix 6.1 (on included CD).  
6.2.4 Analysis 
6.2.4.1 Understanding mechanisms of change – framework analysis (Objective 1) 
All interviews were transcribed verbatim, and entered into NVivo qualitative analysis 
software.(72) Each transcript was thoroughly read, and the audio-recorded interview was re-
listened to, to ensure familiarisation with the content of each interview. In the first instance, 
a framework analysis method was used to analyse the interview data.(176) Using the TDF 
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questionnaire as a guide,(179) questions that related to the key drivers of behaviour were 
selected for use during the one-to-one interviews.  This also formed the basis of an initial 
analytical framework, which was used to code two transcripts. New codes that did not fit 
with this initial analytical framework were noted, and they were added to the revised 
framework (See Additional Appendix 6.2 on included CD for the final analytical framework), 
and codes that were redundant were removed or merged with other codes. The final 
framework was applied to each transcript using NVivo software. Once all data had been 
coded using the analytical framework, the data were summarised in a separate matrix for 
each analytical theme (each matrix comprised one row per participant, and one column per 
code). Themes were generated from the data set by reviewing the matrices and making 
connections within and between participants and categories, influenced by the initial 
framework and new concepts that were generated inductively from the data.  
6.2.4.2 Implementation, context and design issues – thematic analysis (Objectives 2 
and 3) 
Thematic analysis(177) was conducted on the transcripts to identify themes relating to the 
implementation of the intervention (e.g. reach, dose etc.), contextual factors that might affect 
delivery / effectiveness, and design issues. Feedback relating to design elements, format, and 
text / graphic content was recorded, assessed for feasibility, and summarised for further 
development.  
6.3 Results 
6.3.1 Sample  
From 162 invitations, 8 female participants were recruited and interviewed. The age of the 
sample ranged from 21 – 62 years. Patients were at the following stage in the care-pathway 
(see Figure 6.2): waiting for initial appointment (n=1); attended appointment, no diagnosis 
(n=4); cancer diagnosis with no clear treatment options (n=1); cancer diagnosis with clear 
treatment options (n=1); cancer recurrence (n=1). Interviews lasted between 23 and 53 
minutes (35 minutes average).  
 
 192 
6.3.2 Mechanisms of impact – does the intervention produce change, and 
how does it achieve this? 
The initial analytical framework consisted of 16 codes, clustered across six categories related 
to the TDF domains, intended future behaviour and barriers / facilitators. After coding two 
transcripts, two codes were removed as it was not relevant to the interview transcripts (‘what 
to expect’ and ‘capability to be involved’), and some codes were merged due to similarities in 
the coded content: ‘patient’s or clinician’s role to make decisions’ was merged with 
‘acceptability of involvement’; ‘rationale’ was merged with ‘existence of healthcare choices.’ 
One code (‘purpose of booklet’) was grouped under ‘knowledge’ instead of ‘other themes’. 
The final analytical framework that was applied to the remainder of the transcripts consisted 
of 12 codes, clustered across six categories (see Additional Appendix 6.2 on included CD). 
Data were then summarised into a matrix for each category in the analytical framework, with 
one row per participant and one column per code. Verbatim quotes were abstracted and 
entered into the corresponding cell. The following key themes emerged from examination of 
the data matrices:  
 
6.3.2.1  Knowledge – awareness of the existence of SDM 
Knowledge about the existence of healthcare treatment options was a key barrier to greater 
patient participation in SDM, identified in Chapter 2. Therefore, the ‘Your Health, Your 
Choice’ booklet content was designed to ensure that patients were made aware that 
healthcare options exist, as this is the first step in becoming more involved in healthcare 
decisions. The booklet appeared to increase knowledge about SDM among the patients that 
were interviewed. When the patients were asked what they felt the main purpose of the 
booklet was, they all believed that it was to explain that patients should and can be involved 
in healthcare decisions: 
‘I think it’s been designed to give, well show people that they have choices 
that are to be made, and can be made depending on the circumstances, 
whatever that may be.’ [P2] 
‘To try and make healthcare a little bit more accessible to the patient and to 
make us, you know, aware of what’s going on, what’s happening to us.’ [P7]  
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‘I think it gives you the alert to say you’ve got a choice. You’ve go the ability, 
you should ask the questions, you should have the answers back, and if they 
don’t, you should seek the answers back…’ [P4] 
‘Well, to give people the choice of treatment and to maybe don’t always listen 
to ‘you have to take this’, you have choices and together you can find the 
right choice for yourself.’ [P5]  
One patient explained that they did not have treatment choices available after their initial 
breast cancer diagnosis, due to the stage of the cancer, but the booklet still reinforced the 
point that there will sometimes be choices available:  
 ‘There are several types of treatments…obviously in my particular case I 
don’t think there was any other solution for me. But, every person, every case 
is a case, so there are different situations where they can have different types 
of treatment.’ [P4]  
For most patients, the availability of options and choice was not something that they were 
previously aware of, and thus the booklet had managed to change their perceptions about 
patients being involved in healthcare decisions: 
 [P4]: ‘Because it gave me a perspective that I did not have.’ [Interviewer]: 
‘So it’s helped change your views on patient involvement?’ [P4]: ‘Yes.’  
‘For me [in the past] it would be the doctors telling me what to do, and fair 
enough. I would have my questions, but I never thought about me having a 
decision about it.’ [P5] 
‘It made me think, yeah, there’s not always the option that they tell you to 
do.’ [P7] 
For those patients who were previously aware that healthcare choices exist, they still felt the 
booklet would be useful to patients who are not aware, especially those in younger age 
groups: 
‘there were loads of young people there…if you’ve just turned eighteen…you 
don’t realise that you can go and ask questions or if you’re not sure how to 
go about it, you know the setting it out and the checklist or the ‘what do you 
think’, it’s a really good way to explain that yes you can, and this is how you 
can do it.’ [P3] 
‘I think if people knew they had a choice then they probably would want to be 
involved, it’s their lives after all, they’re the ones living with it so if they were 
more involved they’d be able to better manage some of their problems.’ [P6] 
‘I think it’s set out in a very good way so maybe if you weren’t aware…it’s a 
good prompt to get people to do that…’ [P8] 
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6.3.2.2 Professional / social role and identity  
A key barrier identified in Chapter 2 was patients perceiving that they cannot, or should not, 
be involved in decisions, because it is not ‘part of the patient’s role’. Therefore, the booklet 
was designed to reinforce the message that there are two experts in the healthcare decision 
making process, and to emphasise the importance of both the patient’s and clinician’s input. 
Feedback from patients indicates that the booklet gave a clear message that it is part of the 
patient role to be involved, and that they have a right to do this:  
‘It’s not them and us, it’s together, so it’s your life and you should be able to 
take part.’ [P2] 
‘The back page [the checklist], ‘do I have a choice?’, going through all that 
made it very obvious that you are allowed to have a say in the decision.’ [P3] 
‘So this outlines what I always thought was important, we should have the 
opportunity to know our case and if the doctor is unsure or whatever…then 
give you the option to do something so that you both discuss it, and that’s 
what it’s saying in here.’ [P5] 
‘It just gave me the open eye to say, no, hold on…if there are options, if there 
are choices, you can actually have an input. It’s not only up to them, it’s your 
life, it’s your body, it’s your input. That’s how it worked for me.’ [P7] 
‘it makes you review yourself as well, and to the point that, it’s my health. 
Yes, it’s a high responsibility, but then I do have some input. It gives you a bit 
of control.’ [P8] 
 
The feedback suggests that the booklet has moved beyond high level awareness of the 
existence of healthcare options, to helping these patients understand the rationale for their 
part in the decision making process:  
‘I think it’s really important [to be involved]…it gives you the chance as well 
to have some sort of feedback on your own treatment and your own life…you 
know, there are treatments that for the consultant they might be more suitable 
for you, but then if you had a choice, you might go for something else because 
of the outcome, the effect it will have in your life.’ [P4] 
 
Some patients who were interviewed already believed that it was part of the patient role to be 
involved in healthcare decisions, and they were already comfortable taking an active role in 
consultations: 
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[Interviewer]: ‘do you think it is part of the patient’s role to become more 
involved?’ [P2]: ‘Yes, it’s ignorant not to be isn’t it, it’s your health, so yes.’ 
However, P2 went on to explain that the booklet did give a clear message to other patients 
who might not already think in that way. Another patient, who also already believed that it 
was part of the patient role to be involved, discussed the difficulties of some patients 
becoming involved, even if they accept that it is part of their role: 
‘A lot of people, you’re sat opposite somebody who’s got a badge and a 
position and a label, and you know, there’s obviously an imbalance of power 
isn’t there…’ [P1] 
This perceived power imbalance is discussed further under the ‘social influences’ section 
below. Overall the feedback provides evidence that the booklet goes someway to helping 
patients recognise that it is part of their role to be involved in the decision making process, 
when healthcare choices exist.  
 
6.3.2.3  Social influences 
Another key barrier identified in Chapter 2 was the perception that clinicians do not want 
patients to become more involved in their healthcare. The booklet was designed to reinforce 
the message that clinicians, and the healthcare organisation more broadly, want patients 
involved; text content was framed from the clinician perspective, thus providing permission 
and encouragement to take part from an influential source. When asked, patients stated that 
it was clear that the booklet’s messages were coming from clinicians, and it was clear that the 
local healthcare organisation had endorsed the booklet e.g. the logos. However, when 
patients were asked if they believe clinicians want patients to become more involved in 
healthcare decisions, most of the patients believed that clinicians do not really want patients 
to be more involved. They perceive that clinicians would become frustrated by patient 
involvement; clinicians might perceive that they are the ones with the knowledge and the 
training, and it might interfere with them being able to do their job: 
 ‘I think they want them [patients] involved in the way that they want them 
to…I mean, you don’t question them, don’t make them explain, they get 
slightly irritated by that.’ [P1]  
‘By and large, most people are left to do their jobs, so it’s probably quite 
frustrating that a doctor can and has to take on the opinion of the patient 
because it’s them that’s being treated.’ [P3]  
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‘Personally I don’t think so…because if you’ve got a patient that is asking 
questions, and you’re trying to do your job, from their perspective…they are 
the doctors, they are the health experts, they know best.’ [P4] 
‘They don’t like it if you’re verbal, then it’s another problem because 
sometimes people mistake forthrightness for confrontation and it’s not the 
same thing...if you’re asking too many questions thy don’t like it either.’ [P6] 
For some patients, they believe clinicians might not want patients involved because they do 
not have the time: 
‘I don’t think so…I think it’s so rushed, so there are so many patients to see, 
but if somebody is sort of saying ‘oh I want to try this’, and it’s all the time, 
and I know they all need to get their numbers down.’ [P5] 
‘When I was at the clinic, there were so many patients waiting, waiting a long 
time…I don’t think they would want to make the wait any longer. Maybe they 
would want it if there was more time…’ [P8] 
Two patients believed the clinicians do want patients involved, and the booklet emphasised 
this: 
‘I would say the whole booklet to be honest…the fact that it says ‘if you’re 
still not sure’, it gives you explanations of why they think it’s best for you to 
make choices and ask questions.’ [P2]  
‘I mean, it helps having something like that beforehand, it’s like an open-door 
then that you can have a say…they are listening to what you want.’ [P7] 
When asked about whether the healthcare organisation more broadly wants patients to be 
more involved in their healthcare decisions, most patients believed that they did not want 
this:  
 ‘No, I don’t think so…well people are awkward aren’t they, and no two are 
alike and that’s really annoying for a health board when you’re providing a 
service, you want everybody to fit into that nice little box.’ [P1] 
‘I personally think for them it’s going to be a nightmare…GPs, they give you 
ten minutes of their life...and according to the health board that’s the most 
they can spend with a patient…by the time you open your mouth and start 
explaining what is going on, the ten minutes are gone.’ [P4] 
Some patients perceived patient choice and individualised healthcare as an inconvenience to 
the healthcare organisation, and therefore they would not want to encourage patients to 
become more involved. Also, one patient commented on the potential danger if patients try 
to become more involved in the ‘wrong’ way:  
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‘Probably not, because once you start listening to everyone, and then people 
meddle…it’s a bit risky…there’s always a couple of people that take 
something too far, kick up a fuss, rather than going and being appropriate 
about it and being involved.’ [P3] 
One patient believed that healthcare organisations are supportive of patient involvement, as 
there may be benefits for the organisation: 
‘I think it would be beneficial, in the way that maybe they wouldn’t be 
prescribing so many drugs. I’ve had a condition, then given medication that 
made it worse, so that medication was no good, so maybe a bit more of a 
discussion about the problems you have.’ [P5]  
P1 agreed with the principle of patient involvement in healthcare decisions, and was a 
relatively ‘activated patient’ in terms of her own healthcare, but she believed the shared 
decision making approach was not realistic or attainable: 
‘It’s a little bit of NHS propaganda to be honest with you…it’s just fantastic 
that there is this thing patient choice and patient involvement; in reality it 
doesn’t happen.’ [P1]  
P1 firmly believed that clinicians and the organisation do not want patient involvement, and 
whilst she felt that the booklet conveyed the message that patients should become more 
involved, and she believed this herself, she felt that the booklet only served to ‘highlight the 
void between theory and practise.’ [P1] Analysing the data, it is likely that these views are based on 
negative past experiences with the healthcare system; this is discussed in more detail under 
‘contextual factors’ section below.  
 
6.3.2.4  Beliefs about consequences 
A key barrier identified in Chapter 2 was fear of the negative consequences of being involved 
in SDM. Therefore, the booklet was designed to promote the advantages of patient 
involvement, and to reassure patients that there will not be negative consequences. Feedback 
indicated that patients felt the booklet conveyed the benefits of SDM, and these could be for 
patients or clinicians: 
‘Yeah, as a good thing yeah…I think if a person didn’t have choices and 
something went wrong…it could literally go on from there.’ [P2] 
‘I think it makes it easier for the doctor involved as well rather than having to 
sit and detail every single thing, somebody that’s bothered to take an interest 
 198 
in their own health and their own wellbeing, I think that probably makes life 
a bit easier for everybody involved.’ [P3]  
‘You know, there are treatments that for the consultant they might be more 
suitable for you, but then if you had a choice, you might go for something else 
because of the outcome, the effect it will have in your life.’ [P4] 
‘I don’t see disadvantages, only advantages…because if you know you’re 
going to a hospital or clinic or something, you will know that you have the 
choice to either say you want to be involved in the treatment, or no, you make 
the decision for me.’ [P5]  
‘Basically it’s making sure you know what’s going to happen before you 
make a decision, you’re ready for the bad consequences, if they end up 
happening.’ [P7] 
When asked, most patients did not perceive disadvantages of SDM after reading the booklet, 
or disadvantages of sending the booklet to patients. However, P3 noted that there is 
potentially a risk of patients ‘thinking they know too much’:  
‘ I think the only risk that people getting too involved is thinking they know 
too much really…gone away and researched it and practically diagnosed 
themselves with something much worse.’ [P3] 
As discussed above, P1 believes that the SDM approach is ‘idealistic’ and ‘unattainable’. 
When asked if there are any potential disadvantages of promoting patient involvement, P1 
responded: 
‘I think it kind of lulls them into a false sense of security that you will be 
having a nice time.’ [P1] 
 
6.3.3 Contextual factors   
Contextual factors that might impede or strengthen the effects of the intervention were 
considered during the process evaluation. Key themes that emerged from thematic analysis 
of the patient interview data are as follows:  
6.3.3.1  Negative past experiences 
Some patients reported negative past experiences with the healthcare system, such as 
inadequate care processes and poor interactions with clinicians. These past experiences 
appear to have a significant impact on the patients’ beliefs that SDM is an approach that is 
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supported by clinicians and healthcare organisations, and on the feasibility of the approach. 
It is likely that it will also have an impact on how receptive patients are to the key messages 
of the ‘Your Health, Your Choice’ booklet.  In relation to poor care processes, P4 describes 
the ‘battle’ that she went through trying to get her GP to listen to her, and to refer her to the 
breast care team in the first instance: 
‘They sent the GP a letter to say that I went through the first surgery, what 
they’ve done, and then what they were going to do, he rang me [GP]…he said 
‘oh you did have breast cancer’ and really friendly…I’m like, well if I wasn’t 
a pain you wouldn’t have sent me to the breast cancer centre, and I wouldn’t 
be here now.’ [P4]  
P1 describes a situation where information about a friend’s health condition had been 
withheld: 
‘We requested all of her notes…I was in hospital every single day with her, 
I’ve asked all the questions, and only when we went through her notes you 
know, there was a perforated lung from the biopsy nobody told us about 
that…as soon as you get cancer, it just gazumps everything and nobody 
cares, nobody talks to you about it.’ [P1]  
Some patients describe the length of time that they had to wait for an appointment [P8’s was 
for an unrelated health condition]. For these patients, the priority was to be seen by a 
clinician, rather than the ability to take part in their decisions: 
‘He was complaining because he’d been waiting thirty minutes, and I was 
like ‘we’ve been here an hour and a half already’, so there are other issues 
that’s more important than, than your, I don’t know, your dream about this 
patient form.’ [P1]  
‘And you know, despite it being an urgent referral and NICE guidelines 
saying two weeks, it was almost four weeks…I would prefer leaflets that tell 
you where to complain about that, where the NICE guidelines are.’ [P7]  
‘It’s been so drawn out, it’s upsetting that it took so long, I’d chase and chase 
but get nowhere. I mean most people, by the time you’ve waited and waited 
and waited to see consultant, you’re just so bloody grateful you’d do 
anything.’ [P8] 
Poor past interpersonal interactions with clinicians have an impact on patient’s views about 
the feasibility of SDM. One patient describes a situation when there were options available, 
but she was not told about them: 
‘No, they didn’t explain I had options, just a prescription for something, and 
they irritated other symptoms, and when I look it up or whatever, or a 
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different GP, and they’ll say ‘oh well that can cause that’, and you think ‘if 
only I’d known that in the first place!’ [P5]  
Clinicians with poor interpersonal skills and a negative attitude towards patients are a key 
barrier to SDM, and are likely to have an impact on how receptive patients are to the 
message that clinicians want them to become more involved: 
‘Oh yeah, if they had a negative attitude, I wouldn’t share it, I haven’t before, 
it puts you off.’ [P2] 
‘I was feeling really unwell and he comes in and goes ‘so what’s your 
problem?’ [Laughs]. I was a little bit taken aback to be honest, I thought 
surely there’s better ways of putting it. And I’m not generally frightened to 
speak up for myself. [P8] 
For this reason, one patient believed that the focus should be on communication skills of 
clinicians, rather than on patients:  
‘ Her [friend] oncologist, he’s got the personality of a gnat! So even when 
you ask questions, and I’m not shy about asking questions…he just shuffles 
his feet and looks at the floor.’ So it’s wonderful this might be applicable to 
some consultants, but I really do think you should be producing a leaflet for 
the consultants on skills, people skills and communication skills.’ [P1]  
This patient, who is relatively ‘activated’, also reports being actively discouraged from 
becoming more involved:  
‘Yeah, and I mean I’ve sat there with my notebook and pen and I was told 
‘you don’t need to write anything down because I will give you a leaflet’.’ 
[P1] 
As well as being diagnosed with metastatic breast cancer, P1 has a vast amount of experience 
of supporting friends and family through the healthcare process when they have been 
unwell. Therefore, this patient has had first-hand experience of interacting with clinicians, 
experience as a third-party, and she also has experience of various healthcare administration 
processes. It is clear from this patient’s interview transcript that past experiences with 
clinicians and the organisational processes have had a significant impact on her views about 
patient involvement, and the effectiveness of the ‘Your Health, Your Choice’ booklet. As 
mentioned above, P1 agrees with the principle of patient involvement, and believes the 
booklet clearly conveys this message; however, her past experiences have impacted on her 
belief that SDM is attainable: 
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‘I mean, I think if you’d asked me twenty years ago I would have said ‘oh yes, 
it’s a lovely idea, it’s a lovely concept’, I don’t think it’s very realistic.’ [P1]  
‘I guess it just makes me feel disappointed really because I mean, wouldn’t it 
be lovely if it was like this, the NHS was like this…but alas it’s not, you know 
so it is a disappointment, you know, if this is the standard that the NHS is 
reaching for, it’s not, it’s not making it, it’s really not.’ [P1]  
 
6.3.3.2  Emotional factors 
Some patients discussed their emotional state when they were given their cancer diagnosis. 
For these patients, the shock of being told that they have bad news overrode their ability to 
think about being involved: 
‘He sat there and said well ‘you’ve had the biopsy, you’ll come back in a 
weeks time for the results, he said ‘do you have any questions?’ I said there 
isn’t any questions I can ask really unless you’ve got a crystal ball because 
you don’t know until you the biopsy results, and he just went ‘oh but I think 
it’s bad, it’s very bad’; that was a shock.’ [P1]  
‘Because it’s frightening, going to hospital is quite frightening, nobody likes 
going to hospital do they?’ [P3] 
‘When I went to see the consultant, obviously the first day I couldn’t even 
hear what…what the heck she was on about…I wasn’t expecting it, I thought 
it was just a routine thing, it would be just a lump, and they said ‘no’.’ [P4]  
‘They asked if I had questions, but to be honest with you, as soon as you hear 
the C word you don’t really have any questions, you’re just thinking, ‘God, 
I’m doomed’.’ [P8] 
P4 went on to explain that if the booklet were given to her at that first diagnostic 
appointment, she would be unlikely to look at it due to how worried and how nervous she 
was: 
‘Personally, if I was given this on the first day I went, I wouldn’t even look at 
it, not in the state of mind I was in. And the reason why, because you’re in the 
Breast Care Centre, so you know, the chances of having something wrong 
with you are so high, you get so nervous.’ [P4] 
This suggests that emotional factors, such as the shock of diagnosis, might impede a 
patient’s ability to get involved in SDM, regardless of whether the booklet helped to prepare 
them to take part beforehand.  
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6.3.3.3 Time 
Most patients perceived that there is not enough time for clinicians to do SDM, even if they 
wanted to. This is another key barrier that leads patients to perceive that SDM might not be 
feasible in real-life clinical settings:  
 ‘You know they’ve waited months and months to go there [psychiatrist] and 
you get ten minutes with some bloke who’s, you know, wanting you out the 
door and you know he’s not there to listen to your story, he’s just there to 
write you a prescription.’ [P1 
‘The patient care thing has disappeared because of the society we live in, 
everyone’s in such a rush it’s like they go to the doctors, they’re under 
pressure obviously, it’s going back to the time management thing, targets on 
them, then it sort of somehow gets trickled down to the patient.’ [P6] 
 
6.3.4 Implementation and use of the intervention 
I analysed how delivery of the ‘Your Health, Your Choice’ intervention was achieved, and 
what was delivered to patients.  
6.3.4.1 Reach            
All patients received the booklet in the mail before their appointment at the Breast Care 
Centre, as intended. This varied from 4 days – 14 days before the appointment, depending 
on where the patients were placed in the appointment schedule. Almost all patients read the 
booklet straight away when they received it in the post. One patient put the booklet aside for 
a couple of days, as they realised they only needed to read it before the appointment, which 
was a week away. All patients reported that it took them less then ten minutes to read the 
booklet. Some patients spent a couple of minutes skimming through the information, and 
then went back through the booklet in more detail: 
‘About 10 minutes, because obviously you go back over and have a little look 
through something that maybe you’ve not taken in.’ [P5]  
Most patients did not share the booklet with anyone else (e.g. family members or friends). 
One patient [P1] shared the booklet on a professional basis with colleagues at her workplace, 
as they are involved in developing healthcare leaflets. One patient [P6] showed the booklet 
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to her teenage son. Both of these patients felt that the design was more suitable for a 
younger audience (see above).  
6.3.4.2 Dose 
Most patients reported that they read the entire booklet (8 pages). One patient [P1] only read 
the first three pages of the booklet, and then quickly glanced at the remaining five pages. 
However, this patient felt that the ‘patient-centred’ approach was ‘idealistic’ and was unlikely 
to be achieved in practice. Therefore, whilst she was not against the messages portrayed in 
the booklet, she felt that they would not come to fruition and decided not to read the 
booklet in detail (this is discussed in more detail in section 6.3.3 above). Another patient [P3] 
reported that she only ‘flicked’ through the booklet and quickly glanced at each page. 
However, this patient was not sure of the relevance of the booklet to her upcoming 
appointment due to implementation process issues. The covering letter that accompanied 
the booklet did not clearly indicate that it was sent from the Breast Care Centre. The letter 
for this pilot-testing stage was dual purpose, and this could have led to some confusion: it 
was used by the Breast Care Centre to encourage patients to read the booklet before their 
next appointment, and it was also used to recruit patients to the associated interview study. 
Further, it transpired after commencing the study that patients attending the Breast Care 
Centre do not receive paper appointment letters in the post. They receive a telephone call 
from the clinic coordinator to arrange the appointment. As such, the booklet and covering 
letter that encourages patients to read the booklet before their next appointment are sent 
independent of any appointment confirmation. Future implementation should make it 
clearer that the booklet is being sent on behalf of the clinical team that the patient is seeing: 
‘In hindsight I think it’s very informative but it just, it seems silly saying it but 
I just didn’t make the link at all, I presumed it was something to do with the 
uni.’ [P3] 
 
None of the patients used the notepad or the checklist at the back of the booklet ahead of, 
during, or after their appointment at the Breast Care Centre. When asked why they did not 
use the tools, the majority of patients reported that they did not have a decision to make at 
this time (e.g. no cancer identified, routine follow-up check after previous breast cancer 
diagnosis). Again, P1 did not read the entire booklet because she felt the approach was 
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idealistic, and P6 felt that there were other priorities than becoming more involved in 
decisions e.g. timely care. 
However, most of the patients believed that the checklist and the notepad would be helpful 
in future appointments, and it was something that they intended to use, when appropriate: 
‘…it’s a good tick list…because I suppose they are the things that I would 
never think of.’ [P2]  
‘No, I didn’t need to as I say this time but in future I would, yes, yeah that is 
something I would use.’ [P8] 
Some would use the checklist before, during and after the appointment as a way of checking 
that they received the appointment that they should have received, including a SDM process: 
‘I’d take it to the appointment with me and then as I go along I’d just do the 
checklist and then double check it coming back from the appointment and 
check again when I got home.’ [P2]   
‘While I’m waiting I may actually have a look and see the questions…it might 
raise an idea of what I should be asking, and what should be my attitude, and 
then probably afterwards I would go through it and say, okay, I’ve done this, 
I’ve done that.’ [P4] 
Some patients would use the notepad before the appointment to write down questions that 
they have, and to act as an aide memoire whilst they were at the appointment, or suggest that it 
could be used during the appointment to note down what was said for future reference.  
‘Because you’re so bombarded with different things and the hospital is so 
rushed so having somewhere you can put down your points you’d like to 
know is very good….often you go there and you think  oh yeah I’ll ask that 
and it goes around and you think oh I didn’t ask.’ [P5]  
‘It would make it easier, I think, if you took this and used it as a tool, but I 
didn’t do that.’ [P3]  
‘It was quite stressful, you’re so emotional and there’s so much going 
through your mind…maybe not the first consultation [diagnostic], but the one 
when they come to see you a week later to talk about the surgery.’ [P7] 
‘I can see something like this helping my mum too…it’s so easy to forget what 
is going on when you have all that information, and when we ask her what 
was said, she can’t remember.’ [P8] 
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6.3.4.3 Future implementation 
Patients were asked for their opinion on how the booklet could be implemented in future, 
outside of the research study setting. All patients believed that it should be sent to patients 
ahead of their appointment, as it was implemented during the pilot-testing. Preferably, this 
should accompany an appointment letter and any other important information that is sent to 
patients regarding their appointment. : 
‘I think it would be better to be sent, because when you get your appointment 
you get all the jargon, what you have to do before you get there, what you 
have to take…so with that it would be very good because obviously that’s 
making that [the booklet] important.’ [P5].  
However, some patients felt that the booklet should also be available at the place of the 
appointment (e.g. waiting area, consultation room), just in case they forgot about the 
booklet. Posters and additional booklets in the waiting area would prompt them to become 
more involved and ask questions:  
‘I’d say both [sent before appointment and handed out at appointment], just 
in case I forgot.’ [P2] 
‘I think if there was information on the board, because every single 
appointment, I went to thousands of them, I tend to look around, and read the 
news and read this and that, while you’re waiting.’ [P3] 
Patients typically have to wait in a waiting area for their appointment, so the clinic 
receptionist could hand out the booklet, and patients could read it during that time:   
‘It depends what kind of appointment you’ve got. If I go to the GP and that’s 
given to my hand before my appointment, I’ve got enough time, because I’m 
waiting, I will read it and I’ll go through it and yes, do you know, open my 
eyes to what I should be asking.’ [P4] 
 
6.3.5 Design and format feedback 
Overall, the patients were positive about the general design of the booklet. This included the 
colour scheme, graphics, size of booklet, the font used, and the layout of the text and 
graphics. Patients felt that the inclusion of cartoon characters made it approachable, they 
covered a broad spectrum of the population, and they made the booklet different to the 
usual text-heavy leaflets that can be found in waiting areas. However, two patients did feel 
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that the character design would appeal more to a younger audience (e.g. children and 
teenagers), and that adults might be put off by the design: 
‘I have to say I was a bit put off by the cartoon characters…if I was handing 
it to a child I probably would, but I’m not sure I’m the target audience.’ [P1]  
‘Because if you’re giving that to a kid, fair enough, but as a grown up I think 
grown-ups prefer photographic imagery, if you know what I mean.’ [P6] 
The intervention is currently in booklet format; patients were asked if they saw scope for the 
booklet to be created into alternative formats (e.g. website, iPhone app, tablet app). Overall, 
most patients felt that a booklet was the most suitable format for the intervention. Whilst 
positive about the possibility of electronic versions of the intervention for other patients, 
they did not believe that it was something that they either could or would use. This was 
reflected across the different age groups:  
‘I would use it if I knew how to use it!’ [P2, age 26] 
‘It’s not something I’d use no…I think people always want things like that 
don’t they because we use phones now more than paper, so it would probably 
be a good idea.’ [P3, age 21] 
‘I’m going to be honest with you, I don’t have the time, I really don’t…I wish 
I could, but I think I turn on my computer or my tablet about once or twice a 
week, if that much.’ [P4, age 40] 
‘Probably not, I mean I’ve only just got into an iPhone…I think in leaflet 
form even youngsters would read that more than an app.’ [P5, age 59] 
However, P6 felt that an electronic version of the booklet would be more appealing to 
patients, especially those of a younger age group, and a short film in patient waiting areas 
could convey the messages more efficiently. All patients felt that the booklet was easy to 
read, that they could understand the information, and that the text size was appropriate; this 
included one patient with dyslexia [P2]. However, P1 did suggest that some of the sentences 
could be condensed so that shorter and simpler key messages are portrayed: 
‘I think short and sweet with bold questions, just key points is of more use 
when somebody is sat in front of a consultant.’ [P1] 
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6.4 Discussion 
The aim of this chapter was to pilot-test the ‘Your Health, Your Choice’ intervention with 
breast care patients, using a process evaluation method. Overall, the intervention shows 
potential to prepare patients for involvement in healthcare decisions, in the way that it was 
intended: increasing knowledge about what SDM involves, moving patients from thinking 
that they should not be involved to recognising the importance of the patient contribution, 
and patients stating that they want to be involved in future. The intervention was well 
received by a range of patients, with evidence of high levels of reach, dose and fidelity. 
However, important contextual factors, such as negative past experiences, can have a 
significant impact on the overall efficacy of the booklet, and this will be discussed below.  
 
From ‘doctor knows best’ to ‘doctor doesn’t want me involved’?  
Chapter 2 showed that many patients do not perceive that they have choices available in the 
healthcare setting. Clearly, if patients do not know that they have choices available in their 
healthcare, they will be unlikely to participate in the decision-making process. The booklet 
aimed to address this key barrier by explaining when healthcare choices exist and why, and 
describing what is involved in the SDM process. Another key barrier that the booklet 
addressed was patients perceiving that it is not part of their role to be involved in the 
decision making process; for example, ‘doctor knows best, they should make the decision for 
me’. The booklet reinforced that there are two experts in healthcare, the patient and the 
clinician, and explained the importance of the complementary expertise that each brings. 
The results of the pilot-testing suggest that the booklet is addressing these two key barriers. 
When patients were asked about the purpose of the booklet, they all identified that it was to 
let patients know that they have choices available in their healthcare, and that patient 
preferences are important. Therefore, a clear message was reaching the target audience. 
There was some evidence that the booklet raised awareness of healthcare choices, and 
knowledge about why they exist, and it also influenced some patients’ perceptions about 
their role in the consultation. For patients who were not previously aware that they had 
choices, the booklet helped these patients to understand and accept that it is part of the 
patient role to be involved in healthcare decisions, and they subsequently intended to do so 
in future.  
 208 
However, results show that changing patients’ attitudes about what should be the norm, and 
what can be the norm, are very different tasks. Despite patients stating that the booklet has 
reinforced their belief that they should be part of the decision-making process, they still 
believe that clinicians and healthcare organisations more broadly do not want patients 
involved. Patients cite various reasons for this belief, including: clinicians perceiving that they 
are the experts; patient involvement interfering with the clinician’s ability to do their job; lack 
of time to do SDM; the inconvenience of individualised care for the healthcare organisation; 
and the danger of patients becoming involved in the ‘wrong way’. When examining the 
broader contextual factors that might influence outcomes, negative past experiences were a 
significant contributing factor to this belief that clinicians and the organisation do not want 
patients involved.  
For some patients, negative past experiences with the care process dominated their views of 
what might be attainable in future healthcare consultations. Some patients had experience of 
negative interactions with clinicians (e.g. rude / dismissive clinicians), some had received 
inadequate care (e.g. delays in diagnosis, inappropriate medication), and some had experience 
of poor administrative processes (e.g. long delays for referral). When patients had 
experienced delays in treatment, their priority was to receive timely care, not involvement in 
their decisions. Past experiences led some patients to adopt a ‘defensive’ approach to 
consultations, where they expect the worst and feel that they have to ‘fight their corner’. 
Interestingly, the more ‘activated’ patients reported more experiences of poor care and the 
booklet seemed to have less of an impact among these more ‘activated’ patients; these 
patients had positive views about patient involvement, but were the most pessimistic about it 
taking place routinely (e.g. ‘it’s a little bit of NHS propaganda really… it’s great to think 
there’s such a things as patient choice, but in reality it just won’t happen’ [p1]). Interestingly, 
the pilot-testing patients appeared to be more pessimistic about the feasibility of the 
approach than the lay-users interviewed during the pre-testing phase (Chapter 5). However, 
most of the lay-users were not currently receiving care, and were asked to consider 
hypothetical situations. In contrast, the patients who participated in pilot-testing are 
currently receiving care, have recent experience of busy clinical environments and 
interactions with clinicians, some are unwell or have experienced a negative emotional 
response, and some have been in and out of the care system for many years.  
The results suggest that there are two significant types of social norm to be addressed by a 
patient activation intervention: norms about the perceived acceptability of patient 
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involvement (should patients be involved), and norms about perceived clinicians attitudes 
towards patient involvement (would patients actually be involved). Clearly, encouraging 
patients to want SDM and encouraging them to believe and expect that it can be a reality are 
distinct tasks. The booklet attempted to address both of these, but from preliminary small-
scale pilot-testing it appears to have had more influence on the former. Therefore, 
preparation (i.e. changing patients attitudes towards patient involvement / allowing patients 
to make an informed decision to be involved) must be followed by more substantial effort 
and progress towards enablement (i.e. encouraging and supporting patients to become 
involved in SDM). Receptive clinicians who fully endorse principles of person-centred 
healthcare will play a key part in moving those patients who think they should be involved, to 
be those patients who also think that they would be involved. An internally driven approach 
to the ‘Your Health, Your Choice’ intervention is also critical, as it will show patients that the 
clinical team and the healthcare organisation endorse the key messages.  
Overall, the pilot-testing highlights the importance of implementing the ‘Your Health, Your 
Choice’ intervention as part of a multi-faceted SDM intervention, or ‘SDM bundle’: this 
‘bundle’ must address patients’ attitudes, but also clinicians’ attitudes (e.g. skills training), and 
organisational factors (e.g. time for SDM during care pathway). I attempted to achieve this 
during pilot-testing, by implementing the booklet in a team that is receptive to SDM, with 
clinical team members who had received SDM skills training and who use SDM tools, within 
the context of an organisation and team that has supported SDM implementation.(35). 
However, the fidelity of the breast care team’s broader SDM approach is not clear, and this 
may impact on the efficacy of the ‘Your Health, Your Choice’ intervention (e.g. not all 
clinicians had received SDM skills training): this is discussed further in the strengths and 
weaknesses section below. Overall, unless a holistic approach is used, we are in danger of 
preparing patients to want and expect something that they do not feel is attainable.  
 
Use, design, and implementation of the intervention 
Overall, the results show that a booklet format is a feasible and effective way to deliver the 
‘Your Health, Your Choice’ intervention. The booklet had high levels of reach (all of the 
intended target audience came into contact with it before their appointment), relatively high 
levels of fidelity (used as intended, by patients), and relatively high levels of dose (the 
quantity of the booklet that was read by the patients), especially among the less ‘activated’ 
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patients. Regarding fidelity, the patients did not use key aspects of the booklet, such as the 
notepad and checklist. However, most patients did not have a treatment decision to make at 
this time, and most reported that it would be something that they would use in future 
situations when there are decisions. This suggests that the booklet would be useful, and 
possibly more effective, if targeted at patients who had imminent healthcare decisions to 
make. However, it is often difficult to establish this up-front in many settings e.g. general 
practice. The fact that patients without current decisions display positive intentions to use 
the tools and try SDM in the future indicates that there is still potential value in sending the 
booklet to a broad spectrum of patients. 
There was little demand for alternative formats (e.g. electronic versions, phone apps), and all 
but one patient felt that the booklet was the most accessible and usable format that should 
be distributed to patients. This view was shared across the different age groups (21 – 62 
years). It was suggested that the additional work that is involved in accessing online formats 
or downloading a phone app might impact on the reach of the intervention, and the dose 
(quantity of intervention used). In a previous study of a web-based decision support 
intervention for prostate specific antigen testing, participants accessed less than half of the 
available content and did not use the interactive features.(180)This previous study included 
an older male population, but it highlights the importance of developing an intervention that 
is likely to be accessed by all patient groups, especially as perceived power imbalances are 
more pronounced in the older age group.  
In terms of the implementation process, the booklet was meant to be easily integrated into 
the clinical care pathway, as it only needed to be posted to patients by the administrative 
team. However, the Breast Care Centre appointment process was changed after initial study 
plans, and was not ideal for the distribution of the booklet. Patients do not receive an 
appointment letter for their upcoming appointment; they receive a telephone call from a 
clinic coordinator to arrange the appointment, meaning the booklet had to be sent 
independently. Some participants noted that they did not understand that the booklet was 
being sent on behalf of the Breast Care Centre in relation to their upcoming appointment. 
This was probably confounded by the fact that Cardiff University was mentioned in the 
dual-purpose covering letter, which was also trying to recruit patients for pilot-testing 
interviews.  In Chapter 5, lay users believed that the way in which the booklet was 
distributed to patients was key: the booklet should be sent directly from the clinical team 
together with the appointment letters. If it is clear that the clinical team you would be seeing 
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have endorsed and sent the booklet, it provides patients with permission and reassurance to 
take part. As discussed above, many patients believe that clinicians do not want patients 
involved, and this can have a significant impact on how receptive people are to the feasibility 
and expectations of the SDM approach. Future implementation attempts should establish a 
clear link between the booklet and the clinical team, which could be supported by conjoint 
branding and a tailored booklet for each clinical area.  
6.4.1 Strengths and weaknesses 
The pilot-testing phase built on the work conducted in Chapter 5 by testing the intervention 
with real-life patients, currently accessing care. The use of real-life patients in routine clinical 
settings meant that the results of the pilot-testing were more ecologically valid, and that they 
considered a broader range of contextual factors that might influence implementation and / 
or outcomes of the intervention. The framework analysis method enabled me to determine 
whether the theoretically developed booklet has the potential to produce the desired change: 
i.e. promoting positive patient attitudes towards SDM.  
One of the most significant weaknesses of the pilot-testing is the sample size (n=8). 
Experience on parallel SDM research programmes has shown that this patient population is 
particularly difficult to recruit.(181) Many of the patients are extremely emotional and 
worried about a cancer diagnosis after initial referral, and for those who are diagnosed, they 
receive surgery and follow-up treatment within two weeks, and thus they are recovering both 
physically and psychologically. The number of parallel projects taking place at the Breast 
Care Centre, which includes the ongoing MAGIC programme, also impairs recruitment. The 
research nurses are sensitive to demands on the patients, and are keen not to over burden 
them with requests for research participation. As discussed in the methods section, the ‘Your 
Health, Your Choice’ intervention is part of a complex intervention that needs to be 
implemented in a clinical team that is receptive and supportive of the SDM approach, and 
where clinicians have received SDM skills training (where they might also use decision 
support tools for patients to assist with information exchange and preference elicitation).  
There are clear benefits to using such a team, and it is important to the success of the patient 
activation intervention, but it does also present problems. This team has worked closely with 
researchers for five years, developing and testing SDM interventions, and their team has 
undergone some level of cultural change regarding their approach to patient decision-
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making. This is on top of their day-to-day clinical demands, targets and organisational 
restructuring at the local health board level. We have begun to witness ‘research fatigue’ and 
sustainability issues in this team, where some clinical team members have disengaged from 
the research elements of the broader programme of work (e.g. audio-recording of 
consultations for SDM analysis). This must be considered during future testing of the 
booklet (e.g. by considering a new clinical area / team), regardless of the additional 
background work that will be needed to engage and train a new team. Working with 
additional teams is also crucial for knowledge-transfer, and wider rollout of the intervention.  
The sample composition is also a potential weakness. The sample frame for this study 
included all patients referred to the Breast Care Centre over a 16-week period, and could 
have included males or females. Approximately 90% of the patients referred and invited to 
participate were female; unfortunately, only female patients responded to the study request 
and agreed to take part in the study. It is important to consider this when making 
judgements about the feasibility and future implementation of the booklet. Further work 
should test the booklet in a setting that includes a higher proportion of male patients (e.g. 
osteoarthritis orthopaedic / urology setting) to determine if there are important differences 
in the way that male patients interact with the intervention, or if there are unique contextual 
factors that are specific to this population.   
Whilst I can be fairly confident about the fidelity of the ‘Your Health, Your Choice’ 
intervention, I cannot be sure about the fidelity of the broader SDM approach that is used at 
the Breast Care Centre. Most of the clinical team received SDM skills training as part of the 
MAGIC programme. However, some clinicians were unable to attend this session, and new 
team members have also not received this training. Therefore, it is likely that some of the 
patients were not seen by a clinician who had received SDM skills training, or worse, were 
seen by a clinician who was not receptive to the SDM approach. As we have seen from the 
pilot-testing, follow-up from a clinician who outwardly supports and encourages patient 
involvement is important. Future testing of this intervention will also need to ensure fidelity 
of what the clinicians are delivering to patients; a controlled trial setting with a parallel 
process evaluation can support this. A controlled trial would also allow me to determine if 
clinicians with SDM skills, who might also use decision support tools, is sufficient to 
encourage SDM among patients, or if the ‘Your Health, Your Choice’ intervention is a 
necessary (additional) component that would result in greater benefits (this is discussed 
further in Chapter 7).  
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The pilot-testing interviews were based on self-reported use of the intervention. First, we 
cannot guarantee that patients read the content / amount that they reported to read.  Some 
patients might also experience social conformity due to the interviewer being present, feeling 
that they have to report a positive outcome and reaction to the booklet. A think-aloud 
technique might have been more useful in this scenario, where patients would be asked to 
say whatever comes into their mind as they read the booklet. This would ensure that they 
have read the booklet, would identify any areas where they encountered difficulties, and it 
would also give an insight into the patient’s cognitive processes as they read the key 
messages. Clearly, the pilot-testing stage was not a before and after trial. It is therefore 
difficult to know what patients thought beforehand, and whether the booklet did change 
patients’ attitudes. Self-reports from patients are a useful indicator of change, but future 
testing would need to consider patients’ beliefs before and after exposure to the intervention, 
in order to make more concrete judgments about the booklet’s effectiveness.  
6.4.2 Conclusion 
Preliminary pilot-testing has shown that the ‘Your Health, Your Choice’ booklet has 
potential to change patients’ attitudes towards involvement in healthcare decisions, and thus 
prepare them for SDM. However, the intervention had more impact on patients’ beliefs that 
SDM should happen, and less impact on their beliefs that it would happen. Contextual factors, 
such as past negative experiences with healthcare and organisational constraints (e.g. time in 
consultations), play an important role in the potential effectiveness of the messages conveyed 
in the intervention.  The results highlight the importance of different SDM component 
interventions working together; a patient activation measure will not work on its own. 
Ultimately, actions will speak louder than words for patients. Preparation needs to be 
followed by enablement from willing and skilled clinicians, who can reinforce the message 
that they want patients to become equal partners, as it is difficult to convey this message in a 
booklet alone. If preparation is not followed by enablement, we are in danger of creating 
activated patients whose care does not meet their expectations, and exaggerating the void 
between theory (or ideal care) and practise. A holistic approach will ensure that we do not 
only move patients from thinking ‘doctor knows best’ to ‘doctor doesn’t want me involved’: 
it will encourage them to believe that clinicians and healthcare organisations are driving 
forward the principles of person-centred care, and that patients’ input is expected and 
valued. 
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Chapter 7 
Further research plans 
This thesis presents the development and initial pilot-testing of the ‘Your Health, Your 
Choice’ booklet. This chapter will present further research proposals that have arisen from 
the work that has been completed to date, which are beyond the remit of this thesis. Several 
proposals are presented relating to the further development and evaluation of the ‘Your 
Health, Your Choice’ intervention. This culminates with the key research proposal; a cluster-
randomised controlled trial and process evaluation of the ‘Your Health, Your Choice’ 
intervention, embedded in a SDM clinical pathway.  
7.1 Integrated taxonomy of patient reported barriers and 
facilitators, and cultural adaptation  
Chapter 2 resulted in a taxonomy of patient reported barriers and facilitators to involvement 
in SDM. This is the first review, to my knowledge, to focus exclusively on patient-reported 
data. The results of this review have been published in two journal articles: the Patient 
Education and Counselling article (Appendix 2.2)(182) presents the results of the systematic 
review; the BMJ article (Appendix 2.3)(172) is a discussion piece highlighting the key themes 
that emerged from the review and practice implications. As with the preceding review 
published by Legare et al,(57)which focuses on healthcare professional-perceived barriers, 
this review has the potential to inform researchers, implementers, educators, and clinicians 
interested in implementing SDM. Specifically, it highlights the factors that need to be 
considered when trying to engage patients in a SDM process. The taxonomy should be 
considered during SDM intervention development, implementation planning, and SDM 
training and education.  
The taxonomy produced in Chapter 2 focuses exclusively on patient-reported factors, but, as 
discussed, this cannot be considered in isolation. The field of SDM, and patient-centred care 
more broadly, has expanded exponentially over the last decade, evidenced in part by the 
increase in the number of RCTs included in the Cochrane Review of patient decision 
aids,(16) and a move towards implementation learning programmes based in real-life clinical 
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settings.(33) The factors identified in my review need to be considered in conjunction with 
healthcare professional-reported barriers literature,(57) and learning from SDM 
implementation programmes that are taking place internationally. There is scope to build on 
the patient-reported barriers review to produce an integrated taxonomy of factors 
influencing successful SDM implementation; this taxonomy would draw on the existing 
literature around barriers and facilitators, and the learning from implementation 
programmes. This comprehensive integrated framework would better guide researchers, 
implementers, educators, and clinicians attempting to embed SDM into routine care.  
The growth in the number of publications in the area of patient-centred care also means that 
the review should be updated to incorporate new literature published since 2012. Most 
studies included in the review were conducted in Europe (24/44) and North America 
(18/44). This area of research is not well indexed, so it would be important to see if further 
work has been conducted in lower income countries. This would allow us to investigate if 
the barriers and facilitators are culturally specific to those countries included in the review, or 
if they are exacerbated / minimised by different cultural factors. 
7.2 Further development and testing of the ‘Your Health, Your 
Choice’ intervention 
Further pilot-testing 
The pilot-testing in the breast care team (Chapter 6) was significantly limited by the sample 
size and sample composition, and this impacts on the generalisability of the results. Before 
proceeding to a full-scale trial, I would recommend conducting further pilot-testing of the 
‘Your Health, Your Choice’ intervention to broaden understanding of the intervention’s 
acceptability, mechanisms of impact, and implementation. Pilot-testing with eight patients 
indicated that the intervention has relatively high reach, dose and fidelity. However, the very 
low response rate in the breast care team indicates that these eight patients might have been 
more ‘motivated’ patients, and they might not be representative of the broader group of 
patients. Therefore, it is important to test the booklet with a larger group of patients to see if 
the findings are replicated. It would also be important to establish if the pilot-testing 
patients’ attitudes towards the intervention are representative of a larger patient group i.e. 
believing that it is part of the patient’s role to take part in SDM, but also believing that 
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clinicians do not want patients involved in SDM. The pilot-testing in the breast care team 
also identified implementation process issues (the appointment confirmation process) and 
further pilot-testing could be used to progressively refine and establish the most effective 
implementation process, prior to full-scale evaluation. Further pilot-testing could be 
conducted in a breast care setting with more patients, but it would also be useful to conduct 
pilot-testing in other clinical areas with different patients compositions, as this would give a 
better indication of how the intervention might work in other settings.  
Speciality specific 
Currently, the booklet is generic and could be used for any health condition, across primary 
and secondary care. Feedback indicated that there is scope to develop condition specific 
versions of the booklet. To achieve this, we would have to work closely with patient 
representatives from the specific clinical area, and also with clinicians who deliver the care to 
patients. Most of the text content would remain standardised, but the messages could be 
framed from the specific clinical team that is delivering the booklet e.g. ‘your chronic kidney 
disease team want to know what’s important to you.’ Further, it was suggested that the 
inclusion of brief patient stories / quotes might be beneficial to other patients. Patients from 
the relevant clinical area could be interviewed about their experiences of SDM, and these 
stories could be included in the decision specific versions of the booklet.  
Different formats 
There is also scope to develop the booklet into other formats. The overarching view from 
the pre-testing (clinicians and patients) and pilot-testing feedback was that a booklet was the 
preferred, and most accessible, format. If the booklet were created on online / application 
platforms, certain people might not have access to these formats, and it is possible that only 
motivated patients would access these. However, feedback did indicate that the development 
of the booklet in different formats would be useful, if they supplemented rather than 
replaced the booklet. For instance, the booklet could be linked with: a website that could 
provide more detailed information that does not fit within an eight-page booklet (e.g. further 
patient stories, video clips); with tablet / phone applications that include the interactive 
features (e.g. notepad / checklist); various social media accounts (e.g. Twitter, Facebook), 
which might promote engagement. The results of the pilot-testing (Chapter 6) suggest that 
online / virtual formats might be increasingly appropriate for clinical settings. The breast 
care team that were involved in the pilot-testing no longer send out appointment letters to 
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their new patients (i.e. patients who have received a referral from a general practitioner / 
identified via the national cancer screening programme); a call is made to the patient to 
arrange the appointment. Further, several other teams in the Cardiff and Vale University 
Health Board send appointments to existing patients via short messaging services. This 
move to paperless appointment management signals a move towards more cost-effective and 
efficient online formats. However, any further development of the booklet should involve 
patient and public representatives to ensure that the products created are accessible, useable, 
and that they address patients’ needs.  
Pre-testing with hard to reach groups 
Clinician and patient feedback from the pre-testing (Chapter 5) indicated that certain patient 
groups might be harder to engage than others. This might include the elderly, ill or 
vulnerable patients, and patients from poorer backgrounds. It was acknowledged in the 
discussion section of Chapter 5 that the pre-testing sample might be biased to include more 
motivated and engaged patients. As such, there is scope to conduct further pre-testing with 
individuals who represent the groups above. This would allow us to determine if the booklet 
has the same impact on these groups as it did with the sample of patients included in the 
pre-testing, or whether there are specific factors that need to be considered. This could then 
be used to refine / re-develop the booklet, and it would provide specific insight into the 
barriers / facilitators that are most significant within these patient populations, which could 
also contribute to and validate the taxonomy of patient-reported barriers.   
Public health campaign 
Pre-testing feedback established that a targeted approach was essential, whereby the booklet 
was delivered to people who had healthcare appointments, or who would be facing 
treatment decisions. This ensured that the messages conveyed in the booklet were relevant to 
patients. However, many participants (public users and professionals) felt that there was 
scope to complement the targeted approach with a broader public health campaign. The 
focus for a broader campaign should be on developing interactional health literacy;(44)this 
would encourage the development of advanced cognitive and literacy skills so that people 
can use the knowledge acquired to actively participate in the SDM process. This is opposed 
to functional health literacy, where the focus is on transmission of factual information e.g. 
about choices and outcomes.  
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A public health campaign would have broader reach than the targeted approach, as it would 
be delivered to patients attending clinical appointments and to the general public.  There is 
scope to work with organisations such as Public Health Wales or the 1000 Lives Plus 
National Improvement Programme (Wales), to develop a ‘Your Health, Your Choice’ 
campaign. Again, an advisory panel, consisting of patient / public representatives, clinicians, 
and organisational representatives, would be essential to guide the development and 
implementation of this campaign. Further, Health Literacy models, such the Optimising 
Health Literacy (Ophelia) Process, should be considered during development to ensure that 
the health literacy strengths and weaknesses of the target population are understood.(183)  
Targeting children and young people  
One of the key patient-perceived barriers to involvement in SDM, identified in Chapter 2, is 
perceived norms about the patient role. Many patients feel that they cannot, or should not, 
be involved in decision-making, and that they should be passive recipients of care. These 
beliefs are long engrained in many patients, especially those of older age groups. They are 
likely to be the result of many years of interactions with paternalistic orientated clinicians, 
and the belief that ‘doctor knows best’. It was suggested during the pre-testing interviews 
(Chapter 5) that children might be an appropriate target group for the ‘Your Health, Your 
Choice’ intervention. These ‘patients of the future’ could be targeted before they transition 
as independent adult patients into the healthcare system. It would be easier to shape peoples’ 
perceptions about the ‘normal’ patient role, than to change attitudes once they are formed. 
The intervention could be developed as part of a school-based programme and developed as 
a broader health literacy intervention e.g. integrated into the Personal, Social, Health and 
Economic (PSHE) Education component of the UK National Curriculum.  
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7.3 Evaluation Proposal – cluster randomised controlled trial 
and process evaluation of the ‘Your Health, Your Choice’ 
intervention 
7.3.1 Evaluating complex interventions 
The MRC framework(45) that has been used to guide the development of the ‘Your Health, 
Your Choice’ booklet has four key stages: development (Chapters 2, 3, 4, and 5), feasibility / 
piloting (Chapter 6), evaluation, and implementation. The results of Chapter 6 indicate that 
the intervention has relatively high levels of reach, dose and fidelity, and has the potential to 
change patients’ attitudes towards involvement in healthcare decisions, and thus prepare 
them for SDM. However, pilot-testing could not determine effectiveness of the intervention 
as a before-and-after design was not used, and randomisation did not occur.  It is not in the 
scope of this thesis to conduct a full-scale evaluation, but this chapter concludes by 
presenting a detailed study protocol for the evaluation of the ‘Your Health, Your Choice’ 
intervention.  
Chapter 6 described the feasibility / pilot-testing stage of the ‘Your Health, Your Choice’ 
booklet. As discussed above, the further pilot testing is recommended due to the low sample 
achieved. The next stage in the MRC complex intervention framework is the evaluation 
phase.(45) RCTs are the gold standard for establishing effectiveness of interventions, when 
randomisation is feasible. However, effect sizes do not provide researchers with information 
about the mechanisms of change, or policy makers with information on how an intervention 
might be replicated in their specific context, or whether trial outcomes can be reproduced.  
As such, the study protocol that will be presented will incorporate an evaluation of 
effectiveness and a parallel (further) process evaluation (see Figure 6.1, Chapter 6).(46) The 
process evaluation will build on the one conducted as part of the feasibility testing (Chapter 
6), and will aim to assess fidelity and quality of implementation, explore causal mechanisms, 
and identify contextual factors associated with variation in clinical outcomes.   
In addition to evaluating effectiveness and process, it is important for evaluations to examine 
cost-effectiveness and resource use implications. To date, very few trials of decision support 
interventions or SDM implementation programmes have considered system level 
savings.(184) Some studies have shown that SDM leads to a reduction in uptake of elective 
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procedures,(16) so potential cost savings will be important to consider in an evaluation of 
the intervention.  An economic evaluation will be of interest to policy makers and to health 
service decision makers; however, improvements in system efficiency (e.g. reduced waiting 
times for surgery and faster access to alternative therapies) will also be of benefit to patients.  
In summary, the evaluation should address several key issues. First, it should examine if the 
complex intervention results in improved quality of care (i.e. providing the right care for the 
patient) and outcomes (e.g. quality of life) for patients. Second, it should examine the 
mechanisms of change, the quality and fidelity of intervention implementation, and the 
contextual factors that might influence outcomes. Third, it should consider the cost-
effectiveness of the intervention, and examine the impact on system efficiency. Essentially, 
the evaluation should consider whether the complex intervention has the potential to 
provide ‘prudent healthcare’ to patients; that is effective, efficient, and patient-centred.(185) 
The full-study protocol is outlined below.  
7.3.2 Setting and context 
Several factors need to be considered when selecting a setting for the evaluation of the ‘Your 
Health, Your Choice’ intervention. First, the clinical area and the specific decision point 
chosen need to be preference sensitive i.e. decisions which are appropriate for the SDM 
approach, where there is clinical equipoise over treatment options. Ideally, the evaluation 
setting selected should ensure that there are a large number of patients who are eligible for 
the decision point, and thus the sample. During the pilot-testing phase (Chapter 6), the 
intervention was delivered to women with early stage breast cancer, who were eligible to 
choose mastectomy or lumpectomy with radiation. This yielded a relatively small sample of 
women, as many of the women did not have this choice (e.g. those with breast cancer 
recurrence, co-morbidities). Further, breast cancer treatment decisions tend to be time-
sensitive, and surgical decisions are irreversible. It would be valuable to evaluate the 
intervention in a setting where patients have more time to make decisions, and where they 
can revisit the decision point if necessary e.g. long term conditions.  
Osteoarthritis of the knee affects almost 20% of the UK population aged 45 and over (4.7 
million), with over 90,000 knee replacements carried out in 2012 (an increase of 7.5% from 
2011).(186) Faced with an aging population, this is expected to rise considerably in future, 
reaching 6.4 million people by 2035.(187) Therefore, this patient group is relatively large, and 
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has the potential to yield a large sample. Further, treatment options for joint arthritis are 
preference sensitive,(188) they come with substantial trade-offs between benefits and risks to 
the patient, and a person-centred approach is advocated. Results shows that 20% of knee 
replacement patients are not satisfied, and 10% do not get significant pain relief.(189, 190)  
As such, this would provide an ideal setting to conduct an evaluation of the ‘Your Health, 
Your Choice’ intervention, embedded in a SDM care pathway.  
As discussed previously, many SDM interventions are tested in controlled trial settings, 
rather than real-life settings. Healthcare service designers are keen to involve knee 
osteoarthritis patients in the preference sensitive decision-making process to improve patient 
outcomes. The Aneurin Bevan University Health Board (ABUHB), South East Wales, is 
currently redesigning the orthopaedic care pathway for patients with osteoarthritis of the 
knee. The redesigned pathway is based on the principle of person-centred healthcare, a 
cornerstone of NHS care across the UK and the focus of various government publications 
regarding the NHS.(25, 191, 192) The changes also reflect the policy in Wales to achieve 
‘prudent healthcare’; that is to deliver effective, efficient, patient-centred healthcare.(191) 
With increasing pressures on NHS resources, there are calls for health organisations to 
consider how care can be delivered more cost-effectively, whilst maintaining quality; 
orthopaedics is a key priority area due to the number of patients referred to services 
annually.(187) The ABUHB alone deals with approximately 2,000 new referrals for knee 
surgery every year, and around 50% of these patients undergo knee replacement surgery. The 
ABUHB hope to achieve prudent healthcare, in part, by re-designing services around SDM.   
This proposal aims to capitalise on planned service changes within an organisation that is 
committed to the SDM approach using interventions known to be effective for patient-
based outcomes, and based on learning from large-scale implementation programmes on 
how to implement SDM.(33) The proposed redesign of the orthopaedic knee surgery 
services will change the way in which the service is delivered, and the way in which patients 
interact with the service.  This provides an opportunity to evaluate the intervention in real-
life clinical settings.  
In summary, orthopaedic knee arthritis is an ideal setting for the evaluation for several 
reasons: the scale and impact of the healthcare issues (e.g. number of patients using services); 
the preference sensitive nature of knee arthritis decisions; the broader policy drive to deliver 
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‘prudent healthcare’; the supportive and receptive context; and the ability to capitalise on 
planned service changes, thus providing a more ecologically valid evaluation setting.  
7.3.3 Aims and objectives 
The aims of the study will be to evaluate: 
1. Effects of a SDM pathway for osteoarthritis of the knee on patient outcomes, system 
efficiency, and costs; and 
2. Whether an enhanced SDM pathway (with patient activation element i.e. ‘Your 
Health, Your Choice’ booklet) results in greater benefits  
Based on the work conducted as part of thesis, I proposed that the ‘Your Health, Your 
Choice’ patient activation intervention cannot be used in isolation. The booklet needs to be 
implemented as part of a broader complex intervention, and embedded in a SDM 
implementation pathway. This would also include clinician-targeted interventions (e.g. skills 
training, engagement activities) and information provision interventions that provide patients 
with information about the options available (e.g. patient decision support interventions, 
such as Option Grids).(178) The second aim of the proposed study aims to determine if the 
‘Your Health, Your Choice’ booklet is a necessary (additional) component to result in greater 
benefits. To examine this, we would compare an enhanced SDM pathway (which includes 
the patient activation element), with a standard SDM pathway.  
Principal Outcomes 
a) Quality of life  
b) Conversion to knee surgery for patients presenting to GP with osteoarthritis of the 
knee within one year of referral  
By comparing enhanced SDM with usual care, we aim to establish whether SDM leads to 
improved patient outcomes, including quality of life, improved system efficiency and cost 
savings. To date, RCTs of patient decision support tools have focused on patient reported 
outcomes, such as satisfaction, decisional conflict, and decisional regret.(16) Few trials have 
focused on health and resource outcomes, such as quality of life, or cost-effectiveness.(184) 
As above, I would not expect the patient activation intervention to work in isolation, and it 
should form part of a broader programme of SDM implementation. As such, the principal 
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outcome measures were selected on the basis of the whole intervention, rather than patient 
activation component alone.  
Secondary Outcomes 
Quantitative patient reported outcomes: 
 Patient activation 
 Knowledge of treatment options  
 Patient-reported experience of SDM  
 Decisional regret  
Process evaluation 
 Implementation – the structures, resources and processes through which delivery is 
achieved, and the quantity and quality of what is delivered; 
 Mechanisms of impact – how intervention activities, and participants’ interactions with 
them, trigger change (including patients/clinicians attitudes and perceptions towards 
SDM pathways); 
 Context – consider external factors that might influence the delivery and functioning 
of the intervention 
Economic analysis 
 Of non-surgical health services (e.g. GP visits, physiotherapy, weight loss 
management, joint injections) & surgical appointments 
7.3.4 Study design 
A randomised stepped wedge design will be used to examine the impact of the Enhanced 
SDM pathway. The stepped wedge randomised cluster trial is a novel research study design 
that involves random and sequential crossover of clusters from control to intervention 
phases, until all clusters are exposed. It is a pragmatic design suited to the evaluation of 
service redesign, and associated interventions.(193) 
Key comparisons will be: 
 Enhanced SDM pathway (Group 2b) versus usual care (Group 1) (see Figure 7.1) 
 Enhanced SDM (Group 2b) versus standard SDM (Group 2a) (see Figure 7.2) 
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Usual Care (Group 1) 
The usual care pathway (Group 1 i.e. control) is by/with referral direct from a general 
practitioner (GP) to a consultant orthopaedic surgeon, requesting an opinion about 
suitability for surgery. The ABUHB orthopaedic surgeons do not currently use SDM 
tools and have not undergone SDM training; patients do not currently receive a ‘patient 
activation’ intervention, such as the ‘Your Health, Your Choice’ booklet. Typical waiting 
times in ABUHB are about 6-9 months from referral, and a further 6-9 months on 
waiting lists if surgery is recommended (approximately 50% of patients convert to 
surgery).  
 
SDM Care Pathway (Group 2a) 
The standard SDM (redesigned) pathway includes ‘therapy-led education’ clinics led by 
nurses and physiotherapists in the community, instead of the consultant orthopaedic 
appointment: 
 Led by clinical nurse specialists and physiotherapists who have received SDM 
skills training – general skills and how to deliver the educational / SDM 
interventions 
 Group session for approximately 12 patients 
 Patients given educational materials and the Option Grid(178) for osteoarthritis of 
the knee to facilitate discussion of the different management options, e.g. 
physiotherapy, joint injection, and weight management, and discussion of patients’ 
preferences 
 Opportunity for individual discussion and questions; clinics will be supported by 
‘expert patients’ or representatives from Arthritis UK 
 Outcome of this clinic will be the patient choosing self-management or direct 
access to physiotherapy, joint therapy, or weight management 
 Following the ‘therapy-led education’ clinic, patients can also ask their GPs for a 
referral to an orthopaedic specialist 
 Patients can re-access the clinic if needed to review options and choices. 
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Enhanced SDM Pathway (Group 2b) 
The enhanced SDM pathway is the same as the standard SDM pathway, with the 
addition of the ‘Your Health, Your Choice’ booklet (patient activation intervention). 
The booklet will be sent to patients ahead of their appointment at the ‘therapy-led 
education’ clinics. 
The first comparison will be the redesigned enhanced SDM pathway (Group 2b), against 
usual care (Group 1).  This evaluation will take place in the context of service redesign within 
the ABUHB Neighbourhood Care Networks (NCNs), whereby the new enhanced SDM 
pathway will be rolled out to NCNs sequentially. NCNs are described as collaborative 
networks comprising all Primary Care, health, and social care community providers operating 
with the boundaries of the neighbourhood, who plan and deliver services to districts of 
around 50,000 people- typically six-seven general practices and connected providers.(194) As 
these service changes are already planned and will take place in line with the ABUHB’s roll-
out strategy, a traditional RCT is not feasible. However, a cluster trial and stepped-wedge 
design is suitable (see Figure 7.1), and offers a fair and randomized evaluation. NCNs act as 
a form of a cluster; the stepped-wedge design will roll out the enhanced SDM pathway 
across NCNs in a random order, with a before and after analysis conducted within NCNs. 
Patients in NCNs that are not ‘live’ will be in the control group (Group 1), and will act as 
comparators for those in ‘live’ NCNs.  
The second comparison will be enhanced SDM (Group 2b) and standard SDM (Group 2a). 
This comparison will be at the individual patient level; therefore, a RCT will be embedded 
within the cluster trial (see Figure 7.1). Unlike the ‘therapy-led’ education sessions, which are 
being rolled out across the entire NCN as part of routine service change, it is possible to 
direct the additional patient activation intervention (‘Your Health, Your Choice’) booklet in 
the enhanced SDM arm to individual patients. Therefore, patients in ‘live’ NCNs (i.e. the 
SDM arm of the trial) will be randomized to receive either the enhanced SDM (Group 2b) or 
the standard SDM (Group 2a) pathway (see Figure 7.1 and 7.2). This embedded RCT will 
allow us to examine the potential additional impact (or necessity in order to achieve best 
outcomes) of the patient activation element of the enhanced pathway (i.e. the ‘Your Health, 
Your Choice’ booklet).  
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Figure 7.1 Flowchart of study progress  
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Figure 7.2 Randomised stepped wedge study design overview 
 
 
7.3.5 Sample and recruitment  
We will evaluate redesigned services within the ABUHB’s twelve NCNs. The ABUHB 
(South East Wales) serves several local authorities, many of which have high levels of 
deprivation; according to the Welsh Index of Multiple Deprivation, Blaenau Gwent has the 
highest proportion of local areas in the most deprived 10 per cent in Wales (23.4%).(195) 
Between two and four NCNs will initiate the new service. The remaining 8-10 NCNs will 
initially continue usual care, thus acting as comparators (control group). The stepped wedged 
design will add NCNs to the intervention group in a randomised sequence. 
All patients with osteoarthritis of the knee judged by their GP as requiring referral to 
orthopaedics will be eligible. Once GPs have made a referral, a clerical officer working in 
ABUHB’s referral team will identify patients. Patients who are referred within an 
intervention NCN (Group 2a and Group 2b) will be contacted to ask them to consent to 
provide data to the study and consent to randomization. Consenting patients will be 
randomized to the standard SDM pathway (Group 2b) or to the enhanced SDM pathway 
(enhanced SDM). Non-consenting patients will be referred to the standard SDM clinic. 
NCN	Cluster 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
1 T
T1/	
T2 T3
2 T
T1/	
T2 T3
3 T
T1/	
T2 T3
4 T
T1/	
T2 T3
5 T
T1/	
T2 T3
6 T
T1/	
T2 T3
7 T
T1/	
T2 T3
8 T
T1/	
T2 T3
9 T
T1/	
T2 T3
10 T
T1/	
T2 T3
11 T
T1/	
T2 T3
12 T
T1/	
T2 T3
Control	Period Intervention	Period
T	=	SDM	+	new	clinic	training	for	Primary	Care	Nurse	&	physiotherapist	(plus	others	responsible	for	delivering	pathway) 	
T1	=	delivered	at	point	of	referal	from	GP	(Knowledge,	PAM,	QoL)
T2		=delivered	after	SDM	clinic	/	specialist	appointment	(Knowledge,	PAM,	QoL,	CollaboRATE)
T3	=	delivered	12	month	post	intervetion	(after	treatment)	(Knowledge,	PAM,	QoL,	Regret,	Resouce	Use)
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Control NCN patients will receive usual care (appointment with orthopaedic specialist), but 
will be contacted to consent to provide data to the study.   
7.3.6 Outcome measures 
The outcome measures that will be used are outlined below. Three key time points will be 
used during the evaluation: T1 = baseline; T2 = Post-intervention; T3 = 12-month follow-
up. 
Principal outcome measures 
a) Quality of Life (QoL) 
Specific QoL measured using the Oxford Knee Score(196) and generic QoL 
measured using EQ-5D-5L health index.(197)  
T1/2/3 
b) Conversion to knee surgery for patients with osteoarthritis of the knee within one year of referral 
Available from routinely collected data – Secure Anonymised Information Linkage 
(SAIL) Databank(198) 
Secondary Outcome Measures 
Quantitative 
 Patient activation 
Measured using the 13-item Patient Activation Measure (PAM)(199) 
T1/2/3 
 Knowledge 
Assessed by knowledge of treatment options questionnaire (based on information 
provided by the Option Grid)(178) Questionnaire available from previous study(200)  
T1/2/3 
 Patient reported experience of SDM 
Measured using a short 3-item post intervention CollaboRATE questionnaire(174) 
T2 
 Decisional regret 
Measured using the 5-item Decisional Regret Scale(201)  
T3 
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Process Evaluation 
 Implementation  
Clinicians delivering the redesigned pathway will be trained in SDM and they will 
receive training on how. A researcher will observe a limited number of selected 
sessions using a fidelity checklist to assess if the intervention was delivered as 
planned, the clinician’s SDM communication skills, whether patients’ preferences are 
considered during the clinics, and process issues. We will also examine reach 
(whether the intended audience came into contact with the intervention and how) 
and dose (the quantity of the intervention implemented e.g. whether patients read the 
entire booklet).  
 Mechanisms of impact 
Patients’ perceptions and attitudes towards the different care pathways 
Interviews will be conducted with patients in the intervention groups as part of a 
process evaluation (approximately 20 interviews). These will take place in the 
patients’ homes, within 2 weeks of them attending the clinic. These audio-recorded 
interviews will explore participants’ perceptions of the SDM pathway e.g. informed 
decision-making, level of involvement, whether preferences were explored, 
expectations of care, attitudes towards healthcare professional conducting 
appointment, experience of intervention. We will also interview some patients from 
the control groups to understand and describe usual care. Data will be thematically 
analysed to identify emerging themes.(177) 
Clinicians’ attitudes towards the SDM pathways 
Interviews will be conducted with all of the clinicians who deliver the intervention 
pathway (enhanced and standard). This will include clinicians who deliver the 
intervention clinics, and the consultants who deal with referrals from the 
intervention clinics (expected to be between eight-12 clinicians). We will explore 
perceptions of the redesigned pathway, strengths and weakness of the intervention, 
and process / delivery issues. Data will be thematically analysed to identify emerging 
themes.(177)  
 Context 
Throughout the process evaluation, any external factors that might impede or 
strengthen the effects of the intervention, or the way in which it is implemented, will 
be considered. Factors might include readiness or ability to change, organisational 
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norms, or the fact that the intervention is being delivered as part of planned, and 
resourced, service changes, which reflect the organisation’s remit and targets. It will 
be important to consider if any external factors might have an impact on the 
replication of the intervention (process and outcomes). An understanding of the 
planned service change protocol will be key, and all documents (e.g. protocols, 
meeting minutes, project reports) will be examined. Interviews will also be conducted 
with clinicians who deliver the intervention, administrative teams involved in the 
implementation of the redesigned pathway, and with other key stakeholders (e.g. 
ABUHB service planners). Framework analysis(176) will be conducted using core 
constructs of the Normalization Process Theory (NPT).(202) NPT proposes that 
‘complex interventions become routinely embedded (implemented and integrated) as 
the result of people working, individually and collectively, to implement them’.(35, 
203) This theory provides an ideal frame for understanding contextual factors.  
 
Economic analysis 
The economic analysis will include two separate components, it will determine the cost of 
delivering and implementing the intervention pathways and it will assess the NHS resource 
use (or savings) of patients in the intervention and control arms of the study. These will be 
combined and measured against the primary outcome measure to a) inform a cost-
effectiveness analysis and b) against Quality –Adjusted Life Years to inform a cost utility 
analysis. An experienced health economist with experience in evaluation of complex 
interventions would be required to advise and support this economic analysis.  
7.3.7 Sample size 
Group 2 vs. Group 1 
The study is based in the ABUHB NCNs. To my knowledge there are no data on intra-NCN 
correlation coefficients for the proportion of knee surgery referrals who receive surgery. As 
few such intra-cluster correlation coefficients (ICCCs) exceed 0.02, I conservatively base the 
estimated power on an ICCC of 0.02. To yield 80% power to detect differences of 15% in 
surgery rates between post-intervention and pre-intervention NCNs with a significance level 
of 5% requires an effective sample of 366. Hence I need to recruit a total sample of 920 [366 
multiplied by 2.513, namely 1 + (920 / 12 – 1) x 0.02] to allow for clustering. To allow for 
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losses to follow-up by routine data, the target sample is 80 participants per NCN (960). As 
we shall analyse the stepped wedge design by time series analysis, effectively treating each 
cluster as its own control, this estimate is even more conservative. Allowing for losses to 
follow-up by participant-reported questionnaires of 25%, we estimate that this design will 
have 80% power to detect a ‘small’ effect size of 0.31 in Oxford Knee Score or EQ-5D-5L; 
because an ICCC of 0.02 is even less likely for participant-reported outcomes than for 
surgery rates, this is also conservative. 
Group 2b vs. Group 2a 
We shall randomise individual patients between enhanced and standard SDM. As this will 
reduce ICCCs to zero, the sample of 480 participants so randomised will yield analysable 
samples of 460 for surgery rates and 360 for patient-reported outcomes; and thus more than 
80% power to detect differences between enhanced and standard groups of 15% in surgery 
rates and effect sizes of 0.3 in participant-reported outcomes. 
7.3.8 Proposed study team 
To ensure that the study is effectively managed and conducted, the correct team needs to be 
in place, covering the key areas of expertise. The proposed study is a cluster randomised 
controlled trial and a process evaluation. Therefore, a clinical trials unit should be involved 
to support trial methodology, and to manage, monitor, and analyse trial data. The trial 
includes an economic evaluation; therefore the trial team should include an experienced 
health economist, ideally with experience of evaluating complex interventions. An 
experienced qualitative researcher should be consulted for the qualitative elements of the 
study e.g. patient / clinician interviews analysis, NPT framework analysis, observations. 
Researchers with experience of implementation research and methodology should guide the 
process evaluation elements of the study. Patient and public representatives should form part 
of the core study team, and should also be involved in the early study design phase. Key 
ABUHB stakeholders involved in the service redesign should be consulted during the study 
design phase, and included in the core study team. Currently, this would include the 
Assistant Medical Director, the Primary Care Clinical Director, who is coordinating the 
planned services changes to the orthopaedic pathway, and clinical team members who will be 
delivering the new service.  
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7.3.9 Expected outputs and next steps 
This research aims to assess whether a SDM pathway can improve patient-reported and also 
health outcomes, and service efficiency. I would expect the findings of the evaluation to 
show that SDM results in improved outcomes for patients including, quality of life, 
knowledge about condition and treatments, experience of decision-making, increased 
activation, and reduced decisional regret. It is hypothesised that the patient activation 
intervention is a necessary component for additional benefits.  
Currently, there is little evidence regarding the impact of SDM on health outcomes and cost-
effectiveness, the effects of SDM in routine healthcare settings, or the added value of patient 
activation interventions (Group 2b) in achieving greater benefits from SDM interventions. It 
is likely that the results of this process evaluation could influence how SDM programmes are 
implemented and evaluated in future. More broadly, I could expect the results of this study 
to benefit planners of services for knee arthritis across Wales and the UK. Findings will be 
shared with the ABUHB and the Planned Care Strategy Group (Welsh Government), who 
are initiating the planned service changes to the orthopaedic pathway, so they can extend the 
SDM intervention to other services. I expect the SDM pathway to result in fewer but more 
appropriate patients being referred to consultants, thus fewer undergoing surgery but sooner; 
and to enable patients who do not choose surgery to receive alternative treatments sooner. If 
the SDM intervention is effective, similar interventions should be implemented and 
evaluated for other preference-sensitive conditions, especially surgical. 
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Chapter 8 
General Discussion 
The studies described in this thesis aimed to assess patient-reported barriers and facilitators 
to SDM in order to develop and pilot-test a theory-based intervention, which aims to 
prepare patients to participate in SDM. This final chapter of the thesis presents an overview 
of the principal findings, discusses the strengths and weakness of the methodological 
approach, and considers implications for future implementation of SDM.  
8.1 Knowledge is not power for patients – the importance of 
patient-reported barriers to SDM implementation 
Recent efforts to implement SDM into routine clinical settings have tended to neglect 
patient-reported barriers and facilitators to participation. The focus has been on designing 
decision support tools for knowledge transfer, understanding and overcoming clinician-
perceived barriers to implementation, and achieving clinician and healthcare organisation 
engagement. This oversight could be due to researchers and implementation scientists 
underestimating the importance of patient-reported factors, but it is more likely that this 
knowledge was not easily accessible and synthesised in a way that could usefully guide 
implementation attempts. In contrast, two iterations of a systematic review of clinician-
reported barriers have been available to guide implementation programmes since 2006.(57, 
204) The aim of Chapter 2 was to systematically review the literature to identify patient-
reported barriers and facilitators to SDM, and to synthesise these data into a practical 
taxonomy that could be used to guide intervention development and implementation.  
My results showed that patients need knowledge and power to participate in SDM, and they 
highlight the significance of perceived power imbalances in the clinical encounter. The old 
adage that ‘doctor knows best’ is still very much prevalent and engrained in the minds of 
current patients, old and young. To date, researchers have focused on addressing part of the 
knowledge barrier (i.e. adequate information provision). However, my results show that 
knowledge provision alone is unlikely to encourage SDM for the majority of patients: 
perceived power imbalances and perceived acceptability of patient involvement in healthcare 
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decisions must also be addressed. Significantly, the patient-reported barriers identified in 
Chapter 2 contrast with existing literature on clinician-reported barriers, whereby clinicians 
perceive patients not wanting SDM as a key barrier.(57) The results of this thesis have shown 
that most patients feel that they cannot participate, rather than the more common view 
among clinicians that patients won’t participate because they don’t want to. Again, this 
demonstrates the importance of also considering patient-reported barriers during SDM 
implementation, and the significance of clinicians’ attitudes. ‘Collaborative deliberation’ 
between patients and clinicians will rest upon a foundation of constructive interpersonal 
engagement, an invitation from the clinician to participate, and the support to do so.(205) 
Referring back to the ‘activated’ cancer patient in Chapter 2, Mr Schneider, he felt that 
‘medicine could tell us the numbers – probabilities – but to make the choice is the patient’s 
right.’ To achieve SDM in routine clinical practice, we need to develop interventions that 
help patients believe that they can, should and would be involved; that it is their right to be 
involved in decisions about their healthcare.  
Chapter 3 found that existing interventions designed to prepare patients for SDM do not 
comprehensively address the key patient-reported attitudinal barriers to participation, and 
the majority were not theoretically grounded, thus making it difficult to understand 
mechanisms of change. Overall, the theoretical work of this thesis found that overcoming 
‘white coat silence’ is one of the key challenges to successful SDM implementation, and that 
there was scope to develop an intervention that more comprehensively addressed patient-
reported barriers to SDM. The systematic review conducted during Chapter 2 advances the 
field by describing a taxonomy of key patient-reported barriers and facilitators that need to 
be considered during SDM intervention design and implementation, in conjunction with 
clinician-reported barriers and organisational factors.  
8.2 ‘Actions speak louder than words’ - the significance of past 
experiences 
The theory-guided process outlined in Chapter 4 led to the development of the ‘Your 
Health, Your Choice’ intervention. The systematic four-step BCW approach combined 
theory and empirical research to ensure that the key barriers and drivers of behaviour 
identified in Chapter 2 were addressed by the intervention, those being: knowledge; 
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professional role and identity; beliefs about capabilities; beliefs about consequences; and 
social influences. Chapter 5 focused on pre-testing the prototype intervention with lay users, 
clinicians, and local healthcare organisation representatives, using a qualitative interview 
method. Respondents were positive about the booklet’s design and format, and the booklet 
appeared to be addressing key patient attitudinal barriers to participating in SDM, identified 
in Chapter 2. Chapter 6 built on the work of the pre-testing phase by pilot-testing the 
intervention using a process evaluation method, with real patients in a routine NHS setting. 
This allowed for a more ecologically valid view of how this intervention might translate into 
real practice. Patients who were referred to the Cardiff and Vale University Health Board 
Breast Care Centre were sent the intervention prior to their initial appointment, and a sample 
was also recruited for qualitative interviews. The patient group was also generally positive 
about the booklet’s design and format, and the results indicate relatively high levels of reach 
(all of the intended target audience came into contact with it before their appointment), dose 
(the quantity of the booklet that was read by the patients), and fidelity (used as intended, by 
patients), especially among the less ‘activated’ patients.  
The preliminary pilot-testing also found that the ‘Your Health, Your Choice’ booklet has 
potential to change patients’ attitudes towards involvement in healthcare decisions, and thus 
prepare them for SDM. However, the results also highlighted the significance of contextual 
factors, such as patients’ negative past experiences, and the impact this can have on the 
potential effectiveness of the booklet. Compared to the lay user and clinician / organisation 
representative groups, the patient group was far more pessimistic about SDM becoming a 
reality. The booklet helped these patients to know that they had choices available and to 
believe and accept that it is part of the patient role to take part in healthcare decision-
making, but it had less impact on helping these patients to believe that clinicians actually 
want this. It appears that the booklet has adequately addressed the ‘knowledge of choice’ 
‘acceptability of patient involvement’ barrier frequently cited by patients, but it has not 
adequately addressed ‘social influences’, such as perceived social norms about clinicians’ 
attitudes towards patient involvement.  
Fundamentally, negative past experiences with clinicians and the care system stick, and they 
trump the booklet’s message that clinicians value patients’ input. The pilot-testing patients 
reported various accounts of previous inappropriate care (e.g. wrong diagnosis), inadequate 
care processes (e.g. very long delays to see a specialist), and poor interactions with negative 
clinicians, and these experiences were only from a very small sample of eight patients. They 
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are also very aware of the time pressures faced by the clinicians, and the NHS more broadly, 
and this pressure translates to their own behaviour in a consultation e.g. not asking questions 
because of the amount of people in the waiting room. One patient, with vast experience of 
healthcare interactions, even went as far to say that the booklet was ‘NHS propaganda that 
just won’t happen in reality’, and it just served to ‘highlight the void between theory and 
practice’.  When patients do have accounts of negative experiences, it is unsurprising that 
they have priorities other than becoming more involved in their healthcare decisions. In the 
list of top ten patient complaints published by the Patients Association, they broadly relate to 
problems with access, waiting times, and clinicians’ attitudes.(206) The cost of healthcare, or 
lack of resources to provide the NHS, waiting times, and patient safety errors dominate the 
media messages portrayed to patients. A quick scan of the UK online health news for one 
specific day identified the following headlines:  
 
‘Health Board vows 
immediate action after waiting 
time targets missed’  
‘Care Quality 
Commission: three in four 
hospitals failing’  
‘Overseas NHS nurses: 
restrictions lifted amid 
widespread shortages’ 
‘NHS faces biggest financial 
crisis in decades’ 
‘Waiting times hit new 
high’ 
‘Action demanded on 
weekend NHS risk’ 
‘Safety is ‘big concern’ in 
NHS and care’ 
‘7-day GP opening 
unachievable’  
‘Doctor’s Chief warns of 
NHS collapse this winter’ 
 
When patients are presented with these messages on a day-to-day basis, it is unsurprising 
that their safety (which includes staying alive), waiting times, and access to clinicians who are 
not ‘rude’ is much more important than greater engagement with clinicians; as discussed in 
the pilot-testing chapter, any engagement is perceived as better than no engagement for those 
patients who have waited a considerable amount of time to see a specialist. Face-to-face 
communication in healthcare, and other sectors, is at a premium, and patients are acutely 
aware of this. There is a constant drive to move away from these types of interactions 
towards systems that can save time and resources e.g. online repeat prescriptions, self-service 
check-in at GP surgeries, and telephone consultations. When patients are faced with systems 
that discourage interaction and dialogue, it is difficult to also convey the message that 
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healthcare organisations want to encourage dialogue between clinicians and patients about 
healthcare choices. Patients are overwhelmed with the message that the NHS does not have 
enough money, staff or resources to provide safe and / or timely care. Rarely are patients 
presented with the message that the NHS would like them to become more involved in a 
discussion with their GP / nurse / consultant etc.  
If we consider access to medical records, this is also an area where patients might be 
receiving mixed messages. Patient access to medical records remains, on the whole, a limited, 
complex, and sometimes costly process in the UK, although there is some indication of 
change in the US with innovations such as the OpenNotes initiative.(207) On the one hand 
we are trying to reassure patients that clinicians want them to be involved, they are the 
‘experts in their own lives’, and patients should be involved in important decisions about 
their healthcare, which could include surgical and medical treatments. On the other hand, 
information about their eventual choices and outcomes is extremely limited and difficult to 
access. A recent survey on SERMO (a social networking site for doctors) asked members 
‘should patients have access to their entire medical record – including notes, any recordings, 
etc.?’ Two thirds of the respondents were reluctant to share health data with their patients, 
and 17% were completely opposed to the idea. One doctor from the United States stated ‘the 
records remain private property of the physician who generated it for the care of the patient. If the patient 
doesn’t like that fact then they can go elsewhere.’(208) Similar debates have arisen regarding patients’ 
rights to audio-record their consultations;(209, 210) the negative response from some 
doctors suggests that information exchanged within the clinical encounter is somehow owned 
by the clinician, and such requests question the clinician’s integrity. Considering all of the 
above, it is not surprising that the patients interviewed during pilot-testing are sceptical about 
the feasibility of SDM in routine care, and it is likely that other patients will also feel the 
same. That said, it does not mean that these priorities are not changeable; a discrete choice 
experience found that patients who are exposed to SDM place a higher valuation on it than 
those who are not (by randomisation).(124) The challenge is making sure that patients 
experience SDM in the first place.  
Again, referring back to Mr Schneider the cancer patient, I stated he could be the ‘ideal’ 
SDM patient, as he believes that it is a patient’s right to be involved, and understands the 
importance of patients’ personal preferences in the decision–making process. However, the 
fact that he refers to himself as the ‘Patient from Hell’ in his book title also suggests that he 
believes that he is going ‘against the grain’, in some way, and that his behaviour is not 
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supported by some clinicians. If an activation intervention is used in isolation, it is likely that 
we will only change patients’ expectations of what they should receive, but we will leave more 
patients perceiving that they are ‘patients from hell’ for wanting to become more involved. 
Of course, the potential negative implications of patients using the ‘Your Health, Your 
Choice’ intervention must be considered. Whilst the aim is to promote positive attitudes 
towards SDM and to encourage patients to become more engaged, in situations where 
patients are faced with disempowering clinicians, they might believe that the intervention 
‘falsely’ reassured them in some way, which in turn might have a detrimental impact on their 
future beliefs and feelings of self-efficacy. I recommend that the booklet be used in 
conjunction with supportive clinicians with the appropriate skills, and in a receptive and 
supportive healthcare environment. However, even in this setting, there is no way to 
guarantee the receptiveness of every clinician. As such, in future iterations of the 
intervention, it might be more appropriate, and honest, to soften some of the key messages 
presented in the intervention e.g. by using sentences such as ‘most’ healthcare professionals 
welcome patients’ involvement.  
8.3 A ‘SDM bundle’ – patient activation will not work alone 
It was clear from Chapter 2 that social influences and the perceived power imbalance 
between patient and clinician were significant factors affecting participation in SDM, and the 
pilot-testing with patients in Chapter 6 highlighted just how significant these barriers are, 
although this was a small sample. These barriers especially pronounced when the patient has 
experience of inadequate care, poor care processes, and negative interactions with clinicians. 
Pilot-testing revealed that the ‘Your Health, Your Choice’ booklet is a good place to start 
preparing and activating patients, but preparation to participate must be followed by 
enablement, and delivered as one component intervention as part of a broader ‘SDM 
bundle’: several interventions / practices that when performed collectively and reliably, have 
the potential to improve SDM outcomes for patients. Preliminary results indicate that ‘Your 
Health, Your Choice’ could be useful for signalling that healthcare choices do exist, 
providing a rationale for patient choice, and changing patients’ attitudes towards the 
perceived acceptability of the active patient role in healthcare decision-making. However, it 
might have less impact on changing patients’ attitudes about whether clinicians and 
healthcare organisations want them to become more involved (or social influences). For 
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patients, especially those with negative past experiences, actions will speak louder than 
words. Positive attitudes towards SDM and evidence of SDM behaviours amongst clinicians 
delivering patients’ care will be key to reinforcing the messages delivered in the booklet: that 
patients should be involved, they can be involved, and clinicians want them involved. I 
acknowledge that clinicians will not be able to change the experience of every patient, 
especially those who still believe it is not part of the patients’ role, but they should try to 
make it easier and safer for patients to feel included and respected when they want to be 
involved.   
More broadly, preparation for and enablement to do SDM needs to be delivered in an 
organisational culture that overtly supports the approach. Contextual factors that support 
successful improvement and sustainability of quality in healthcare organisations have been 
synthesised in a recent review published by The Health Foundation.(211) ‘Quality and 
coherence of policy’ and ‘supportive organisational culture’ are two of the most important 
contextual factors at the meso level. This would include, for example, aligning the 
organisational objectives of delivering SDM with SDM human resource and training 
strategies that ensure the workforce is skilled, and the degree to which SDM is viewed and 
emphasised (possibly rewarded) as an organisational priority. It should be acknowledged that 
structural change, such as introducing patient choice and SDM, also requires psychological 
change (cultural change among patients, clinicians and the organisation). The Model for 
Understanding Success in Quality (MUSIC) also proposes that senior management support 
and organisational culture (i.e. values, beliefs and norms present in the microsystem) are key 
aspects of context that can influence successful quality improvement.(212) Fundamentally, if 
attempts to prepare and enable patients to do SDM are not embedded in a supportive 
organisation, they are unlikely to be successful.   
This thesis has highlighted the significance of patients’ perceptions about clinicians’ beliefs 
and healthcare organisations’ practices. If we want every patient to feel that they want to 
become more involved and that they are able to become more involved, implementation 
scientists will need to think more broadly than local clinical team and hospital level, and 
drive these messages from a public health angle using mass media. The ‘#hello my name is’ 
campaign is one example of a successful mass social media campaign.(40) The campaign was 
started by a clinician with terminal cancer, who made the stark observation that most staff 
looking after her did not introduce themselves before delivering care. It aims to improve the 
relationship and human connection between clinician and patient, build trust, and promote 
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passionate care. Raising awareness that patient involvement is supported by the healthcare 
organisation is key for successful SDM, and mass media (including social media) campaigns 
have wide exposure and can increase awareness quickly and effectively.  This might go some 
way to counteracting the negative mass media messages that patients are more familiar with. 
Fundamentally, successful and sustainable implementation of routine SDM in healthcare 
rests upon two types of cultural change, which is a momentous challenge: cultural change 
amongst many clinicians and the healthcare organisation, and cultural change amongst 
patients, whereby both groups have their own values, goals, perceived roles, experiences, 
attitudes and assumptions. Given the challenges of cultural change, implementation 
researchers may want to focus their attention on ‘moulding’ attitudes and behaviours at the 
‘grass roots’ level, rather than ‘changing’ them: it is difficult to turn a big ship, but it can be 
set on a different course for future generations. Embedding SDM into the undergraduate 
medical and nursing curriculum, and junior doctor and inter-professional training is essential. 
A receptive culture will only truly exist if clinicians see SDM as usual practice and as a 
fundamental component of safe and effective healthcare for patients, not as an optional style 
of communication if they have the time. A number of successful local improvement 
initiatives have been targeted at and driven by junior doctors, including the ‘Ask 1 Question’ 
campaign. It simply involves asking a patient ‘what can I do for you today’, with the goal of 
improving care at the bedside and understanding the patient’s daily goals.(213) Adolescents, 
children, and pregnant women, or ‘patients of the future’, would also be an ideal target 
audience for SDM interventions, as they are learning to interact with and navigate the 
healthcare system. It might be easier to shape perceptions about appropriate behaviour in a 
healthcare consultation before they have had experience of them, especially negative 
experiences.  
8.4 Methodological strengths and weaknesses 
8.4.1 Patient-reported taxonomy and review of interventions 
The first key step in developing a complex intervention is to understand the existing 
evidence base. Two comprehensive literature reviews were conducted as part of this thesis, 
which provide a sound evidence base for intervention development: a systematic review and 
a literature review. The systematic review identified and described patient-reported barriers 
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and facilitators to patient involvement in healthcare decisions. To my knowledge, this is the 
first systematic review to focus exclusively on patient-reported barriers and facilitators to 
SDM, and direct enquiry with patients in the primary studies is a significant strength of this 
study. The results from 44 studies were synthesised to produce a taxonomy that guided the 
development of the intervention, ensuring it was based on empirical evidence. The literature 
review identified and critically evaluated existing interventions that aim to prepare patients to 
participate in SDM. The identified interventions were evaluated against the patient-reported 
barriers and facilitators identified in Chapter 2, thus allowing me to make a reasonable 
judgment about the need for a new intervention. I have acknowledged that new 
interventions were identified after the review was conducted (August 2013), but examination 
of these found that they would not change the results of the literature review, and there was 
still scope to develop a more comprehensive intervention that addressed the key barriers 
identified in Chapter 2.  
8.4.2 MRC framework and BCW approach to intervention design and 
testing 
The ‘Your Health, Your Choice’ intervention was developed using an accepted and robust 
framework for developing complex interventions.(45) The MRC framework ensured that the 
intervention was developed systematically, using the best available evidence, and appropriate 
theory.  Behaviour change interventions tend to be more effective if they are based on 
evidence-based principles of behaviour change (theoretically grounded).(161) With this in 
mind, a theory-based intervention was developed using the Behaviour Change Wheel (BCW) 
Guide(47) To my knowledge, this theory has not previously been used to develop SDM 
interventions, and thus offers a novel approach in this field of research. Various alternative 
behaviour change theories exist, and could have been used for the development of the 
intervention. For instance, the Health Belief Model(214) could have provided some insight 
into the peoples’ beliefs about active patient involvement, their perceived benefits of this 
approach, their perceived barriers to involvement, and the impact of self-efficacy on their 
ability to enact the behaviour. However, the danger of selecting one or two theoretical 
approaches to guide intervention development is the possibility of missing the full range of 
possible influences, and key determinants of behaviour not being addressed by the 
intervention. This is especially important given the different barriers reported by patients in 
Chapter 2, and the significance of social influences. Therefore, the BCW guide was chosen 
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to guide the theoretical development of the intervention. The BCW is an integrated 
behaviour change framework, which combined 33 different behaviour change theories, and 
128 theoretical constructs of behaviour change. The origins of the framework are in clinical 
implementation settings, which is also suitable for this thesis as the intervention was pilot-
tested in a routine breast care setting. The systematic four-step approach combined theory 
and empirical research to select intervention components, moving through a process of 
identifying target behaviours, mapping barriers / facilitators to theoretical domains, selecting 
behaviour change techniques, and developing the intervention. The BCW allowed me to 
design an intervention that addressed the key barriers identified, and it also provided a 
framework for understanding potential mechanisms of change during the pilot-testing.  
8.4.3 Intervention testing methods 
The pre-testing process (Chapter 5) included members of the general public, clinicians, and 
health board representatives; this ensured that feedback was sought from all parties who 
would eventually be involved the implementation of the booklet. The clinician sample 
consisted of nurses who are currently involved in a large-scale SDM implementation 
programme, and individuals whose role focused on the improvement in patient care. The 
user group who volunteered to take part in the interviews (convenience sample) are probably 
quite motivated individuals. Therefore, it is important to consider that the pre-testing was 
conducted with individuals who are likely to be more receptive to the SDM approach, and 
the user-group may be more ‘activated’ than the general population.  
Qualitative interviews were chosen for pre-testing and pilot-testing, and this allowed for 
detailed understanding of causal mechanisms and the potential impact of the booklet on 
patients’ attitudes. However, this method also relied on self-reported use of the intervention, 
which may not provide an accurate representation of reach, dose, fidelity, or respondents’ 
actual beliefs. In the one-to-one interview setting, respondents might have provided socially 
acceptable answers that did not represent how they felt about the booklet, or the true impact 
of the booklet on their attitudes, especially if they knew what the purpose of the booklet was 
and if they perceived that the interviewer developed the booklet. They might have wanted to 
appear engaged in the booklet, and reported that they read more than they did. Further, 
whilst every effort was made to remain neutral and to use the semi-structured interview 
questions to guide discussions, that fact that I have been heavily involved in the 
development of the booklet might have led to some moderator bias.  
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Think-aloud techniques might be more useful in future work as it will guarantee that the 
patients have used the booklet in the way that is intended, and it would help to understand 
patients’ cognitive processes as they read the key messages. The ‘think-aloud’ method is 
commonly used for usability testing, and involves participants thinking aloud as they 
perform a task. This approach would allow better insight into how users of the booklet 
interpret and respond to it, and analysis of this data could feed into iterative development of 
the intervention. An independent researcher who makes it clear that they have not been 
involved in the development of the booklet would also be beneficial for future testing. 
Clearly, the pilot-testing stage was not a before and after trial. It is therefore difficult to know 
what patients thought beforehand, and whether the booklet did change patients’ attitudes. 
Self-reports from patients are a useful indicator of change, but future testing would need to 
consider patients’ beliefs before and after exposure to the intervention, in order to make 
more concrete judgments about the booklet’s effectiveness. It should be noted that the 
sample consists only of females, which might limit the generalizability of the findings; further 
work must test the booklet in settings with higher proportions of male patients to determine 
if there are unique contextual factors that might influence booklet implementation and 
effectiveness. It was not feasible to conduct a full-scale evaluation of the ‘Your Health, Your 
Choice’ booklet as part of this thesis, which would address some of the weaknesses listed 
above. However, clear plans for further work, including a cluster-randomised trial and 
process evaluation, are detailed in Chapter 7. 
8.4.4 Implementation setting – ‘research fatigue’ 
The ‘Your Health, Your Choice’ intervention is based on a clear analysis of need, it has a 
strong theoretical basis, and the development and testing process was guided by well-
established methods. However, a significant weakness of this thesis has been the ability to 
effectively pilot-test the intervention in a real-life clinical setting with a sufficient sample of 
patients. As discussed throughout the thesis, I would not expect the ‘Your Health, Your 
Choice’ intervention to work in isolation, it would only work in combination with 
complementary SDM processes. It needed to be embedded within a team that agreed with 
the principle of SDM, who were receptive to their patients becoming more involved, and 
who had the necessary SDM skills to support the patient through the decision making 
process. The team might also use decision support interventions to assist with knowledge 
transfer of treatment options, and to support the deliberation process. Fortunately, the 
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research team where I am based in Cardiff University have worked very closely with the 
Cardiff and Vale Breast Care Centre over the last five years on an ongoing SDM 
implementation programme. The Breast Care Centre is supportive of SDM, team members 
have attended skills training workshops, they were involved in the development and testing 
of SDM interventions, and they have embedded a decision support tool(178) and routine 
decision quality measurement into their care pathway.  On paper, this team offered an ideal 
scenario for embedding a new SDM intervention, which complemented the wider SDM 
practices. However, a number of factors might have impacted on the ability to obtain a 
reasonable sample of patients in this team, and on the overall effectiveness of the pilot-
testing. 
Experience on parallel SDM research programmes has shown that this patient population is 
particularly difficult to recruit.(181) Many of the patients are extremely emotional and 
worried about a cancer diagnosis after initial referral, and for those who are diagnosed, they 
receive surgery and follow-up treatment within two weeks, and thus they are recovering both 
physically and psychologically. The number of parallel research projects taking place at the 
Breast Care Centre also impaired recruitment; this includes the ongoing MAGIC 
programme, but also other clinical and non-clinical research. The research nurses are 
sensitive to demands on the patients, especially when many of them are dealing with a cancer 
diagnosis, and they are keen not to over burden them with requests for research 
participation. Therefore, when recruitment was low during pilot-testing, it was a difficult task 
to ask the research nurses to send more invitations to an already ‘over-researched’ 
population. In less emotional settings, it might be feasible to follow-up invited patients more 
closely in order to achieve a higher sample; however, it was not deemed acceptable in this 
setting. 
Additional team factors might have also impacted on the effectiveness of the pilot-testing 
more broadly, regardless of the sample size.  Whilst I can be fairly confident about the 
fidelity of the ‘Your Health, Your Choice’ intervention, I cannot be sure about the fidelity of 
the broader SDM approach that is used at the Breast Care Centre. Most of the clinical team 
received SDM skills training as part of the MAGIC programme. However, some clinicians 
(mainly consultants / surgeons) were unable to attend this session, and new team members 
who have been recruited since the last training session in 2013 will not have received this 
training. Therefore, it is likely that some of the patients were not seen by a clinician who had 
received SDM skills training, or worse, they were seen by a clinician who was not receptive 
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to the SDM approach. As we have seen from the pilot-testing, follow-up from a clinician 
who outwardly supports and encourages patient involvement is important. Work by Lloyd et 
al(35) has shown just how difficult it is to engage some clinicians, and the challenge of 
‘building coherence’, or a shared understanding of the SDM approach amongst different 
team members. Some clinicians are outwardly against the approach (e.g. seeing their role as 
decision maker to ‘protect’ their patients), and some clinicians cannot see how SDM differs 
to their current care (e.g. ‘we do this already’).  The SDM skills workshops were key in 
building coherence and shared values about SDM amongst team members, and this is the 
first step in embedding new interventions into routine clinical care.(202) If some team 
members did not attend the SDM workshops, it is likely that they view SDM differently 
from their colleagues who did attend, and who have been involved in the SDM 
implementation programme from inception.  
The importance of a local clinical champion leading change was a key learning point from 
the first phase of the MAGIC implementation programme;(33) a factor that has been 
identified as important to success across other improvement programmes(211) Throughout 
the MAGIC implementation programme, the project was driven by a motivated clinical 
nurse specialist. This person was the key contact with the research team, they played a 
significant role in engaging other clinical team members in the work, and they took 
responsibility for the overseeing the development, testing, and delivery of the different SDM 
initiatives (e.g. making sure that all clinicians used the Option Grid). This same clinical nurse 
specialist also agreed to act as lead for the pilot-testing phase of the thesis, and I worked 
closely with her to develop the protocol. However, this nurse has since retired from her role, 
and her leave coincided with the recruitment of patients for the pilot-testing. Subsequently, 
this led to some implementation process issues that could not have been foreseen during the 
planning phase. After the pilot-testing protocol had been developed, and the booklet / 
recruitment documents had been sent to patients in the post, it transpired that the Breast 
Care Centre do not send appointment letters to patients; they telephone each patient who 
has been referred to arrange an appointment, with no confirmation letter. The disconnect 
between the telephone appointment confirmation process used by the Breast Care Centre 
and the intervention being sent via post meant that some patients did not make the link 
between the two. It is likely that this caused problems for recruitment; some of the patients 
who agreed to take part in the pilot-testing stated that they were not aware that it had 
anything to do with the Breast Care Centre, and they perceived it as a Cardiff University 
project. Feedback from Chapter 5 indicated that the booklet should be sent directly from the 
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team that patients would be seeing, as this provides ‘permission’ to take part; this seems 
especially important given patients’ views in Chapter 6 that clinicians do not want patients 
involved. Therefore, this process issue caused problems for recruitment, and it might also 
impact on the effectiveness of the booklet.   
 
As discussed above, an engaged team that is routinely using SDM interventions was deemed 
important for the successful implementation of the ‘Your Health, Your Choice’ intervention. 
There are clear benefits to using such a team, and it is important to the success of the patient 
activation intervention, but it does also present problems. I have begun to witness ‘research 
fatigue’ in this team, with some team members disengaging from the broader SDM work. 
They have worked closely with researchers for five years, developing and testing SDM 
interventions. This team has also undergone some level of cultural change regarding their 
approach to patient decision-making, and to some extent, they have embedded SDM 
interventions into their routine clinical practice. Sustainability and maintaining motivation in 
implementation teams is a key challenge, and this was not facilitated by the departure of the 
key clinical champion for this work. Also, it might be the case that the clinicians perceive 
that they are already delivering a SDM approach, and there is little need for any further 
interventions. Their patients receive a decision support tool (when relevant), most of the 
team have received SDM training, and routine data collection has shown an improvement in 
patients’ knowledge about their treatment options over time. In terms of building coherence 
about the SDM approach,(35, 202) we might have reached a point where these clinicians 
again view that they ‘do this already’, and they do not perceive any value in further 
interventions. Clearer attempts should have been made to highlight the key patient-reported 
barriers to SDM, and to explain that their efforts as clinicians alone are not sufficient to 
actively engage most patients in a SDM dialogue. Fundamentally, further attempts should 
have been made to explain how all of the different parts of the ‘SDM intervention bundle’ 
might work together to achieve better results and greater patient engagement.  
Overall, the sample limitation should be carefully considered when discussing the 
applicability and generalisabilty of the results in Chapter 6. This thesis has developed a 
theoretically sound intervention, and provided preliminary results about the potential 
effectiveness and feasibility of the intervention; but, further pilot-testing and a follow-up trial 
are essential to address some of the weaknesses identified above. Suggestions for further 
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research are presented in Chapter 7, but in short, further pilot-testing with a larger group of 
patients will establish if the pilot-testing patients’ attitudes towards the intervention are 
representative of a larger patient group i.e. believing that it is part of the patient’s role to take 
part in SDM, but also believing that clinicians do not want patients involved in SDM. Pilot-
testing in other clinical areas with different patients compositions would give a better 
indication of how the intervention might work in other settings. Future testing of this 
intervention will also need to ensure fidelity of what the clinicians are delivering to patients, 
or the broader SDM approach; a controlled trial setting with a parallel process evaluation can 
support this. A controlled trial would also allow me to determine if clinicians with SDM 
skills, who might also use decision support tools, is sufficient to encourage SDM among 
patients, or if the ‘Your Health, Your Choice’ intervention is a necessary (additional) 
component that would result in greater benefits (this is discussed further in Chapter 7).  
8.5 Conclusion 
The work in this thesis has highlighted the significance of patient-reported barriers in the 
development and implementation of SDM interventions. Preparing patients for SDM is an 
important part of making sure that it becomes embedded into routine clinical practice. 
However, one of the biggest challenges will be to change patients’ perceptions that clinicians 
do not want them to become more involved in their healthcare decisions. Implementation 
researchers are not only dealing with behaviour and attitudinal change at an individual 
patient level; they are faced with the considerable task of changing cultural norms amongst 
patients, clinicians and organisations. Therefore, preparation followed by enablement in a 
receptive organisation is essential. Fundamentally, we must be careful not to activate patients 
so that they perceive themselves as ‘the patient from hell’ for wanting to take part in their 
healthcare decisions. Unfortunately, researchers are tasked with embedding patient and 
clinician-targeted SDM interventions in a healthcare culture characterised by scarcity and 
time pressures, and patients seem to be acutely aware to this: patients might supress their 
desire to be informed and involved as it could be a recipe for conflict and burnout. We need 
to reassure patients and public that their input is encouraged, valued, and feasible, but 
organisational culture might be one of the biggest barriers to reassuring patients that SDM 
can be a reality.    
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Appendix 2.2 – Patient Education and Counseling publication 
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Appendix 2.3 – BMJ publication 
 
 
 
 
 
 
 
 
 
 
 283 
 
 
 
 
 
 
 
 
 
 
 
 284 
 
 
 
 
 
 
 
 
 
 285 
Appendix 4.2  
Prototype version of the ‘Your Health, Your Choice Booklet’  
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Appendix 5.4 – List of design, format and content changes to the ‘Your Health, Your Choice’ booklet 
Category Issue identified Page Section Participant(s) quote(s) Change(s) made 
Terminology Patients may not understand 
the term interact used in the 
quote ‘we want to get the 
message out there that it’s 
okay to interact differently 
with healthcare workers…’ 
3 Let’s work 
together… 
‘How’d you mean interact? I’m just being devil’s 
advocate here…do people know what interact means?’ 
[P1] 
Term interact removed. Replaced 
with sentence: ‘We want to get the 
message out there that it’s okay to 
change the way we talk with 
healthcare workers…we can work 
together with them as part of a 
team’ 
 Patients may not know who 
healthcare workers are. This 
term needs to be more 
clearly defined or a different 
term used. 
Throughout Throughout ‘Healthcare workers, like again, is that nurses, 
doctors?...maybe say something like ‘your nurses, 
doctors and consultants are healthcare workers, 
because they would think that somebody in green 
[uniform] was their healthcare worker…so maybe…a 
little example of who your healthcare worker is.’ [P1] 
The following text has been added 
to page 3 of the booklet to clarify 
the term healthcare workers 
‘Healthcare workers include 
doctors, nurses, consultants, 
surgeons, dentists, midwives, 
physiotherapists…basically anyone 
who is involved in your care’ 
 Some of the terms used are 
not user-friendly and some 
patients might not know 
what they mean e.g. ‘pros 
and cons’, ‘options’, 
‘outcomes’, ‘watchful 
waiting’. Consider using 
alternative terminology.  
 
Throughout Throughout ‘Umm, no this is what I wasn’t happy with, we will tell 
you what your options are and what they involve, we 
will describe the likely outcomes, including the pros 
and cons, I didn’t like that…maybe you need to think 
of some other way of asking that…umm, negative and 
positives I suppose…I didn’t feel it [pros and cons] 
was user friendly at all’. [P1] 
 
‘Although I’m not an expert in terms of literacy levels, 
it was just occasionally I was reading it and though oh 
The term ‘pros and cons’ has been 
changed to ‘positive and negative 
outcomes’, throughout the booklet. 
 
The term ‘option(s)’ has been 
changed to ‘choice(s)’, throughout 
the booklet. 
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outcomes, pros, cons, options, watchful waiting, still 
sounded a bit medical…we’ve used choice, so it could 
be choices, and was I told what might happen or what 
the effects might be’ [C1] 
 
 
 In the checklist, the item 
‘was I told how likely they 
are?’ needs to make 
reference to outcomes so it 
is clear what the item relates 
to.  
8 Your 
appointment 
checklist 
‘I was just thinking…was I told the possible 
outcomes?...so tick yes, was I told how likely they 
are…how likely are the outcomes?...I’m just thinking 
that could be worded differently, but I’m just not sure 
how at this stage…’ [P1] 
 
‘You know the only one I was a bit confused about 
was, it might be obvious when you read it, but it could 
be a bit more explicit…the third box, was I told the 
possible outcomes?, and then there’s was I told how 
likely they are?, maybe you could say was I told how 
likely the possible outcomes are?...’ [P6] 
Checklist item has been changed to 
include reference to outcomes: 
‘Have I been told how likely these 
outcomes are?’ 
 Some participants felt that 
the term ‘like you’ used for 
the percentages was too 
familiar and personalised; 
indicated that every patient 
is the same with the same 
condition etc.  
2 Statistics ‘it’s just implying that everyone’s like you, everyone’s 
got your same condition, everyone’s got your same 
issues…it just has to be when we asked 100 other 
people’ [P9] 
Removed ‘like you’ from the 
sentence on page 2.  
 Remove the word ‘next’ 
from the statement ‘please 
read me before your next 
healthcare appointment’.  
1 Front Cover ‘…perhaps it should say please read me before your 
healthcare appointment not next…’ [C4] 
Removed the term ‘next’, from the 
sentence on Page 1.  
 The term ‘clinic’ on the 
right hand side of the front 
page looks like ‘nic’ – 
consider removing (see 
comment below of 
1 Front Cover ‘…her head there obviously covers the word ‘clinic’ so 
all you get left with it ‘nic’…rather than just have her 
head partially covering some of the sign, do we need to 
have a sign on both sides?’ [C6] 
The term ‘clinic’ has been removed 
(see below for further changes) 
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alternative term suggestion) 
 By using the term ‘clinic’ on 
the front cover, some 
patients might think that 
there are only choices at a 
clinic. It doesn’t refer to 
hospitals, GP surgeries etc. 
(other secondary, primary, 
community settings) 
1 Front Cover ‘…you know, are we only saying that there are choices 
available at a clinic?...I don’t know if this is aimed at 
more primary care, or whether it’s something that we 
should be incorporating in secondary care, community 
setting, perhaps just not narrowing it down at all’ [C6] 
One building has been changed to 
‘hospital’ and the other building has 
been changed to ‘surgery’ (to 
represent primary and secondary 
care. 
General 
Design  
(colour 
scheme, font 
style, font 
size) 
The use of the colour red for 
the leaflet held by the 
clinician on the front of the 
booklet might be perceived 
as negative e.g. danger, bad. 
Also the use of green and 
red for the different clinics 
might indicate good and bad 
clinics / decisions.  
1 Front Cover ‘It’s got a red card like being sent off though…well, it 
is, when you use colours, like green’s good for clinic, 
but red’s bad clinic there isn’t it, so do you want to go 
to the good clinic or the bad clinic? ‘ [P9] 
 
‘I mean the red, well it looks like, it does look like he’s 
holding a red card, which I suppose…in sporting you 
know, she’s come to ask a question and he’s sent her 
off [laughs]’ [C6] 
 
The leaflet colour has been changed 
to green. 
 
The buildings have been changed to 
green.  
 Some of the letters may be 
difficult for people with 
visual impairments to 
interpret e.g. the ‘g’ in the 
body of the text. Change 
these to basic san-serif font 
types 
Throughout Throughout ‘…see the g’s there, you know they’re not…they’re 
fancy, and I think people with visual impairments 
…see the g…it’s not clear, there’s a word for it but I 
can’t think’ [C4] 
The main body font has been 
changed to a basic sans serif font.  
 Patients might perceive that 
‘health’ is more significant 
than ‘choice’ due to the font 
sizes in the title. Consider 
changing these around? 
1 Front Cover ‘maybe if anything your choice is, if I was going to do 
anything I would reverse it, maybe just balancing out 
the size so it’s, it’s more equal’ [C6] 
Colour emphasis has changed to 
make ‘your choice’ more prominent 
than previously. 
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 The ‘please read me before 
your next healthcare 
appointment’ call out could 
be made more prominent. 
Some patients’ focused on 
the red call-out below. 
1 Front Cover ‘Mind you I’ve looked through this now several times 
as you can tell, and that’s the first time I’ve seen that’ 
[C7] 
The ‘please read me before your 
[next] healthcare appointment’ call 
out has been made more prominent. 
Character 
design 
Some participants felt there 
could be a better mix of 
patient & clinician 
characters in the booklet. All 
clinicians appear to be 
young, and most patients are 
older.  
Throughout Throughout ‘All the patients appear to be old as well…’ [P9] 
 
‘Yeah I suppose there is a bit more older people…it 
would seem that the professionals look younger’[P10] 
The clinician on page 5 (‘Doctor 
knows best, what do I know?’ 
section) has been changed to an 
older male character.  
 Some patients wondered 
about the relevance of the 
background images on page 
3 e.g. coffee cup, apple. This 
might distract patients / they 
might misinterpret their 
meaning. 
3 Let’s work 
together 
‘the apple, is it an apple a day keeps the doctor away, 
is that what I means…do they really need to be there?’ 
[C6] 
 
‘Is that a coffee cup? Why is there a coffee cup on 
there?... Oh yeah, it says about coffee, that’s why’ 
[P10] 
These background images have 
been removed from page 3.  
Format, 
Layout, & 
Specific 
Design 
Elements 
Some participants felt that 
the notepad could be larger 
to provide more space for 
questions and / or more clear 
guidance on how to use the 
notepad e.g. what it is for, 
when, what types of 
questions, example 
questions, prompts to 
consider what’s important to 
me. 
7 What can help 
me get more 
involved? 
‘Yeah, I thought that was helpful, but it’s not a great 
amount of space, I would have saved that for the 
appointment, but would have liked perhaps a little bit 
more space to write down…it says you can ask 
questions, and yes I could have written them there, but 
then if I’d used that space, I wouldn’t have had any 
room to write anything at the appointment maybe, so 
maybe just a little more room…[and] maybe like a 
little notepad above saying questions I want to ask, and 
then they’re all on the same page then, you can write 
down your answers as well…’ [P6] 
 
‘…if there was any fault at all, I would have liked 
another notepad to write questions prior to the 
The notepad on page 7 is larger, 
allowing more space for writing.  
 
Clearer guidance has been provided 
to patients about how to use the 
notepad i.e. to write down questions 
before the appointment, and to write 
down how they feel about the 
choices offered: 
 
‘If you have an appointment, you 
probably have lots of questions you 
would like to ask, but it can 
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appointment, on top of the one, then I could write my 
answers…’ [P6] 
 
‘…the one inside, which is free for you [to write], I 
don’t really know what sort of questions you want to 
ask there…’ [P9] 
 
‘What did I think of the options, and I’m just 
wondering if there’s scope for encouraging people to 
think more about this, what’s important to me end of 
it…if one of the key things around choosing the right 
option is around knowing what’s important’ [C1] 
 
‘…yeah you know, maybe giving again, giving some 
suggestions about the type of questions that you might 
want to ask, just examples again…because there’s a 
chance then that you lead people into narrowing down 
the questions, when in reality you want them to ask 
whatever they want to ask’ [C6] 
 
‘You’ve got some prompts you know – ask us about 
what your options are, and tell us what’s important to 
you, but you might, if you’re going to make some 
more space, perhaps you need some more prompts 
about what they need, the sot of things, the sort of 
questions they can ask, and how they can frame that…’ 
[C7] 
 
sometimes be difficult to remember 
them – use this notepad to write 
down your questions before your 
appointment… If you have choices, 
you can use the notepad to write 
down what you think about them – 
what do they mean to you 
personally?’ 
Some examples of questions and 
things that might be important to 
patients have also been included as 
prompts: 
 
‘e.g. What are my choices? What 
will they involve? Will I have to 
take time off work?... e.g. I am a 
full-time carer, a hospital stay 
would be difficult for me’ 
 
 
 The checklist might be more 
useful if framed as a 
preparation tool for use 
before the appointment, and 
possibly during. Due to 
8 Checklist ‘…so whilst there could be a checklist, you’ve almost, 
you’ve missed the boat to some degree, because if the 
answer to them is no…you’ve missed the opportunity 
really, because the consultation is gone, so whilst in 
theory yes, okay well I didn’t get the answers so I’d 
The guidance for using the checklist 
has been changed to preparation for 
the appointment (rather than solely 
as a post-hoc tool). For example, it 
now encourages patients to think 
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structure of appointments, it 
might not be useful to 
complete the checklist after 
an appointment e.g. unlikely 
to see that same consultant 
for some time afterwards. 
Also prompt patients to ask 
if the clinician has not 
answered their questions or 
covered any of the checklist 
items. Consider splitting the 
checklist into two parts – 
one part for appointment 
preparation and one part for 
during the appointment. 
like to ring up and make another appointment, the 
reality is it doesn’t work like that and it could be 
months before you get to see the same person 
again…so maybe the checklist, maybe the questions 
could be in preparation for a consultation’ [C6] 
 
‘…so have I done this? Have I done that? Have I got 
my questions listed down?’ [C6] 
about these questions during their 
upcoming appointment.  
 
‘It is really important that you are 
involved in decisions about your 
healthcare. If you are told you 
have choices in your next 
appointment, make sure that the 
items in the checklist are 
covered…’  
 
 
 Possibility of having a tear-
off (perforated) page for the 
notepad and checklist 
7/8 Checklist / 
Notepad 
‘…you know that page could be kept, ripped off and 
kept, so you’d obviously want your notepads on a 
separate page…then the checklist could be kept by the 
surgery…[as a research tool collecting data]’ [P6] 
 
‘Oh, that would be good actually, ‘cause the checklist 
are on both sides…It’s almost like an appointment 
control sheet’ [P9] 
 
‘Yeah definitely, ‘cause that’s the little bit you can 
take then…’ [P10] 
 
The booklet will be printed with a 
tear-off perforated back page, and a 
prompt to tear off and take to 
appointment will be included.  
 The checklist and notepad 
would benefit from a prompt 
to bring to the next 
appointment 
7 Notepad / 
Checklist 
‘Does it say bring it with you? I can’t remember 
now…particularly with that bit [points to 
notepad]…the checklist, yeah’ [C1] 
 
 
A prompt has been added to the 
notepad page to bring to the next 
appointment: 
 
‘Bring me to your next 
appointment’ (in a call out) 
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 The checklist could benefit 
from an additional item e.g. 
‘was I told what would 
happen next’. Currently, the 
booklet does not cover this 
or prompt patients to make 
sure that they know.  
8 Checklist ‘…there’s an issue about what happens next…if 
there’s room, another checklist issue is was I told what 
would happen next? or do I understand what’s going to 
happen next? ‘Cause then it leads into what does 
happen next…and do I get the chance to revisit…is 
this the final chance. I think that would then just lead 
into a process, or a flow, rather than a single event’ 
[C1] 
The following has been added to the 
checklist on page 8: 
 
‘Have I been told what will happen 
next?’ 
 The arrows on the ‘What 
will I have to do?’ flowchart 
might be misleading. Some 
patients read the content 
from left to right, rather than 
downwards in the columns.  
6 What will I have 
to do? 
‘but I didn’t really know how to read the end bit by 
here, do I read all of them at once, then all of them, 
then all of them, or do I work my way across each one? 
I don’t know which way to go…’cause obviously I was 
reading it that way, where the arrows told me to go’ 
[P9] 
Arrows removed from the flowchart 
on page 6 
 Some participants felt that 
the statistics on the bottom 
of page 2 could benefit from 
a prompt e.g. ‘what do you 
think?’ This would make it 
more relevant and useful to 
the person reading it. 
2 This leaflet 
explains… 
(percentages 
section) 
‘…the bit at the bottom with the percentages, which is 
fine, but I just wondered, it just sort of stopped there, 
you know in terms of…well should there be something 
there that says what do you think?  Even if it’s a when 
we asked 100 other people…what do you think…or we 
will now explain what getting involved really means, or 
something like that’ [C1] 
The following prompt has been 
added to the bottom of page 2, to 
accompany the statistics:  
 
‘most people would rather share a 
decision - what do you think?’  
 It could be made clearer 
who the booklet is from e.g. 
the local health board. 
Consider moving the logo to 
the front of the booklet. 
Might also benefit from a 
broader organisation logo 
e.g. NHS Wales 
1  Front cover ‘…if it’s under public health, it should be up there, I 
think it’s on the back, well Cardiff University, but I 
think it’s public health information…so maybe, 
[people] will think well I can use that in my hospital’ 
[C4] 
 
‘The one thing I note is that you’ve got the NHS Wales 
[logo] which is obviously quite an identifiable logo on 
the back, um, and I just wondered whether that would 
be better on the front so that people would identify that 
The Cardiff & Vale University 
Health Board logo has been 
included on the front page of the 
booklet (in addition to the Cardiff 
University logo on page 8) 
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this is information relevant to the NHS, rather than a 
booklet about something else in an NHS setting’ [C6] 
 The booklet would benefit 
from examples of the types 
of decision that might be 
made in healthcare, at a 
general / broad level (e.g. 
surgery may be an option for 
you, or you may be offered 
different types of tablet) 
This would complement the 
examples of decisions that 
people make in everyday life 
(i.e. holiday, lunch).  
3 Let’s work 
together 
‘I think the key message that I get is that it’s an 
encouraging leaflet to want you to ask questions, or to 
have choice…I think it could go a little further to 
explain what perhaps those choices could be e.g. 
maybe if surgery is being considered….what we’re 
saying is explore all the options, and give them some 
scenarios’ [C6] 
Some examples of healthcare 
choices have been provided on page 
3 of the booklet:  
 
‘Some examples of healthcare 
choices 
 Surgery or physiotherapy to 
manage your condition 
 Different types of tablets for 
your illness 
 Hospital or home birth for 
your baby’ 
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Appendix 5.5  
Pilot-testing version of the ‘Your Health, Your Choice’ booklet’  
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